t i
t h
i n
a n
r e
e n
e r
e d</w>
o f</w>
th e</w>
o n
o n</w>
r o
an d</w>
a ti
i n</w>
a t
i t
a l</w>
a r
o r
- @</w>
@ -@</w>
s t
a l
e s</w>
s i
d i
a s
a c
e c
e l
i c
in g</w>
e r</w>
t o</w>
o r</w>
o m
u l
o l
u r
ati on</w>
a s</w>
t s</w>
e s
re s
p ro
o s
en t</w>
t r
d e
u n
T h
it h</w>
w ith</w>
i s</w>
v e</w>
l y</w>
c on
a t</w>
p l
ti on</w>
a p
a n</w>
c h
a m
i l
i m
u c
er e</w>
e m
i s
t er
a g
e x
e n</w>
i d
u s
at ed</w>
f or</w>
p h
a b
i c</w>
o c
w as</w>
c om
f f
Th e</w>
e t
it y</w>
p er
o u
w ere</w>
c e</w>
on s</w>
e v
en ts</w>
c l
o g
o t
s u
i g
q u
o p
a d
at e</w>
th at</w>
b y</w>
m e
p ati
o w
st r
a r</w>
l e</w>
v i
as e</w>
i f
w h
re n
u m
p res
t ed</w>
si s</w>
u d
d uc
s e
in e</w>
n e
ar e</w>
l e
re d</w>
s p
ti n
c el
si on</w>
t e
ic al</w>
re c
h a
f or
pati ents</w>
m o
i b
ro m</w>
ac ti
f rom</w>
n o
g en
c o
m ent</w>
ti c</w>
l o
s h
p a
e p
an t</w>
i r
ur e</w>
p o
m a
s y
p re
v er
0 .
p ar
u t
e en</w>
g n
th e
e ff
ro u
b e</w>
as s
en ce</w>
ti ve</w>
i z
r a
en t
p or
ati ons</w>
u s</w>
h e
r i
ti c
ig h
c re
m on
re l
en ti
v el
al ly</w>
si gn
t er</w>
t re
ti m
u m</w>
ol og
h y
t ro
o b
l s</w>
ar y</w>
ag e</w>
on al</w>
s c
for m
b et
ul ar</w>
tin g</w>
th er</w>
a in
sp ec
in f
en d
s er
an g
if ic
ou s</w>
l i
di c
di ff
i d</w>
tr an
d er
st ud
as ed</w>
res p
eff ec
e ren
th is</w>
on e</w>
t h</w>
es e</w>
e ar
f ac
an c
o d</w>
I n</w>
al y
i al</w>
ati ve</w>
stud y</w>
es s</w>
an ce</w>
re g
c or
v ed</w>
o x
no t</w>
m or
in ter
or s</w>
p os
cel ls</w>
o d
i es</w>
s ur
th er
an t
a f
g rou
su b
m in
in cre
y p
d ing</w>
acti v
diff eren
sign ific
ab le</w>
an ti
pro te
er s</w>
ar i
ic h</w>
di s
o un
or y</w>
es s
b i
w een</w>
s e</w>
an aly
res ul
v e
al l</w>
oc i
i a</w>
bet ween</w>
st e
wh ich</w>
ha ve</w>
m ic
re s</w>
c ar
t ec
tre at
os e</w>
en c
ap os
in v
& apos
un c
us e</w>
f i
y m
in g
p r
y t
al u
l ev
ti ons</w>
as es</w>
at es</w>
l ow
i r</w>
u t</w>
th an</w>
y l
af ter</w>
cel l</w>
treat ment</w>
es t</w>
l u
duc ed</w>
us ed</w>
t u
W e</w>
a y</w>
i t</w>
resp on
ati n
ass oci
a y
en tr
lo w</w>
ul ation</w>
e st
it s</w>
el s</w>
al s</w>
com pl
m un
il ity</w>
me th
i th
tran s
b e
r an
v ari
t w
ar g
us ing</w>
ro m
d s</w>
v id
d er</w>
con tro
ur ing</w>
0. 0
pres sion</w>
o l</w>
th ese</w>
& #
c ur
i ti
&# 9
di se
ot h</w>
h ib
Th is</w>
h as</w>
b een</w>
f unc
el ec
c a
t or</w>
ou t</w>
atin g</w>
O N
u di
igh t</w>
j ec
sh ow
w e</w>
em ent</w>
s o</w>
vel y</w>
b l
cl in
b ut</w>
N A</w>
f ol
de vel
g l
b in
ther ap
st udi
cl ud
v er</w>
re e</w>
grou p</w>
r ap
mor e</w>
on g</w>
ac ter
t a
os t</w>
d ec
c ol
i p
resul ts</w>
as t</w>
ma y</w>
I n
tw o</w>
m an
t en
am in
oun d</w>
m at
str uc
1 .
w e
s t</w>
ig h</w>
activ ity</w>
prote in</w>
the ir</w>
per i
el y</w>
r u
p ol
devel op
er al</w>
h igh
ha d</w>
i st
c an</w>
at a</w>
vi r
t ;</w>
tr ac
ou r</w>
a st
s ec
og en
d uring</w>
iz ed</w>
al so</w>
olog ical</w>
mic ro
associ ated</w>
p e
b oth</w>
h igh</w>
m et
a v
con c
me di
ul d</w>
ch ang
t yp
1 0</w>
re qu
f in
c r
dise ase</w>
t ors</w>
id e</w>
es ti
analy sis</w>
in hib
m al
re por
sy n
S I
pro c
d e</w>
pa red</w>
t ain
r is
me as
g h</w>
ant ly</w>
g g
im mun
em b
w ith
e l</w>
de p
2 0
c ul
ch em
in clud
ab ility</w>
clin ical</w>
he al
om e</w>
w or
si ve</w>
ti onal</w>
h um
si st
s uc
e d
n or
R E
anc er</w>
iz ation</w>
g r
l in
su gg
d ata</w>
k e</w>
ec h
pa th
po si
o ther</w>
ear s</w>
m ul
pl e</w>
s am
ay s</w>
t om
t um
rap h
un der
f ic
ev er</w>
it e</w>
f r
n i
C L
de ter
ac h</w>
lev els</w>
incre ased</w>
tim e</w>
p ot
ex pression</w>
id enti
T S</w>
f ir
signific antly</w>
an ts</w>
e t</w>
l oc
d om
duc tion</w>
ob ser
ati c</w>
rel ated</w>
t ure</w>
effec ts</w>
s en
pres s
f ound</w>
ev alu
b le</w>
el l
in s</w>
therap y</w>
g ro
v en
signific ant</w>
M E
0 0</w>
effec t</w>
com pared</w>
di ag
d ro
dep end
e ar</w>
ent al</w>
per form
S U
studi es</w>
c ancer</w>
com p
e i
se qu
ch ar
o per
n o</w>
pl as
ti vely</w>
inf ec
s ev
m al</w>
el l</w>
ac h
il e</w>
al l
ap pro
ste m</w>
og raph
al ity</w>
&apos ;</w>
ris k</w>
p s</w>
D S</w>
u al</w>
ow ever</w>
m s</w>
differen t</w>
hum an</w>
su p
meas u
in dic
t o
l t;</w>
& lt;</w>
qu ot
show ed</w>
& quot
&quot ;</w>
y ears</w>
il l
esti g
&apos ;
r ate</w>
vi e
sur g
b ased</w>
contro l</w>
in duced</w>
s es</w>
ou t
m a</w>
A l
olog y</w>
sh o
mo d
e re
por t
ti s
C ON
inv estig
ac tion</w>
an is
at er</w>
a ff
ti es</w>
conc entr
T H
pati ent</w>
U SI
f e
CL USI
k ing</w>
u ro
CON CLUSI
h o
m ost</w>
enti al</w>
pl ic
fi ed</w>
on ic</w>
om a</w>
&apos; s</w>
v al
in to</w>
k s</w>
id ence</w>
k n
2 .
f u
c es</w>
m il
SU L
m ar
a in</w>
form ation</w>
RE SUL
ac c
o ph
b lo
RESUL TS</w>
de tec
if ic</w>
it ed</w>
c y
c h</w>
u e</w>
dec re
cl e</w>
enc y</w>
Th ese</w>
y n
ra di
rec ep
pres ent</w>
A C
ut e</w>
b o
c yt
os ph
tic al</w>
ur al</w>
pro vid
vi v
c al
w ell</w>
s ol
g re
m ech
d es
char acter
ol ec
tr a
e g
e tic</w>
c ases</w>
grou ps</w>
u tion</w>
ch il
func tion</w>
um b
im pro
gen e</w>
k in
spec ific</w>
T I
high er</w>
oc yt
si ons</w>
TH O
on ly</w>
resp ec
o ver
ME THO
de l</w>
con tr
1 9
uc le
v alu
respon se</w>
an s</w>
1 ;</w>
&#9 1;</w>
en z
blo od</w>
typ e</w>
m ents</w>
obser ved</w>
f l
tis su
a il
3 ;</w>
&#9 3;</w>
ec ted</w>
y si
ti v
gro w
ro s
th ree</w>
ing s</w>
com m
s ti
gen er
hy dro
l if
reg i
u p
er g
at ory</w>
m p
f lu
im port
en g
mo del</w>
y l</w>
de mon
demon str
a d</w>
fol low
v ing</w>
D NA</w>
nor mal</w>
p op
i um</w>
METHO DS</w>
d ru
suc h</w>
sy stem</w>
wh o</w>
a th
on g
s o
at ure</w>
ot al</w>
1 2</w>
in c
heal th</w>
u p</w>
ro le</w>
h ist
N D</w>
tec h
s tim
ren t</w>
fac tors</w>
an d
par tic
tic s</w>
depend ent</w>
wh en</w>
b r
c are</w>
n on</w>
ph osph
C h
ac id</w>
5 0</w>
hy per
mul ti
f ib
H owever</w>
th rou
m ut
m y
e th
v as
com bin
o ver</w>
I I</w>
chil d
fir st</w>
z ed</w>
y s
ic i
kn ow
pr im
at s</w>
ent ly</w>
con di
ac t</w>
ex amin
d el
pro g
th ose</w>
it r
tre ated</w>
in al</w>
inv ol
for e</w>
chang es</w>
m olec
tain ed</w>
ph ysi
2 0</w>
pro duc
ass ess
n umb
mech anis
R NA</w>
con t
ar d</w>
s ul
lev el</w>
di vid
po st
g en</w>
3 .
R O
t y</w>
as s</w>
t otal</w>
m is
er y</w>
incre ase</w>
re n</w>
or t</w>
per im
it al</w>
ab l
no sis</w>
T o</w>
m emb
r ang
cl u
st em
od y</w>
si ble</w>
ad di
c ular</w>
m us
re vie
l arg
l ess</w>
deter min
x im
ab ol
ati onal</w>
respec tively</w>
or g
o re
car di
meth od</w>
develop ment</w>
tr i
l im
u res</w>
o sis</w>
ep ti
pre dic
f er
co un
grow th</w>
ag es</w>
is h
th s</w>
ne w</w>
ter n
b ody</w>
tum or</w>
p er</w>
perform ed</w>
a re
ne uro
ic ally</w>
m ac
od s</w>
acti ve</w>
am ong</w>
a i
pl ac
out com
me dic
9 5</w>
os p
co uld</w>
E C
pot ential</w>
w om
O N</w>
child ren</w>
t em
s elec
f requ
sen si
cr ib
di rec
sub jec
fac tor</w>
p at
en ted</w>
i v
y ing</w>
ma in
m i
al ph
0 1</w>
l am
low er</w>
i ed</w>
me an</w>
ph en
an e
c ap
k ed</w>
d ed</w>
ter s</w>
f t</w>
s ity</w>
con si
numb er</w>
1 5</w>
ri p
o us
with in</w>
si mil
c in
import ant</w>
C on
m g</w>
repor ted</w>
c ase</w>
ex perim
sy stem
reg ul
h em
throu gh</w>
th ou
recep tor</w>
includ ing</w>
b re
res s</w>
d ings</w>
ad e</w>
ear ly</w>
om e
bi o
u r</w>
id s</w>
is ol
b ra
bin ding</w>
di sc
iti es</w>
n on
rel ati
y c
4 .
am ine</w>
te st
we e
ti l
re ve
ex pos
n ucle
ograph y</w>
wom en</w>
v ol
n ec
p ec
e x</w>
with out</w>
ON S</w>
s ed</w>
posi tive</w>
y ear</w>
A n
3 0</w>
tissu e</w>
r ats</w>
com par
mon ths</w>
n os
I t</w>
ag ing</w>
prote ins</w>
l ym
enz ym
di d</w>
met abol
t est</w>
e ther</w>
ot yp
u b
ol d</w>
A T
mic e</w>
identi fied</w>
ti on
ap p
col l
a si
v es</w>
d ays</w>
ni qu
m it
t ly</w>
des crib
fac e</w>
g o
the sis</w>
t arg
ar ter
alph a</w>
it er
ha vi
e ach</w>
ch rom
S t
d o
tiv ity</w>
i red</w>
C I</w>
wor k</w>
d ue</w>
C D
ic e</w>
th ere</w>
o id</w>
d ose</w>
in divid
e u
sugg est</w>
memb ran
ing le</w>
ch r
g u
tech niqu
ogen e
sc op
c al</w>
inhib it
bet a</w>
pl es</w>
min i
ma j
g h
diag nosis</w>
z e</w>
n ing</w>
ver y</w>
hy po
per c
CONCLUSI ONS</w>
w il
re sist
tu res</w>
oper ative</w>
c at
ti s</w>
fin dings</w>
or der</w>
s k
sy mp
vir us</w>
thou gh</w>
oc cur
et y</w>
ar di
infec tion</w>
inf lu
on d
fu l</w>
acti ons</w>
ous ly</w>
fic ation</w>
i p</w>
be havi
sur viv
al e</w>
5 .
pres ence</w>
or al</w>
ur ther</w>
is e</w>
dru g</w>
a x
l l
in iti
C om
bra in</w>
b ec
ser um</w>
f il
m ot
ad ul
it es</w>
vas cular</w>
prim ary</w>
wh ile</w>
for m</w>
diag nos
a sis</w>
in t
surg ery</w>
w ay</w>
p ri
ati s
s ingle</w>
ex pl
or e</w>
re duced</w>
ox id
i l</w>
simil ar</w>
f em
l ab
1 4</w>
P ro
en h
activ ation</w>
ent ation</w>
differen ces</w>
pop ulation</w>
ex trac
s ing</w>
A s</w>
h osp
ros s</w>
al ed</w>
ad mini
know n</w>
ev idence</w>
r ati
in tr
pol y
ear ch</w>
d ay</w>
inf lam
mor ph
spec ies</w>
sup por
ob tained</w>
at ely</w>
P C
plas ma</w>
ac y</w>
l ine</w>
b acter
2 5</w>
a u
gen es</w>
6 .
pre vi
studi ed</w>
j u
f o
ab out</w>
revie w</w>
a ut
1 1</w>
f am
differen ti
l at
rec ei
stim ul
decre ased</w>
un der</w>
en e
s ome</w>
d en
is m</w>
sy ch
v is
measu red</w>
condi tions</w>
er i
ro ph
p ul
Th ere</w>
ish ed</w>
ne ur
t al</w>
K G
e qu
g s</w>
B AC
l ong</w>
m ental</w>
cl es</w>
1 6</w>
7 .
ter m</w>
symp tom
RO U
concentr ation</w>
follow ing</w>
2 4</w>
k ers</w>
BAC KG
BACKG ROU
s el
comm on</w>
j ur
p an
BACKGROU ND</w>
p ur
sho uld</w>
lym ph
am e
ar ti
li ver</w>
ec t</w>
compl et
addi tion</w>
concentr ations</w>
as si
ac ute</w>
n er
v enti
a z
m all</w>
gl uc
1 8</w>
I V</w>
d es</w>
develop ed</w>
cel l
itr o</w>
tran sc
ic s</w>
1 3</w>
repor t</w>
l ac
R es
reve aled</w>
rang e</w>
st ate</w>
peri od</w>
im pl
cor rel
chem ical</w>
a di
re duc
g e</w>
in te
on d</w>
ex c
surviv al</w>
C A
subjec ts</w>
ar t</w>
v ement</w>
b one</w>
on sh
1 0
f ul
E x
elec tr
the y</w>
ain s</w>
P A
co h
chang e</w>
ne g
an im
investig ated</w>
demonstr ated</w>
di ab
character is
d rom
ch ol
res sion</w>
elec tro
sho w</w>
c op
di str
chr onic</w>
in jur
effec tive</w>
compl ic
s mall</w>
ag ement</w>
proc ed
ven tion</w>
v itro</w>
st ress</w>
anc ed</w>
ig n
f our</w>
st er
ocyt es</w>
m ine</w>
molec ular</w>
ei ther</w>
enc es</w>
struc ture</w>
est er
includ ed</w>
pr acti
p sych
m en
ad v
res earch</w>
we ight</w>
k e
es ting</w>
a c</w>
press ure</w>
press ed</w>
membran e</w>
sam ples</w>
larg e</w>
un d</w>
CONCLUSI ON</w>
t ox
relati onsh
c er
yn am
maj or</w>
sugg est
re si
pa in</w>
4 0</w>
r ates</w>
compl ex</w>
k g</w>
examin ed</w>
func tional</w>
an y</w>
O B
car cin
sur face</w>
lo b
ol e</w>
w ater</w>
eff ici
c ir
ox y
ain st</w>
J EC
evalu ated</w>
oc c
I L</w>
M e
em ia</w>
ab s
determin ed</w>
proc ess
b ility</w>
W h
con tin
meth ods</w>
pro duction</w>
8 .
pro b
appro ach</w>
ag ainst</w>
o f
i tion</w>
der s</w>
g a
di es</w>
p u
se t</w>
par ti
O ur</w>
deter mine</w>
ph ase</w>
ren al</w>
ve l</w>
TI V
syn drom
n ess</w>
d r
ant i</w>
f urther</w>
1 00</w>
transc rip
g ra
partic ip
pro per
el d</w>
l os
es tim
OB JEC
A c
l un
qu ality</w>
vir on
po in
m in</w>
cur rent</w>
st and
us es</w>
OBJEC TIV
disc us
qu anti
be fore</w>
ap plic
s ch
ar ly</w>
distr ib
re le
valu es</w>
con duc
E R
er c
mus cle</w>
ta ke</w>
g t;</w>
& gt;</w>
in formation</w>
ver se</w>
sam e</w>
v s</w>
1 7</w>
op ath
c an
b as
r at</w>
tain ing</w>
symptom s</w>
ome tr
D i
a e</w>
gre ater</w>
ic ity</w>
si de</w>
f ree</w>
heal th
is t</w>
lif e</w>
ain ing</w>
li ke</w>
str ation</w>
h or
proc ess</w>
mo di
posi tion</w>
wh ether</w>
f ail
en ing</w>
de m
wil l</w>
o therapy</w>
a use</w>
en viron
6 0</w>
contr ib
vari ous</w>
provid e</w>
at us</w>
spec tive</w>
show n</w>
under st
el ial</w>
f y</w>
t ality</w>
neg ative</w>
in jec
ane ous</w>
as ing</w>
f oc
di st
S C
f low</w>
respon ses</w>
man agement</w>
av ail
con sist
A d
expos ure</w>
e al</w>
ell ular</w>
ex peri
im p
ta in</w>
si ze</w>
tic ally</w>
at eg
p epti
fol low</w>
surg ical</w>
olog ic</w>
comp on
ur ation</w>
detec ted</w>
ul es</w>
de fic
cyt o
rati o</w>
v al</w>
0.0 5</w>
h om
en s</w>
invol ved</w>
mechanis ms</w>
syndrom e</w>
pres ented</w>
enzym e</w>
wh ere
pos sible</w>
wee ks</w>
f eren
multi ple</w>
suc c
sev eral</w>
om ic</w>
l ong
en e</w>
no vel</w>
mor tality</w>
og ni
proper ties</w>
rec ur
ren ce</w>
tin al</w>
clu sion</w>
at or</w>
m uc
sel f</w>
o th
u k
outcom es</w>
pro tec
T w
ag ed</w>
at ures</w>
com mun
O n
im aging</w>
b il
lun g</w>
perform ance</w>
differen ce</w>
de fin
ll ed</w>
t ur
resist ance</w>
therap eu
man y</w>
de red</w>
assess ed</w>
measu re
flu o
medic al</w>
li p
t en</w>
A L
regi on</w>
car b
tom y</w>
he art</w>
s cre
n an
associ ation</w>
rec or
n al</w>
re duction</w>
at r
et es</w>
contro ls</w>
str ateg
s al
I N
con fir
los s</w>
mod els</w>
i ly</w>
S T
viv o</w>
mechanis m</w>
immun e</w>
at h</w>
l ight</w>
where as</w>
o ur
c entr
1 9</w>
org an
un d
est abl
d u
y st
en d</w>
sti tu
et al</w>
injur y</w>
par ame
al ized</w>
s ite</w>
ar mac
E n
m ed</w>
de f
le uk
I m
lif er
isol ated</w>
gr ad
h el
pre gn
pos e</w>
ad en
N e
C T</w>
o st
ec tion</w>
typ es</w>
in duc
bo dies</w>
yl ation</w>
ogene sis</w>
e p</w>
sequ ence</w>
mat ory</w>
medi ated</w>
P ati
frequ ency</w>
anc y</w>
ograph ic</w>
p ap
m ag
sev ere</w>
a ro
ang i
oc ardi
anc es</w>
ac et
2 1</w>
C O
G F</w>
in sul
tu b
pro lifer
H e
m ass</w>
y ro
at al</w>
analy zed</w>
bl oc
o ch
em ents</w>
com po
is h</w>
v entr
cy cl
res c
be ing</w>
H IV</w>
am p
A M
sensi tivity</w>
b ac
st age</w>
t ural</w>
evalu ate</w>
ran dom
tran sp
c ere
i e
val ence</w>
techniqu e</w>
us e
a ir
ass ay</w>
contin u
a ver
inhib ition</w>
mon ary</w>
em s</w>
ic es</w>
therapeu tic</w>
su s</w>
cal c
fu sion</w>
reg ulation</w>
suppor t</w>
iz e</w>
s mo
t end
li k
pos ed</w>
valu e</w>
contr ast</w>
are a</w>
y r
characteris tics</w>
relationsh ip</w>
iti s</w>
A n</w>
s us
dise ases</w>
der i
d ys
w a
fam ily</w>
ti n</w>
gen etic</w>
tem per
i an</w>
in ten
i on</w>
vi a</w>
vol um
ag on
Al l</w>
0.0 0
ogen ic</w>
al ization</w>
a m</w>
cl assi
gr am
9 .
pe a
ic ular</w>
sec re
ter min
an n
inflam matory</w>
et er</w>
le ft</w>
w ays</w>
ph ot
hosp ital</w>
gluc ose</w>
parame ters</w>
st atis
decre ase</w>
individ u
8 0</w>
S A</w>
le sions</w>
outcom e</w>
con struc
M S</w>
ec ts</w>
combin ation</w>
met ast
detec tion</w>
Al though</w>
pu bl
de x</w>
al ing</w>
o t</w>
d os
ain ed</w>
erg y</w>
ser v
health y</w>
in ary</w>
ma in</w>
mis sion</w>
re action</w>
ex p
bre ast</w>
inc idence</w>
ic h
oc ial</w>
A I
l og
admini stration</w>
ic ul
pos t</w>
P re
pro f
is on</w>
con taining</w>
cell ular</w>
0.0 01</w>
e ding</w>
me tr
es c
s af
fi ve</w>
U n
trans pl
ist s</w>
A D
indic ate</w>
mal e</w>
system s</w>
re tro
R e
st atus</w>
ca used</w>
ab il
l as
th rom
k er</w>
h owever</w>
ad ing</w>
vi ties</w>
requ ired</w>
it ation</w>
e ph
describ ed</w>
ic acy</w>
ab ly</w>
deri ved</w>
he pati
cardi ac</w>
b ene
ten sion</w>
rele ase</w>
consi dered</w>
ac cur
an ding</w>
ca use</w>
distrib ution</w>
or ig
s ites</w>
n it
test ed</w>
i di
evalu ation</w>
l ig
si m
follow ed</w>
inte gr
or ders</w>
g e
tum ors</w>
per s
op tim
s y</w>
si g
recep tors</w>
or ing</w>
previ ously</w>
o di
high ly</w>
ag g
avail able</w>
the si
spec ific
os om
sec ond</w>
st s</w>
M R
anim als</w>
syn thesis</w>
A f
pro mot
otyp e</w>
ul ts</w>
R ec
carcin oma</w>
ph armac
dis tin
en s
resul t</w>
s oci
A B
9 0</w>
F or</w>
targ et</w>
20 0
I C
i ev
l iter
scop y</w>
in es</w>
identi fy</w>
conduc ted</w>
H ere</w>
th ro
pro duced</w>
correl ation</w>
immun o
A ND</w>
investig ate</w>
insul in</w>
e ts</w>
m RNA</w>
OBJECTIV E</w>
direc t</w>
on ary</w>
el ev
complic ations</w>
if ied</w>
p tion</w>
Pati ents</w>
kin ase</w>
ex hib
l es</w>
ai m</w>
O R</w>
recei ved</w>
experim ental</w>
amin o</w>
ap pl
in ation</w>
bec ause</w>
ra m</w>
del i
tin e</w>
res t</w>
defic i
ul e</w>
Af ter</w>
ma xim
m er
m l</w>
C a
o ste
ass ess</w>
influ ence</w>
dru gs</w>
ex pressed</w>
b ro
o s</w>
all eng
ot ox
P O
co ur
2 2</w>
atr ic</w>
ep ith
imp act</w>
fe atures</w>
gl yc
eff icacy</w>
C R
mat er
anti bodies</w>
op to
de ath</w>
impro ved</w>
diab etes</w>
bet ter</w>
gen eral</w>
assess ment</w>
E ff
r h
tran si
n at
ri al</w>
el ine</w>
u ted</w>
stand ard</w>
t oc
car ri
y s</w>
d ynam
aly sis</w>
stim ulation</w>
ho w</w>
A s
int es
i f</w>
con f
he ter
su ff
pre valence</w>
adul t</w>
in trac
s in
individu als</w>
on es</w>
at ten
c ri
iv en</w>
d am
hydro x
ocyt e</w>
volum e</w>
mon it
d ow
Res ults</w>
str ic
u re
aff ected</w>
m m</w>
fail ure</w>
hor mon
gener ation</w>
path way</w>
ch alleng
le d
7 0</w>
i ally</w>
the tic</w>
fi eld</w>
un i
ap opto
sk in</w>
lik ely</w>
h al
I g
h er
l eng
tim es</w>
k en</w>
im pa
ro sis</w>
e y
si onal</w>
pl o
S E</w>
o ff
H C
sub st
t le</w>
ati n</w>
arter y</w>
ol ic</w>
pol ym
acti vities</w>
physi cal</w>
sam ple</w>
sur ve
ant ation</w>
fr ac
ol y
g am
inv a
cont ent</w>
un ds</w>
anti body</w>
1 ,
ul ations</w>
th en</w>
A R
at ors</w>
liter ature</w>
A r
h ep
u til
incre asing</w>
id ity</w>
a im
par t</w>
tissu es</w>
in dependent</w>
D E
pat tern
sensi tive</w>
over all</w>
si mul
fluo resc
w o
indic ated</w>
1 2
trans f
r ing</w>
pul monary</w>
en ergy</w>
ox ide</w>
A P
dis orders</w>
r y
pl at
c ross</w>
b el
pl ay</w>
ev en</w>
rel ative</w>
feren ce</w>
radi ation</w>
individ ual</w>
s l
m en</w>
ad ju
inter action</w>
dom in
inter vention</w>
analy ses</w>
o m</w>
v acc
si x</w>
in dex</w>
ol s</w>
wh ere</w>
neur ons</w>
w ent</w>
o p</w>
y oun
ol ution</w>
1 3
t ation</w>
fem ale</w>
cor related</w>
cal cul
temper ature</w>
of ten</w>
u sion</w>
mal ign
mo use</w>
ter n</w>
sequ ences</w>
den sity</w>
tu red</w>
ne ed</w>
is ed</w>
sig n</w>
led ge</w>
or b
contro lled</w>
character ized</w>
le ast</w>
m ade</w>
proced ure</w>
vir al</w>
complet e</w>
o red</w>
br al</w>
at eral</w>
impro ve</w>
under went</w>
sc ore</w>
o tic</w>
b ri
appro xim
l y
19 9
ver sus</w>
i sion</w>
R N
N o</w>
so ur
i de
iz ing</w>
aver age</w>
particip ants</w>
pat tern</w>
ud e</w>
the re
diagnos tic</w>
am oun
o ti
poin t</w>
1 4
gh t</w>
str ains</w>
ro p
p rec
pattern s</w>
N F</w>
n et
demonstr ate</w>
se par
ke y</w>
bi ological</w>
initi al</w>
enh anced</w>
ste red</w>
cul ture</w>
B M
b or
ob jec
s co
I II</w>
P s</w>
b ur
ven ess</w>
te red</w>
ad he
enc ed</w>
techniqu es</w>
regi ons</w>
ati vely</w>
ir atory</w>
obser v
succ ess
reg ar
P h
E S</w>
occur red</w>
cor ding</w>
g iven</w>
test s</w>
m ight</w>
ag ents</w>
i .
n er</w>
appl ied</w>
phosph or
2 8</w>
om as</w>
abl es</w>
centr al</w>
combin ed</w>
cor onary</w>
S D</w>
P A</w>
an ds</w>
re mo
A t</w>
id ne
pot enti
cl os
r ight</w>
mo der
u ally</w>
adul ts</w>
end oth
ur ther
s ocial</w>
al es</w>
si l
ful ly</w>
urther more</w>
are as</w>
ond ary</w>
ev ents</w>
mi x
al low
tr ial</w>
pa ren
2 3</w>
su m
activ ated</w>
ex erc
ach iev
min im
t ol
pap er</w>
3 5</w>
inhibit or</w>
gre es</w>
leng th</w>
str y</w>
P D</w>
loc al</w>
on t
behavi or</w>
re pe
sign aling</w>
inhib ited</w>
struc tural</w>
e duc
know ledge</w>
process es</w>
th al
gu id
w ide</w>
b ir
Tw o</w>
p H</w>
5 3</w>
se en</w>
PC R</w>
ut es</w>
pepti de</w>
ay ed</w>
coll ected</w>
lim ited</w>
infec ted</w>
qu e</w>
discus sed</w>
de grees</w>
prolifer ation</w>
och ond
spec tr
lin es</w>
struc tures</w>
erg ic</w>
F urthermore</w>
anti gen</w>
ventr icular</w>
the m</w>
ex t</w>
peri ph
un it</w>
w id
s em
spec tro
practi ce</w>
7 5</w>
sign ed</w>
sh ort</w>
di men
in e
rec ent</w>
compo unds</w>
par t
wo uld</w>
compar ison</w>
ch ain</w>
ch arg
l it
G F
ne ed
resul ted</w>
use ful</w>
cor rec
go od</w>
ul tr
inter actions</w>
er ing</w>
th yro
. 0
fol d</w>
reg ression</w>
se g
c ogni
or ption</w>
D is
U sing</w>
re main
plas m
k idne
form s</w>
intes tinal</w>
tr aining</w>
s it
confir med</w>
oph ag
ut ure</w>
revie w
m el
cr iter
suggest ed</w>
tech n
P T
au th
ec tomy</w>
hist ory</w>
- -
mag ne
d uration</w>
c i
m ation</w>
s w
bacter ial</w>
incre ases</w>
defin ed</w>
tri als</w>
0.0 1</w>
m ig
ner ve</w>
de v
mo l</w>
re pres
is tic</w>
o vascular</w>
injec tion</w>
n ur
P E
measu res</w>
su per
medi an</w>
an e</w>
ac ross</w>
ch o
applic ation</w>
st re
l or
underst anding</w>
t op
bas eline</w>
an al
ast ro
a k
ra y</w>
c ou
pan cre
d oc
suggest s</w>
scre ening</w>
calc ium</w>
experim ents</w>
e b
fib r
sco res</w>
selec ted</w>
o in
ur ine</w>
t ow
ul ated</w>
nec ess
al coh
e red</w>
ar ds</w>
establ ished</w>
S ur
l ay
pa ir</w>
t able</w>
ch ed</w>
P ar
re comm
im plic
approxim ately</w>
P L
os cop
ver sity</w>
d ra
0 00</w>
om y</w>
pro posed</w>
metabol ism</w>
C o
str ain</w>
S E
ur s</w>
t ory</w>
dam age</w>
sub sequ
acc um
4 5</w>
P S</w>
previ ous</w>
sub str
sugg esting</w>
Th us</w>
D e
bi om
func tions</w>
consi der
ep t</w>
n u
2 7</w>
pro por
sec ondary</w>
p ow
ter i
nor mal
esti on
On e</w>
emb ry
exerc ise</w>
ga str
mut ations</w>
differenti ation</w>
periph eral</w>
diagnos ed</w>
my ocardi
He al
4 8</w>
gl ut
h ar
st ro
og en</w>
cap ac
sc ale</w>
con clud
id es</w>
dis order</w>
measure ments</w>
ad ap
al tern
examin ation</w>
l l</w>
apopto sis</w>
quanti t
2 6</w>
r im
A P</w>
is chem
1 5
C lin
arti cle</w>
o v
rel ev
pop ulations</w>
form ed</w>
pregn ancy</w>
d o</w>
pro gram
post operative</w>
st able</w>
gl y
C T
vis ual</w>
metabol ic</w>
ac ids</w>
es pec
dom ain</w>
y i
ess ential</w>
espec ially</w>
al one</w>
3 1</w>
Th e
d ou
3 6</w>
p ite</w>
1 6
d on
r are</w>
mit ochond
compon ents</w>
provid es</w>
ai ly</w>
3 2</w>
cri tical</w>
s et
c t</w>
medi ate</w>
infec tions</w>
venti onal</w>
1 8
do es</w>
Wh en</w>
sol ution</w>
de sign</w>
ic ro
t esting</w>
le ad</w>
dic al</w>
th us</w>
T R
se x</w>
enc ing</w>
b u
b asis</w>
bi op
oxy gen</w>
a or
requ i
compl ex
cour se</w>
experi ence</w>
hosp it
c u
lip id</w>
transcrip tion</w>
B i
or i
sti ll</w>
oc y
cogni tive</w>
fr ag
b al
ad s</w>
con ver
ul arly</w>
ac cording</w>
le ar
el ing</w>
r ine</w>
criter ia</w>
ent er</w>
effici ent</w>
fac il
prog ression</w>
tra um
or atory</w>
ho urs</w>
v it
m id
re fl
resist ant</w>
aff ect</w>
sign al</w>
ser ies</w>
sen s
is o
electr on</w>
strateg ies</w>
st ability</w>
Q u
on set</w>
impro vement</w>
wee k</w>
rap id</w>
cl ear</w>
am pl
in tra
rec over
g lob
de g
resi d
cor respon
diff icul
addi tional</w>
th i
estion n
resp iratory</w>
A D</w>
ut aneous</w>
di g
I F
cy cle</w>
m es
meth yl
path ways</w>
sc i
gam ma</w>
appro pri
pro bl
eri or</w>
or ity</w>
ne l</w>
scop ic</w>
em plo
re ma
ol der</w>
cl er
d aily</w>
rema ins</w>
in si
p i
kidne y</w>
coh ort</w>
ve red</w>
up take</w>
inhibit ors</w>
us t</w>
chol ester
S P
M R</w>
M eth
o ple</w>
describ e</w>
f uture</w>
reduc e</w>
t ent</w>
d ri
st ed</w>
tol er
ific ation</w>
abs ence</w>
str ong
gr ade</w>
deli very</w>
chem otherapy</w>
M D
flu id</w>
ten sive</w>
pro mis
commun ity</w>
fo od</w>
rel i
B P</w>
my el
re ver
al though</w>
produc ts</w>
sp inal</w>
molec ules</w>
plac ement</w>
dos es</w>
lin ked</w>
m am
r e</w>
3 7</w>
consist ent</w>
t as
c ost</w>
id ine</w>
3 8</w>
O f</w>
3 4</w>
og n
provid ed</w>
ant agon
ther s</w>
recomm end
ach es</w>
in duction</w>
g i
ac e</w>
W ith</w>
po or</w>
t a</w>
ac coun
random ized</w>
U R
d at
import ance</w>
de grad
6 5</w>
medi um</w>
b ial</w>
loc ation</w>
epith elial</w>
b ar
A T</w>
expos ed</w>
is su
s pl
lin ear</w>
3 3</w>
Heal th</w>
O S</w>
ar ch</w>
inter val</w>
im ens</w>
proced ures</w>
om er
deg ree</w>
2 9</w>
er y
sol u
C s</w>
ol esc
pr e</w>
de pression</w>
admini stered</w>
hyper tension</w>
youn g</w>
ogen ous</w>
s le
v ent</w>
g ran
di et</w>
nucle ar</w>
O n</w>
conc er
th ir
hormon e</w>
am ide</w>
en ting</w>
l ation</w>
l ying</w>
o w</w>
re at
environ ment</w>
og ether</w>
regul ated</w>
resul ting</w>
pri or</w>
plat el
A N
B oth</w>
MR I</w>
en co
Ch in
capac ity</w>
ren g
elev ated</w>
ultr as
condi tion</w>
gro und</w>
physi ological</w>
transp ort</w>
probl ems</w>
di um</w>
mar kers</w>
recover y</w>
compon ent</w>
in tro
ib le</w>
nat ural</w>
o si
pre par
in ity</w>
mech an
e ds</w>
ic an</w>
inflam mation</w>
hep at
n ot
A S</w>
T ran
pe ople</w>
hepati c</w>
1 7
i ting</w>
pos si
il s</w>
C S
c o</w>
Th ere
defici ency</w>
M ore
er ity</w>
achiev ed</w>
trans fer
R T</w>
G en
o z
it on
os ome</w>
ta ken</w>
h ost</w>
C H
arter ial</w>
suff ici
r ation</w>
secre tion</w>
More over</w>
r ib
tox icity</w>
teri or</w>
al ter
a er
p ut</w>
In ter
partic ularly</w>
inva sive</w>
mut ation</w>
cat aly
mon th</w>
p en
ast s</w>
saf ety</w>
op en</w>
pur pose</w>
ne um
magne tic</w>
l ed</w>
cr yst
t e</w>
s om
endoth elial</w>
chrom at
st reng
S er
mar k
fic ial</w>
si a</w>
gastr ic</w>
cardi ovascular</w>
system ic</w>
sup pl
vari ables</w>
o ids</w>
fi x
4 2</w>
tr ig
de n</w>
myocardi al</w>
termin al</w>
necess ary</w>
en ter
modi fied</w>
stro ke</w>
mac roph
stimul ated</w>
val ent</w>
e ight</w>
ad verse</w>
cl ass</w>
c epti
con ventional</w>
ch lor
ip s</w>
anti bio
appropri ate</w>
phosph ate</w>
19 8
polym er
0. 5</w>
cere bral</w>
or ies</w>
mot or</w>
RN As</w>
S H</w>
ex amine</w>
s ex
am in</w>
G rou
e tics</w>
ill ary</w>
coun tr
al g
vie w</w>
need ed</w>
specific ity</w>
statis tically</w>
yc in</w>
pro toc
transf er</w>
transpl antation</w>
ear ance</w>
am eter</w>
f un
b ul
org anis
ol ar</w>
There fore</w>
l ast</w>
su mp
St ud
col i</w>
quantit ative</w>
selec tive</w>
wh ole</w>
et ed</w>
eri als</w>
m em
recor ded</w>
p al
re stric
pl ant</w>
l ate</w>
prog ram</w>
poly morph
M M
lac k</w>
ne w
fib ro
on ucle
ar c
e tion</w>
j unc
ca uses</w>
fluoresc ence</w>
j oin
F in
b enz
cl e
monit oring</w>
at t
mod ul
includ e</w>
ti veness</w>
opath y</w>
throm b
direc tly</w>
ab dom
fe w</w>
fi t</w>
fam il
val id
tem por
vari ation</w>
d ate</w>
og lob
em entation</w>
0. 9
gen ic</w>
eph al
he ad</w>
cholester ol</w>
c m</w>
aim ed</w>
high est</w>
carri ed</w>
ad olesc
4 4</w>
intr av
un its</w>
sev erity</w>
al k
l a
diab etic</w>
venti ons</w>
calcul ated</w>
sus cepti
as p
partic ular</w>
P D
sul f
up on</w>
there fore</w>
TI ON</w>
lat eral</w>
an terior</w>
devel op</w>
bacter ia</w>
ur b
regar ding</w>
ri x</w>
an ning</w>
H R</w>
identi fication</w>
rec ogn
tre m
distin ct</w>
p ig
dou ble</w>
ati c
ac qu
on omic</w>
estim ated</w>
2 ,
ic ation</w>
cor por
re pair</w>
sim ple</w>
meas ure</w>
z ation</w>
anim al</w>
ir e</w>
c um
malign ant</w>
ho od</w>
tion ing</w>
inf ants</w>
te x</w>
e .</w>
u ter
ad d
li qu
so dium</w>
res sive</w>
tion ally</w>
Ca 2</w>
under lying</w>
res on
amoun t</w>
m an</w>
or d
otyp es</w>
id al</w>
ter ms</w>
qu estionn
A mon
ro w</w>
S T</w>
sev en</w>
P R
alcoh ol</w>
ro gen</w>
plic ation</w>
t ogether</w>
osom al</w>
relev ant</w>
environ mental</w>
gen s</w>
om y
r ab
in ated</w>
appro aches</w>
treat ments</w>
C N
d op
V E
pl ing</w>
enzym es</w>
f at</w>
H y
ag ent</w>
D uring</w>
as pec
x i
dys function</w>
ar r
ent y</w>
0. 8
ometr ic</w>
str ong</w>
metr y</w>
ne o
oper ation</w>
g li
sle ep</w>
per fusion</w>
se p
ac ts</w>
th ic
rec tal</w>
Amon g</w>
mut ant</w>
M ul
maxim um</w>
rel ation</w>
ha ving</w>
l ec
p neum
f at
lab oratory</w>
4 3</w>
review ed</w>
surve y</w>
arti cles</w>
n g</w>
develop ing</w>
res h
re al</w>
ri tis</w>
relati vely</w>
occ ur</w>
muc h</w>
i. e.</w>
b est</w>
moder ate</w>
i stry</w>
D L</w>
ad ren
ar ch
a qu
E D</w>
intrac ellular</w>
S ev
exhib ited</w>
measure ment</w>
C A</w>
indic ating</w>
pa rent</w>
ip p
accur acy</w>
pre vention</w>
os a</w>
dow n</w>
gen ome</w>
v ical</w>
app ears</w>
Clin ical</w>
process ing</w>
con st
ph yl
de signed</w>
inter ventions</w>
strateg y</w>
5 5</w>
Grou p</w>
c rip
o od</w>
stud ents</w>
cur ren
air e</w>
comp are</w>
le m</w>
le ading</w>
emplo y
mal es</w>
subsequ ent</w>
s atis
adv anced</w>
micro scopy</w>
frequ ently</w>
el i
ab normal
acc ep
altern ative</w>
en sive</w>
bir th</w>
pre ven
sump tion</w>
educ ation</w>
di atric</w>
7 2</w>
pea k</w>
C l
hy bri
U S</w>
ometr y</w>
hal f</w>
m L</w>
re x
invol vement</w>
p ac
an ol</w>
fem ales</w>
inten sity</w>
c y</w>
bac k</w>
in take</w>
t i</w>
vi sion</w>
contrib ute</w>
it ary</w>
dimen sional</w>
vie w
effec tiveness</w>
s pati
v en</w>
tr ation</w>
olog ically</w>
main ly</w>
facil it
a k</w>
n s</w>
rec ently</w>
thesi zed</w>
al ong</w>
P er
sp e
el ed</w>
A b
L A</w>
gener ated</w>
pro spective</w>
mat rix</w>
enc ies</w>
hel p</w>
me ans</w>
accum ulation</w>
lit tle</w>
eb o</w>
on tal</w>
lear ning</w>
impa ir
S S</w>
net work</w>
ex tent</w>
oc k</w>
sh or
ru p
ax is</w>
op o
inhibit ory</w>
sour ce</w>
perc ent
R eg
es ophag
A mer
S ub
der iv
fr action</w>
loc ated</w>
sh if
oti de</w>
SI G
re construc
ne u
s al</w>
tu al</w>
poin ts</w>
ell a</w>
conf idence</w>
vari ate</w>
asi c</w>
to ol</w>
P UR
at tr
e ting</w>
L I
charg e</w>
vari able</w>
carb on</w>
rou s</w>
a de
auth ors</w>
s per
PUR PO
wil d</w>
go ing</w>
ur inary</w>
- 1</w>
mater ial</w>
th em
sh ap
ep tion</w>
mel an
coll ag
A p
objec tive</w>
aff inity</w>
plac ebo</w>
ot rop
2. 5</w>
am e</w>
O R
PURPO SE</w>
im ages</w>
h and</w>
D ata</w>
O 2</w>
b le
subst anti
ol ig
mem ory</w>
thir d</w>
in corpor
selec tion</w>
effici ency</w>
ner v
C a</w>
inc ub
an es
hist o
oph il
3 9</w>
adv ant
og s</w>
A u
as th
prob lem</w>
ab o
per sist
regul atory</w>
re st
gn os
com position</w>
P C</w>
ar b
et ary</w>
sy m
w all</w>
B y</w>
mit ted</w>
no w</w>
thyro id</w>
cor tex</w>
com mon
re tin
hypo thesis</w>
sin ce</w>
v ar
mat ure</w>
e ti
ass ays</w>
ic a</w>
mitochond rial</w>
s qu
show s</w>
t y
res ection</w>
inter nal</w>
4 1</w>
C ol
throu gh
kn ess</w>
cul tures</w>
reson ance</w>
le sion</w>
g astro
or ation</w>
ig n</w>
trac t</w>
phosphor ylation</w>
Stud y</w>
ing ly</w>
repor ts</w>
or ph
pro fil
es tion</w>
A C</w>
isol ates</w>
u tive</w>
ne on
Th ree</w>
f av
ste p</w>
um er
ade qu
liqu id</w>
recur rence</w>
predic ted</w>
fat ty</w>
em ic</w>
re produc
oxid ative</w>
f etal</w>
applic ations</w>
correspon ding</w>
ar ity</w>
meth yl</w>
remain ed</w>
6 7</w>
all el
ou th</w>
k ground</w>
N or
ha em
investig ation</w>
col on
hem at
p yr
l ater</w>
trans mission</w>
tend ed</w>
oc l
dem ic</w>
C or
res olution</w>
L e
se ud
protec tive</w>
optim al</w>
syn ap
mor b
aor tic</w>
ati ves</w>
a ir</w>
re actions</w>
hydrox y
aut o
asi a</w>
mechan ical</w>
organ ic</w>
substr ate</w>
d le</w>
S i
r al</w>
con nec
ar th
em er
sp ont
cat eg
nu tri
ex trem
p h</w>
4 6</w>
st ages</w>
lac t
T r
pro xim
en ous</w>
g el</w>
ch ing</w>
wor l
dat ab
lay er</w>
st er</w>
mi R</w>
ER I
a b</w>
el etal</w>
clin ically</w>
an at
exp ected</w>
prog nosis</w>
uni que</w>
com e</w>
I I
abdom inal</w>
plas tic</w>
pro state</w>
al b
atten tion</w>
ch an
mus t</w>
T reat
vari ety</w>
b ound</w>
es ity</w>
ad der</w>
complex es</w>
4 9</w>
hy th
cer vical</w>
gnos tic</w>
ap pe
de ta
emer gen
chil d</w>
publ ic</w>
un known</w>
smo king</w>
larg er</w>
pl ants</w>
i on
ell ing</w>
pres sive</w>
5 6</w>
ful l</w>
respon sible</w>
S C</w>
G l
induc e</w>
parti al</w>
sch o
der ly</w>
prof ile</w>
y g
tom ography</w>
prof es
streng th</w>
retro spective</w>
ar yn
P V</w>
B ased</w>
spec imens</w>
5 2</w>
b ase</w>
ul in</w>
as ym
vit amin</w>
cor e</w>
biop sy</w>
w ar
fun g
degrad ation</w>
ap pea
M A</w>
ari ly</w>
f ying</w>
appea red</w>
re as
4 7</w>
chromat ography</w>
agg reg
serv ices</w>
perc ent</w>
er ro
dynam ics</w>
cyt otox
platel et</w>
ester n</w>
extrac ellular</w>
um in
li po
ir on</w>
H B
1. 5</w>
abo ve</w>
produc t</w>
strong ly</w>
cul tured</w>
s at
tro ph
or ts</w>
ne ural</w>
oxid ation</w>
l ap
success ful</w>
m entation</w>
st aining</w>
mo tion</w>
S N
re ad
common ly</w>
F or
as c
percent age</w>
propor tion</w>
re ference</w>
maj ority</w>
comp ut
enh anc
under going</w>
recei ving</w>
i ous</w>
tern al</w>
Treat ment</w>
continu ous</w>
SIG N</w>
C I
M AT
con sumption</w>
eth yl
6 4</w>
em o
di sp
Di ff
sign s</w>
countr ies</w>
z ing</w>
resi du
mater nal</w>
signific ance</w>
5 4</w>
in ce</w>
long er</w>
M o
o vari
ven ous</w>
publ ished</w>
or rh
up per</w>
e m</w>
cer tain</w>
produc e</w>
simul t
DE SIGN</w>
s in</w>
OBJECTIV ES</w>
ra ther</w>
on ch
d y
AT P</w>
di tional</w>
las er</w>
em erg
S h
chem istry</w>
mig ration</w>
T NF</w>
dynam ic</w>
f ish</w>
gly co
F urther</w>
20 0</w>
st ained</w>
ex am
pre domin
remo val</w>
t ren
6 2</w>
pl ays</w>
pro st
al tered</w>
ti t
Com par
lymph ocytes</w>
doc um
An alysis</w>
an xi
S im
ide mi
ec ting</w>
E N
k er
Mul ti
t or
divid ed</w>
p on
5 1</w>
mat erials</w>
The y</w>
pl asia</w>
os ine</w>
ob struc
residu es</w>
H g</w>
v ation</w>
st ar
post erior</w>
bas al</w>
met al</w>
ti co
pepti des</w>
Meth ods</w>
atten u
M I
pl ast
satis fac
cor tical</w>
pre pared</w>
hepati tis</w>
chan nel</w>
press ing</w>
O b
ane ously</w>
pow er</w>
bl adder</w>
D es
inf arc
re active</w>
, 000</w>
fibro bl
S pec
S y
M y
neur onal</w>
th or
con trac
0. 1</w>
chrom osome</w>
pl ed</w>
el ium</w>
tempor al</w>
pre vent</w>
occur s</w>
foc us</w>
a w
el derly</w>
man if
neuro log
mar ker</w>
S p
inf usion</w>
pro jec
ogni tion</w>
promot er</w>
morb idity</w>
tas k</w>
rec ip
ex tr
im age</w>
rec ru
om es</w>
collag en</w>
abnormal ities</w>
al lo
pur ified</w>
hum ans</w>
emb er</w>
os yn
ob ic</w>
pancre atic</w>
for ce</w>
C B
tub er
0 0
MAT ERI
mat ched</w>
b en
6 3</w>
s on</w>
0. 7
invol ving</w>
e .
micro M</w>
n ational</w>
C M
cler osis</w>
E R</w>
mil d</w>
op e</w>
gen ase</w>
y et</w>
ol ip
ar cin
ac char
gen ital</w>
fl ex
g er</w>
potenti ally</w>
re combin
ver s</w>
Im mun
phen otype</w>
ag re
ti al</w>
cont act</w>
6 8</w>
t on</w>
pro gnostic</w>
s ph
tem p
k es</w>
membran es</w>
th resh
or ith
gra ft</w>
ap h
fer red</w>
con sec
Wh ile</w>
si vely</w>
plasm ic</w>
path ogenesis</w>
B ac
an th
H D</w>
S O
mix ed</w>
do m</w>
spati al</w>
el ines</w>
AL S</w>
pr inc
5 8</w>
A A</w>
ob esity</w>
man ner</w>
c anc
acet yl
ju g
aspec ts</w>
d enti
ab normal</w>
heter ogene
complet ed</w>
bar ri
n ed</w>
molec ule</w>
n ature</w>
sub stitu
differenti al</w>
system atic</w>
plast y</w>
inter pre
res our
ro w
ve si
ar ing</w>
cor d</w>
it able</w>
ro les</w>
abs orption</w>
v ul
reduc ing</w>
in ser
w ard</w>
F rom</w>
gen der</w>
relationsh ips</w>
join t</w>
g est
til ity</w>
P I
alter ations</w>
fe eding</w>
ach ed</w>
bec ome</w>
5 7</w>
v ements</w>
as al</w>
n ine</w>
V I
ic le</w>
B e
implic ations</w>
mar row</w>
od ynam
frequ ent</w>
ar com
questionn aire</w>
us ually</w>
AM P</w>
te en</w>
arth ritis</w>
di etary</w>
kin etics</w>
nucle us</w>
dis co
S tr
h ere</w>
throm bo
bene fit</w>
suffici ent</w>
N C
ser ved</w>
sec tion</w>
pro long
P G
lo ro
traum a</w>
us al</w>
ass es</w>
appe ar</w>
M T
wh ite</w>
6 6</w>
metast asis</w>
plac e</w>
ey e</w>
5 9</w>
attr ib
M et
alg orith
challeng e</w>
M ost</w>
protoc ol</w>
sp ace</w>
hypo x
curren tly</w>
U C
D M</w>
determin ation</w>
predic tive</w>
tum our</w>
N a</w>
biom ar
chang ed</w>
difficul t</w>
pre h
orig in</w>
con clusion</w>
wid ely</w>
S P</w>
character ization</w>
classi fication</w>
ie ve</w>
o ve
conclud e</w>
om en
is ting</w>
ery thro
A R</w>
v ity</w>
dow n
li ving</w>
lym ph</w>
ep id
osom es</w>
app ing</w>
of f</w>
f ed</w>
L i
A L</w>
inte rest</w>
v ec
str um
con stitu
m M</w>
id ly</w>
detec t</w>
ar s</w>
ipp oc
H R
medic ine</w>
em ph
transi tion</w>
parti cles</w>
& amp
&amp ;</w>
in d
ar ization</w>
N O</w>
y cl
olog ous</w>
it ud
olog ies</w>
ne ut
8 5</w>
lo ad</w>
acc ess</w>
psych i
sec tional</w>
l ys
glob al</w>
sex ual</w>
d or
is ing</w>
IN T
promis ing</w>
P r
ar m</w>
acti n</w>
O ver
if or
end oscop
plac ed</w>
ultras ound</w>
ippoc amp
ev ol
tiv es</w>
th ym
pl us</w>
str i
su peri
polymer ase</w>
el ements</w>
protec tion</w>
pot ent</w>
g raph
macroph ages</w>
tr yp
i i</w>
n umer
D ec
t el
or th
E uro
at temp
tow ard</w>
id ent</w>
en ro
cont ext</w>
rec ognition</w>
ne ph
ev olution</w>
st abil
ster one</w>
impa ired</w>
s ha
l yc
ex ternal</w>
we igh
s ess
wor ks</w>
success fully</w>
impair ment</w>
adju sted</w>
ach ing</w>
spec i
thesi a</w>
sti t
t ob
le ads</w>
ovari an</w>
A fr
complet ely</w>
d ogs</w>
consec utive</w>
n m</w>
O H</w>
hy dr
spec tively</w>
E M
il ep
g .</w>
behavi oral</w>
di ameter</w>
medi a</w>
g er
vacc ine</w>
C C</w>
b ile</w>
pos ite</w>
occ us</w>
sol id</w>
ul a</w>
neu tr
recur rent</w>
ci ans</w>
aro und</w>
6 1</w>
predic t</w>
si on
anxi ety</w>
vir uses</w>
sus p
de x
ap s</w>
1. 0
org an</w>
requi res</w>
recombin ant</w>
ti l</w>
occur rence</w>
f al
co ag
k ine</w>
const ant</w>
in d</w>
ne ar</w>
e. g.</w>
ma king</w>
comp an
U ni
Diff eren
statis tical</w>
b ut
can di
memb ers</w>
Des pite</w>
Ne w</w>
ec onomic</w>
c utaneous</w>
S L
as h
yi el
dom ains</w>
7 3</w>
sequ encing</w>
kin es</w>
C D</w>
h ex
gener ally</w>
kin etic</w>
al ine</w>
iton eal</w>
e ous</w>
rap idly</w>
oxid ase</w>
sh e
vas cul
3 H</w>
h ippocamp
H osp
SC s</w>
c enter</w>
infarc tion</w>
o id
nan op
compar able</w>
sur fac
he at</w>
clu sions</w>
ver te
g in
through out</w>
radi o
qu al
asth ma</w>
set ting</w>
H igh</w>
6 9</w>
Fin ally</w>
p y
k ne
IF N</w>
stre am</w>
el im
bio chemical</w>
o ked</w>
m ia</w>
compo und</w>
in strum
ac ting</w>
lig and</w>
psych ological</w>
C P</w>
H A</w>
Eff ects</w>
F A</w>
ac r
ent ary</w>
mod eling</w>
spectr um</w>
ad j
dev ice</w>
oc k
re main</w>
ischem ia</w>
C l</w>
disc rim
ne eds</w>
metast atic</w>
profil es</w>
it u
anti gens</w>
canc ers</w>
solu ble</w>
saf e</w>
R A</w>
O r
1 0.
ran ial</w>
v ag
adequ ate</w>
C S</w>
P hy
P M
injur ies</w>
r s</w>
associ ations</w>
od ds</w>
expl ore</w>
targ ets</w>
pe diatric</w>
dra w
accur ate</w>
el ic
P I</w>
ocl onal</w>
oc ular</w>
i ons</w>
ex isting</w>
l er</w>
dec ision</w>
frac ture</w>
respec t</w>
r he
form ing</w>
ey es</w>
guid elines</w>
develop mental</w>
yl ated</w>
D I
br onch
st ates</w>
7 8</w>
ed ly</w>
diff er</w>
leuk emia</w>
tuber cul
re tinal</w>
m as
M icro
thal am
characteris tic</w>
f its</w>
ra z
p tom
S yn
n itr
anc ies</w>
mar ked</w>
cl on
ischem ic</w>
vari ability</w>
dist al</w>
Eff ect</w>
chr on
fac ial</w>
D a</w>
ep ilep
il i
def ects</w>
thor ac
P K
il l</w>
qu in
nec k</w>
experi enced</w>
C an
comp uted</w>
B ec
ble eding</w>
famil ies</w>
ep is
organis ms</w>
ro ot</w>
transfer ase</w>
tic ular</w>
al low</w>
re present</w>
targ eted</w>
pro p
lab eled</w>
wh at</w>
o rectal</w>
pneum on
s es
program s</w>
co sts</w>
min utes</w>
sign als</w>
not ed</w>
an other</w>
h ol
on c
S M
manif est
therap ies</w>
fib rosis</w>
ro ti
ch ic
aryn g
pres entation</w>
toler ance</w>
c ed</w>
b on
1 1.
pa ir
nec rosis</w>
allow s</w>
S R
V A</w>
il ed</w>
sub unit</w>
p ast</w>
thic kness</w>
path ological</w>
T L
specific ally</w>
oxid ant</w>
intrav enous</w>
superi or</w>
am s</w>
al most</w>
adhe sion</w>
A F
phen omen
com pe
7 1</w>
d ental</w>
st en
p ut
b asic</w>
extrac tion</w>
h ab
nerv ous</w>
morph ology</w>
S ince</w>
phot o
spont aneous</w>
gram s</w>
ich ia</w>
fin ding</w>
suscepti bility</w>
com preh
ic in</w>
inhib it</w>
di an</w>
pres er
E C</w>
bi t</w>
prob ably</w>
wa ve</w>
syn th
az ole</w>
observ ations</w>
employ ed</w>
B C</w>
soci ation</w>
con jug
int act</w>
ab und
rati os</w>
Tw enty</w>
N S
CS F</w>
pres s</w>
con tained</w>
lap aro
recommend ed</w>
s mal
l igh
ap parent</w>
numb ers</w>
l and
J ap
i ve</w>
CD 4</w>
tic ip
ar y
prepar ation</w>
rang ed</w>
7 4</w>
tain s</w>
accoun t</w>
ac k</w>
r ich
at er
cont amin
ver s
cir cul
bor n</w>
sit u</w>
g as</w>
com pr
oc arcin
at rial</w>
ogen etic</w>
mo vement</w>
ther mal</w>
ane ur
oly tic</w>
H C</w>
Chin ese</w>
ch ann
n ic
uc id
C P
ec tive</w>
tow ards</w>
Amer ican</w>
atic ally</w>
C R</w>
ep idemi
di versity</w>
n am
adolesc ents</w>
the ory</w>
mid dle</w>
end ogenous</w>
techn ology</w>
indic ates</w>
ove rex
gra f
t un
ear ing</w>
gre at
mo de</w>
ther n</w>
R A
le t</w>
aneur ys
em ented</w>
pol ic
mam m
enc ephal
mic r
as sist
bal ance</w>
cel er
on in</w>
op tical</w>
H um
en ic</w>
metr ic</w>
in stitu
M P</w>
don or</w>
o il</w>
discus s</w>
3 ,
medic ation</w>
c en
vol un
sour ces</w>
des pite</w>
y lo
succ ess</w>
tra ditional</w>
per me
se arch</w>
bo v
en ed</w>
7 6</w>
a ine</w>
ac u
E p
yi eld</w>
fin al</w>
reconstruc tion</w>
loc alization</w>
g on
T P</w>
to m</w>
a ther
glut am
s on
underst and</w>
esophag eal</w>
depend ently</w>
e str
leuk in</w>
sit u
m ing</w>
transp or
ty ros
prolong ed</w>
eth anol</w>
recogn ized</w>
bloc k</w>
ca th
vari ants</w>
ch ym
op i
gl and</w>
meth od
un til</w>
9 6</w>
cal e</w>
al le
C ancer</w>
pre operative</w>
8 8</w>
nur sing</w>
P F
E sch
emergen cy</w>
electro ph
An ti
cyt es</w>
mon oclonal</w>
Hosp ital</w>
c all
del ayed</w>
oph ysi
H T</w>
cr uc
ob l
Ad di
ma ke</w>
physi cians</w>
immun os
chann els</w>
7 9</w>
Esch er
extrac t</w>
requ ire</w>
l and</w>
7 7</w>
estim ate</w>
Escher ichia</w>
k Da</w>
D A</w>
olec ular</w>
defici ent</w>
random ly</w>
S I</w>
- 0.
oc om
analy sed</w>
syn thesized</w>
re ly</w>
issu es</w>
so il</w>
immuno histo
par as
maxim al</w>
ang li
em is
bene fits</w>
tr im
en si
neut roph
ib r
im en</w>
ten ance</w>
fr ame
proxim al</w>
e di
targ eting</w>
des crip
Ch il
fib ers</w>
an tim
1 3.
cl ose</w>
frac tures</w>
stimul i</w>
our s</w>
end ing</w>
enh ance</w>
tox ic</w>
regi onal</w>
3 0
p 53</w>
Un ited</w>
kne e</w>
h ome</w>
an ted</w>
3 D</w>
app earance</w>
on ate</w>
ac compan
experim ent</w>
inter fer
ar thro
sch iz
um in</w>
oc or
D M
no de</w>
Th ir
Over all</w>
R el
ep s</w>
hy p
inva sion</w>
met a</w>
re plication</w>
F ol
hem orrh
Ig G</w>
R ev
complic ation</w>
re placement</w>
gen omic</w>
y e
a p</w>
recur s
g al
us ual</w>
bil ateral</w>
pl ayed</w>
an u
spectro scopy</w>
fin d</w>
ei ved</w>
in ate</w>
oph ren
distin gu
T A
wh ose</w>
nucle otide</w>
inter mediate</w>
8 6</w>
se iz
ve in</w>
p el
antibio tic</w>
scho ol</w>
ac celer
requi re
ul ate</w>
ang u
cho ice</w>
no d
syn thetic</w>
oglob in</w>
ang le</w>
d one</w>
T 1</w>
m ic</w>
es tions</w>
ex pan
classi fied</w>
MATERI ALS</w>
antagon ist</w>
ap hy
f ast</w>
mut ants</w>
se ems</w>
foc al</w>
sk eletal</w>
T B
avail ability</w>
P E</w>
D s</w>
ev ent</w>
jec tion</w>
depend ence</w>
mil k</w>
oc rine</w>
F e
acti c</w>
os al</w>
uc h</w>
cur ve</w>
ph il
p recurs
N ational</w>
psychi atric</w>
agre ement</w>
injec ted</w>
av age</w>
ass emb
e ase</w>
at ase</w>
ev ery</w>
typ ical</w>
ex cre
5 0
an a
chol ine</w>
provid ing</w>
equ i
rel ap
P las
co ord
neon atal</w>
initi ation</w>
itud inal</w>
ear li
ar in</w>
reli able</w>
possi bility</w>
ben ign</w>
Bec ause</w>
t ase</w>
am b
id en
n or</w>
path ology</w>
st or
prog ressive</w>
f ore
aut om
grow ing</w>
ell ar</w>
av es</w>
transi ent</w>
E lec
dist ance</w>
anal og
H LA</w>
S ign
oper atively</w>
el ucid
B r
cell ent</w>
b ly</w>
BM I</w>
F ac
physi c
pregn ant</w>
ad ded</w>
lymph oma</w>
mo bil
ex change</w>
co ding</w>
micro grams</w>
ari a</w>
conclud ed</w>
rel ax
main tenance</w>
is ation</w>
rou tine</w>
su itable</w>
metabol ites</w>
recip i
it us</w>
Rec ent</w>
g radi
a vi
pres enting</w>
ex tensive</w>
sh ock</w>
9 3</w>
mul ti</w>
inf il
un clear</w>
transpl ant</w>
hydro gen</w>
h und
C F
mark edly</w>
v als</w>
electroph ore
ir radiation</w>
epis od
T E
repe ated</w>
ill ness</w>
ti ous</w>
an ine</w>
z es</w>
g ain</w>
thresh old</w>
sens ory</w>
cyt os
ex ist
1. 0</w>
ch loro
re f
arcom a</w>
R S</w>
w al
fail ed</w>
transcrip tional</w>
ot omy</w>
se ts</w>
1 2.
it ative</w>
observ ation</w>
enro lled</w>
hy d
R ep
r ich</w>
gre at</w>
O F</w>
wor king</w>
ver sion</w>
oly sis</w>
bov ine</w>
ra dical</w>
ess els</w>
path y</w>
abil ities</w>
8 4</w>
D ev
vari ed</w>
ha z
5 00</w>
anu ary</w>
st ly</w>
pro s
tin gs</w>
J anuary</w>
ac t
tyros ine</w>
M an
prim arily</w>
enco ding</w>
h ip</w>
hospit als</w>
k ary
gastro intestinal</w>
loc alized</w>
ri a</w>
phosph olip
al is</w>
port un
tur n</w>
dis charge</w>
ogen s</w>
val ve</w>
gran ul
og ra
cycl ic</w>
dop amine</w>
c ros
predic tion</w>
T A</w>
smo oth</w>
v essels</w>
a rom
ex cellent</w>
compe ti
col on</w>
8 3</w>
c ent
smal ler</w>
ar t
ran dom</w>
iden tical</w>
w ound</w>
synap tic</w>
Hum an</w>
occur ring</w>
cou pled</w>
metast ases</w>
D O
peri ods</w>
show ing</w>
aim s</w>
minim al</w>
fib er</w>
commun ication</w>
col orectal</w>
parti ally</w>
ster oid</w>
s ou
pol yp
schiz ophren
u tions</w>
k et
8 2</w>
C ur
induc es</w>
roti d</w>
challeng es</w>
it ory</w>
vi ous</w>
cyto kines</w>
child hood</w>
pro pose</w>
di ed</w>
main tained</w>
amoun ts</w>
to ols</w>
heal ing</w>
gen e
p seud
dev ices</w>
bel ow</w>
fol l
Pro te
o thers</w>
acqu ired</w>
l ing</w>
P 1</w>
oc ity</w>
L PS</w>
inter vals</w>
On ly</w>
g o</w>
mal ian</w>
ch es</w>
m urine</w>
subjec t</w>
serv ice</w>
trans l
odynam ic</w>
0.00 01</w>
pl ate</w>
1 4.
sup pression</w>
deriv atives</w>
F r
si an</w>
promot e</w>
behavi ors</w>
shif t</w>
In cre
est er</w>
ris e</w>
impl ementation</w>
yl ase</w>
Me dic
pro be</w>
h abil
de hydro
W estern</w>
or ly</w>
S ec
tubercul osis</w>
L DL</w>
Th er
g angli
de ep</w>
conver sion</w>
2 50</w>
exc ept</w>
health care</w>
nanop articles</w>
r ho
view s</w>
ly sis</w>
w ise</w>
dist urb
tre at</w>
C Y
9 8</w>
frame work</w>
G S</w>
contro ll
vi si
incub ation</w>
hist ological</w>
alle l</w>
extrac ted</w>
in oc
St ates</w>
b ular</w>
diff usion</w>
ad s
wor kers</w>
n ative</w>
gra m</w>
inter leukin</w>
ar ies</w>
er r
epid er
sur ro
9 2</w>
res ting</w>
o k</w>
T a
cor ne
mus cles</w>
er ic</w>
a ud
vel ocity</w>
es sive</w>
adju v
e f
datab ase</w>
de pl
domin ant</w>
asp ir
Sev eral</w>
dr in
op portun
b and</w>
recor ds</w>
emb ol
S V</w>
en rich
fil m</w>
ati tis</w>
inten sive</w>
9 9</w>
clos ely</w>
E valu
he re
GF R</w>
f ar</w>
ill us</w>
E E
i b</w>
an a</w>
in du
en ia</w>
res ol
fem oral</w>
foc used</w>
ten tion</w>
8 1</w>
Chin a</w>
direc ted</w>
oz yg
trans formation</w>
em p
issu e</w>
lim b</w>
pers on
equ al</w>
shap e</w>
produc ing</w>
m arg
ex ten
re verse</w>
pl ex</w>
ent ally</w>
P V
arter ies</w>
vari ations</w>
res sed</w>
ocy tic</w>
pers ons</w>
so ft</w>
lat ter</w>
pro mo
0. 2</w>
Con tro
ach ieve</w>
mat ter</w>
p in
paren ts</w>
e a</w>
ow n</w>
st ers</w>
impl antation</w>
as ting</w>
ex pressing</w>
ser ious</w>
p ed</w>
air way</w>
ill in</w>
s low</w>
hyper tensive</w>
o ro
vi ol
hybri di
hund red</w>
analy ze</w>
anti oxidant</w>
seg ment</w>
S cale</w>
P H</w>
ser a</w>
A S
F our</w>
prote in
extrac ts</w>
decre ases</w>
chlor ide</w>
c ent</w>
t al
il ls</w>
in dependently</w>
E 2</w>
mam malian</w>
organ ization</w>
melan oma</w>
1 1
radi otherapy</w>
fix ed</w>
I R</w>
8 9</w>
nur ses</w>
compar ing</w>
N H
C al
ow el</w>
ath s</w>
if y</w>
as tic</w>
D L
tic ul
the ore
con genital</w>
pul se</w>
fluo ro
8 7</w>
ac in</w>
Ex perim
n a
ad mission</w>
rab bit</w>
fibrobl asts</w>
P R</w>
C r
def ect</w>
igh tly</w>
Ne uro
influ enced</w>
it ations</w>
comm erc
practi ces</w>
G C</w>
C ell</w>
uter ine</w>
9 4</w>
ye ast</w>
20 14</w>
rec tomy</w>
ocarcin oma</w>
Sur g
perc eived</w>
o ts</w>
U D
chrom e</w>
remain ing</w>
H ist
B S</w>
ab or
algorith m</w>
expl ored</w>
net works</w>
iz es</w>
t ant</w>
neurolog ical</w>
larg ely</w>
aff ecting</w>
E T</w>
meth ylation</w>
morph ological</w>
z in
ati on
om al
B 1</w>
modi fication</w>
ex clud
H z</w>
op a
est rogen</w>
mag nit
N G</w>
habil itation</w>
In f
HC V</w>
20 15</w>
A 1</w>
ex tended</w>
3 00</w>
fr ontal</w>
gl omer
res er
solu tions</w>
G A</w>
par allel</w>
compreh ensive</w>
impro ving</w>
dem ographic</w>
sam pling</w>
om at
underst ood</w>
A t
pro ved</w>
cruc ial</w>
con tains</w>
differenti ated</w>
exhib it</w>
alb umin</w>
gen otype</w>
m er</w>
wor k
s ting</w>
e de
T 3</w>
behavi our</w>
n ia</w>
il lu
an ese</w>
di verse</w>
stit ute</w>
wh om</w>
earli er</w>
otyp ic</w>
ad op
sum mar
worl d</w>
f ill
repres ents</w>
1 20</w>
stimul us</w>
ris ks</w>
chem o
I M
Tran s
enhanc ement</w>
cy s
S ome</w>
epti de</w>
tox in</w>
electr onic</w>
antibio tics</w>
substanti al</w>
cir cum
surg e
d a</w>
ab r
conc ept</w>
9 7</w>
sl ightly</w>
ob ese</w>
col um
h ome
t ac
pre g
osyn thesis</w>
c DNA</w>
new ly</w>
fe ed
Com pared</w>
Uni versity</w>
Me an</w>
sci enti
4 ,
stor age</w>
con tain</w>
spectro metry</w>
predic tors</w>
establ ish</w>
Con clusion</w>
sec tions</w>
P ase</w>
agon ist</w>
mod ulation</w>
high ligh
enti a</w>
posi tively</w>
meas uring</w>
ad es</w>
i od
le th
satisfac tion</w>
ac ter</w>
m m
con served</w>
ar ray</w>
contrib ution</w>
glyc er
Me dical</w>
se l</w>
fl av
tr iti
immun ity</w>
sp re
cyto kine</w>
G AB
detec table</w>
and ed</w>
9 1</w>
S tu
us ers</w>
su stained</w>
e tr
reve al</w>
U T
sal ine</w>
bene ficial</w>
expl ained</w>
olog ists</w>
1 5.
u es</w>
c ad
ex er
L C</w>
yl ate</w>
E LI
impl ant</w>
N a
dec line</w>
t age</w>
accompan ied</w>
it ude</w>
RO D
G H</w>
p il
add ress</w>
ste re
k age</w>
Ch ar
1. 2</w>
icro bial</w>
ca re
log istic</w>
stand ardi
aff ects</w>
T GF</w>
im er</w>
ac ted</w>
de part
oc clusion</w>
eng ine
N P</w>
org ans</w>
A 2</w>
bu il
de hy
D R
sc anning</w>
H 2
describ es</w>
0. 3</w>
T yp
regul ate</w>
itu itary</w>
adjuv ant</w>
el op
sup pressed</w>
cl earance</w>
can not</w>
con sequences</w>
vari ant</w>
st om
C C
ROD UC
traum atic</w>
di ver
multi variate</w>
in ter</w>
phen yl
immun ore
sy st
em bl
HC C</w>
electr ical</w>
lim it</w>
re activity</w>
influ enz
INT RODUC
f a
o virus</w>
S u
long itudinal</w>
frag ment</w>
electr ic</w>
ch est</w>
no v
20 16</w>
integr ated</w>
consist ed</w>
20 13</w>
S M</w>
F unc
del ta</w>
b s</w>
INTRODUC TION</w>
allow ed</w>
i pl
h am
ne t</w>
roph y</w>
ast er</w>
effec tively</w>
acet ate</w>
S al
po orly</w>
PA R
otrop ic</w>
adhe rence</w>
Dev elop
O p
oph osph
U V</w>
P P</w>
I CA
assemb ly</w>
P ol
acchar ide</w>
Stu dies</w>
sten osis</w>
r ig
de vi
coun t</w>
magnit ude</w>
al ities</w>
a emia</w>
nor m
fr actions</w>
el ement</w>
persist ent</w>
press or</w>
ol ds</w>
estim ates</w>
d ual</w>
ath i
low ing</w>
E B
bur den</w>
respon si
fac t</w>
fix ation</w>
ampl itude</w>
gh ts</w>
Bac kground</w>
t ance</w>
co ver
nit rogen</w>
st ay</w>
par ts</w>
ici ans</w>
ens in</w>
pro phyl
biomar kers</w>
d ation</w>
ob tain</w>
an dro
N F
cl early</w>
out put</w>
ell itus</w>
ib ility</w>
cir c
In te
advant ages</w>
P l
separ ation</w>
pl e
erro r</w>
inhib its</w>
se as
A F</w>
h our</w>
substr ates</w>
rang ing</w>
de si
ap er
suppor ted</w>
nutri tion</w>
e f</w>
conc ep
dep th</w>
gener ative</w>
D el
Addi tionally</w>
qu estions</w>
al dehy
7. 5</w>
pres ents</w>
con serv
fluoresc ent</w>
volun te
ri um</w>
an k
polymorph ism</w>
com it
a wa
exam ple</w>
infec tious</w>
pair s</w>
expl ain</w>
vis u
sh ip</w>
n asal</w>
clin ic</w>
rhe um
epith elium</w>
go al</w>
ev oked</w>
valid ated</w>
N K</w>
ca rotid</w>
subst ance</w>
ede ma</w>
C O</w>
pers onal</w>
H I
c os
junc tion</w>
is es</w>
as signed</w>
sen se</w>
PE T</w>
l angu
cap able</w>
end ocrine</w>
ex pec
car bo
O c
ost asis</w>
func tioning</w>
1 6.
docum ented</w>
A G
determin ing</w>
reproduc tive</w>
symp tom</w>
le ts</w>
pel v
thorac ic</w>
si c</w>
micro bial</w>
medi ately</w>
b owel</w>
Sim il
As sess
ill ance</w>
ather os
princ i
pol y</w>
O ut
resid ual</w>
mo thers</w>
g ent</w>
facilit ate</w>
av y</w>
orig inal</w>
W or
embry onic</w>
per itoneal</w>
bet a
Euro pe
cor d
sper m</w>
o res</w>
intro duced</w>
ul c
ul monary</w>
comput er</w>
min or</w>
prolifer ative</w>
S ch
Chil d
sensi ti
C V
restric ted</w>
di a</w>
en al</w>
pol ar</w>
al ve
reg ular</w>
aden osine</w>
assist ed</w>
anal ge
k ill
continu ed</w>
Ser um</w>
sal t</w>
surfac es</w>
a id</w>
no ise</w>
Compar ison</w>
A V
f it
ir ing</w>
de aths</w>
Par ticip
syst olic</w>
correl ations</w>
b yp
medi al</w>
at tit
le a
h r</w>
resour ces</w>
u preg
illu str
N O
car r
R R</w>
anes thesia</w>
p ituitary</w>
flu x</w>
ph ag
confir m</w>
C E
am ous</w>
compar t
h is</w>
circul ating</w>
aer obic</w>
hypox ia</w>
t am
re habilitation</w>
aryng eal</w>
cryst al</w>
pharmac o
m ol
emis sion</w>
is ms</w>
phosph atase</w>
M a
AC T</w>
ma x</w>
R adi
dis played</w>
thou ght</w>
Ch ang
call ed</w>
he aring</w>
chym al</w>
vec tor</w>
m ellitus</w>
frag ments</w>
lymph ocyte</w>
del etion</w>
C F</w>
youn ger</w>
Phy si
es sel</w>
reli ability</w>
insi c</w>
Au str
Evalu ation</w>
A M</w>
cl im
ELI SA</w>
ach ment</w>
ad mitted</w>
fibr ill
p ing</w>
fung al</w>
sulf ate</w>
4 0
s p</w>
au g
m im
ur ia</w>
yt o
os in</w>
allel e</w>
on e
I s</w>
T C</w>
ser ve</w>
si es</w>
val idity</w>
S R</w>
ocyt osis</w>
susp ected</w>
regul ating</w>
di alysis</w>
f und
r ac
symptom atic</w>
pl anning</w>
excre tion</w>
H E
emo tional</w>
set tings</w>
d yl
endoscop ic</w>
loc us</w>
he imer</w>
cataly tic</w>
investig ations</w>
g ir
Europe an</w>
z one</w>
pig s</w>
gener ate</w>
eti ology</w>
f et
Al z
cath eter</w>
ot or</w>
co efficient</w>
util ization</w>
he ight</w>
car til
schizophren ia</w>
mo ti
hybridi zation</w>
possi bly</w>
clu ster</w>
ech ocardi
ul f
recommend ations</w>
cytotox ic</w>
dem entia</w>
tren d</w>
bi ology</w>
end ed</w>
trac he
L D</w>
20 12</w>
ta king</w>
og ram</w>
repres ent
bacter ium</w>
remo ved</w>
muc osal</w>
0.0 2</w>
av oid
B et
P rim
posi tions</w>
1. 1</w>
i si
l ar
plas m</w>
iz ations</w>
pl er</w>
st anding</w>
mac ro
A g</w>
f re
Alz heimer</w>
cor tico
sol ute</w>
cre atin
zin c</w>
B D</w>
per f
am ent</w>
c AMP</w>
muc osa</w>
isol ation</w>
tu be</w>
ec al</w>
tre ating</w>
carb ox
aqu eous</w>
character ize</w>
P ost
al ign
re tention</w>
20 00</w>
sw it
qual itative</w>
umb ar</w>
rever sible</w>
deta iled</w>
angi ography</w>
ul tra
vacc ination</w>
dehydro genase</w>
nit ro
PL C</w>
0. 4</w>
venti lation</w>
hist opath
in clusion</w>
controll ing</w>
il ateral</w>
electrophore sis</w>
fic ations</w>
r hyth
el ds</w>
recei ve</w>
at ter
T B</w>
subjec ted</w>
neph ro
pharmac ological</w>
frequ encies</w>
gradi ent</w>
1. 3</w>
bloc ked</w>
intr a</w>
parti cle</w>
op ic</w>
no des</w>
I GF</w>
M E</w>
d ents</w>
D N
hybri d</w>
demonstr ates</w>
per form</w>
synth ase</w>
del ay</w>
D ep
e asi
bro ad</w>
d end
cyto chrome</w>
vari ance</w>
M on
simult aneously</w>
con form
correc t</w>
o ic</w>
v ate</w>
consider able</w>
im mediately</w>
pre feren
separ ate</w>
var ying</w>
potenti als</w>
fe ature</w>
su ic
ot ensin</w>
Dis ease</w>
ste ine</w>
langu age</w>
P e
integr ation</w>
Thir ty</w>
1. 4</w>
L P</w>
Sign ific
im e</w>
p ic
fav or
Res earch</w>
D op
af f</w>
wom an</w>
in sec
em entary</w>
elec tive</w>
barri er</w>
sc an</w>
re ached</w>
ev er
spe ed</w>
obstruc tion</w>
gen it
um p</w>
N MR</w>
am ph
feed back</w>
urb an</w>
lu tion</w>
u tion
el ess</w>
blo t</w>
experi ences</w>
bl ind</w>
T H</w>
ec h</w>
b its</w>
b ond</w>
C E</w>
D C</w>
assess ing</w>
cryst all
bac kground</w>
opath ic</w>
u ting</w>
ro om</w>
duc t</w>
U C</w>
r ural</w>
inf ant</w>
pres crib
speci al
interfer on</w>
1 50</w>
ac ent</w>
3. 5</w>
z ym
aggreg ation</w>
sp i
ec tin</w>
pr in
ptom atic</w>
spec ial</w>
oc aine</w>
compar ative</w>
B lo
dri ven</w>
reduc es</w>
Ex pression</w>
alph a
embry os</w>
perc eption</w>
bi as</w>
C ardi
coun ter
er b
om ical</w>
numer ous</w>
f ru
n e</w>
G u
antim icrobial</w>
V ari
nucle i</w>
byp ass</w>
P a
ud es</w>
A K
ish ing</w>
MD A</w>
di ast
spectr a</w>
er a</w>
4 00</w>
D R</w>
et h</w>
bu ff
M ore</w>
path ophysi
m ented</w>
r in
physic ian</w>
cy cles</w>
In hib
he avy</w>
C G</w>
seg ments</w>
de oxy
prob ability</w>
ex ist</w>
apopto tic</w>
equi valent</w>
tum ours</w>
tiv ation</w>
tion ed</w>
I V
arr hyth
mix ture</w>
M any</w>
includ es</w>
assi um</w>
exist ence</w>
hypo thalam
retro spectively</w>
nitr ic</w>
lipo protein</w>
athi one</w>
invol ves</w>
C L</w>
wh e
phenomen on</w>
de generation</w>
il ib
men ing
ast oma</w>
st ment</w>
F e</w>
heterogene ity</w>
prepar ations</w>
n ar
ch ec
L H</w>
rele ased</w>
sk ills</w>
I denti
dor sal</w>
B L</w>
cycl o
glutam ate</w>
os in
C M</w>
it ol</w>
2. 0</w>
R s</w>
complic ated</w>
aldehy de</w>
el ls</w>
preven ted</w>
vi ability</w>
d ase</w>
comp et
program m
L V</w>
subsequ ently</w>
L E
ca using</w>
t on
v essel</w>
cou pling</w>
ul l
Me as
b earing</w>
um ab</w>
prog ress</w>
at um</w>
F ive</w>
v o
s .
low est</w>
AI M</w>
N I
repor ting</w>
restric tion</w>
C u</w>
phen yl</w>
U l
cys tic</w>
pi g</w>
attenu ated</w>
so f
adj acent</w>
ul l</w>
theore tical</w>
lo ading</w>
az ol
Austr al
sal iv
sim ulation</w>
dis per
cyto plasmic</w>
fi elds</w>
triti onal</w>
an omal
Particip ants</w>
g et
u bi
dis ability</w>
circ ulation</w>
ster oids</w>
eth n
implic ated</w>
Afr ican</w>
perc ep
m 2</w>
mon o
on as</w>
im mediate</w>
f ic</w>
si des</w>
in a</w>
or i</w>
T 2</w>
influenz a</w>
alve olar</w>
E arly</w>
polic y</w>
identi fying</w>
polym er</w>
0. 6</w>
Dec ember</w>
vers ely</w>
.0 01</w>
r s
reg ard</w>
hyper troph
lin e
acc o</w>
distrib uted</w>
od on
eff orts</w>
CY P
aden ocarcinoma</w>
th re
su b</w>
m os
cor tis
respec tive</w>
H PV</w>
cere b
Di ag
0. 8</w>
un treated</w>
man ip
a x</w>
st atic</w>
recru ited</w>
st rom
am ylo
micro g</w>
volunte ers</w>
squ amous</w>
minim um</w>
Typ e</w>
di min
1 8.
initi ally</w>
hemorrh age</w>
lim itations</w>
rou gh</w>
tra its</w>
p ine</w>
es tive</w>
re perfusion</w>
de pressive</w>
st aff</w>
f ever</w>
me t</w>
et ro
aphy loc
tic ity</w>
lu e</w>
o plasty</w>
re ferred</w>
Con clusions</w>
vesi cles</w>
direc tion</w>
op tic</w>
immun oglob
F I
construc ted</w>
B M</w>
esc ence</w>
cartil age</w>
1. 6</w>
adap tation</w>
c ess
st eps</w>
laparo scopic</w>
G R
au re
ro t
In v
ex per
al ter</w>
com posed</w>
ine a</w>
enti re</w>
om ics</w>
rab bits</w>
K 1</w>
profes sional</w>
auto immune</w>
sin us</w>
on ce</w>
cir rho
bin d</w>
b ic
monit ored</w>
com posite</w>
mitochond ria</w>
2 -</w>
phosph ati
arg in
dis cre
o g</w>
cen ters</w>
concer ning</w>
M in
disc ipl
struc tured</w>
ar rang
elev ation</w>
p ene
b ran
S outh</w>
ta x
ad ed</w>
clos ed</w>
eth yl</w>
ai l</w>
sequ ently</w>
evalu ating</w>
le p
o sterone</w>
asi bility</w>
Ac ute</w>
pot assium</w>
spl een</w>
D P</w>
w er</w>
sat ur
Char acter
expan sion</w>
coll ection</w>
shor ter</w>
con comit
pol arization</w>
put ative</w>
smo kers</w>
simult aneous</w>
predomin antly</w>
tin g
s chem
bec ame</w>
read y</w>
p us</w>
f ing
in ner</w>
mo bility</w>
adv ances</w>
standardi zed</w>
adi ol</w>
it ment</w>
inser tion</w>
sil ic
1. 8</w>
there by</w>
injec tions</w>
consi sting</w>
respon sive</w>
SE T
epilep sy</w>
reg imen</w>
G er
overex pression</w>
suscepti ble</w>
k in</w>
3. 3</w>
ad renal</w>
H M
recipi ents</w>
cle avage</w>
A b</w>
ph ases</w>
i ance</w>
te tr
carcin omas</w>
ad y</w>
k ly</w>
R is
surro un
oscop y</w>
TI NG</w>
S S
relax ation</w>
don ors</w>
depend ing</w>
br id
T s</w>
pl atin</w>
be d
E ach</w>
lig ands</w>
opi oid</w>
Ch r
AI DS</w>
ex tension</w>
ST R
F ir
ca vity</w>
1. 7</w>
ati g
end ometr
neg atively</w>
p ly</w>
Blo od</w>
contrac tion</w>
pa ired</w>
chol in
l um
idi c</w>
episod es</w>
g ut</w>
pl an
fr acti
extrem ely</w>
depend s</w>
glut athione</w>
rec o
diast olic</w>
nan o
compl ement</w>
ro b
G I
D 1</w>
pre treatment</w>
res ear
practi cal</w>
cl asses</w>
as ingly</w>
ren ess</w>
glyc os
mat uration</w>
am mon
angi otensin</w>
p ass
util ized</w>
v in
m apping</w>
tas ks</w>
i ent</w>
ep it
ic illin</w>
oc ellular</w>
Fol lowing</w>
polymorph isms</w>
le g
cytotox icity</w>
grow n</w>
allow ing</w>
EE G</w>
P 2</w>
path ogens</w>
ser ot
otox in</w>
Child ren</w>
ro se</w>
sp ine</w>
f lo
reco vered</w>
re t
4. 5</w>
plasm id</w>
def ine</w>
clos ure</w>
VE GF</w>
util ity</w>
I f</w>
surve illance</w>
re generation</w>
lo op</w>
d wide</w>
cur ves</w>
A g
path ogenic</w>
de position</w>
F if
M D</w>
S uch</w>
consi der</w>
guid ed</w>
valid ation</w>
20 10</w>
pr o</w>
al ways</w>
man di
os por
incorpor ation</w>
dr y</w>
emph asi
sp ring</w>
en se</w>
coun ts</w>
asym ptomatic</w>
s ome
P S
insi ghts</w>
flu or
sub units</w>
CO 2</w>
arter i
O x
res s
AT Pase</w>
atig ue</w>
trans genic</w>
y le</w>
l amin
20 17</w>
th in</w>
separ ated</w>
refl ect</w>
oper ating</w>
M T</w>
v ic
nic o
col or</w>
p yl
As sociation</w>
ab use</w>
precurs or</w>
drin king</w>
0. 9</w>
cardi omy
A G</w>
enzym atic</w>
si c
me d
A m
favor able</w>
i onic</w>
sc ales</w>
tw are</w>
tw ice</w>
ch ains</w>
Assess ment</w>
lay ers</w>
M ar
E m
onucle ar</w>
candi date</w>
thrombo sis</w>
vol tage</w>
H F</w>
os c
pre lim
macroph age</w>
p p
METHO D</w>
correc tion</w>
Prim ary</w>
ester one</w>
R I
mo stly</w>
temper atures</w>
t an
2 D</w>
ast om
ol e
incre asingly</w>
Ther ap
ST UD
hyd rate</w>
STUD Y</w>
immunos up
L 1</w>
resid ents</w>
om eg
ru ption</w>
pa thetic</w>
in st
inter face</w>
m u
r in</w>
in direct</w>
requ iring</w>
aure us</w>
i etic</w>
ubi qu
ot ting</w>
du od
inf ra
ren e</w>
le x</w>
dr am
suppl ementation</w>
l umbar</w>
fil ms</w>
valu able</w>
adap tive</w>
ana es
P ur
CN S</w>
dec i
agg ressive</w>
defic its</w>
vir ul
predic ting</w>
str ati
f s</w>
H S</w>
or adi
inf erior</w>
par ameter</w>
main tain</w>
sen sus</w>
perme ability</w>
2. 2</w>
commun ities</w>
qu estion</w>
te eth</w>
gi ve</w>
si ties</w>
g over
Pati ent</w>
m ach
1 7.
S V
en coun
categ ories</w>
worl dwide</w>
indic es</w>
attrib uted</w>
pos es</w>
scienti fic</w>
te tra
om s</w>
loc ations</w>
col d</w>
Str uc
ne arly</w>
test osterone</w>
ene sis</w>
ori entation</w>
on dro
b p</w>
hem oglobin</w>
profes sion
ar rest</w>
pr on
Sy stem
coag ulation</w>
P O</w>
influ ences</w>
N OS</w>
ri tic</w>
relap se</w>
ig ible</w>
con sum
Pre vious</w>
bi osynthesis</w>
e w
oc al</w>
20 11</w>
h i
m mol</w>
dec om
cell ul
T ra
impl ants</w>
ac e
erro rs</w>
oti des</w>
predic tor</w>
se e
prote ase</w>
aud itory</w>
require ments</w>
mo vements</w>
CD 8</w>
cl ones</w>
manifest ations</w>
ilib rium</w>
emerg ing</w>
op tions</w>
Ob jec
regul ates</w>
su g
cl ar
g old</w>
unc er
oper ated</w>
L ong</w>
nu tritional</w>
tob acco</w>
n M</w>
repe at</w>
spre ad</w>
E D
PA TI
The ir</w>
exc ess</w>
resi due</w>
R h
mm Hg</w>
abl ation</w>
ve h
impro vements</w>
s clerosis</w>
t ations</w>
li ve</w>
exc it
prelim inary</w>
re mission</w>
comp ens
SET TING</w>
2 5
10 00</w>
pelv ic</w>
om ers</w>
C ar
P T</w>
T R</w>
sep sis</w>
N L
ari ties</w>
o side</w>
pneumon ia</w>
colum n</w>
PATI EN
corne al</w>
fi st
fo ot</w>
sof tware</w>
M I</w>
Jap anese</w>
ga p</w>
ell ed</w>
2. 1</w>
ag land
ag ne
estr adiol</w>
h and
hippocamp al</w>
10 0
advant age</w>
pl ex
0. 7</w>
pl an</w>
struc tion</w>
spectr al</w>
in ating</w>
is ons</w>
fe asibility</w>
lin ed</w>
great ly</w>
C ase</w>
Sur ve
G 1</w>
p s
p ren
ex press</w>
ful ness</w>
d ine</w>
pati onal</w>
estim ation</w>
easi ly</w>
Ris k</w>
occ u
O P</w>
acqu isi
li on</w>
cyt e</w>
hydro ph
ud g
es es</w>
ifor m</w>
W e
4 50</w>
M olecular</w>
re plic
lim its</w>
ti le</w>
de sign
f abr
S ep
om onas</w>
intr insic</w>
aneurys m</w>
simul ations</w>
ol ys
H O</w>
all ergic</w>
vi de
stimul ating</w>
decre asing</w>
E vid
kn ock
su med</w>
scop e</w>
ant um</w>
U se</w>
activ ator</w>
lac king</w>
lyc er
al in</w>
pl ay
opo ietic</w>
promo ting</w>
reas ons</w>
ox y</w>
i ther</w>
gre en</w>
id osis</w>
cop per</w>
tren ds</w>
a que</w>
rheum at
n ers</w>
fund am
clu sters</w>
re ticul
off er</w>
Dop pler</w>
In tr
lip ids</w>
rever sed</w>
evol ution
0.0 3</w>
intro duction</w>
2. 3</w>
induc ing</w>
v ents</w>
depart ment</w>
h er</w>
educ ational</w>
opa usal</w>
lact ate</w>
hom ogene
ab solute</w>
we ak</w>
he ad
D F
per spective</w>
with draw
activ ating</w>
ed ed</w>
vag inal</w>
sch ed
asp ase</w>
antagon ists</w>
ethyl ene</w>
f ro
inter views</w>
un usual</w>
19 .
examin ations</w>
O A</w>
trans lation</w>
loc i</w>
prog esterone</w>
Chang es</w>
ul ative</w>
se di
dis rup
entr y</w>
argin ine</w>
medic ations</w>
hormon es</w>
home ostasis</w>
y r</w>
method ology</w>
ax ial</w>
gu ide</w>
r un
D H</w>
Plas ma</w>
IC U</w>
oun d
adren ergic</w>
D et
malign ancy</w>
osc ill
RO S</w>
s plic
gu inea</w>
A ut
gest ation</w>
c ut
indic ators</w>
ie f</w>
Develop ment</w>
p ent
ep i
tro p
deli vered</w>
re frac
Chr onic</w>
M od
fl ic
correl ate</w>
r icul
ve get
N T</w>
seiz ures</w>
resol ved</w>
barri ers</w>
phen otypes</w>
challeng ing</w>
l ess
en chymal</w>
tran s</w>
Evid ence</w>
micro bi
dra in
in form
C K
MM P</w>
lin k</w>
hypo thesized</w>
datab ases</w>
ow s</w>
rob ust</w>
ip al</w>
thromb in</w>
cap illary</w>
SC C</w>
can n
b is
S e
ste ady</w>
Hy per
anat omical</w>
ob acter
under taken</w>
ol i
c ephal
T ri
ain ts</w>
all ing</w>
fe a
F 1</w>
Al so</w>
dis section</w>
tr ue</w>
top ic</w>
W il
L O
end o
intr am
commerc ial</w>
cap sul
di stress</w>
2. 4</w>
re mark
glyco protein</w>
yiel ded</w>
n one</w>
are t
ra ised</w>
path ogen</w>
ch ers</w>
haz ard</w>
N on
biop sies</w>
Rev ie
cere bro
classi cal</w>
analy tical</w>
6 0
Or g
CL C</w>
subst ances</w>
prec ip
le uc
ox in</w>
P G</w>
n ext</w>
chrom atin</w>
og r
C H</w>
i tive</w>
al ready</w>
particip ation</w>
f atigue</w>
fe wer</w>
in activation</w>
in come</w>
Bi o
ga ve</w>
graf ts</w>
disco very</w>
Si x</w>
P seud
ig aret
lab eling</w>
acquisi tion</w>
diff ered</w>
Rec ently</w>
micro scopic</w>
p toc
charg ed</w>
en sis</w>
arti ficial</w>
compl iance</w>
P M</w>
fl ap</w>
profession als</w>
heterogene ous</w>
m ary</w>
2 3
P ath
eph rine</w>
gest ational</w>
ozyg ous</w>
al anine</w>
di arr
initi ated</w>
Multi ple</w>
c is
typ ically</w>
ev ident</w>
pol ar
amin o
n ose</w>
re in
e in</w>
environ ments</w>
in put</w>
it ems</w>
be y
contrib utes</w>
G E</w>
fil tration</w>
L ow</w>
insi ght</w>
al izing</w>
N o
Fir st</w>
dis play</w>
Par kin
men opausal</w>
og ly
us cular</w>
reve als</w>
n atal</w>
it ec
om ycin</w>
un t</w>
neutr al</w>
provid ers</w>
B R
awa reness</w>
bey ond</w>
electro de</w>
func tion
cont ents</w>
re fer
practi tion
concomit ant</w>
ophil a</w>
de generative</w>
conf ig
T um
H em
ca regi
adju stment</w>
le y</w>
os y
protoc ols</w>
se em</w>
hep arin</w>
dis m</w>
sc aff
mut ag
N TS</w>
G 2</w>
hippocamp us</w>
respon d</w>
su pr
mul tic
review s</w>
con sensus</w>
aut ophag
responsi veness</w>
C are</w>
m atic</w>
soci o
paren tal</w>
I r
con sul
depl etion</w>
mal aria</w>
weigh ted</w>
ampl ification</w>
pers on</w>
I ts</w>
HB V</w>
em por
ads orption</w>
oc cal</w>
G y</w>
b ot
ou ter</w>
H PLC</w>
high light</w>
interpre tation</w>
roph ic</w>
O L</w>
ne ither</w>
determin ants</w>
d yst
tr ained</w>
O ther</w>
detec ting</w>
GAB A</w>
H DL</w>
in os
exc e
an astom
cir cu
S tre
ogra ft</w>
l ibr
inhib iting</w>
AB STR
ub er
l ens</w>
platel ets</w>
acc es
clin icians</w>
immuno deficiency</w>
d less</w>
epider mal</w>
en abl
P H
relev ance</w>
re tri
at yp
it self</w>
Qu anti
t es
por tion</w>
modi fications</w>
incub ated</w>
S te
pre valent</w>
1. 9</w>
ABSTR ACT</w>
impro ves</w>
contro ver
AI MS</w>
m ess
she ep</w>
hospit alization</w>
di l
W OR
atic s</w>
d ates</w>
under go</w>
com pression</w>
U S
ot a</w>
N E
intro duc
syn erg
sou ght</w>
preven ting</w>
N S</w>
prost agland
b al</w>
ti ary</w>
immunoglob ulin</w>
cr y
M AP
5. 5</w>
hydro lysis</w>
S up
av oid</w>
pro ven</w>
ch ondro
scre ened</w>
ig en
D I</w>
diff use</w>
PATIEN TS</w>
For ty</w>
D ru
prec ise</w>
fibr in
N an
F s</w>
clon ed</w>
ha ir</w>
W ith
simil arity</w>
N AD
re ading</w>
attit udes</w>
bre ak
pyl ori</w>
ex clu
B A</w>
G a
lu tin
ma x
enrich ed</w>
2. 6</w>
z o
co ated</w>
un ilateral</w>
creatin ine</w>
st ent</w>
we a
om er</w>
l ost</w>
colon y</w>
por t</w>
en able</w>
inf er
Si x
arch itec
C entr
L ev
port al</w>
A I</w>
ure a</w>
dig ital</w>
yl ic</w>
op tion</w>
bac k
adi ly</w>
rec i
refrac tory</w>
ic ans</w>
pol l
B raz
need le</w>
S oci
embry o</w>
gon ad
N Ps</w>
AT ED</w>
ocor tico
sp ir
perc utaneous</w>
ul t</w>
exclud ed</w>
U NC
ra ys</w>
s a
N on</w>
memb er</w>
agon ists</w>
coag ul
ex ogenous</w>
tend ing</w>
pre d
sub types</w>
identi ty</w>
com pati
P eri
correl ates</w>
.0 0
combin ations</w>
li pos
per for
observ ational</w>
plic ations</w>
pil ot</w>
im mobil
x en
 g</w>
dat as
transcrip ts</w>
T otal</w>
en sion</w>
ar ach
3. 0</w>
c am
ne a</w>
ic les</w>
A B</w>
G T
impl emented</w>
In tern
cortis ol</w>
medi ates</w>
trans location</w>
an ing</w>
norm ally</w>
I C</w>
P oly
A SU
techn ical</w>
co he
p ure</w>
M ech
bil i
is ot
abund ance</w>
c ut</w>
C ells</w>
hom ologous</w>
vis its</w>
c it
S F</w>
amin es</w>
off ers</w>
f all</w>
le aves</w>
ch amb
Parkin son</w>
k ade</w>
os es</w>
pl aque</w>
AC E</w>
inter sti
secre tory</w>
morph ine</w>
P sych
2. 8</w>
gen otypes</w>
lim iting</w>
2. 7</w>
S H
promot es</w>
lo be</w>
WOR DS</w>
ME ASU
on to</w>
spe ech</w>
com es</w>
be am</w>
abs orb
ste ad</w>
reduc tase</w>
pro min
lu te
M at
auth or</w>
tr ic
im id
fundam ental</w>
con stric
obstruc tive</w>
ta il</w>
pro genit
subjec tive</w>
ex ac
re presented</w>
sp ac
ser ine</w>
e j
surviv ors</w>
c igaret
e osin
dimen sions</w>
dos age</w>
enter ic</w>
Signific ant</w>
cover age</w>
ai res</w>
chang ing</w>
Prote in</w>
lea f</w>
un changed</w>
consist s</w>
V ir
pre ad</w>
bre a
as sive</w>
substanti ally</w>
exc ision</w>
surroun ding</w>
suppor ting</w>
di ets</w>
Contro l</w>
pres sions</w>
5 7
suppor ts</w>
itr al</w>
ex ists</w>
h is
ac a
Z n</w>
si zes</w>
pres um
trig lycer
L L
gli al</w>
prob es</w>
ath yro
adolesc ent</w>
hab it
ou gh</w>
ur ity</w>
w estern</w>
chem ically</w>
f ine</w>
n oc
sub set</w>
consist ently</w>
od e</w>
c aspase</w>
cre ated</w>
accep table</w>
bel ong
c l</w>
TR UNC
TRUNC ATED</w>
Com bin
r it
iti n</w>
fo ur
micr o</w>
simul ated</w>
concer n</w>
c ine</w>
trans duction</w>
qu ad
re tur
b lue</w>
M ut
elic ited</w>
fibrill ation</w>
agne tic</w>
9 9
sp in
trans fusion</w>
indic ations</w>
concer ns</w>
evolution ary</w>
emp ir
satur ated</w>
M 1</w>
app ed</w>
resour ce</w>
particip ated</w>
cirrho sis</w>
pres crip
F lu
Ar ab
Res pon
un e</w>
op es</w>
ati le</w>
chrom osomal</w>
T E</w>
A E</w>
E V
6. 5</w>
S el
ra rely</w>
phosphati dyl
agg lutin
pre term</w>
as h</w>
contr acti
pron oun
epidemi ological</w>
D 2</w>
ran e</w>
metabol ite</w>
es pread</w>
r a</w>
oper ations</w>
pol ys
occu pational</w>
sper mat
cy steine</w>
G L
z e
activ ate</w>
trans formed</w>
fal se</w>
5. 0</w>
reg imens</w>
rheumat oid</w>
intrac ranial</w>
equ ilibrium</w>
eli hood</w>
fea sible</w>
be gin
devi ation</w>
te am</w>
in ess</w>
o ing</w>
d ar
intes tine</w>
on ing</w>
sc ans</w>
ca the
a uc
s or
sp in</w>
syn chron
inc id
qu antum</w>
complex ity</w>
AR T</w>
b ed</w>
inter national</w>
re jection</w>
Ph armac
elim ination</w>
som at
gen us</w>
as one</w>
enco ded</w>
mes enchymal</w>
mo tility</w>
retri ev
sci ence</w>
3. 2</w>
sym pathetic</w>
Cur rent</w>
eff lu
ti zed</w>
ec ological</w>
att achment</w>
correc ted</w>
ting ly</w>
sol vent</w>
projec t</w>
infil tration</w>
gir ls</w>
P 3</w>
adi pose</w>
th eses</w>
con str
occ up
dec ades</w>
an emia</w>
oph thal
sup ply</w>
ogen icity</w>
AI N</w>
i dism</w>
abs ent</w>
in stability</w>
su res</w>
M O
al ize</w>
allel es</w>
down stream</w>
0.0 4</w>
hydrox y</w>
pronoun ced</w>
indic ator</w>
paras ite</w>
app a</w>
per man
odi c</w>
t es</w>
ay er</w>
enti ally</w>
carri ers</w>
m id</w>
s ar
ester ase</w>
Bet ween</w>
2 7
con n
Sy stem</w>
Revie w</w>
us h
ep tive</w>
ol ol</w>
techn ologies</w>
G s</w>
te aching</w>
CO PD</w>
sub cutaneous</w>
I R
hepat ocellular</w>
aor ta</w>
alk aline</w>
deci sions</w>
f asting</w>
is ch
situ ation</w>
min eral</w>
tim ing</w>
per in
out patient</w>
bin ds</w>
der mal</w>
ab err
tox ic
H L</w>
bl ack</w>
bili ary</w>
ag e
pl ane</w>
prophyl axis</w>
os ocial</w>
.0 5</w>
et e</w>
serot onin</w>
categ or
3. 1</w>
I L
res sing</w>
K ore
lo aded</w>
res h</w>
St aphyloc
lik elihood</w>
vacc ines</w>
vul ner
as cular</w>
atheros clerosis</w>
res tingly</w>
atin gs</w>
Ig E</w>
og lyc
ph y
begin ning</w>
difficul ties</w>
v ary</w>
carri er</w>
oun ds</w>
M al
Intern ational</w>
2 4
W om
3 -</w>
ann ual</w>
star ting</w>
li th
1 25</w>
chrom osomes</w>
veh icle</w>
H T
nam ely</w>
Identi fication</w>
m T
st art</w>
Un der</w>
r ated</w>
pow er
cyt ometry</w>
mo ther</w>
re ach</w>
f ar
attemp t</w>
discrim ination</w>
ast er
Func tional</w>
5 ,
H F
cy an
wid espread</w>
inter act</w>
to ph
p ump</w>
vis ed</w>
tu ally</w>
G M</w>
G re
1 A</w>
discipl inary</w>
amylo id</w>
S W
ap ical</w>
diagnos es</w>
man aged</w>
monit or</w>
Surg ical</w>
Pre dic
li es</w>
ar is</w>
bloc kade</w>
2. 9</w>
i ae</w>
ter tiary</w>
Immun o
om orph
resear chers</w>
B ar
Incre ased</w>
j udg
ess es</w>
k eletal</w>
neutroph ils</w>
p es
glycer ol</w>
scre en</w>
an tic
dep ri
m ent
adi g
som atic</w>
angi ogenesis</w>
ro tation</w>
form ations</w>
D ros
engine ering</w>
respon dents</w>
P B
hepat ocytes</w>
intersti tial</w>
hydroph obic</w>
trans mit
verte bral</w>
neutroph il</w>
regar dless</w>
carbo hydrate</w>
tac hy
200 9</w>
selec tively</w>
ultras on
H a
modul ate</w>
be g
volum es</w>
E GFR</w>
Jap an</w>
My co
differenti ally</w>
pancre as</w>
intra operative</w>
T e
ir radi
mil lion</w>
recru itment</w>
cis platin</w>
R 1</w>
emerg ed</w>
hist amine</w>
inter n
Ac cording</w>
pro spectively</w>
c ro
invol ve</w>
uc tu
Dros ophila</w>
Wom en</w>
ot es</w>
S 1</w>
leth al</w>
am ycin</w>
P o
con flic
satisfac tory</w>
O ver</w>
In dex</w>
sens or</w>
main taining</w>
as y</w>
quanti fied</w>
plat form</w>
Afr ica</w>
odi alysis</w>
ref lex</w>
phen otypic</w>
P L</w>
t uring</w>
immunohisto chemistry</w>
idi opathic</w>
organis m</w>
competi tive</w>
ath ing</w>
gl auc
res ses</w>
ens ure</w>
b ol
str ial</w>
bre ak</w>
phil ic</w>
atyp ical</w>
post natal</w>
for ces</w>
M HC</w>
iv es</w>
ma kes</w>
gl ands</w>
transpor ter</w>
h old</w>
v .</w>
J une</w>
m itral</w>
part um</w>
A E
Sub jec
Ig M</w>
CR P</w>
princi ples</w>
ur g
f low
ul y</w>
pro per</w>
e ating</w>
quanti fication</w>
I P</w>
fer til
Elec tr
great est</w>
suff ering</w>
ses sions</w>
g all
sup pressor</w>
transf ected</w>
end s</w>
mamm ary</w>
secre ted</w>
U p
represent ative</w>
3. 6</w>
H ep
hist ologic</w>
at rophy</w>
l ist</w>
sus pen
ong oing</w>
out side</w>
cardi a</w>
cl onal</w>
follow s</w>
r ice</w>
T 4</w>
construc t</w>
con sequence</w>
perform ing</w>
sol ub
. S
y ed</w>
C 1</w>
lin king</w>
effici ents</w>
ann ed</w>
aca demic</w>
V I</w>
3. 8</w>
par adig
ol ed</w>
sc en
le g</w>
ma p</w>
6. 7</w>
R H</w>
mis sions</w>
sub group</w>
2 6
H igh
sha red</w>
lun gs</w>
echocardi ography</w>
assess ments</w>
S O</w>
sequ ential</w>
abol ic</w>
M AIN</w>
H ere
inter ference</w>
bacter i
endometr ial</w>
immunohisto chemical</w>
elucid ate</w>
infil tr
lab el</w>
In dia</w>
pre ferred</w>
accur ately</w>
CR C</w>
ha pl
p g</w>
ta kes</w>
Staphyloc occus</w>
contamin ation</w>
stimul ate</w>
new born</w>
z er
de press
B re
4. 7</w>
mon ol
c ation</w>
questionn aires</w>
integr ity</w>
effici ently</w>
ventr al</w>
u g
re modeling</w>
regul ator</w>
eth asone</w>
malign ancies</w>
withdraw al</w>
on line</w>
se ed</w>
mon ella</w>
ograph s</w>
S F
C o</w>
pro ton</w>
con g
ul der</w>
P ot
lin kage</w>
t ext</w>
em bed
incorpor ated</w>
ulc er</w>
cat ech
unc ture</w>
G r
ac ous
surge ons</w>
ac tual</w>
S ci
Inte restingly</w>
St atis
enhanc ing</w>
biomar ker</w>
ox idi
produc es</w>
termin ation</w>
super oxide</w>
v a</w>
drain age</w>
vi sible</w>
st o
adi p
der m
abund ant</w>
phosphor ylated</w>
deter i
s we
fl uctu
f aster</w>
cum ulative</w>
et on</w>
ho use
Gen etic</w>
U K</w>
ro ute</w>
prec ision</w>
co efficients</w>
larg est</w>
expl an
ogr ams</w>
b rom
h e</w>
lo x
S equ
y ces</w>
MEASU RE
con formation</w>
an ch
M L
compar isons</w>
sum mary</w>
path ologic</w>
f atal</w>
b ands</w>
oc in</w>
C V</w>
hem is
sub type</w>
gener alized</w>
substitu tion</w>
op enia</w>
ure th
c ement</w>
pan el</w>
hypertroph y</w>
im etr
iev ed</w>
Ch em
stom ach</w>
o x</w>
t us</w>
strom al</w>
B acter
az ine</w>
f resh</w>
toler ated</w>
ic k</w>
del e
om otor</w>
vi able</w>
bro ad
repres enting</w>
inos itol</w>
ul tim
2 A</w>
d ly</w>
induc ible</w>
hy pot
ner ves</w>
distin c
v ital</w>
ra dic
D G</w>
las tic</w>
deriv ative</w>
promin ent</w>
abol ished</w>
id ae</w>
suic ide</w>
compl ementary</w>
demonstr ating</w>
T M
random ised</w>
N A
respon ded</w>
pr an
omer ic</w>
over view</w>
or a</w>
f f</w>
countr y</w>
re adily</w>
glomer ular</w>
der ing</w>
en cour
n ever</w>
ob acter</w>
ra in</w>
consider ation</w>
R ole</w>
promot ed</w>
C X
pre mature</w>
oc ca
Di ab
wid th</w>
Dru g</w>
eg g</w>
hist one</w>
4. 2</w>
r ace</w>
ne igh
enh ances</w>
dis sem
bri ef</w>
mi RNAs</w>
g ing
str and</w>
distrib utions</w>
i x</w>
paren tly</w>
7 0
autom ated</w>
ch im
par athyro
n ight</w>
v an
hem odynamic</w>
th reat
I tal
de pressed</w>
selec tivity</w>
oste opo
sur vi
osi tion</w>
ach e</w>
grad u
t ability</w>
k appa</w>
for ward</w>
to oth</w>
impl anted</w>
predomin ant</w>
dimin ished</w>
descrip tion</w>
eff ort</w>
A V</w>
ol amine</w>
wor se</w>
myel oid</w>
lo g</w>
polyp eptide</w>
endoth elium</w>
vascul arization</w>
mod alities</w>
calcul ations</w>
stud ying</w>
neo plastic</w>
pe di
t ative</w>
D 3</w>
a udi
shap ed</w>
rup ture</w>
dis ruption</w>
2 8
ul atory</w>
fil am
pro t
dis c</w>
dend ritic</w>
defic it</w>
ec tions</w>
Sal monella</w>
quanti fy</w>
th eless</w>
no ver</w>
Ig A</w>
ever theless</w>
mandi bular</w>
S ym
si al</w>
gener ating</w>
tr ic</w>
sti ff
tre e</w>
T G</w>
pe d
cy st</w>
micro som
I A</w>
p assive</w>
j ust</w>
n mol</w>
stand ards</w>
3. 4</w>
tis m</w>
otox icity</w>
in her
ol ym
F our
1 -</w>
pre ference</w>
ker at
di al</w>
b er
al c
p e</w>
f ts</w>
mon ocytes</w>
I s
ic ardi
ish ment</w>
exac erb
ev ent
s arcoma</w>
As soci
oxy gen
Qu ality</w>
L ab
t ab
8. 5</w>
add ressed</w>
s ent</w>
cat tle</w>
op sis</w>
V al
autophag y</w>
yiel ds</w>
contr al
Un der
os ing</w>
substitu ted</w>
protec ted</w>
pregn ancies</w>
c ats</w>
infra red</w>
squ are</w>
tryp sin</w>
l d</w>
particip ate</w>
ur on
comput ational</w>
ter al</w>
I mp
vas o
co vered</w>
Nor th</w>
sc ap
con sci
NS CLC</w>
E 1</w>
disco vered</w>
fol ding</w>
ca ud
cyto plasm</w>
immun ization</w>
wal king</w>
percep tions</w>
Org an
TI ONS</w>
en erg
instrum ent</w>
mod ality</w>
expl o
fac tory</w>
tend on</w>
iso forms</w>
H O
gen ce</w>
S ingle</w>
mo bile</w>
N ot
ke ys</w>
min er
trac tion</w>
virul ence</w>
physi ology</w>
w in
process ed</w>
oste o
pot ency</w>
ech n
bo ys</w>
nutri ent</w>
CA D</w>
man u
j o
compr ised</w>
m om
perman ent</w>
ne gl
In flu
plac ental</w>
A k
consider ably</w>
ar ticular</w>
mar k</w>
dis sociation</w>
ab sc
Hy dro
wa vel
an ical</w>
repe ti
nur se</w>
no vi
4. 4</w>
accoun ted</w>
i m</w>
per oxidase</w>
f ur
gene tically</w>
il e
4. 3</w>
4. 0</w>
gu an
200 8</w>
Co x</w>
gluc ocortico
u ous</w>
bloc king</w>
post operatively</w>
form ulation</w>
por cine</w>
ver tical</w>
princ ipal</w>
pos sess
gl ass</w>
cri tically</w>
pathophysi ology</w>
propor tional</w>
reduc tions</w>
if er
radi ographic</w>
f el
kin ases</w>
experim entally</w>
- -</w>
t um</w>
us c
carr ying</w>
hemat opoietic</w>
3. 7</w>
Fif ty</w>
condi tioning</w>
si um</w>
ul ating</w>
off spring</w>
AD P</w>
micro tub
foc using</w>
M arch</w>
M C</w>
neuro pathy</w>
P N</w>
tur nover</w>
v acu
intr aper
immun ological</w>
immuno assay</w>
re combination</w>
over come</w>
hemis ph
W T</w>
pyr id
seiz ure</w>
c ocaine</w>
inf u
to p</w>
Pseud omonas</w>
bi di
se e</w>
consider ing</w>
ic king</w>
H D
acu ity</w>
e res</w>
E F</w>
M ed</w>
star ted</w>
f if
transl ational</w>
peri od
re turn</w>
a virus</w>
scen ari
der mat
lat ency</w>
PK C</w>
el ong
sub groups</w>
A ge</w>
my co
pres sures</w>
 B</w>
Elec tro
12 5
ec tom
min ute</w>
el igible</w>
fin ed</w>
dep end</w>
20 18</w>
pan ic</w>
promis e</w>
2 9
o ocytes</w>
adap ted</w>
pren atal</w>
ther mo
P res
acous tic</w>
at o</w>
A UC</w>
H b
for ced</w>
ret ar
E GF</w>
bloc ks</w>
sul ph
ex on</w>
fibrobl ast</w>
orb ent</w>
immunore activity</w>
e asy</w>
4. 1</w>
prostagland in</w>
P u
Inhib ition</w>
visi t</w>
defin ition</w>
R F
Di rec
ventr icle</w>
osi tive</w>
Objec tive</w>
os us</w>
ste in</w>
mod es</w>
protec t</w>
ap parently</w>
c ran
oz o
S B
tr aff
sha m</w>
moder n</w>
v ae</w>
un affected</w>
prop ag
on ed</w>
pap ill
I D</w>
E lev
radi ological</w>
met allo
R etro
re tained</w>
to ok</w>
Com pl
be an</w>
ad a</w>
T T</w>
0. 0</w>
situ ations</w>
ec on
in suffici
pro mp
mod ulated</w>
chamb er</w>
equ ation</w>
I sol
SE M</w>
ac idic</w>
ju red</w>
sem i</w>
in ally</w>
contral ateral</w>
dy e</w>
embol ism</w>
alter ation</w>
contin ue</w>
4. 6</w>
encoun tered</w>
p .
de form
k b</w>
fe ed</w>
AT A</w>
T en</w>
In iti
preven tive</w>
manu fac
hyper plasia</w>
B o
view ed</w>
recor ding</w>
if e</w>
av ing</w>
fill ed</w>
w ast
eu tical</w>
os ens
az ep
H e</w>
Surve y</w>
N C</w>
M B
bon ds</w>
can al</w>
imp acts</w>
ch olec
syndrom es</w>
or ally</w>
g el
C y
c is</w>
dec ade</w>
id ation</w>
S ol
regi stered</w>
I D
famil ial</w>
- 2</w>
mon onuclear</w>
Sel f</w>
irradi ated</w>
ag ic</w>
he ar
ar ched</w>
ass embl
shor ten
om eter</w>
co d
8 0
H ear
optim ized</w>
power ful</w>
psych osocial</w>
5. 6</w>
ic als</w>
H 2</w>
de pos
row th</w>
ep tor</w>
top ical</w>
acchar ides</w>
institu tion</w>
S A
sign alling</w>
re d
his ti
do x</w>
le ge</w>
est yle</w>
ro ots</w>
practition ers</w>
eu kary
anes the
retin a</w>
ere ly</w>
G ene</w>
d al
P K</w>
cy sts</w>
hom ology</w>
C d
R 2</w>
M or
plas ticity</w>
c as
contrib uting</w>
E P</w>
isol ate</w>
aut ologous</w>
fr on
P erc
gen cy</w>
C d</w>
rou gh
1 80</w>
i asis</w>
in jured</w>
Dep art
ri l</w>
ff e
conform ational</w>
in n
pre disp
wee kly</w>
conn ected</w>
zym e</w>
programm e</w>
fracti on
whe at</w>
N s</w>
et a</w>
0.00 5</w>
sen sing</w>
z en</w>
ch ro
cop y</w>
sug ar</w>
aff eren
i er</w>
Fac tors</w>
R P</w>
Ta ken</w>
se arched</w>
ul cer
L ym
compart ment</w>
C enter</w>
prescrib ed</w>
B 2</w>
int ell
can ine</w>
Soci ety</w>
P F</w>
B D
glauc oma</w>
hormon al</w>
phosph o
brea ks</w>
stre t
highligh ts</w>
EC G</w>
M ed
anat omy</w>
an thro
With in</w>
s n
facil ities</w>
epti des</w>
el astic</w>
exhib its</w>
ran k</w>
el ve</w>
w ash
op ulmonary</w>
b ound
D ue</w>
ac ks</w>
ath l
ac etic</w>
bronch ial</w>
discus sion</w>
neur on</w>
atter ing</w>
buff er</w>
Qu estionn
recor d</w>
st one</w>
hor iz
bidi ties</w>
pro l
sho ulder</w>
w k</w>
saliv ary</w>
form er</w>
ex act</w>
candi dates</w>
em ul
bal lo
arrang ement</w>
reticul um</w>
lab elled</w>
4. 8</w>
tur ally</w>
phospholip id</w>
reas on</w>
Im pro
st ain
5. 7</w>
arom atic</w>
cat ar
phen ol</w>
en larg
dig estion</w>
c ows</w>
rel ations</w>
do g</w>
radi al</w>
m olar</w>
accep ted</w>
po ol</w>
s low
V er
ocom pati
in side</w>
3 5
ex pressions</w>
tra it</w>
clin ic
en in</w>
contrib uted</w>
indu stry</w>
per m
d ur
diarr he
C r</w>
m ers</w>
ex ec
acr yl
differenti ate</w>
ucle ar</w>
fr ame</w>
cap ture</w>
fist ula</w>
clim ate</w>
Character ization</w>
architec ture</w>
os arcoma</w>
u gin
electro des</w>
sev erely</w>
bre athing</w>
T est</w>
g one</w>
em a</w>
or dered</w>
am ethasone</w>
g ate</w>
rou ght</w>
ap o
J uly</w>
deta il</w>
dem and</w>
su d
con duction</w>
9. 5</w>
H P</w>
bio tic</w>
difficul ty</w>
M ay</w>
us ting</w>
phyl ogenetic</w>
el in</w>
un related</w>
aer ugin
EC T</w>
cre ate</w>
guid ance</w>
oxy genase</w>
d in
rele asing</w>
omat ous</w>
erythro cytes</w>
hist or
D IN
stiff ness</w>
pur ification</w>
nat ur
tub ular</w>
S w
strong er</w>
lar vae</w>
com for
sc attering</w>
disturb ances</w>
as ked</w>
L V
di vision</w>
CM V</w>
m RNAs</w>
Can di
P ub
aerugin osa</w>
P RO
7. 4</w>
h n</w>
duc ts</w>
per tur
pancre atitis</w>
aster n</w>
amin ation</w>
combin ing</w>
vide o</w>
fre e
exc essive</w>
Here in</w>
ple ural</w>
g els</w>
cul tural</w>
M s</w>
cord ance</w>
M ac
H is
am bul
F l
N E</w>
c asc
hospit alized</w>
retur ned</w>
otyp ing</w>
opportun ities</w>
require ment</w>
T F
Man agement</w>
pal li
en ables</w>
person ality</w>
med ull
re dox</w>
moti f</w>
C 3</w>
connec tivity</w>
SL E</w>
f ies</w>
vi br
trache al</w>
l ands</w>
acetyl choline</w>
neon ates</w>
andro gen</w>
graph y</w>
Be havi
M g
2 2
war ran
con current</w>
G P</w>
amin ergic</w>
VI D</w>
Meas ure
5. 2</w>
nico tine</w>
ej un
L in
s ess</w>
w s</w>
S ou
curren ts</w>
o idal</w>
dis placement</w>
N one</w>
ca dian</w>
exc itation</w>
coord ination</w>
ker atin
in ic</w>
gly col
un common</w>
met als</w>
lymph oid</w>
on ia</w>
i. v.</w>
ge red</w>
chic ken</w>
o es</w>
wor ds</w>
ses sion</w>
e gg
3. 9</w>
lig ament</w>
5. 3</w>
bor ne</w>
st aging</w>
ren in</w>
U .S
sph er
fac es</w>
In c
pneumon iae</w>
kin in</w>
com b
O UT
am bi
e y</w>
indic ation</w>
P SA</w>
bre eding</w>
optim ization</w>
cellul ose</w>
ub icin</w>
200 7</w>
ca us
sur ance</w>
obl astoma</w>
cholin ergic</w>
log ical</w>
n em
pl ates</w>
spont aneously</w>
Differen t</w>
super ficial</w>
k ap
t ex
200 5</w>
fo ods</w>
suppl emented</w>
P an
sp p</w>
leuk ocyte</w>
Ph ot
cereb ellar</w>
ger m</w>
nod ules</w>
it em</w>
ther mia</w>
mus cular</w>
OUT CO
Depart ment</w>
ace ae</w>
S even</w>
dys plasia</w>
idi um</w>
system atically</w>
er ia</w>
0.00 2</w>
inc ident</w>
sat uration</w>
mat ch</w>
tes ticular</w>
1 10</w>
Im port
retro viral</w>
categ ory</w>
de m</w>
per oxide</w>
exclu sively</w>
Mo del</w>
yt e</w>
ophil ic</w>
weigh ts</w>
surge on</w>
effec tor</w>
rest ored</w>
analog ues</w>
insuffici ency</w>
R T
A pri
concep ts</w>
to o</w>
line age</w>
E igh
as part
A 1
E l
est ed</w>
hist ology</w>
T ime</w>
Z n
dec lined</w>
empir ical</w>
in hal
ili ary</w>
ol es</w>
clar ify</w>
arb ox
Apri l</w>
N 1</w>
ob lastic</w>
eng er</w>
flex ible</w>
in stead</w>
S 2</w>
vec tors</w>
foll icular</w>
over weight</w>
aspir ation</w>
plas ms</w>
G SH</w>
tain ty</w>
anti tumor</w>
Ad mini
anti depress
equ ally</w>
at omic</w>
vas odi
fru it</w>
G iven</w>
rhyth m</w>
n t</w>
INT ER
hel p
En gl
r ag
cr yp
fil ter</w>
T i
ev id
refer ral</w>
bel ieved</w>
chem icals</w>
re flux</w>
Simil ar</w>
embed ded</w>
analog ue</w>
E ight</w>
t esti
op posite</w>
p es</w>
olog ist</w>
suc rose</w>
algorith ms</w>
r RNA</w>
14 C</w>
libr ary</w>
conf oun
ti g
N ur
s light</w>
K n
j ejun
20 01</w>
d l</w>
S we
n c
head ache</w>
fit ness</w>
pro v
kap pa
grad ually</w>
orb ital</w>
acceler ated</w>
com orb
L T</w>
aneurys ms</w>
enc ap
li pop
stabil ization</w>
Subjec ts</w>
cy st
mar ine</w>
t one</w>
am p</w>
an k</w>
ps ori
Ad v
bi polar</w>
acet yl</w>
appro ved</w>
G I</w>
R F</w>
199 9</w>
condi tioned</w>
den se</w>
util izing</w>
fer tility</w>
ju ven
col itis</w>
sh ear</w>
sy novi
tend ency</w>
Euro pe</w>
objec t</w>
anomal ies</w>
Engl ish</w>
g ated</w>
19 90</w>
cataly zed</w>
surve ys</w>
us ti
con ven
use fulness</w>
under gone</w>
Hear t</w>
quin ol
kidne ys</w>
L S</w>
c at</w>
ex tra
Com mun
pol i
lep tin</w>
c ef
M SCs</w>
ax el</w>
b ab
ery them
Tum or</w>
200 6</w>
am ni
alk al
emph asis</w>
Ul tr
expos ures</w>
un g</w>
ethn ic</w>
de man
tub ation</w>
G n
2 8.
sw elling</w>
hear ts</w>
ab in
omer ase</w>
arthro plasty</w>
9 0
conserv ative</w>
ob i
help ful</w>
R a
contin ence</w>
lu pus</w>
an al</w>
cul tiv
controver sial</w>
at oms</w>
Centr al</w>
osyn thetic</w>
O C</w>
mus cul
wavel eng
N MDA</w>
Experim ental</w>
En h
perf used</w>
distingu ish</w>
C K</w>
di hydro
loc ally</w>
V is
dri ving</w>
period ontal</w>
C oun
Syn thesis</w>
6. 2</w>
199 8</w>
immuno fluorescence</w>
6 00</w>
ga it</w>
CA M</w>
ir ation</w>
D em
statis tics</w>
om ing</w>
sh are</w>
bir ds</w>
C ro
trans membrane</w>
Diag nos
olys accharide</w>
col onic</w>
Out comes</w>
esc ent</w>
V T</w>
compati ble</w>
5. 8</w>
repor ter</w>
at onin</w>
pat ch</w>
DI SC
sel ves</w>
refl ected</w>
mi RNA</w>
6. 3</w>
spec tives</w>
ch le
0.00 0
lif estyle</w>
in active</w>
upreg ulated</w>
ide al</w>
BM D</w>
align ment</w>
Surg ery</w>
peri operative</w>
dar k</w>
Q o
5. 4</w>
N evertheless</w>
e an</w>
F am
adren aline</w>
conjug ated</w>
vi r</w>
fin anc
pharmaco kinetic</w>
anti viral</w>
cess ation</w>
Tran sc
er arch
l uc
L A
Co A</w>
B G</w>
antic ancer</w>
Quanti tative</w>
SI ON</w>
ster ing</w>
mo od</w>
hypothalam ic</w>
four th</w>
cl one</w>
U r
gover n
sc al
pos sess</w>
6. 4</w>
ure tic</w>
trig gered</w>
opath ological</w>
dom es
S D
tum orig
d ent
ac ch
H 1</w>
s a</w>
opportun ity</w>
inten se</w>
M AP</w>
Simil arly</w>
recor dings</w>
ocy an
vis c
ep igen
Austral ia</w>
el eton</w>
ST AT
dex amethasone</w>
o ural</w>
fl ur
MAP K</w>
S c
Au g
glob ulin</w>
w aves</w>
G ol
preser vation</w>
ion ine</w>
res embl
op ia</w>
press es</w>
centr e</w>
us age</w>
analge sia</w>
In divid
SN Ps</w>
T o
off ered</w>
Questionn aire</w>
plac ent
C yt
ex ual</w>
att ached</w>
ballo on</w>
transfer red</w>
TB I</w>
es are
b und
cran i
ag ue</w>
prescrip tion</w>
ist ar</w>
ank le</w>
k le</w>
ell ite</w>
lif e
6. 8</w>
6. 6</w>
or ial</w>
us er</w>
examin ing</w>
par tly</w>
F uture</w>
os ensi
gen omes</w>
por e</w>
mit tent</w>
str ic</w>
b ic</w>
pr is
an ion</w>
th in
Det ection</w>
dos ing</w>
l en
C er
bil ities</w>
S DS</w>
7. 8</w>
aro se</w>
ost omy</w>
omeg al
influ encing</w>
attemp ts</w>
s cler
rib onucle
me al</w>
Mech anis
P P
E r
Six ty</w>
hem odialysis</w>
preser ved</w>
CA 1</w>
paradig m</w>
M V
exam ples</w>
An aly
investig ating</w>
duod enal</w>
olig onucle
os en</w>
neo plasms</w>
b a
in sufficient</w>
I S</w>
en vel
C och
gli oma</w>
v ast
cytos olic</w>
Ak t</w>
coh orts</w>
7. 1</w>
esare an</w>
exten sively</w>
v ill
F O
G ram</w>
po oled</w>
di methyl
qu it
19 95</w>
medi ators</w>
op ening</w>
V i
A sian</w>
precurs ors</w>
y outh</w>
Sep t
ag o</w>
us h</w>
ag ain</w>
199 7</w>
le ad
acryl amide</w>
socio economic</w>
remark able</w>
alcoh olic</w>
neu rom
lab or
St ate</w>
en ium</w>
T 2
res tim
func tionally</w>
diff r
de b
Bac illus</w>
id ase</w>
epidemi ology</w>
W istar</w>
immun otherapy</w>
l a</w>
at om</w>
ob ut
F IN
tra jec
ic ations</w>
L .</w>
re mia</w>
ogen es</w>
ol factory</w>
up stream</w>
AD HD</w>
CO VID</w>
R an
C ap
pros thesis</w>
dist ant</w>
I T
Qo L</w>
G O</w>
uni versity</w>
homogene ous</w>
them selves</w>
mig r
an aerobic</w>
Differen ces</w>
CO X</w>
em ed</w>
R am
F SH</w>
bo x</w>
ampl ified</w>
Sept ember</w>
go als</w>
aspec t</w>
ultrason ography</w>
gangli on</w>
st a
s ound</w>
od g
m osph
st ress
Pub Med</w>
DISC US
threat ening</w>
6. 0</w>
dram atically</w>
assi st</w>
N ov
Wor ld</w>
mon keys</w>
ax ons</w>
pharmaco kinetics</w>
0. 25</w>
mix tures</w>
200 2</w>
low ering</w>
125 I</w>
osteopo rosis</w>
tan dem</w>
a emic</w>
val id</w>
instrum ents</w>
M i
C 57
le ak
electro l
bec omes</w>
physi ologic</w>
def ense</w>
ch osen</w>
transcrip t</w>
pred n
extr a</w>
M A
ser ial</w>
inn ate</w>
4 5
DISCUS SION</w>
hel ix</w>
Admini stration</w>
x ia</w>
CV D</w>
qu ite</w>
flex ion</w>
os mo
P U
U.S .</w>
hydr ation</w>
Imp act</w>
En ter
obl asts</w>
biom ass</w>
emergen ce</w>
protein ase</w>
exp anded</w>
ish es</w>
M 2</w>
tob er</w>
cir cadian</w>
res in</w>
ograph ical</w>
glomer ul
appl ying</w>
Con tr
ati cal</w>
adj usting</w>
simil arly</w>
contamin ated</w>
ogene ic</w>
C 2</w>
T arg
ammon ium</w>
en ess</w>
B one</w>
L a</w>
immunore active</w>
anal og</w>
st ored</w>
anc h</w>
T re
exp on
Oc tober</w>
graph ene</w>
an tic</w>
caregi vers</w>
shif ts</w>
id opsis</w>
spec imen</w>
in verse</w>
ent ations</w>
ic ated</w>
proper ty</w>
ver sal</w>
te trac
rel ief</w>
egg s</w>
an g</w>
avi an</w>
pp m</w>
f ash
B rain</w>
man ual</w>
sol ved</w>
M g</w>
def ective</w>
PE G</w>
se c</w>
cigaret te</w>
m ium</w>
ra ine</w>
g yn
lys ine</w>
r ic
no re
5. 1</w>
H odg
config uration</w>
through put</w>
199 6</w>
progenit or</w>
si bility</w>
ov ary</w>
termin us</w>
histopath ological</w>
ar sen
Arab idopsis</w>
some times</w>
ptoc occus</w>
my o
nov o</w>
ta il
bur n</w>
ther m
compl etion</w>
diarrhe a</w>
In stitute</w>
ec osy
nucle otides</w>
7. 2</w>
chec k
at ch</w>
clu sive</w>
in tim
fung i</w>
No vel</w>
gli a</w>
clin ics</w>
t ap
natur ally</w>
anat omic</w>
bl ing</w>
B cl</w>
x y
occ i</w>
M O</w>
microbi ota</w>
Therap y</w>
descrip tive</w>
zer o</w>
Me dian</w>
mod elling</w>
w t</w>
the size</w>
on yl</w>
in complete</w>
ain t</w>
cardiomy opathy</w>
conduc tance</w>
compr ising</w>
am eli
SO D</w>
ti tis</w>
Medic ine</w>
G MP</w>
inter view</w>
B B</w>
graf ting</w>
2 9.
ation ally</w>
schem e</w>
un iform</w>
seas on</w>
aqu es</w>
cont ex
psych otic</w>
n as
acc ess
predic tions</w>
G T</w>
ch i
contrib utions</w>
over l
1 a</w>
m um
ob last</w>
see king</w>
visi ae</w>
ing u
op sy</w>
sud den</w>
mat ching</w>
R I</w>
Hodg kin</w>
F GF</w>
er o
fro zen</w>
cere visiae</w>
sc oring</w>
viol ence</w>
4. 9</w>
micro scope</w>
T SH</w>
CI PA
a red</w>
on ectin</w>
St and
anthro p
s me
scho ols</w>
v esti
mi as</w>
neurolog ic</w>
Th en</w>
ro bo
200 4</w>
depri vation</w>
bl ast
a w</w>
ere bral</w>
otox ic</w>
7. 3</w>
un able</w>
Nor thern</w>
const ants</w>
Na Cl</w>
aspart ate</w>
gran ules</w>
leuk ocytes</w>
PT SD</w>
cal ib
erythro cyte</w>
T ur
C at
bl in
R B
7. 0</w>
otrop in</w>
pl oid</w>
Spec ific</w>
H b</w>
ph yto
o ther
construc tion</w>
A SD</w>
ma them
e jection</w>
part ners</w>
1 40</w>
C ross</w>
ph age</w>
magne sium</w>
T F</w>
fib res</w>
ti p</w>
f ri
W HO</w>
CK D</w>
B AL
cros s
ost atin</w>
P N
F F
cycl ase</w>
d ox
strati fied</w>
6. 1</w>
M M</w>
H ence</w>
rap h</w>
co chle
las ting</w>
cycl in</w>
athl etes</w>
myocardi um</w>
as sumed</w>
wast e</w>
An ti</w>
s ing
pre -</w>
H SV</w>
Braz il</w>
respon ders</w>
aw are</w>
pu ts</w>
I U</w>
fash ion</w>
de t
a u</w>
S K
discus ses</w>
pin ephrine</w>
fing er</w>
aspir in</w>
cu es</w>
C ul
minim ally</w>
equ ip
ynam ic</w>
tr unc
anis h</w>
di c</w>
EC s</w>
lab or</w>
bul k</w>
MATERI AL</w>
numer ical</w>
th o
2. 0
dem ia</w>
j usti
mamm als</w>
competi tion</w>
iz umab</w>
lig ation</w>
dex tr
v ent
FIN DIN
sh ar
Candi da</w>
M V</w>
G R</w>
glyc ine</w>
trans mitted</w>
M B</w>
- 3</w>
ur ic</w>
pri vate</w>
P a</w>
n al
ifor m
N in
rest oration</w>
B ur
kappa B</w>
p to
T er
coun sel
O ral</w>
ver ified</w>
st ac
si fication</w>
trig g
g yr
E M</w>
electro chemical</w>
ar ising</w>
addi tive</w>
B A
Q OL</w>
mach ine</w>
ol er
sil ver</w>
thresh olds</w>
FINDIN GS</w>
in formed</w>
trac king</w>
contracti le</w>
enco des</w>
Ac tivity</w>
cler otic</w>
m ast</w>
op s</w>
me an
ac yl
in adequate</w>
T ox
lev i
im mature</w>
EB V</w>
OUTCO ME</w>
efflu x</w>
ph asic</w>
gal act
g p
R ap
f ear</w>
polic ies</w>
et amine</w>
c ranial</w>
su m</w>
medi ating</w>
AC S</w>
immun op
p .</w>
Compar ative</w>
est ers</w>
or ubicin</w>
AC TH</w>
Sur viv
troph ic</w>
consist ency</w>
7. 6</w>
AM L</w>
enrich ment</w>
ol in</w>
Myco bacterium</w>
5. 9</w>
indu strial</w>
op in
ist er</w>
h eld</w>
pol lution</w>
interpre ted</w>
continu ously</w>
adren oc
d L</w>
a dic
ti um</w>
prost atic</w>
cir cular</w>
optim um</w>
cop ing</w>
- 5</w>
1 30</w>
quantit atively</w>
b if
In formation</w>
bl otting</w>
fal ls</w>
ti bial</w>
flu ids</w>
umb il
G rowth</w>
s ac
design ated</w>
paras ites</w>
u tri
P RE
en anti
m enti
Ph osph
ch el
aut onomic</w>
C u
anti bacterial</w>
w ards</w>
epigen etic</w>
m aps</w>
arom yces</w>
pl anned</w>
at mosph
lam p
g es</w>
separ ately</w>
ell es</w>
hypox ic</w>
conserv ation</w>
lox acin</w>
per oxidation</w>
fill ing</w>
gene sis</w>
sh ell</w>
O VA</w>
Ex pos
H I</w>
polym ers</w>
de ed</w>
bi a</w>
N T
an ium</w>
j our
max illary</w>
applic able</w>
an o
aut osomal</w>
L s</w>
cerebro spinal</w>
br anch</w>
te e</w>
Fin dings</w>
promis ed</w>
persist ence</w>
e es</w>
ger min
tri ple</w>
Can ada</w>
moder ately</w>
p uber
t RNA</w>
inte resting</w>
gi ant</w>
py ru
. 01</w>
stit utes</w>
g ri
x yl
en ough</w>
ho sts</w>
en demic</w>
ex clusion</w>
la p</w>
achiev ing</w>
g ives</w>
AC h
sh e</w>
inter mittent</w>
al ised</w>
Ph ase</w>
ver bal</w>
sc in
transpl anted</w>
ut able</w>
G D</w>
a ur
pur poses</w>
epi demic</w>
acch aromyces</w>
200 3</w>
my osin</w>
199 4</w>
elucid ated</w>
per spectives</w>
leak age</w>
S am
m ill
ec lamp
R o
super nat
re vision</w>
testi s</w>
f os
in patient</w>
pro motion</w>
fet uses</w>
7. 7</w>
ost atic</w>
recomm end</w>
manip ulation</w>
ta u</w>
ac yl</w>
post partum</w>
abnormal ity</w>
M ic
rou tin
bon ding</w>
haem at
umin escence</w>
on ally</w>
Retro spective</w>
edi c</w>
ad y
iv al</w>
T N
if ug
bio film</w>
mas sive</w>
par i
t ary</w>
accum ulated</w>
non invasive</w>
sc ar
micro organisms</w>
behavi oural</w>
SI S</w>
cryst als</w>
correc tly</w>
Statis tical</w>
4 -</w>
exp ensive</w>
ambul atory</w>
C ir
S ocial</w>
1 01</w>
anaes thesia</w>
ca usal</w>
s s</w>
H ER
repres entation</w>
ti ally</w>
6. 9</w>
C N</w>
ad dic
cour ses</w>
ho use</w>
des c
con vul
li p</w>
ip si
K A</w>
diffr action</w>
os yl
Coch rane</w>
os an</w>
c ally</w>
suspen sion</w>
integr in</w>
tachy cardia</w>
8. 3</w>
iod ine</w>
N R
He pati
Pro spective</w>
pharmac eutical</w>
Con si
GF P</w>
adop ted</w>
sil ica</w>
horiz ontal</w>
est ro
ori ented</w>
7 ,
inoc ulated</w>
ass ayed</w>
splic ing</w>
m on</w>
ol ing</w>
In tra
dis h</w>
admini str
S pr
or bidities</w>
episod e</w>
Spec ific
Pre valence</w>
rang es</w>
al levi
F i
foc uses</w>
ar rays</w>
de struction</w>
less er</w>
constric tion</w>
respon ding</w>
I GF
w at
i k
M ex
lat ent</w>
contr actions</w>
M ater
c ure</w>
life time</w>
filam ents</w>
g ing</w>
PT H</w>
ant en
spl en
inser ted</w>
De pression</w>
w ing</w>
viol et</w>
lat or</w>
extrem ity</w>
transf ection</w>
lipop olysaccharide</w>
c row
CT s</w>
buil ding</w>
defin itive</w>
ed ge</w>
phot on</w>
r ings</w>
nore pinephrine</w>
D D
wh y</w>
ren tly</w>
nit rate</w>
at ories</w>
ocyt o
join ts</w>
men str
disturb ance</w>
L arg
3 2
empor al</w>
ro tic</w>
ag on</w>
astro cytes</w>
ici an</w>
po rous</w>
tin ib</w>
U SA</w>
M n</w>
pea ks</w>
ocompati bility</w>
eng agement</w>
profil ing</w>
surg ically</w>
se d
capsul e</w>
 m</w>
analy zing</w>
conver ted</w>
perin atal</w>
se a</w>
recipi ent</w>
part ner</w>
multic enter</w>
P ain</w>
sequ enced</w>
me et</w>
sup press</w>
sep tic</w>
form ulations</w>
connec tion</w>
in nov
inter acting</w>
y el
p ep
h ind</w>
i e</w>
activ ates</w>
examin es</w>
ish man
in nerv
non linear</w>
cr ude</w>
m asses</w>
h in
recogn ize</w>
omy el
prol actin</w>
cap ability</w>
lat ation</w>
A N</w>
- induced</w>
Diab etes</w>
on ine</w>
tryp toph
Inv estig
objec tives</w>
suff ered</w>
hem e</w>
ome dical</w>
deta ils</w>
oxygen ation</w>
re aching</w>
fore ign</w>
hi erarch
Physi cal</w>
deteri oration</w>
Im aging</w>
Pro g
ve ter
end it
str anded</w>
aden oma</w>
PI 3
pre vents</w>
aph rag
if ying</w>
fr uc
S cre
sat ellite</w>
Cardi ac</w>
financ ial</w>
phenomen a</w>
ag ricul
discre te</w>
G lu
M it
co ver</w>
palli ative</w>
Aug ust</w>
un k</w>
Stre ptococcus</w>
pene tr
M orph
s --
di lution</w>
reas on
N i</w>
an us</w>
g i</w>
ell um</w>
evalu ations</w>
pap illary</w>
stri atum</w>
PAR TI
Influ ence</w>
synerg istic</w>
cod on</w>
S e</w>
consider ations</w>
pic ture</w>
p yro
G al
A no
app reci
air y</w>
regul ators</w>
O ste
mit otic</w>
valid ate</w>
establ ishment</w>
H ow</w>
oph yl
post menopausal</w>
enti ty</w>
id ed</w>
endoscop y</w>
pul ses</w>
anastom osis</w>
un stable</w>
oscop ic</w>
umbil ical</w>
embol ization</w>
extrem e</w>
cholec yst
seg reg
ch ir
ru n</w>
P b</w>
L im
u red</w>
illustr ate</w>
re placed</w>
mel atonin</w>
cat al
selec t</w>
PARTI CIPA
comfor t</w>
per ox
R enal</w>
an ticip
n ig
h u
modul ating</w>
enabl ed</w>
ob vious</w>
in surance</w>
do or</w>
anti genic</w>
mac ular</w>
i ar</w>
expl oration</w>
ast ed</w>
sim pl
iton e
- 6</w>
PARTICIPA NTS</w>
con stitute</w>
stud ent</w>
per g
thyro idism</w>
st e</w>
discre p
te m</w>
Under standing</w>
sp or
NC E</w>
aggreg ates</w>
determin ant</w>
discrim in
F em
ge ometry</w>
histo chemical</w>
esophag us</w>
cat enin</w>
at ri
t onic</w>
mer cur
bl astoma</w>
ing estion</w>
Rep ort</w>
C 3
pene tration</w>
ogra fts</w>
sist ance</w>
odynam ics</w>
arrhyth mias</w>
trans forming</w>
ow ing</w>
trans duc
Ad ditional</w>
pari etal</w>
neuro degenerative</w>
vi ously</w>
lum en</w>
Ser v
oxidi zed</w>
ER K</w>
direc tions</w>
meth ionine</w>
intra ocular</w>
all erg
stem s</w>
stri atal</w>
radi ographs</w>
rib osomal</w>
benz ene</w>
E th
t ants</w>
attrib utable</w>
eosin oph
l id
ent ory</w>
F S</w>
th ood</w>
com orbidities</w>
r ule</w>
V it
pros thetic</w>
Diag nosis</w>
radic als</w>
n a</w>
Gn RH</w>
princi ple</w>
R i
dis ulf
ob ste
cont acts</w>
m V</w>
h aled</w>
menti oned</w>
di mer</w>
myel oma</w>
carcin ogenesis</w>
fu r</w>
pe er</w>
al umin
SN P</w>
st at
fol ate</w>
attenu ation</w>
sl ices</w>
ho t</w>
ulc ers</w>
at trac
we ak
ar ise</w>
ent an
P ost</w>
sep tal</w>
3 8
Li ver</w>
E G
dro p</w>
cor tic
AR S</w>
gangli a</w>
modi fy</w>
equ ations</w>
P op
trig ger</w>
fibrin ogen</w>
asym metric</w>
om al</w>
M S
equip ment</w>
ap tic</w>
K a
eth ical</w>
k el</w>
epilep tic</w>
oc ul
N P
ac tor</w>
ac compl
199 2</w>
En do
hypothalam us</w>
ang les</w>
ol ab
199 3</w>
car ies</w>
6 ,
chromat ographic</w>
sh unt</w>
pes tic
analge sic</w>
am ic</w>
m o</w>
e -</w>
other wise</w>
op res
en op
bec oming</w>
1 60</w>
form ula</w>
hom ogen
C57 BL</w>
upreg ulation</w>
pyru vate</w>
ser op
iso form</w>
lith ium</w>
pol e</w>
r atings</w>
juven ile</w>
app ly</w>
d itary</w>
PC s</w>
o rous</w>
pertur b
ie fs</w>
cent ur
sc av
S uc
anesthe tized</w>
dop aminergic</w>
exer t</w>
immunos orbent</w>
calc ulation</w>
T PA</w>
d ent</w>
B ri
catar act</w>
stimul ates</w>
summar ize</w>
10 5</w>
ameli or
Syn drom
t od
aff ective</w>
con den
Hy po
lam b
Expos ure</w>
G e
N 2</w>
b is</w>
run ning</w>
gi ving</w>
ti zation</w>
bo w</w>
T D</w>
pre clinical</w>
attr active</w>
ca ro
v om
avoid ance</w>
P os
knock down</w>
PA P</w>
f ig
A l</w>
N ine</w>
kin e
ap par
ultim ately</w>
st ain</w>
Op tim
t ose</w>
Sh ort</w>
Direc t</w>
surfac tant</w>
ro und</w>
i pati
exp endit
ot rophic</w>
end ocardi
me at</w>
F T</w>
ot actic</w>
out break</w>
epit opes</w>
direc tional</w>
i ii</w>
dri ve</w>
ore r</w>
draw n</w>
si x
wor d</w>
Ran dom
con junc
N et
T NF
1 </w>
electro cardi
h ence</w>
cardi opulmonary</w>
ograph ically</w>
dec ay</w>
E ven</w>
Ep idemi
bl ic</w>
pr one</w>
yt es</w>
pl ant
Ap plication</w>
ang ina</w>
p ip
in form</w>
Pr acti
N either</w>
Th rough</w>
visu alization</w>
usc itation</w>
at ro
8. 6</w>
attemp ted</w>
ox if
continu ation</w>
int ended</w>
sub sets</w>
dy sp
g ained</w>
immunosup pressive</w>
speci alized</w>
k al
Sh e</w>
Z e
institu tions</w>
Gen er
resid ent</w>
epid ural</w>
bel ieve</w>
R E</w>
P or
at tending</w>
flur ane</w>
mig raine</w>
distr ic
ve ins</w>
evol ved</w>
pro ve</w>
trim ester</w>
opres sin</w>
visc eral</w>
on eph
A ff
st ones</w>
- 4</w>
ca ffe
att ack</w>
p it
min ogen</w>
epit ope</w>
ch e
qu ar
thromb ocyt
M us
H is</w>
ham ster</w>
clon ing</w>
w ounds</w>
bloc kers</w>
all ogeneic</w>
B as
al do
hist ologically</w>
warran ted</w>
b rate</w>
u n</w>
ch ori
osteo arthritis</w>
obser ver</w>
thym idine</w>
trac e</w>
ipsi lateral</w>
K i</w>
mis sing</w>
R D</w>
0.00 3</w>
tor ial</w>
heter o
cho ol</w>
m outh</w>
br ady
casc ade</w>
fluor ide</w>
m u</w>
f ecal</w>
Diagnos tic</w>
xim ab</w>
or ic</w>
exten d</w>
ome tri
adv anc
c a</w>
L ife</w>
in versely</w>
all ergy</w>
c ity</w>
sam pled</w>
8. 2</w>
hydrox ylase</w>
er t</w>
sar co
nephro pathy</w>
los ses</w>
histor ical</w>
s ular</w>
resp iration</w>
An im
var ies</w>
mo tiv
7. 9</w>
ac il</w>
In dian</w>
F U</w>
t ot
vast atin</w>
L ac
D F</w>
facilit ated</w>
ab ine</w>
l ity</w>
ur ance</w>
Ab s</w>
re mot
verte br
ipati ng</w>
Wh at</w>
ol l
all ograft</w>
propor tions</w>
rh iz
atheros clerotic</w>
ar ct</w>
smo ke</w>
ay ers</w>
Ultr as
swit ch</w>
F L
in continence</w>
end ometri
Pro gram</w>
M agnetic</w>
ep ing</w>
Inte gr
polymer ization</w>
S il
quanti ty</w>
calcul ate</w>
e pa
U V
venti l
L ip
e us</w>
S accharomyces</w>
excit atory</w>
Austral ian</w>
oc occal</w>
preferen ces</w>
endo plasmic</w>
adhe sive</w>
G lob
ec es</w>
con junction</w>
glyc ogen</w>
prophyl actic</w>
F DG</w>
n ull</w>
r y</w>
criter ion</w>
normal ized</w>
l et
Vari ous</w>
uncer tainty</w>
cogni tion</w>
inc ision</w>
Ap pro
develop ments</w>
con clusions</w>
transmit ter</w>
lam y
charg es</w>
B s</w>
ma st
igh ts</w>
trans verse</w>
di oxide</w>
h ard</w>
amph etamine</w>
Sec ondary</w>
Gen eral</w>
ion ization</w>
f resh
odon tic</w>
struc turally</w>
acces sible</w>
im ide</w>
res sively</w>
objec ts</w>
ph thal
inoc ulation</w>
p ation</w>
doc tors</w>
psych o
anti coagul
tryptoph an</w>
counsel ing</w>
M il
fl am
lim bs</w>
engine ered</w>
PI3 K</w>
tw enty</w>
em atic</w>
obser ve</w>
H A
T M</w>
P 450</w>
rib ed</w>
S ensi
colon ization</w>
frag mentation</w>
del ine
ar ms</w>
slow ly</w>
B W</w>
wa ve
P at
pro line</w>
bro w
appar atus</w>
Rec om
199 1</w>
simil arities</w>
cardi o
M el
con e</w>
fib rom
al isation</w>
CH D</w>
ophthal m
par asi
elim inated</w>
susp ici
m iti
D at
reproduc ibility</w>
tic a</w>
I N</w>
organ ized</w>
routin ely</w>
8. 8</w>
acc id
it ated</w>
P W
System atic</w>
th y</w>
Multi variate</w>
ycl ine</w>
ol ateral</w>
p et
envel ope</w>
labor atories</w>
od ec
er adic
In trac
her nia</w>
f en
mal formations</w>
refl ects</w>
exc eption</w>
belong ing</w>
absc ess</w>
ch i</w>
phosphor us</w>
F ib
in organic</w>
lipos omes</w>
Struc tural</w>
ag ar</w>
Ger many</w>
EM G</w>
em enting</w>
m entally</w>
knock out</w>
S tro
ris t</w>
g ed</w>
disper sion</w>
bal anced</w>
am id
placent a</w>
An gi
mon ocyte</w>
medi as
ad junc
ess entially</w>
epa m</w>
clu stering</w>
D aw
hor ses</w>
construc ts</w>
pos ites</w>
Ram an</w>
relati ves</w>
T rial</w>
F eb
Ac tivation</w>
multi disciplinary</w>
om od
bio availability</w>
describ ing</w>
over lap</w>
cohe rence</w>
reproduc ible</w>
in ase</w>
F ood</w>
f used</w>
emplo ying</w>
ide a</w>
har d
in sp
A1 c</w>
z er</w>
Bre ast</w>
S mall</w>
po is
m t
ob arb
od es</w>
el ast
mit ogen</w>
Syndrom e</w>
R ats</w>
seas onal</w>
hy dra
d airy</w>
preferen tially</w>
exper t</w>
f ate</w>
Sec ond</w>
survi ved</w>
l ic
igh t
F C</w>
predic ts</w>
dist or
1, 2</w>
sl ope</w>
I Q
as cor
mathem atical</w>
ter med</w>
pro po
ul ed</w>
In tro
insec t</w>
aug mented</w>
ru ary</w>
eclamp sia</w>
l nc
var ic
Fac tor</w>
Gl uc
Associ ated</w>
P ulmonary</w>
G TP</w>
fi er</w>
eukary otic</w>
br ac
dam aged</w>
am yg
vom iting</w>
ti ters</w>
regar ded</w>
Feb ruary</w>
her in</w>
bor ns</w>
fertil ization</w>
c e
mos quit
glyc emic</w>
0. 6
ax onal</w>
M G</w>
Nov ember</w>
den sities</w>
influ x</w>
st arch</w>
so y
mut ase</w>
o k
lim itation</w>
desi r
har b
fibr onectin</w>
di aphrag
re al
De sign</w>
8. 0</w>
immobil ized</w>
waveleng th</w>
fl ight</w>
adul thood</w>
hom ozygous</w>
aden omas</w>
Respon se</w>
P ac
dro pl
sp ar
t ome</w>
hel ical</w>
fet us</w>
F V
lat er
ec topic</w>
rever sal</w>
L ung</w>
s lower</w>
o yl</w>
8. 9</w>
C ycl
anal ogs</w>
c .
fac ility</w>
mes enteric</w>
Ad ult</w>
O T</w>
micro vascular</w>
jo b</w>
aver aged</w>
ab str
tem plate</w>
dimen sion</w>
stabil ized</w>
f asc
plas minogen</w>
v ap
icardi al</w>
carr y</w>
Rel ati
Amer ica</w>
P 4</w>
distingu ished</w>
wa ste
T 1
ad missions</w>
cathe ter
immun ized</w>
in he
employ ment</w>
id in</w>
meth anol</w>
in tubation</w>
conver ting</w>
compl aints</w>
parathyro id</w>
h all
ox al
gradu ate</w>
scin ti
oph en
ogni tive</w>
sens ors</w>
introduc e</w>
transi tions</w>
nan ot
cho ro
o ides</w>
compet ence</w>
se arch
glucocortico id</w>
proc e
explan ation</w>
PR L</w>
leg al</w>
arach id
micro environment</w>
3 4
CYP 2
po orer</w>
all ic</w>
T CR</w>
H s</w>
IC 50</w>
bel iefs</w>
co ating</w>
gal ac
foll icles</w>
G ra
col lo
psori asis</w>
transl ated</w>
S af
aut on
IN E</w>
inher ited</w>
immunop recip
amyg dal
highligh ted</w>
den at
T issue</w>
phospholip ase</w>
fer mentation</w>
ad ding</w>
mercur y</w>
Daw ley</w>
ari um</w>
leuc ine</w>
m ir
ap ine</w>
her pes</w>
Tw elve</w>
regi stration</w>
nan oc
re production</w>
cl amp</w>
2 a</w>
domes tic</w>
ep sil
Relati onsh
intraper itoneal</w>
si RNA</w>
Spr ague</w>
ul ty</w>
un g
High er</w>
sensiti zation</w>
atin um</w>
ph ant
tr is
re a</w>
um inal</w>
k y</w>
MEASURE S</w>
method ological</w>
plan ar</w>
derm atitis</w>
res uscitation</w>
uni versal</w>
hydro ly
inf arct</w>
datas et</w>
manifest ation</w>
mut ated</w>
se eds</w>
Pot ential</w>
saliv a</w>
desi red</w>
peri odic</w>
osmo tic</w>
f oun
co de</w>
them es</w>
spl enic</w>
8 00</w>
res ected</w>
end otoxin</w>
s s
circu it</w>
mark et</w>
P B</w>
5 p</w>
m us</w>
ac tin
8. 4</w>
z ones</w>
azep ine</w>
fer ri
trans form</w>
mo ving</w>
e diatric</w>
po protein</w>
hom olog
AL L</w>
nucle ic</w>
con fined</w>
vesti bular</w>
si zed</w>
i. p.</w>
wor sen
com ing</w>
mutag enesis</w>
I BD</w>
ph on
di az
0. 5
P BM
E N</w>
junc tions</w>
B in
conduc t</w>
quin one</w>
Gol gi</w>
ame ters</w>
repeti tive</w>
an sw
ong ue</w>
S r
micro gram</w>
et c</w>
ech anical</w>
app en
calib ration</w>
bil ir
sub mitted</w>
establ ishing</w>
C s
triglycer ide</w>
H u
precip itation</w>
al izations</w>
P lat
lin ks</w>
pl ans</w>
in struc
b atter
Post operative</w>
cortico steroids</w>
sequ ent</w>
ab ec
synth et
care ful</w>
hol ds</w>
la w</w>
al i
B a
pre treated</w>
poly acrylamide</w>
pig ment</w>
mening itis</w>
Experim ent</w>
micro array</w>
acti vely</w>
flav on
comp uter
st ep
enti onal</w>
fo rest</w>
li e</w>
C B</w>
elong ation</w>
inhal ation</w>
minim ize</w>
R V</w>
bi omedical</w>
in ium</w>
gen etics</w>
Cro hn</w>
1 H</w>
4, 5</w>
I F</w>
su stain
F 2</w>
nam ed</w>
pro found</w>
assembl ed</w>
20 19</w>
depl eted</w>
gluc agon</w>
verte brate</w>
detec tor</w>
ectom ized</w>
ambi ent</w>
it ting</w>
commerc ially</w>
cycl ing</w>
H2 O2</w>
T ogether</w>
tr unk</w>
cur ative</w>
spermat ozo
Reg i
ograph ics</w>
ter a</w>
flex ibility</w>
vulner able</w>
dram atic</w>
ang ular</w>
S tim
l aryngeal</w>
sco red</w>
thrombo tic</w>
par a
ili ac</w>
ophil ia</w>
Con tin
aberr ant</w>
B I</w>
9. 2</w>
hyper sensitivity</w>
O l
K 2</w>
glyco l</w>
hemorrh agic</w>
8. 1</w>
angi oplasty</w>
NAD PH</w>
Sev enty</w>
kin ds</w>
re fr
li um</w>
marg in</w>
Ph en
b red</w>
cord ingly</w>
tr abec
nar row</w>
re constitu
su ture</w>
rati on
pac ing</w>
en ously</w>
Ca uc
ar ri
er ies</w>
w w
fib rous</w>
b uc
hypo theses</w>
entr icular</w>
ogen e</w>
aer os
ophosph ate</w>
scaff old</w>
Con sequently</w>
Per form
as m</w>
fluctu ations</w>
duod en
ren ces</w>
M ale</w>
Transc rip
prob able</w>
marg inal</w>
i ents</w>
em ental</w>
coll abor
promo ters</w>
2, 3</w>
repe at
repe ats</w>
Differen tial</w>
mechanis tic</w>
partic ipating</w>
SC T</w>
Sou thern</w>
cycl ospor
optim ize</w>
u si
use a</w>
menstr ual</w>
ex plic
beta 1</w>
0. 2
bol us</w>
dox orubicin</w>
integr al</w>
glut amine</w>
Eff icacy</w>
8. 7</w>
overl apping</w>
ge ographic</w>
MI C</w>
0.0 6</w>
datas ets</w>
Specific ally</w>
un saturated</w>
16 S</w>
commun ic
estim ating</w>
ud ge</w>
low ered</w>
C arb
sph eres</w>
B ay
pre frontal</w>
y o
qu i
crystall ine</w>
olig os
E S
3 3
as sum
D en
kill ing</w>
scaff olds</w>
di s</w>
h aps</w>
i ety</w>
Gen ome</w>
arrang ements</w>
continu es</w>
consci ous</w>
autom atic</w>
sil encing</w>
caro ten
mo id</w>
prop yl
P 2
house hold</w>
In jur
l t</w>
us p
x anth
infer tility</w>
dele tions</w>
dom eth
glyc emia</w>
cereb ellum</w>
connec tions</w>
vis cos
VE N
ophosph amide</w>
rec all</w>
el as
M odi
arti le</w>
evid enced</w>
I S
Ar g</w>
pat h</w>
soci o</w>
C op
intrav enously</w>
new borns</w>
ic o</w>
RO C</w>
centur y</w>
posi tioning</w>
h t
dis mutase</w>
ren ch</w>
erythem at
os ity</w>
L M
9. 4</w>
9. 6</w>
pal sy</w>
Ch rom
bi ologically</w>
fron t</w>
colon ies</w>
pro to
ab oration</w>
non specific</w>
re l</w>
bloc ker</w>
play ing</w>
connec tive</w>
ow er</w>
O CT</w>
d i</w>
mo iety</w>
persist ed</w>
S m
cad herin</w>
M ice</w>
AR Y</w>
thym us</w>
gro ss</w>
person nel</w>
dometh acin</w>
9. 3</w>
CA T</w>
retin opathy</w>
ul us</w>
synovi al</w>
dis charged</w>
pl aques</w>
qu artile</w>
L a
prog ressively</w>
heter ozygous</w>
I T</w>
man age</w>
on ds</w>
se emed</w>
Res p
os keletal</w>
ph al
ig u
H V</w>
hy gi
s or</w>
In flam
1 11</w>
p 38</w>
pro vision</w>
fac ts</w>
l ib
E A</w>
Cl assi
circum st
haz ards</w>
refl ecting</w>
str a
remot e</w>
em a
In sul
con sumed</w>
do w</w>
pran olol</w>
si ded</w>
D ay</w>
bre ast
B ut</w>
rel im
ur acil</w>
pro pi
accep tance</w>
hypot ension</w>
bra fish</w>
deli ver
er ous</w>
vic tim
angi ogenic</w>
deman ds</w>
opath ology</w>
Can adi
i res</w>
PG E2</w>
moti fs</w>
bio active</w>
kill ed</w>
cent res</w>
ch it
M Y
propag ation</w>
disulf ide</w>
Perform ance</w>
P ri
conjug ates</w>
neurom uscular</w>
Surviv al</w>
mon ic</w>
x in</w>
b ones</w>
desc ending</w>
A U
anti retroviral</w>
bri ef
pro pen
constr aints</w>
sist ent</w>
u sive</w>
brid ge</w>
categor ized</w>
dist ances</w>
swit ching</w>
ob taining</w>
B T</w>
desir able</w>
retar dation</w>
Ma j
D Cs</w>
L eu
oxid ants</w>
foc i</w>
poll ut
TL R
re acted</w>
cyt ology</w>
G V
ha ir
INTER VEN
T L</w>
sc at
prin ting</w>
10 2</w>
retro grade</w>
lip i
Kore an</w>
en or
S HR</w>
pris ingly</w>
st op
n om
ar ial</w>
chic k
here ditary</w>
Al l
PA R</w>
in ous</w>
S K</w>
abor tion</w>
fabr icated</w>
anes thetic</w>
presum ably</w>
pl eg
aryn x</w>
E s</w>
BAL B</w>
9. 1</w>
cad mium</w>
Lym ph
ech o</w>
pap ers</w>
sp ray</w>
cop e</w>
d odec
I OP</w>
r ating</w>
fil ament</w>
reser vo
prote olytic</w>
at osis</w>
ph orb
Cauc asi
fu sions</w>
Larg e</w>
r ing
waste water</w>
c ing</w>
cur ricul
sem i
fin ally</w>
rein for
lin ing</w>
Scre ening</w>
mor tem</w>
F c</w>
p up
CA SE</w>
pyr idine</w>
d ust</w>
S a
vir tual</w>
0. 3
scre w</w>
L oc
we t</w>
mar ks</w>
de ep
C p
ol ine</w>
perfor ation</w>
multi variable</w>
V e
seg mental</w>
tin s</w>
F o
Th ose</w>
fr am
demonstr ation</w>
vas opressin</w>
facilit ates</w>
s acr
Ex amination</w>
challeng ed</w>
ped ance</w>
wal ls</w>
V ol
plasm ids</w>
res orption</w>
posi tivity</w>
p iv
T U
up uncture</w>
hyp oglyc
st atin</w>
am el</w>
Ger man</w>
so ils</w>
he dr
feren ces</w>
CD 3</w>
L ong
mo un
cop ies</w>
Con versely</w>
M et</w>
Y oun
cle ft</w>
au gh
l actic</w>
sched ule</w>
nat ri
compart ments</w>
adequ ately</w>
Ex c
b ases</w>
ultra structural</w>
pl atinum</w>
C ognitive</w>
N at
ex in</w>
F rench</w>
198 8</w>
S B</w>
f ell</w>
N H</w>
conjug ate</w>
is let</w>
M id
phorb ol</w>
N CT
thic k
198 9</w>
St ress</w>
win dow</w>
f MRI</w>
y a</w>
ogly can</w>
neuro endocrine</w>
id a</w>
Pre vention</w>
he ating</w>
poll en</w>
re vascularization</w>
te ach
ul ates</w>
M ental</w>
b order</w>
oth i
k now</w>
inter acts</w>
bur st</w>
ubiqu itin</w>
g aps</w>
ot roph
lit axel</w>
Wh ite</w>
1, 3</w>
b ud
Intro duction</w>
K O</w>
or ities</w>
diff ers</w>
prim ers</w>
ous ness</w>
ic idal</w>
transpor ters</w>
mim ic</w>
di latation</w>
centr ifug
mess enger</w>
T2 DM</w>
We b</w>
in ates</w>
B ody</w>
na usea</w>
viscos ity</w>
ap nea</w>
eg ative</w>
classi c</w>
V AS</w>
constitu ents</w>
D er
Mat erials</w>
p mol</w>
qu ic
m Ab</w>
L M</w>
ati onic</w>
ru b
onc ology</w>
kin d</w>
spermatozo a</w>
sph inc
i otic</w>
projec tion</w>
shorten ing</w>
P CI</w>
alb icans</w>
publ ications</w>
Glob al</w>
cor ro
caffe ine</w>
produc tivity</w>
inf used</w>
Cur rently</w>
H2 O</w>
au tism</w>
an ter
T c</w>
1, 000</w>
aut opsy</w>
haem orrh
ultra violet</w>
suc cin
trop ical</w>
w rit
u ed</w>
mic rom
lymph atic</w>
St age</w>
or imetr
d ated</w>
phospholip ids</w>
con sent</w>
nor adrenaline</w>
leng ths</w>
st resses</w>
hy al
Incre asing</w>
cal ves</w>
Organ ization</w>
fibr in</w>
ten d</w>
un de
nico tin
form in</w>
exper ts</w>
ag it
H er
phen olic</w>
in dex
m apped</w>
N -</w>
W est</w>
ul in
er ship</w>
ur ium</w>
rex ate</w>
pharmac y</w>
event ually</w>
mobil ization</w>
T n
I a</w>
rec essive</w>
tempor ary</w>
Cal c
lymph omas</w>
amin ase</w>
ra w</w>
grad ed</w>
hab its</w>
H 3</w>
electrol yte</w>
lo t</w>
R CC</w>
T ai
solub ility</w>
Be sides</w>
st al
L o
mum ol</w>
vacc inated</w>
Combin ed</w>
oc at
ke ts</w>
ot opic</w>
me eting</w>
therapeu tics</w>
fin ite</w>
calc ification</w>
encap sul
uni variate</w>
or p
modul ates</w>
ty ph
en tered</w>
C 4</w>
gro w</w>
organ izations</w>
3 7
ati onary</w>
Dat ab
electro physiological</w>
de signs</w>
ot e</w>
W nt</w>
H or
isot ope</w>
dis appeared</w>
He ter
SP ECT</w>
H ol
D u
cle a
mat urity</w>
dis soci
aug mentation</w>
modul in</w>
o king</w>
mean ing
myel in</w>
F P</w>
AL T</w>
cover ing</w>
uncer tain</w>
amp ut
R AS</w>
re str
aldo sterone</w>
e sian</w>
B or
fav our
AB E
f ly</w>
10 3</w>
vesi cle</w>
accoun ting</w>
Out come</w>
agglutin in</w>
1 st</w>
hand ling</w>
av ig
man aging</w>
S i</w>
kill er</w>
ten si
diag nose</w>
sp ot</w>
E stim
 M</w>
typ ing</w>
polar ized</w>
impair ments</w>
ro d</w>
Ha em
sp ent</w>
ads orb
retriev al</w>
R CTs</w>
lamb da</w>
we ar</w>
lys osomal</w>
b all</w>
ul t
er n
1 2.5</w>
In duced</w>
ic ac
bound ary</w>
Reg ulation</w>
10 4</w>
synthet ase</w>
Sci ence</w>
Insul in</w>
play ers</w>
continu ing</w>
1 </w>
pow der</w>
il lo
it ance</w>
T I</w>
CD 34</w>
sul fur</w>
fi able</w>
gluc uron
f ol</w>
et te</w>
sugg estive</w>
triglycer ides</w>
sp ite</w>
ub es</w>
provid er</w>
volun tary</w>
n es
D ATA</w>
caus ative</w>
c ot
 1</w>
bran ches</w>
B u
termin als</w>
ir reversible</w>
cycl ophosphamide</w>
comm it
sec onds</w>
D SM</w>
P al
land scap
accoun ts</w>
gradi ents</w>
foll icle</w>
beg an</w>
scenari os</w>
f ra
y ment</w>
0.00 4</w>
H elic
encephal opathy</w>
CE A</w>
9. 7</w>
HER 2</w>
en es</w>
defin ing</w>
an tr
P ositive</w>
path ic</w>
sub cellular</w>
k ept</w>
t ongue</w>
Pe diatric</w>
li ves</w>
H SP
a un
pass age</w>
3 p</w>
H al
ar d
tit anium</w>
adv ance</w>
ot rexate</w>
blin ded</w>
si al
Ital y</w>
fibr e</w>
immun ocom
E mer
D E</w>
m is</w>
N i
care fully</w>
S core</w>
am orph
in activated</w>
Canadi an</w>
sti g
y tic</w>
yr in</w>
il ian</w>
EC M</w>
nor thern</w>
H S
char acter</w>
sou thern</w>
so ver</w>
Therap eu
inter mediates</w>
ucle otide</w>
d B</w>
dis sec
in stem</w>
conflic t</w>
n aph
mod est</w>
expec tations</w>
9. 8</w>
3 6
S eph
Rap id</w>
os s</w>
ap oli
medi ator</w>
ammon ia</w>
ub in</w>
rel ating</w>
st ock</w>
ic on
Compl ete</w>
CB F</w>
am idal</w>
prescrib ing</w>
spl it</w>
IC D</w>
shor t
no tic
E duc
har v
ethn icity</w>
glycos ylation</w>
analy se</w>
se dation</w>
her ni
individu ally</w>
cit rate</w>
uter us</w>
dem ographics</w>
Commun ity</w>
spin dle</w>
tend s</w>
p in</w>
V s</w>
100 ,000</w>
I g</w>
c itr
ser ves</w>
concentr ated</w>
a ren
M ei
spectro scopic</w>
ag ers</w>
alg ia</w>
coord inated</w>
t us
ann ot
at ology</w>
docum ent</w>
M emb
ging ival</w>
12 3</w>
att acks</w>
G P
abol ism</w>
nutri ents</w>
His panic</w>
ocy cl
Eigh ty</w>
regi stry</w>
D D</w>
J o
im pedance</w>
fo ot
l ign
T echn
remo ve</w>
cochle ar</w>
Pur pose</w>
E ast</w>
end ovascular</w>
ch lo
br ach
prote as
exhib iting</w>
N ig
pul sed</w>
A u</w>
reg urg
ax illary</w>
seg mentation</w>
diff ering</w>
P en
Com pu
chir al</w>
LL ED</w>
m ang
0. 75</w>
W here
r as</w>
TA TION</w>
buil t</w>
catal ase</w>
os se
omyel itis</w>
En viron
afferen t</w>
in ephrine</w>
bir ths</w>
c ations</w>
gyr us</w>
ter ing</w>
consul tation</w>
sex es</w>
r am
thre at</w>
per haps</w>
mod al</w>
Import antly</w>
U NL
ro x
lec tin</w>
Fam ily</w>
sym metry</w>
inter viewed</w>
E X
form al</w>
programm es</w>
dyst rophy</w>
ABE LLED</w>
mic rom</w>
M n
sp oradi
sporadi c</w>
UNL ABELLED</w>
incorpor ating</w>
w inter</w>
Re si
Hb A1c</w>
lum inal</w>
all er
innov ative</w>
cathe ters</w>
mac rom
ock et</w>
stimul atory</w>
tw in</w>
Fol low</w>
fir ing</w>
pen icillin</w>
Co h
id ing</w>
emo tion</w>
at ectomy</w>
2, 4</w>
deform ity</w>
re sted</w>
s ati
o ocyte</w>
spi ke</w>
it ability</w>
we b</w>
ze brafish</w>
microtub ule</w>
conduc ting</w>
tic k</w>
om et
am o
S CI</w>
ifer ase</w>
mT OR</w>
Where as</w>
ti ce</w>
pop ular</w>
s ation</w>
enti n</w>
M c
z ol
0. 15</w>
Amer icans</w>
t ories</w>
conduc tivity</w>
computer ized</w>
Sev ere</w>
th elial</w>
in puts</w>
nan os
thic k</w>
Kn ow
ti de</w>
soy bean</w>
Meth od</w>
reason able</w>
circum ference</w>
program ming</w>
hum oral</w>
BD NF</w>
Tai w
F R</w>
En d
S le
lymph ocytic</w>
as sign
bra ins</w>
en amel</w>
circumst ances</w>
lip ase</w>
b asi
pro inflammatory</w>
i or</w>
lymph o
pa ediatric</w>
st ationary</w>
bi ologic</w>
od op
transc ribed</w>
end point</w>
at opic</w>
particip ant</w>
Pro tec
medi ation</w>
tr ich
polymorph ic</w>
add ressing</w>
vascul ature</w>
v ig
IQ R</w>
a i</w>
Random ized</w>
L F</w>
Lev el</w>
modi fying</w>
o protein</w>
ur gent</w>
tic us</w>
com mod
benz odi
l avage</w>
sex ually</w>
K m</w>
modi um</w>
shif ted</w>
ang er</w>
eff icac
tre es</w>
omeg a</w>
pro pranolol</w>
hydro l
sedi ment</w>
antidepress ant</w>
0. 4
k eleton</w>
it ro
pac k
e tin</w>
auto antibodies</w>
mon key</w>
enabl ing</w>
depos its</w>
cen tered</w>
Inf ection</w>
ir respective</w>
met er</w>
C lo
agit tal</w>
projec tions</w>
on a</w>
defin ite</w>
di mer
CF U</w>
pi per
He La</w>
parame tric</w>
ti gh
ush ing</w>
rel ate</w>
pois oning</w>
ul as</w>
re m
198 7</w>
occ ip
am il</w>
tin c
institu tional</w>
solub il
bin ary</w>
fl an
gra in</w>
Inv entory</w>
govern ment</w>
min ority</w>
pre operatively</w>
th ly</w>
ht t
oscill ations</w>
arach no
retriev ed</w>
suppor tive</w>
quanti ties</w>
recei ver</w>
be hind</w>
AM I</w>
in domethacin</w>
aff or
Pr o</w>
3, 4</w>
ubiqu it
polyp eptides</w>
k it</w>
yl in
me tic</w>
nod al</w>
eff usion</w>
prop yl</w>
ac idosis</w>
cataly st</w>
Ir an</w>
0 2</w>
L it
gall bladder</w>
asym metry</w>
line ages</w>
5 -</w>
gran ule</w>
spe a
e ties</w>
pseud o
eng ue</w>
cros sover</w>
B al
af ter
trac er</w>
s arcom
A 4</w>
per si
isol one</w>
Know ledge</w>
f entan
ra ise</w>
obacter ia</w>
adv oc
ar yl</w>
aly tic</w>
raz ole</w>
gra y</w>
soci ety</w>
co valent</w>
En dos
est s</w>
absorb ed</w>
fem ur</w>
bre ath</w>
al ga
sal v
ec ology</w>
lo ok</w>
circul atory</w>
car inic</w>
si dase</w>
Medic are</w>
propen sity</w>
Struc ture</w>
L y
chic k</w>
aden ine</w>
plex us</w>
eph one</w>
fracti onal</w>
F A
ill ing</w>
sensiti zed</w>
tumorig enesis</w>
writ ten</w>
Lev els</w>
cholin esterase</w>
0.0 8</w>
M es
C CR
microsom al</w>
ro c
sk ull</w>
sequ el
h CG</w>
fil l</w>
radio activity</w>
har ve
brief ly</w>
Bin ding</w>
Cal ifor
el e</w>
inhe rent</w>
Tran si
vertebr ates</w>
bra instem</w>
Ka plan</w>
CC K</w>
counter parts</w>
sion ally</w>
f ail</w>
reci proc
cytos ol</w>
amygdal a</w>
ME DL
sub til
iv ac
encephal itis</w>
hel per</w>
itr on</w>
par um</w>
com ycin</w>
tox ins</w>
multi drug</w>
fal ci
Bi om
allerg en</w>
anti hypertensive</w>
S Y
constitu tive</w>
L E</w>
ac illus</w>
fac torial</w>
1 B</w>
enh ancer</w>
- ATPase</w>
ac ycl
19 80</w>
Four ier</w>
chick ens</w>
p ass</w>
wea kness</w>
gluc os
N GF</w>
TR I
- dependent</w>
AN OVA</w>
aden ovirus</w>
P PAR
stric t</w>
lar val</w>
spher ical</w>
sp ots</w>
H E</w>
neo plasia</w>
h ole</w>
r o</w>
MR SA</w>
MEDL INE</w>
Mg 2</w>
sim plex</w>
Le u</w>
R BC</w>
le an</w>
R SV</w>
am ylase</w>
Plas modium</w>
thrombocyt openia</w>
sh ed</w>
in effective</w>
sen escence</w>
publ ication</w>
intell ig
alk yl</w>
infu l</w>
C yto
meth ane</w>
anti fungal</w>
c ra
p al</w>
Kore a</w>
se al</w>
al and</w>
surve yed</w>
o resc
S o
g ar
iz er</w>
erythemat osus</w>
re ward</w>
PA H</w>
pa inful</w>
prim ing</w>
fl ag
prec eding</w>
G o
clin ician</w>
0.0 7</w>
fic i
down regulated</w>
lipo proteins</w>
vol atile</w>
l ings</w>
ox yt
immun ocyto
mo tivation</w>
ureth ral</w>
falci parum</w>
Datab ase</w>
mon otherapy</w>
chit osan</w>
an os
olec ules</w>
mat r
prote ases</w>
onc ogene</w>
brow n</w>
consum ing</w>
cholester ol
somat ostatin</w>
un likely</w>
se ed
Al tern
te dly</w>
p um
Vis ual</w>
ph one</w>
es cap
guid eline</w>
on cho
D A
al og
ie sis</w>
DN As</w>
ad ec
struc tive</w>
iton in</w>
Califor nia</w>
AK I</w>
Tra um
H 3
GI ST
ac upuncture</w>
ma ize</w>
F GF
pac litaxel</w>
e o
ferri tin</w>
co sis</w>
oph aryngeal</w>
synap ses</w>
adip ocytes</w>
i as</w>
od end
path ologies</w>
S er</w>
identi fies</w>
sh aring</w>
l o</w>
Therapeu tic</w>
10 6</w>
lo ads</w>
ab ro
Ex peri
ell ul
o ate</w>
ph yt
A sia</w>
Ap proxim
P art</w>
pro pan
un expected</w>
war f
HI F</w>
chron ically</w>
N AD</w>
198 5</w>
emb le</w>
Ac c
sacr ific
par ac
cor n</w>
all ed</w>
ti ter</w>
radi us</w>
dic ated</w>
monol ayer</w>
sol ar</w>
9. 0</w>
oc t
tub ules</w>
plac ing</w>
peri odon
behavi ours</w>
Le w
sp ong
summar izes</w>
remark ably</w>
M CF</w>
Cor relation</w>
co il</w>
cou gh</w>
Th rom
AC h</w>
Contro lled</w>
Ar ter
phen y
exp iratory</w>
coun ting</w>
proced ural</w>
Pop ulation</w>
m ating</w>
li ved</w>
is lets</w>
lear ned</w>
thromb us</w>
V R</w>
co des</w>
nor mot
glyco proteins</w>
al located</w>
ep inephrine</w>
ICA M</w>
12 6</w>
n ar</w>
10 8</w>
immun ost
X enop
ther mod
ICA L</w>
Mei er</w>
oste oc
hy ste
S G</w>
hemisph ere</w>
lymph aden
S elec
oc occus</w>
illustr ated</w>
intr on</w>
e tine</w>
4 8
L R</w>
a way</w>
oc yst
li vers</w>
re pression</w>
c esarean</w>
car ni
c GMP</w>
asc ites</w>
G G</w>
it ating</w>
if t</w>
Saf ety</w>
N umer
agricul tural</w>
in ver
ro dent</w>
Ne ur
S s</w>
here in</w>
Cl ass</w>
in haled</w>
o venous</w>
Experim ents</w>
epsil on</w>
ax on</w>
w el
lac tation</w>
i tions</w>
coll aboration</w>
Lab oratory</w>
down regulation</w>
ed ull
sum mer</w>
predn isolone</w>
o der
degrad ed</w>
ol a</w>
rig id</w>
rest or
ar ate</w>
Mor tality</w>
sp orts</w>
Ze aland</w>
L DH</w>
natri uretic</w>
sp ond
Chil d</w>
the ories</w>
microsom es</w>
percep tual</w>
Ad olesc
de polarization</w>
Xenop us</w>
Sequ ence</w>
epti dase</w>
on ym
et ting</w>
mar ri
Pa ren
fif th</w>
cal modulin</w>
a stric</w>
Net work</w>
inter f
im ag
vir tually</w>
vol u
mix ing</w>
G ly</w>
initi ate</w>
B R</w>
ne y</w>
cal f</w>
bilir ubin</w>
W he
oler ance</w>
grad ing</w>
po real</w>
Col lege</w>
P MA</w>
str ies</w>
suffici ently</w>
indic ative</w>
f um
meaning ful</w>
sc ar</w>
N K
L ocal</w>
tub ulin</w>
pl ast</w>
catheter ization</w>
caud al</w>
nor mo
A den
Im plications</w>
diagnos ing</w>
meth otrexate</w>
Ex trac
0 5</w>
regul arly</w>
T V</w>
PF S</w>
in appropriate</w>
adolesc ence</w>
tub es</w>
extr ap
cortico sterone</w>
attit ude</w>
histi dine</w>
dil ated</w>
14 5</w>
polys accharide</w>
od al</w>
program med</w>
trans l</w>
emis sions</w>
Helic obacter</w>
9. 9</w>
ut ely</w>
fl ora</w>
agre ed</w>
neutr alizing</w>
fol ded</w>
sw ine</w>
ster ic</w>
al ters</w>
F as</w>
EM T</w>
ir rig
TH E</w>
fl aps</w>
adrenoc eptor</w>
he avi
cor pus</w>
SP R</w>
expendit ure</w>
sp ort</w>
o in</w>
L I</w>
oxif en</w>
mach in
depart ments</w>
my ocytes</w>
interf ere</w>
co oling</w>
O 3</w>
Ab out</w>
elic it</w>
pos ing</w>
I M</w>
hydro chloride</w>
re agents</w>
pac ema
pal mit
o is
M ont
Met a</w>
lipi demia</w>
A 3</w>
c ationic</w>
1 beta</w>
quic kly</w>
expon ential</w>
immunosup pression</w>
y rate</w>
deli ver</w>
Reg ar
As perg
opath ies</w>
strong est</w>
O M</w>
har m
anti sense</w>
yel low</w>
ot om
arachno id</w>
c ru
muscul oskeletal</w>
Electr on</w>
arachid onic</w>
fruc tose</w>
s un
198 6</w>
nem at
S em
r ational</w>
log ic</w>
coll ap
inten sities</w>
ati te</w>
Ma xim
o -</w>
PA F</w>
ven om</w>
ex ha
concer ned</w>
discrim inate</w>
possi bilities</w>
sp an</w>
exce eded</w>
l in</w>
cerebro vascular</w>
grad es</w>
dig estive</w>
3 A</w>
characteris ed</w>
dissem inated</w>
st ents</w>
1 b</w>
ing ual</w>
endoth elin</w>
wor m</w>
Y or
k il
un iform
s orption</w>
p all
dis plays</w>
PC A</w>
neo plasm</w>
scav eng
omegal ovirus</w>
strati fication</w>
expl oratory</w>
favour able</w>
Gl u</w>
il st</w>
access ory</w>
tr ain
Initi al</w>
ver ify</w>
decom pression</w>
sp ut
L ap
B el
sup presses</w>
CR F</w>
ophysi cal</w>
silic on</w>
aden ylate</w>
Cor onary</w>
summar ized</w>
impl ement</w>
ti ght</w>
insul in
cur v
applic ability</w>
Injur y</w>
Be fore</w>
IC C</w>
thym ic</w>
ren ew
accompl ished</w>
endometri osis</w>
CT L</w>
PF C</w>
alk yl
elim inate</w>
traff ic</w>
P t</w>
ta ste</w>
there after</w>
Mater nal</w>
bi ased</w>
dis location</w>
pres entations</w>
e k</w>
initi s</w>
duc tal</w>
is tics</w>
S ER
ac commod
w rist</w>
osens ory</w>
intra uterine</w>
propo fol</w>
- 7</w>
phenyl alanine</w>
allel ic</w>
one ur
Fr ance</w>
protec ts</w>
pat ency</w>
r ules</w>
NS AI
w ire</w>
ti a</w>
keratin ocytes</w>
break down</w>
comorb idity</w>
poly clonal</w>
1 15</w>
o tri
paren teral</w>
cyclo hex
Sur face</w>
K in
dri vers</w>
phant om</w>
ser ological</w>
di lu
en comp
con focal</w>
nan o</w>
P re</w>
thalam ic</w>
medic inal</w>
De termination</w>
electrophore tic</w>
co chemical</w>
hemat oma</w>
ail s</w>
luc iferase</w>
es thetic</w>
T em
neut rop
eri atric</w>
exer ted</w>
e au</w>
reconstruc ted</w>
hom ocy
sl udge</w>
unde restim
n esses</w>
perox is
resc ue</w>
AP C</w>
spec ified</w>
b ar</w>
rh in
D ys
radio active</w>
tel ephone</w>
ad d</w>
dro p
int ox
Addi tion</w>
de plo
neigh b
Elev en</w>
S BP</w>
1 R</w>
tr ip
gonad otropin</w>
immun omod
BM P</w>
partic ulate</w>
Reg istry</w>
grou ped</w>
ti d
cre ating</w>
F re
stre ptoc
loc omotor</w>
habit at</w>
I K
dis continuation</w>
Sim ult
amni otic</w>
sec tor</w>
id ol</w>
erythro po
brom ide</w>
micro glia</w>
ole ic</w>
B O
regurg itation</w>
O ut</w>
Pre gn
fabr ication</w>
pathophysi ological</w>
y ph
C he
L og
h ands</w>
anti serum</w>
ocardi al</w>
saf ely</w>
fore arm</w>
SU MM
D N</w>
Vit amin</w>
a ic</w>
transfer rin</w>
mon thly</w>
confir ming</w>
cro p</w>
nar row
neuro blastoma</w>
u als</w>
experi encing</w>
fung us</w>
p 21</w>
vulner ability</w>
O s
e able</w>
n if
percent ages</w>
oc clud
to sis</w>
sel enium</w>
Flu oresc
rest ore</w>
breast feeding</w>
cont empor
om avirus</w>
emb olic</w>
N AF
ge ographical</w>
alter ing</w>
abdom en</w>
ulcer ative</w>
sequel ae</w>
sph ing
Pre operative</w>
un ion</w>
R em
overex pressed</w>
ivac aine</w>
mil l</w>
psych osis</w>
leuk emic</w>
marg ins</w>
R V
or poreal</w>
di methyl</w>
Approxim ately</w>
in equ
as sumption</w>
char t</w>
di i</w>
sem en</w>
bund le</w>
prim er</w>
de formation</w>
i us</w>
E c
ic eptive</w>
Com put
ultras onic</w>
SUMM ARY</w>
tus sis</w>
stri king</w>
traff icking</w>
Rec ur
Ig G
pl ur
Nin ety</w>
piv otal</w>
Asperg illus</w>
granul ocyte</w>
p an</w>
inter ventional</w>
Youn g</w>
B SA</w>
L i</w>
transcrip tase</w>
G i
cl aims</w>
out breaks</w>
der line</w>
Al coh
L 2</w>
dis solved</w>
e rec
exec utive</w>
inf eren
Sub sequently</w>
O SA</w>
cortico steroid</w>
n avig
disrup ted</w>
Ne w
TE M</w>
hydrox yl</w>
exer ts</w>
sol e</w>
13 3</w>
flo or</w>
om ically</w>
matr ices</w>
bo y</w>
ur idine</w>
con sequently</w>
confir ms</w>
F requ
fac ulty</w>
PD GF</w>
v is</w>
s agittal</w>
as ci
differenti ating</w>
lu oro
gran ular</w>
aqu atic</w>
E V</w>
id y</w>
post synaptic</w>
Un like</w>
hierarch ical</w>
ie tin</w>
inter cellular</w>
methyl ated</w>
differen tly</w>
10 7</w>
odi um</w>
l ide</w>
n ude</w>
isch aemic</w>
gu anine</w>
weak ly</w>
vit re
suppl ement</w>
Emer gency</w>
neuro psychological</w>
pri ority</w>
mus carinic</w>
inv ari
chim eric</w>
scinti graphy</w>
PM N</w>
cytos keleton</w>
suff er</w>
osi des</w>
R ob
hom es</w>
Bay esian</w>
S pain</w>
she et</w>
Con centr
R C</w>
gener a</w>
Mut ations</w>
throm ycin</w>
Ital ian</w>
transp os
ox one</w>
special ist</w>
apoli poprotein</w>
D P
th ening</w>
arsen ic</w>
is s
sens or
ai ve</w>
ai ting</w>
s ely</w>
salv age</w>
co bal
ran ts</w>
ac cordance</w>
gen ous</w>
c ylin
am ate</w>
tr if
f er</w>
dec arbox
alcoh ol
S L</w>
AP P</w>
ED TA</w>
in sensitive</w>
Sp anish</w>
o dic
ge ometric</w>
bo ard</w>
T O
is s</w>
15 7</w>
re arrangement</w>
hygi ene</w>
th ous
om o
sw im
br oncho
emphasi ze</w>
At l
mor ning</w>
PA I</w>
i v</w>
oth or
arrhyth mia</w>
te ar</w>
ocor tical</w>
w an
t rou
us sion</w>
ex tending</w>
noc tur
Vir us</w>
investig ators</w>
we aning</w>
i NOS</w>
B NP</w>
du plication</w>
suic idal</w>
obarb ital</w>
b up
aff in</w>
acr ylate</w>
dri ed</w>
CR T</w>
ch ance</w>
the red</w>
Chem ical</w>
protein uria</w>
fraction ated</w>
W ater</w>
nit ros
sal ts</w>
S elective</w>
P relim
Ph e</w>
aberr ations</w>
F low</w>
M F</w>
appen dic
contr ary</w>
chemo kine</w>
ro dents</w>
Maj or</w>
reli ably</w>
O V
N D
lap se</w>
amino transferase</w>
Ac id</w>
Di etary</w>
sc aling</w>
ro utes</w>
ser otype</w>
tra di
conjunc tiv
fibr ils</w>
heter ozyg
fing er
cop ic</w>
recur rences</w>
inten tion</w>
Analy ses</w>
ip ot
cum in</w>
judg ed</w>
NA c</w>
fluoresc ein</w>
hydro gel</w>
it oring</w>
cer ti
iz ational</w>
at ax
satis fied</w>
poly ethylene</w>
initi ating</w>
Al a</w>
hepat ocyte</w>
qu ine</w>
cap abilities</w>
Inter net</w>
hydr o</w>
Prelim inary</w>
adhe rent</w>
st op</w>
Intr av
Fif teen</w>
avoid ed</w>
energ ies</w>
attrib utes</w>
cu ff</w>
infu sions</w>
in directly</w>
col lege</w>
lamin a</w>
Tr yp
dis abilities</w>
opin ion</w>
creatin e</w>
ker atin</w>
prin ted</w>
cop olym
V ascular</w>
confoun ding</w>
plo idy</w>
sti ll
ap on
C arcin
asc ending</w>
hapl otype</w>
dis solution</w>
end oc
H B</w>
Relationsh ip</w>
be ads</w>
medic ines</w>
A ca
oligonucle otide</w>
D esc
inter rup
some what</w>
re di
accep tor</w>
ap atite</w>
qu en
encapsul ated</w>
substitu tions</w>
as k</w>
Measure ment</w>
denti n</w>
m e</w>
facilit ating</w>
phag ia</w>
NAF LD</w>
concep tual</w>
carb oxy
Enh anced</w>
medull ary</w>
SM C</w>
nanop article</w>
phosphatidyl inositol</w>
ap amil</w>
L T
neur ones</w>
Str ateg
ap o</w>
H sp
4 4
hydro philic</w>
Met abolic</w>
b ub
R as</w>
enlarg ement</w>
in o</w>
RN A
Measure ments</w>
ter at
hyste rectomy</w>
oxid es</w>
an es</w>
P ap
sym metric</w>
jec t</w>
thi ol</w>
w elling</w>
il ing</w>
expec t
tax a</w>
chemo therapeutic</w>
os um</w>
mes h</w>
laparo tomy</w>
orig ins</w>
anth rac
i ana</w>
on ical</w>
Nor mal</w>
L D
as i</w>
air ways</w>
Ano ther</w>
oneph ritis</w>
det achment</w>
carb ons</w>
HB s
os elective</w>
te a</w>
br ids</w>
Ob serv
deb ate</w>
mt DNA</w>
A </w>
MT X</w>
fraction ation</w>
morph ologic</w>
echocardi ographic</w>
T i</w>
dissem ination</w>
contrac eptive</w>
idi d
ster ol</w>
AK T</w>
con sol
TL V</w>
2 B</w>
fl at</w>
Pro f
as par
clea ved</w>
confir mation</w>
out flow</w>
strom a</w>
ep tors</w>
curricul um</w>
in consistent</w>
mom ent</w>
Cardi ovascular</w>
c us</w>
en ol
res ec
13 1</w>
go v</w>
cri sis</w>
de trim
AN CE</w>
Dec re
X 2</w>
radi olab
pul p</w>
lat tice</w>
art an</w>
spre ading</w>
Sensi tivity</w>
wo od</w>
9 ,
ad ducts</w>
harve sted</w>
G B</w>
u ve
G ly
st ressed</w>
in us</w>
exc ited</w>
visu alized</w>
orig inating</w>
Consi dering</w>
function ality</w>
h ind
pre p
diver gence</w>
acceler ation</w>
di ameters</w>
S mo
MD R</w>
oph ore</w>
Up on</w>
10 9</w>
radio immunoassay</w>
biom echanical</w>
Col lec
Gl c
yn aptic</w>
SU B
hypertroph ic</w>
ch aper
cou ples</w>
ophyl line</w>
on itr
tim ely</w>
at tend
domin ated</w>
com promised</w>
ser ving</w>
y ran
Lit tle</w>
Com po
enco de</w>
V O
assist ance</w>
ex ons</w>
tail ored</w>
Ac cur
odend ro
Sle ep</w>
periodon titis</w>
normot ensive</w>
B F</w>
f 2</w>
pharmac ologic</w>
den er
b it
tis h</w>
r id
trunc ated</w>
it ors</w>
pos tin
c all</w>
C ri
U N
M SC</w>
D ist
Or th
re agent</w>
id ectomy</w>
ene di
vi x</w>
grad ual</w>
CH O</w>
w est</w>
decom position</w>
ib ution</w>
am en</w>
1 12</w>
ac tually</w>
re act</w>
gir l</w>
ster oidal</w>
immobil ization</w>
ta m</w>
D ou
tot ally</w>
F ail
1, 4</w>
mal formation</w>
my ri
har m</w>
circu its</w>
Stro ke</w>
in ing</w>
occip ital</w>
Lap aro
vi ri
di hydroxy
os per
ti tle</w>
sol vents</w>
wat ers</w>
D ig
um ination</w>
polyp s</w>
refl ection</w>
d rought</w>
hyper glycemia</w>
potenti ation</w>
phag ocytosis</w>
ir regular</w>
r on
up date</w>
orig inally</w>
trajec tories</w>
distric t</w>
sal ic
el eg
L N</w>
AC L</w>
addic tion</w>
anti oxidants</w>
ME NTS</w>
n aive</w>
pros theses</w>
transpl ants</w>
osi tis</w>
fel t</w>
cr im
met formin</w>
v ocal</w>
ak es</w>
am il
b rought</w>
us sian</w>
end points</w>
N r
man n</w>
tod ay</w>
otyp ed</w>
fit ted</w>
Braz ilian</w>
H om
System ic</w>
A min
accum ulate</w>
ot emporal</w>
CA P</w>
B CG</w>
teri ous</w>
at rop
promp t</w>
homogene ity</w>
- 10</w>
Re sistance</w>
X A</w>
ren sic</w>
mon omer</w>
En gland</w>
sig ma</w>
hedr al</w>
oin t</w>
0 3</w>
di lation</w>
sign ature</w>
AT 1</w>
pa id</w>
succ essive</w>
ber g</w>
pur su
deri ve</w>
sched uled</w>
VI P</w>
L ys</w>
retin oic</w>
SIG N
F L</w>
spac es</w>
cholecyst ectomy</w>
inst ances</w>
ac tors</w>
an te
anticoagul ant</w>
contrib ut
AV P</w>
Ac cordingly</w>
bil ayer</w>
onc ogenic</w>
U s</w>
cut off</w>
an ia</w>
og raph</w>
S n
0.9 9</w>
manifest ed</w>
ur able</w>
M CP</w>
agglutin ation</w>
W a
al s.
ger m
oxyt ocin</w>
ch a
conven ient</w>
go es</w>
W I</w>
interfer ing</w>
im mer
z ine</w>
x y</w>
l ex
is ely</w>
J NK</w>
az one</w>
On c
men is
post ulated</w>
12 8</w>
enti rely</w>
impl ementing</w>
C ys</w>
neuro protective</w>
STAT 3</w>
d ural</w>
anti coagulation</w>
Taiw an</w>
in version</w>
predic table</w>
syn thesize</w>
ation wide</w>
omat osis</w>
IV F</w>
atr y</w>
2 40</w>
fail ures</w>
vol ution</w>
transcrip tome</w>
H N
sol ely</w>
scenari o</w>
Pos sible</w>
landscap e</w>
Whe ther</w>
exc ised</w>
epider mis</w>
or in</w>
ing redi
ogen y</w>
rec ycl
lab elling</w>
Pro c
o esophageal</w>
perc enti
SUB JEC
at tended</w>
insec tic
reve aling</w>
off ic
13 5</w>
L oss</w>
del ays</w>
Y et</w>
suppl ements</w>
HBs Ag</w>
ly so
harm ful</w>
1 70</w>
pyr amidal</w>
M K</w>
1 16</w>
tetrac ycline</w>
buil d</w>
lact am
len ses</w>
bor derline</w>
ur a</w>
for tun
fit ting</w>
no v</w>
oph er
br ile</w>
prof en</w>
rel ig
bi o</w>
bas ement</w>
ill a</w>
resi li
st aphyloc
agg ed</w>
le b
in tran
dis ordered</w>
ap art</w>
idid ym
c .</w>
so on</w>
angi ographic</w>
ing e</w>
compens ation</w>
posi tional</w>
GR P</w>
ration ale</w>
el bow</w>
Le ft</w>
tab lets</w>
phosphatidyl choline</w>
0.0 9</w>
lin ear
N AC</w>
sulph ate</w>
van comycin</w>
un like</w>
p i</w>
acet ylation</w>
efficac ious</w>
hel ps</w>
mol ars</w>
contex ts</w>
sol itary</w>
cor on
streng ths</w>
RE GIST
Peri ph
Cl 2</w>
rough ly</w>
eradic ation</w>
T P
dele terious</w>
cl ients</w>
Th 1</w>
c m2</w>
extrem ities</w>
in ability</w>
v or
W S</w>
medull a</w>
tinc tion</w>
t et
i ence</w>
I .</w>
cre ation</w>
micro RNA</w>
g et</w>
al location</w>
suspici on</w>
H TLV</w>
C re
re generative</w>
PA GE</w>
micro mol</w>
F M</w>
produc tive</w>
design ing</w>
ecosy stem</w>
ha m</w>
T K
off ice</w>
ov ine</w>
scop ically</w>
depos ited</w>
ec tual</w>
g ast
distinc tive</w>
tetr am
S N</w>
asth matic</w>
C am
per tussis</w>
e ste
p ocket</w>
RE M</w>
lear n</w>
subtil is</w>
de ad</w>
Bas eline</w>
O per
An g</w>
dop ed</w>
Me di
Suc cess
metr ics</w>
virul ent</w>
t s
d engue</w>
al ive</w>
lid ocaine</w>
contempor ary</w>
nitr ite</w>
me aning</w>
An xi
pan demic</w>
am ong
stret ch</w>
par affin</w>
er ation</w>
ven a</w>
18 7</w>
os yl</w>
A SA</w>
pollut ants</w>
reser ve</w>
inter active</w>
physi cochemical</w>
negl igible</w>
B l
post ural</w>
ultr a</w>
H o
val ves</w>
my c</w>
I U
IC P</w>
spi ro
IC s</w>
batter y</w>
electro static</w>
B lack</w>
4 6
edull ary</w>
20 1</w>
F er
E T
man d
roph yl
vari ates</w>
E ch
R ab
Yor k</w>
y rene</w>
RA TION</w>
Clo str
pos itron</w>
mis sed</w>
ov ulation</w>
cad aver
min d</w>
acc ident</w>
Ur inary</w>
it ch</w>
ab is</w>
mal nutrition</w>
q PCR</w>
N utri
function alized</w>
bi phasic</w>
F EV
N eu
Func tion</w>
Pol ym
defici encies</w>
atmosph eric</w>
1 22</w>
rac ial</w>
hy brids</w>
D own</w>
sump tions</w>
develop s</w>
warf arin</w>
proxim ity</w>
among st</w>
heter ologous</w>
S ES</w>
wid er</w>
i odi
proteas ome</w>
stre pto
sub populations</w>
bl ings</w>
oste otomy</w>
escap e</w>
gener ic</w>
MT T</w>
adv ice</w>
supernat ant</w>
2 R</w>
alb umin
L ight</w>
B C
des ensi
h app
tit ude</w>
pal ate</w>
hypo thermia</w>
sep tum</w>
inf requ
sem antic</w>
M r</w>
diagnos tics</w>
par all
w ri
SUBJEC TS</w>
immunoprecip itation</w>
V P</w>
15 5</w>
L ear
hem odynamics</w>
Tri als</w>
ot ed</w>
dend r
la g</w>
fru its</w>
organ izational</w>
dis abl
dis comfort</w>
IC A</w>
Rel ated</w>
leuk aemia</w>
benz o</w>
nic kel</w>
G BM</w>
us tion</w>
pat ches</w>
es in</w>
opath ologic</w>
prolifer ating</w>
log y</w>
an z
can onical</w>
ul ins</w>
atin ib</w>
r if
lin early</w>
NCT 0
r yst
Isol ation</w>
0. 10</w>
mil itary</w>
arg ue</w>
ic us</w>
ater ally</w>
but yrate</w>
Th 2</w>
sphinc ter</w>
2 b</w>
cu red</w>
po res</w>
g ating</w>
Ch lamy
trigg ers</w>
endocardi tis</w>
en oic</w>
gen tam
ill nesses</w>
qu estion
im urium</w>
possess es</w>
cap ill
sta ke
Rep e
g em
intrav ascular</w>
gam ma
ph i</w>
itud es</w>
necess arily</w>
ic os
N B</w>
cer vix</w>
no tion</w>
util ize</w>
ar ranged</w>
thick ening</w>
microtub ules</w>
F ree</w>
check point</w>
aggreg ate</w>
C as
hydrol ase</w>
special ty</w>
M K
CL IN
pol arity</w>
az ide</w>
p uncture</w>
V III</w>
T op
prec ed
micr ons</w>
In duction</w>
detrim ental</w>
galac to
surg eries</w>
carbox yl</w>
adop tion</w>
ep ididym
MEASURE MENTS</w>
over load</w>
Gl yc
olig odendro
Periph eral</w>
parasi tic</w>
appropri ately</w>
metr ical</w>
yr ic</w>
vi ro
polymer ic</w>
Ar g
fav or</w>
Sam ples</w>
val ently</w>
acces sibility</w>
por ph
0 4</w>
perm its</w>
ec e</w>
A v
correspon ded</w>
onucle ase</w>
syn thesi
ati vity</w>
Caucasi an</w>
trac k</w>
expl oring</w>
st yle</w>
an di
- 8</w>
ene m</w>
e igh
tun nel</w>
sp o
free zing</w>
hyper cholesterol
agg ression</w>
On t
free ze</w>
onitr ile</w>
an tin
AC C</w>
disp arities</w>
Co V</w>
chondro cytes</w>
Bacter ial</w>
Ex pl
ren ol</w>
Im pl
arteri ovenous</w>
lute al</w>
D T</w>
H ar
hypo thyroidism</w>
mening i
sup ra
AN P</w>
gr ass</w>
REGIST RATION</w>
tain ment</w>
is sion</w>
devi ations</w>
flu idic</w>
segreg ation</w>
b atch</w>
progenit ors</w>
vi sions</w>
n ich
k cal</w>
ish able</w>
sed entary</w>
mod ule</w>
0.00 6</w>
L ower</w>
medias tinal</w>
tetra hydro
L L</w>
P ear
M en
hor n</w>
famil iar</w>
com posites</w>
ra is
bab ies</w>
C EN
contracti lity</w>
als. gov</w>
tr ib
k o
T T
altern atives</w>
incre mental</w>
her bal</w>
C ys
epidemi ologic</w>
an il
mes oth
ati zation</w>
oste osarcoma</w>
1 14</w>
de duced</w>
sup pressing</w>
dis appearance</w>
gu n</w>
P s
MD D</w>
gli oblastoma</w>
exist ed</w>
reservo ir</w>
re arrangements</w>
ran ean</w>
paren chym
Del ta
docum entation</w>
cyt omegalovirus</w>
innerv ation</w>
pati al</w>
perm it</w>
O H
noctur nal</w>
pran dial</w>
met allic</w>
Ne ther
neuro transmitter</w>
osse ous</w>
lit er</w>
re ad</w>
eri an</w>
analy tic</w>
In deed</w>
met a
Ex erc
bl ast</w>
S ARS</w>
fil ters</w>
I P
diab etics</w>
Com mit
Clin ic
cigaret tes</w>
ris ing</w>
W M</w>
fu el</w>
carb onyl</w>
out patients</w>
m y</w>
ut ch</w>
As p</w>
hyper activity</w>
p y</w>
im balance</w>
ca emia</w>
mon ophosphate</w>
I sl
or n
expan ding</w>
hypoglyc emia</w>
lo ops</w>
I X</w>
ul ae</w>
T yr</w>
mod eled</w>
yiel ding</w>
dodec yl</w>
sput um</w>
8 ,
l umin
on ium</w>
Gu id
sub clinical</w>
di aly
v oc
step wise</w>
ep sin</w>
rel in</w>
nal oxone</w>
Swe den</w>
em inal</w>
sp aring</w>
galact ose</w>
g ains</w>
employ ees</w>
cat alysis</w>
rheum atic</w>
Tran spl
1 24</w>
Grou ps</w>
toler ability</w>
E g
spectro phot
refr active</w>
surviv ing</w>
spati ally</w>
special ists</w>
ampl itudes</w>
vo ice</w>
du plex</w>
F il
pro of</w>
T OF</w>
3 a</w>
FI SH</w>
Hist ological</w>
1 alpha</w>
Di str
amput ation</w>
err y</w>
enti ties</w>
tigh tly</w>
bi osynthetic</w>
A H</w>
N ic
ly tic</w>
L Y
is op
es us</w>
presum ed</w>
h r
pro pri
Classi fication</w>
PC a</w>
si mp
os mol
tam oxifen</w>
gener ates</w>
gra vity</w>
oper oxidase</w>
avoid ing</w>
arb onate</w>
imp ly</w>
amin op
prep are</w>
te ams</w>
plur ipot
toler ant</w>
Sp ont
di genous</w>
catech ol
ro ad</w>
3 T3</w>
O ve
es cal
en ters</w>
as sumptions</w>
chol angi
N ot</w>
A ver
physic ally</w>
M u
lim us</w>
Immuno histochemical</w>
mo ve</w>
s and
defin itions</w>
Mit ochond
Rep or
CX CR
ang e</w>
3 9
M L</w>
Nether lands</w>
Four teen</w>
ath eter</w>
end er</w>
Mex ico</w>
Ul tra
NAD H</w>
0 6</w>
refl ex
Inc idence</w>
h an
acet ab
si blings</w>
Pan cre
L iter
radi ography</w>
Plat el
0. 12</w>
age ing</w>
Pre viously</w>
hy pe
estro gens</w>
con stitutes</w>
Success ful</w>
ul um</w>
inv asi
Anxi ety</w>
Fem ale</w>
P arti
M AL
or um</w>
ad ox
mot oneur
distingu ishable</w>
ile um</w>
do si
ol og</w>
som nia</w>
puber tal</w>
tri phosphate</w>
ingu inal</w>
Long itudinal</w>
M G
Rev er
exp and</w>
198 4</w>
T or
phot osynthetic</w>
T el
micro spheres</w>
insec ts</w>
al ge
el lo
cho ices</w>
Stand ard</w>
inc i
plo ts</w>
enlarg ed</w>
thal ass
cry op
de al</w>
Serv ice</w>
broad er</w>
atin s</w>
ar ized</w>
lac ks</w>
cong ru
vesi cular</w>
Wh ole</w>
selec tin</w>
pestic ides</w>
 g</w>
on uc
simp ly</w>
ro bu
robo tic</w>
Gr ade</w>
6 7
F F</w>
un necessary</w>
CLIN ICAL</w>
ac ro
isch aemia</w>
nucle oside</w>
edi pine</w>
PC OS</w>
inter play</w>
tu re
M CI</w>
ex tinction</w>
condi tional</w>
compet ent</w>
si d</w>
Com plex</w>
tw ins</w>
necess ity</w>
anti sera</w>
ph o
n itro</w>
S chool</w>
real istic</w>
Cp G</w>
ri t</w>
dextr an</w>
T GF
GV HD</w>
evol ving</w>
H yp
depend ency</w>
reg ime</w>
R PE</w>
hemat ological</w>
-- a</w>
accid ents</w>
G ST</w>
par alysis</w>
emul sion</w>
prec isely</w>
eosinoph ils</w>
ther mic</w>
emphasi zed</w>
G astro
plat eau</w>
fin ement</w>
ent rop
machin ery</w>
thir ty</w>
ver apamil</w>
alga e</w>
Stim ulation</w>
co variates</w>
clinic opathological</w>
Isol ated</w>
obacter ium</w>
im idine</w>
rel ies</w>
f a</w>
Ox y
1. 25</w>
Ol der</w>
tid al</w>
w ater
Cs A</w>
Cor rec
orth op
co ded</w>
v ular</w>
col our</w>
prin t</w>
plac es</w>
0.9 8</w>
D oes</w>
top ics</w>
d s
meth oxy
Compu ted</w>
it or</w>
ac idi
wa ist</w>
1. 00</w>
P i</w>
4 7
R ou
i tin
icon duc
Ultras ound</w>
phosph odi
cap tured</w>
am ol</w>
C ity</w>
dis k</w>
Ove rex
y e</w>
Fe w</w>
histopath ology</w>
integr ating</w>
aller gens</w>
P i
u sions</w>
0 9</w>
il ty</w>
in takes</w>
e i</w>
reser ved</w>
immun ologic</w>
5 49</w>
sy ring
Educ ation</w>
victim s</w>
mir ro
silic one</w>
cataly sts</w>
coll ateral</w>
impl ies</w>
potenti ated</w>
requ is
normal ization</w>
ket amine</w>
electro my
miner alization</w>
pro pos
NP Y</w>
mechan ics</w>
orth odontic</w>
comorb id</w>
sto ol</w>
microbi ome</w>
CH F</w>
eng aged</w>
Le ishman
intell ectual</w>
ost er</w>
Mo der
selec ting</w>
Con sistent</w>
integr ate</w>
b im
obste tric</w>
per iton
Zn O</w>
cardiomy ocytes</w>
s mar
pat ent</w>
le i
Fail ure</w>
S kin</w>
ific ations</w>
gentam icin</w>
bec tomy</w>
hem angi
cas ein</w>
pacema ker</w>
rot ational</w>
inc is
hem olytic</w>
toc opher
gener ations</w>
1 17</w>
exerc ises</w>
anticip ated</w>
Com plications</w>
doc king</w>
Ac et
nec rotic</w>
projec ts</w>
cong estive</w>
sustain able</w>
Dis e
ch ip</w>
v ast</w>
13 2</w>
adsorb ed</w>
As s
flow s</w>
HC l</w>
Mus cle</w>
til es</w>
determin es</w>
represent ations</w>
ev ery
eleg ans</w>
prec eded</w>
neph rectomy</w>
Hepati tis</w>
In c</w>
FEV 1</w>
sedi ments</w>
F DA</w>
anomal y</w>
con cordance</w>
ac in
vul g
prote renol</w>
depend ed</w>
inform atics</w>
compens atory</w>
occa sionally</w>
flan king</w>
ter ic</w>
N ec
radi ologic</w>
st ores</w>
per i</w>
prof loxacin</w>
toxic ities</w>
parenchym a</w>
Nat ural</w>
E 3</w>
o edema</w>
ogly co
Nur sing</w>
Inter action</w>
config ur
ocyst s</w>
fac ing</w>
aud i</w>
Individ ual</w>
she ath</w>
Pre treatment</w>
ke eping</w>
b and
tho rough</w>
pres ynaptic</w>
ma kers</w>
carni tine</w>
exclud ing</w>
Coh ort</w>
otrop y</w>
R b</w>
fortun ately</w>
rup tured</w>
Individ uals</w>
doc tor</w>
s ac</w>
M N</w>
7 00</w>
CR I
penetr ating</w>
Clostr idium</w>
12 9</w>
F E</w>
CA BG</w>
opi oids</w>
hemat ologic</w>
E SR
inf ancy</w>
end urance</w>
0. 95</w>
bon y</w>
Pri or</w>
K D</w>
haem oglobin</w>
disper sed</w>
immunost aining</w>
U p</w>
micro wave</w>
d ol
de tox
B V</w>
cyt ogenetic</w>
pro ton
monol ayers</w>
D im
brach ial</w>
mis match</w>
lamin in</w>
Exerc ise</w>
rh initis</w>
di mers</w>
compe ting</w>
neo adjuvant</w>
k a</w>
resid ence</w>
Met ast
rec tum</w>
Collec tively</w>
An d</w>
Ch ol
AB C</w>
AE s</w>
IGF BP</w>
Rec eptor</w>
os clerosis</w>
survi ve</w>
transi t</w>
oper ate</w>
anaes the
G Ps</w>
tr on</w>
o con
Endos copic</w>
w it
el ia</w>
ox ane</w>
Cr yst
lo oked</w>
A Z
Sym ptom
appro val</w>
N PC</w>
Q T</w>
hapl otypes</w>
Desc rip
up dated</w>
diarr ho
am ides</w>
lymph oblastic</w>
i osis</w>
oci ties</w>
ir r
0.8 5</w>
bronch i
v ar</w>
1 13</w>
Ab str
Elev ated</w>
Resp iratory</w>
ish er</w>
anc ing</w>
pelv is</w>
anten atal</w>
nod ule</w>
Th yro
c ue</w>
gen otyping</w>
re vised</w>
correspon d</w>
worsen ing</w>
n d</w>
x ine</w>
Ad ults</w>
.00 01</w>
aeros ol</w>
L ang
prost atectomy</w>
consci ousness</w>
centrifug ation</w>
under lie</w>
secre ting</w>
R AN
trajec tory</w>
f lies</w>
ed om</w>
R ed</w>
son ography</w>
fluoro uracil</w>
reciproc al</w>
For mul
Mont e</w>
bran ched</w>
AL Y
oper ator</w>
excit ability</w>
X T</w>
aut oradi
Character istics</w>
st och
iter ranean</w>
constitu tively</w>
cul tivation</w>
p unc
en ke
view ing</w>
bic arbonate</w>
4 50
Cl -</w>
3 50</w>
U T</w>
k m</w>
intram uscular</w>
V alu
incorpor ate</w>
sk ill</w>
Six teen</w>
teach ers</w>
TRI AL</w>
M H</w>
vascul itis</w>
S MA</w>
import antly</w>
Ar e</w>
Ob esity</w>
sec urity</w>
le af
thre onine</w>
pre eclampsia</w>
electro encephal
L R
W F</w>
ch er</w>
bl es</w>
pl asts</w>
ju ice</w>
vibr ation</w>
vel ocities</w>
A O
g .
bound aries</w>
Ad ju
sh i
ri m</w>
hep ar
tre ad
metallo proteinase</w>
L VE
de myel
alumin um</w>
M ass</w>
Pu blic</w>
histopath ologic</w>
opa edic</w>
it ate</w>
rhe a</w>
Rel ative</w>
fri end
tub ule</w>
stress ors</w>
stabil izing</w>
not ably</w>
Car lo</w>
ent ous</w>
ill i</w>
per ic
protein ases</w>
conf er</w>
u z
as tig
TR H</w>
PL ICA
Dise ases</w>
thalam us</w>
ing er</w>
sc ann
C erebral</w>
consum ers</w>
compr ises</w>
ing dom</w>
shar p</w>
oc ks</w>
prog ressed</w>
D ynamic</w>
0 7</w>
Spont aneous</w>
n als</w>
ipp ed</w>
proper ly</w>
ec to
CM L</w>
uber cul
I O
B r</w>
ti d</w>
om ere</w>
t ying</w>
12 7</w>
ster ile</w>
- 2
Min im
Cr yp
ag en
age -</w>
collabor ative</w>
eth ics</w>
hyp og
ocy st</w>
ac tu
fro g</w>
remo ving</w>
1 21</w>
ex ud
fe brile</w>
oc ele</w>
chol est
colum ns</w>
n ic</w>
quad r
d ay
P AC
7 5
0.9 6</w>
cam era</w>
an ions</w>
B loc
ere bro
Alcoh ol</w>
cyclo oxygenase</w>
wh ilst</w>
phosph at
resul tant</w>
psych ometric</w>
1 18</w>
X 1</w>
V max</w>
der al</w>
oglyc ans</w>
v on</w>
ur onic</w>
sup pressive</w>
sarco idosis</w>
ari an</w>
sme ar</w>
P t
where by</w>
pon ectin</w>
is omers</w>
0.00 7</w>
highligh ting</w>
simul ate</w>
por tions</w>
ob stac
N uclear</w>
graph ic</w>
S o</w>
intr ad
ham sters</w>
S ex</w>
oc rit</w>
f are</w>
Thir teen</w>
Calc ium</w>
coun ter</w>
Ad he
CA R</w>
 ve</w>
sem inal</w>
micro satellite</w>
prote olysis</w>
fentan yl</w>
preferen tial</w>
- 1.
usp id</w>
A Q
nan ow
Dis orders</w>
Med iterranean</w>
tun ing</w>
co operation</w>
test es</w>
read mission</w>
M F
a res</w>
papill omavirus</w>
n ame</w>
id el
Re duction</w>
i ate</w>
0.9 7</w>
R eal</w>
arch a
V D</w>
mag n
disturb ed</w>
om ide</w>
sup ine</w>
eng age</w>
po ols</w>
shap es</w>
ecosy stems</w>
fo rensic</w>
a ult</w>
accep tability</w>
- di
t acti
Radi ation</w>
t 1</w>
all op
l aryng
tread mill</w>
ca va</w>
ent um</w>
re per
carb am
Me an
transi ently</w>
Qu al
electr on
enro ll
index es</w>
E d
ac utely</w>
ec ta
os ed</w>
ind ole</w>
omorph ic</w>
aff in
transpor ted</w>
quad ru
il eal</w>
back bone</w>
hyper thermia</w>
multic entr
sub arachnoid</w>
Medic aid</w>
simpl ified</w>
cam pa
AM E</w>
ro ta
B BB</w>
Dis order</w>
Mon itoring</w>
Hep at
hol ders</w>
consi st</w>
co w</w>
B E</w>
scar ce</w>
achiev ement</w>
ox etine</w>
0 8</w>
phen ols</w>
e z
Log istic</w>
deter gent</w>
ynam ics</w>
ana emia</w>
Commit tee</w>
B ax</w>
pre y</w>
P rom
N V</w>
A ch
T MS</w>
Overex pression</w>
is ometric</w>
quanti tation</w>
Ri ver</w>
um e</w>
di e</w>
form at</w>
V acc
Pear son</w>
re place</w>
pyr ro
aro usal</w>
Hep G2</w>
continu ity</w>
neuro pathic</w>
Gl ut
Eff ici
pleg ia</w>
bel ong</w>
L ys
stop ped</w>
coll ecting</w>
dys regulation</w>
Re duc
d yl</w>
t ar
pur ity</w>
infiltr ating</w>
Lac tob
laparo scopy</w>
4 9
TI R</w>
Ep stein</w>
N ext</w>
G LP</w>
paren chymal</w>
sol ving</w>
rhyth ms</w>
b us
coll ect</w>
inher itance</w>
bacteri oph
C RE
el le</w>
hist ocompatibility</w>
corne a</w>
Symptom s</w>
Objec tives</w>
mig rants</w>
meas les</w>
t ag
bl ed</w>
colon oscopy</w>
er ated</w>
z ot
Ac tive</w>
mim icking</w>
2 10</w>
Swe dish</w>
V TE</w>
co res</w>
sub tle</w>
gre w</w>
ti vities</w>
correspon ds</w>
M em
morph ologically</w>
th an
Clin ic</w>
ti se</w>
si veness</w>
neutrop enia</w>
M e</w>
Bar r</w>
b aro
trig eminal</w>
CL L</w>
HR H</w>
mod ules</w>
P y
thir ds</w>
cl ock</w>
gastro enter
G W
organ elles</w>
lyso zyme</w>
b umin</w>
mandi ble</w>
Lew is</w>
gli omas</w>
b er</w>
trabec ular</w>
periton itis</w>
0.00 8</w>
haemorrh age</w>
cap sular</w>
ent h</w>
surro gate</w>
htt p</w>
198 2</w>
ti tr
ol ate</w>
s ulation</w>
opo iesis</w>
neuro imaging</w>
Aver age</w>
Environ mental</w>
atrop ine</w>
co valently</w>
co operative</w>
explic it</w>
ar a</w>
socio demographic</w>
E P
ster il
pa rox
w aiting</w>
accompan ying</w>
work place</w>
ophil us</w>
co at</w>
MM A</w>
ascor bic</w>
anti psychotic</w>
form alin</w>
E E</w>
Respon ses</w>
ub ic</w>
ati s</w>
Ar ti
perform ances</w>
fil es</w>
C lu
overex pressing</w>
cyclospor ine</w>
bi osens
mand atory</w>
choro idal</w>
endometr ium</w>
r d</w>
G D
clu stered</w>
Bri tish</w>
AB A</w>
scal p</w>
Pe ople</w>
gro unds</w>
ubiquit ous</w>
prote omic</w>
RN ase</w>
imid azole</w>
intox ication</w>
Ne on
lab our</w>
Lear ning</w>
0 s</w>
resec table</w>
bac te
ocyt oma</w>
in ve
og aster</w>
prim ed</w>
C x
estr us</w>
is tically</w>
C aro
bot tom</w>
Immun e</w>
a etiology</w>
hyd rates</w>
chec k</w>
diver gent</w>
en osis</w>
g eriatric</w>
curv ature</w>
FO X
abs orp
A ST</w>
reper to
Simult aneous</w>
relap sed</w>
homocy steine</w>
erythro id</w>
Regi onal</w>
muc us</w>
physi ologically</w>
oligonucle otides</w>
pseud o</w>
obl otting</w>
fol i
Impro vement</w>
C ellular</w>
Rec or
h at
ati d</w>
plac ements</w>
it atively</w>
ure teral</w>
tom ato</w>
form ulated</w>
inter faces</w>
discrep ancy</w>
X R</w>
mo ist
O s</w>
b ending</w>
cann abin
P HA</w>
o plas
stig ma</w>
ex tern
arrhyth mic</w>
catech olamine</w>
14 4</w>
libr aries</w>
prot otype</w>
PD T</w>
pre vent
glycos ylated</w>
ca ver
b ing</w>
h id
A c</w>
99 mT
pon in</w>
therap ists</w>
ro limus</w>
D H
13 C</w>
0.9 4</w>
manufac turing</w>
k ling</w>
resol ve</w>
AF P</w>
ultr af
W s</w>
capill aries</w>
ipp ing</w>
sph ere</w>
mosquit o</w>
br ush</w>
D HA</w>
y sis</w>
s av
y mo
atax ia</w>
de oxy</w>
198 3</w>
veget ables</w>
ich i
splic e</w>
2 20</w>
sem in
D utch</w>
cos metic</w>
sem iconduc
ri o</w>
ic ol</w>
hist ories</w>
neuro trophic</w>
A OR</w>
f uc
st enting</w>
oc o
gri p</w>
tom ographic</w>
dise ased</w>
Liter ature</w>
calc itonin</w>
Contin uous</w>
meas urable</w>
qu asi</w>
1 p</w>
cal ls</w>
align ed</w>
Laparo scopic</w>
investig ates</w>
onym ous</w>
pa re
F O</w>
Phy l
coord inate</w>
Nig eria</w>
histo chemistry</w>
te ars</w>
Recom bin
Ad verse</w>
po t</w>
en teen</w>
fibro tic</w>
radi onuc
op ac
min i</w>
bon ded</w>
e e</w>
illustr ates</w>
sedi mentation</w>
rophyl l</w>
T radi
D U
d ness</w>
war m</w>
xen ograft</w>
0.9 3</w>
B P
99 m</w>
lei omy
bi ore
cann abis</w>
guan osine</w>
epith eli
L as
swim ming</w>
o ils</w>
macro scopic</w>
C ases</w>
oper ational</w>
sic kle</w>
fun ding</w>
M er
E W</w>
0.9 2</w>
Anim als</w>
thrombo embolism</w>
op posed</w>
capsul es</w>
id one</w>
Ste m</w>
ic ate</w>
germin ation</w>
adi um</w>
auton om
dis placed</w>
Tra ining</w>
nif edipine</w>
H Y
c ame</w>
bro il
disp ens
ton si
le aving</w>
le ak</w>
reinfor cement</w>
Pro per
13 7</w>
C 6</w>
hospit alizations</w>
answ er</w>
D ose</w>
hypo thesize</w>
extrac orporeal</w>
A x
L OS</w>
hor se</w>
s acc
r on</w>
amph i
A O</w>
Ve ter
V E</w>
c ogn
att entional</w>
see k</w>
antidepress ants</w>
id azole</w>
protec ting</w>
attenu ates</w>
expl ores</w>
un detectable</w>
comb ine</w>
pa in
smal l
Mechanis ms</w>
pre fer
tensi le</w>
CT A</w>
app rais
an i</w>
Leishman ia</w>
pro gen
P d</w>
conden sation</w>
intern alization</w>
intr ap
ti te</w>
g ol
IF ICA
BA SE</w>
Spec tr
manif est</w>
responsi bility</w>
dropl ets</w>
analog ous</w>
na ve</w>
decarbox ylase</w>
AG E</w>
vitre ous</w>
ocarcin omas</w>
methyl ene</w>
sil ent</w>
2 31</w>
morph ogenesis</w>
ag en</w>
Investig ation</w>
ad min
pharmac ists</w>
un ting</w>
ci profloxacin</w>
de dicated</w>
oste ogenic</w>
em e
K idne
st and</w>
propor tion
Pro ject</w>
not e</w>
ma ze</w>
PLICA TIONS</w>
Pro gnostic</w>
domin ance</w>
si bly</w>
th eta</w>
re ality</w>
sor ting</w>
ser otypes</w>
B ir
cephal us</w>
cer amic</w>
suspen sions</w>
T C
Bi ological</w>
cur cumin</w>
0.8 9</w>
ge ometr
Im proved</w>
0.8 8</w>
trigg ering</w>
jour nals</w>
s en</w>
su red</w>
0.8 3</w>
seed lings</w>
c ities</w>
E PO</w>
compati bility</w>
om yc
conflic ting</w>
preser ving</w>
imp acted</w>
in patients</w>
Sur prisingly</w>
M is
E 2
C amp
expect ancy</w>
st ments</w>
h op
Sr c</w>
somat osensory</w>
U L
ph aryngeal</w>
SIGN IFICA
c il
x es</w>
f ec
tol u
Dou ble</w>
collag en
di ploid</w>
emp tying</w>
1 19</w>
at ur
posi tioned</w>
val vular</w>
her pes
al ism</w>
z i</w>
I B</w>
ser o
Gluc ose</w>
administr ative</w>
in spec
v ated</w>
an olamine</w>
an ore
n ationwide</w>
cytos keletal</w>
D ental</w>
In dic
M AC</w>
Com mon</w>
Spec tro
don ation</w>
ab s</w>
E VI
Re duced</w>
encour age</w>
ot echn
par am
P GF
enter oc
sug ars</w>
ol itis</w>
f arm</w>
P neum
T ech
D om
E L</w>
com promise</w>
paras it
co al</w>
ep ig
trans gene</w>
or iti
ultim ate</w>
en sing</w>
instrum ental</w>
adjunc t</w>
AM PK</w>
ili ated</w>
tom ic</w>
R et
periph ery</w>
L eg
SIGNIFICA NCE</w>
tradi tionally</w>
6 -</w>
iso proterenol</w>
w ell
regul ations</w>
hyp oc
V 1</w>
infec tive</w>
0.9 1</w>
ar te
transduc er</w>
E t
M C
Rec on
g p</w>
or rho
dr ying</w>
conc eption</w>
Pro duction</w>
ti bia</w>
exacerb ation</w>
scienti sts</w>
p H
mon ocyt
0.8 6</w>
at tained</w>
Sp inal</w>
oligos accharides</w>
omo tion</w>
bran ching</w>
cl o
sign atures</w>
modul us</w>
end ocytosis</w>
distingu ishing</w>
P ul
inter personal</w>
gast rectomy</w>
edi ting</w>
co x
el usive</w>
S k
1, 25</w>
glob ally</w>
synchron ous</w>
r DNA</w>
anthrop ometric</w>
M align
ab ain</w>
contr ain
op yran
as cer
ER K1</w>
M N
obser vers</w>
del eted</w>
cu stom
L N
melan ogaster</w>
emo tions</w>
spec ially</w>
micro biological</w>
V ib
Lactob acillus</w>
at rium</w>
Inflam matory</w>
Not ably</w>
al op
bio tin</w>
99mT c</w>
Pro v
practition er</w>
percenti le</w>
heter odi
dysp nea</w>
ar dis
TLR 4</w>
tr ade</w>
Al ter
encour aging</w>
re sts</w>
mit osis</w>
conform ations</w>
arr ative</w>
Pl ant</w>
super family</w>
b es</w>
13 8</w>
diaphrag m</w>
puber ty</w>
lat est</w>
Su per
serop ositive</w>
L ibr
M uc
My ocardial</w>
configur ations</w>
Del ta</w>
activ ators</w>
V L
R ating</w>
0.8 7</w>
in deed</w>
inter quartile</w>
glob in</w>
Mean while</w>
heavi ly</w>
irrig ation</w>
ay ing</w>
contamin ants</w>
deteri or
ir ium</w>
wal k</w>
the ast</w>
s oph
por ted</w>
sti tis</w>
Hepati c</w>
ad ver
habit ats</w>
tra vel
graf ted</w>
shorten ed</w>
trans m
sens ation</w>
h ap
trac ts</w>
avi r</w>
mid line</w>
impa ir</w>
lead ership</w>
t amine</w>
x ed</w>
T ol
dy es</w>
eti ological</w>
G ST
ventil atory</w>
0. 13</w>
0. 11</w>
ri ver</w>
ch ond
re pl
qual itatively</w>
e astern</w>
inform ative</w>
micro RNAs</w>
man agers</w>
K L</w>
Pac ific</w>
prim ates</w>
AB P</w>
dis continued</w>
cul t</w>
comm itment</w>
consum er</w>
S ens
con clusive</w>
the ophylline</w>
discus sions</w>
conjug ation</w>
method ologies</w>
azol am</w>
F V</w>
ast al</w>
AM D</w>
dys phagia</w>
ro str
exper tise</w>
col li
poli tical</w>
er ve</w>
br and</w>
1 0.5</w>
li sts</w>
mang anese</w>
Sub sequent</w>
duoden um</w>
cut aneously</w>
0.7 8</w>
introduc ing</w>
0. 14</w>
5 5
I 2</w>
man nose</w>
iz able</w>
PBM C</w>
A AA</w>
caregi ver</w>
ot axis</w>
o val
pedi cle</w>
PK A</w>
character izing</w>
care er</w>
ob enz
h ope</w>
Practi ce</w>
men op
T G
SM Cs</w>
abs tin
ra ising</w>
iodi de</w>
vin yl</w>
serot on
An g
Inter leukin</w>
ner ship</w>
N egative</w>
AD C</w>
th ecal</w>
collap se</w>
o facial</w>
but yl</w>
prote omics</w>
as certain</w>
Rec over
persi st</w>
c iliary</w>
ari th
intellig ence</w>
- 9</w>
Regar ding</w>
az ol</w>
A er
war ming</w>
hydro carbons</w>
clon idine</w>
path ogenicity</w>
arti facts</w>
vag al</w>
oz one</w>
ventr icul
CP R</w>
sc oli
DF T</w>
sti s</w>
e ur
gn ess</w>
V C</w>
me g
Ga stric</w>
st yrene</w>
EM BASE</w>
pr amine</w>
stoch astic</w>
Th ough</w>
D Q
F H</w>
im entin</w>
Inter vention</w>
Tr ic
O 1</w>
Eigh teen</w>
ant able</w>
Li ke</w>
Behavi or</w>
radi ology</w>
add resses</w>
bur ns</w>
A pop
probl ematic</w>
ke wise</w>
S G
ul ing</w>
we b
PC P</w>
enti nel</w>
reconstitu ted</w>
wea ker</w>
omer ization</w>
we d
P PI</w>
sel en
acyl glycerol</w>
thin king</w>
rh esus</w>
Ox id
thermod ynamic</w>
Con genital</w>
CD K
PT EN</w>
0.8 4</w>
cer amide</w>
n in
En g
L ig
comp ul
C IN
tel omerase</w>
sl ice</w>
a sive</w>
IM PLICATIONS</w>
amin idase</w>
pneum ococcal</w>
post ure</w>
U A</w>
G al</w>
altern ate</w>
nan ocom
b est
neuro toxicity</w>
plat forms</w>
gyn ec
an ionic</w>
PL A</w>
volu metric</w>
ER T</w>
l ingual</w>
op re
B 3</w>
0. 16</w>
exclu sive</w>
foun dation</w>
mun ic
C GRP</w>
germ line</w>
dep ic
INTERVEN TIONS</w>
un complicated</w>
sch ist
E st
ocom ial</w>
m ari
exc ep
dis charges</w>
Bio chemical</w>
em pl
M DS</w>
AL P</w>
bio tics</w>
resili ence</w>
spar se</w>
Ad ap
cath epsin</w>
fresh water</w>
perturb ation</w>
im es</w>
v ic</w>
di ol</w>
bl unt</w>
des orption</w>
ne sted</w>
sub cutaneously</w>
m 3</w>
19 0</w>
C CL
RE VI
po int
transfer ases</w>
bl ind
0. 35</w>
ul nar</w>
comp act</w>
adap t</w>
associ ate</w>
scre ws</w>
G am
re pressor</w>
w anted</w>
ar yl
ra ises</w>
S audi</w>
glucocortico ids</w>
vaso constriction</w>
gro und
ey el
house holds</w>
instrum entation</w>
capac ities</w>
p m</w>
nod ular</w>
0.8 2</w>
star vation</w>
di chloro
itone ally</w>
pa rotid</w>
Nr f2</w>
I Q</w>
R at</w>
SA H</w>
chem oradi
pac ked</w>
affin ities</w>
Formul a</w>
CRI SPR</w>
v ox
un favorable</w>
f air
R he
ra in
gastr in</w>
mit ting</w>
Col l
Pharmac o
Mul ti</w>
S .
g lu
er nal</w>
ail ed</w>
perf ect</w>
0. 90</w>
pair ing</w>
prescrip tions</w>
B L
attenu ate</w>
pro spec
sa icin</w>
. .</w>
com positions</w>
in soluble</w>
le ishman
re activation</w>
cohe rent</w>
is land</w>
NH 2</w>
at orial</w>
individu alized</w>
fre edom</w>
cro ps</w>
ov aries</w>
carcin ogenic</w>
le pro
nicotin ic</w>
si ella</w>
ste el</w>
cyt osine</w>
mic elles</w>
pass ed</w>
Adv anced</w>
bl asts</w>
198 1</w>
tra vel</w>
augh ter</w>
DE NCE</w>
diaz epam</w>
far ms</w>
gl and
pen ile</w>
P lac
al titude</w>
sulf on
H 4</w>
b FGF</w>
tic ated</w>
co factor</w>
pac kage</w>
re alized</w>
sci atic</w>
in somnia</w>
compr ise</w>
be ats</w>
homogen ates</w>
un ded</w>
cobal t</w>
fig ures</w>
tax onomic</w>
TR A
mos aic</w>
rem n
nas opharyngeal</w>
ot ted</w>
prim ate</w>
inver ted</w>
degrad able</w>
techn ological</w>
A po
es sion</w>
ic um</w>
0. 45</w>
0. 80</w>
equ ine</w>
prov ince</w>
SC D</w>
mas k</w>
plex es</w>
Stud ents</w>
neuro peptide</w>
met ac
sacrific ed</w>
hem i
bacter icidal</w>
A 549</w>
Q U
ox o</w>
mar ital</w>
tor que</w>
pu ps</w>
en sur
CX CL
brady kinin</w>
F D</w>
vis ited</w>
oper idol</w>
og rou
eu tic
GAB A
epti n</w>
Numer ous</w>
Nutri tion</w>
ic ide</w>
fos sa</w>
pa rous</w>
Kidne y</w>
k D</w>
un controlled</w>
adi ponectin</w>
cultiv ars</w>
neigh bor
E L
trem or</w>
P SC</w>
lin ker</w>
addi tionally</w>
brac hy
exclud e</w>
K en
br ing</w>
is one</w>
D ic
du plic
Platel et</w>
omegal y</w>
c d
L ate</w>
be ef</w>
tocopher ol</w>
Sup pl
p ter
fore brain</w>
V S</w>
an ic</w>
sme ars</w>
osp ec
pl ank
K S</w>
di thi
requis ite</w>
c rest</w>
carbo hydrates</w>
Not ch</w>
red und
determin ations</w>
classi fy</w>
Associ ations</w>
13 9</w>
mal on
b ite</w>
PA C</w>
orig inated</w>
cirrho tic</w>
0.7 6</w>
pri oriti
pro tr
ph alin</w>
tel omere</w>
notic ed</w>
st ance</w>
di aldehyde</w>
0.8 1</w>
broad ly</w>
possess ed</w>
1. 01</w>
go ats</w>
convul s
sp ores</w>
pac king</w>
ill ed</w>
j e</w>
an um</w>
su ited</w>
E ar
ari o</w>
carb onate</w>
par ity</w>
EVI DENCE</w>
leg is
Un it</w>
Heal th
acqu ire</w>
sub stitute</w>
silic o</w>
ob lig
she ets</w>
um en</w>
tro ponin</w>
diarrho ea</w>
2, 2</w>
b ever
meth an
K Cl</w>
Eff ective</w>
eutic als</w>
L G
ti tration</w>
D V</w>
ol k</w>
s. c.</w>
S ar
K ingdom</w>
acceler ate</w>
hydro gels</w>
linear ity</w>
person alized</w>
di ure
Th at</w>
n ev
sol ve</w>
A gg
10. 0</w>
ou tw
inst ance</w>
Behavi oral</w>
sto ichi
it on</w>
un infected</w>
pl ain</w>
lnc RNAs</w>
lam bs</w>
scaveng ing</w>
o ter
prolong ation</w>
N u
10 ,000</w>
sp anning</w>
Libr ary</w>
menop ause</w>
clos er</w>
a ided</w>
ubercul osis</w>
E astern</w>
n ail</w>
junc tional</w>
supernat ants</w>
an aphy
14 2</w>
RA F</w>
tex ture</w>
Lip id</w>
Eff ec
dri ver</w>
vap or</w>
chro mo
super vised</w>
li ve
buc cal</w>
M en</w>
sp as
z z
ill umination</w>
si vity</w>
1.0 2</w>
fac ed</w>
f loc
F isher</w>
En ergy</w>
progen y</w>
fir e</w>
bif ur
assign ment</w>
a str
Tem per
Experi ence</w>
In vol
o ventricular</w>
Leu k
amorph ous</w>
insp iratory</w>
T g</w>
O D</w>
0.7 7</w>
schizophren ic</w>
conjunctiv al</w>
pro lapse</w>
Heal thy</w>
H el
E B</w>
ben ch
L ist
D BP</w>
Ac tiv
distinc tion</w>
un differentiated</w>
HR V</w>
min ing</w>
s ent
Met S</w>
muc in</w>
day time</w>
vulg aris</w>
collo idal</w>
fi ers</w>
nanot ubes</w>
radi ologists</w>
bro mo
sh el
intr al
immun ogenicity</w>
Proper ties</w>
dis pers
ie ties</w>
Appro ach</w>
de structive</w>
Parti al</w>
xanth ine</w>
pa res</w>
13 4</w>
Qual itative</w>
f lower</w>
t ym
othor ax</w>
tel e
til t</w>
atro l</w>
sti pation</w>
R G
16 5</w>
monocyt ogenes</w>
ou pling</w>
re p
ane u
new er</w>
allo y</w>
vacu um</w>
resid ential</w>
sub optimal</w>
pot ato</w>
stabil ize</w>
ca ution</w>
tab let</w>
3 44</w>
K d</w>
ubiqu itin
11. 2</w>
High ly</w>
afferen ts</w>
erc etin</w>
SP SS</w>
interpre t</w>
transi tional</w>
replic ated</w>
B 6</w>
Rh o</w>
In stead</w>
amin s</w>
rel la</w>
deep er</w>
V II</w>
vers atile</w>
mutag enic</w>
fe et</w>
er up
mamm ography</w>
Pro state</w>
For mation</w>
Un fortunately</w>
chlor o</w>
B ro
pul s
recommend ation</w>
oste oblasts</w>
Carcin oma</w>
over t</w>
dendr ites</w>
flav in</w>
ver atrol</w>
0.7 4</w>
r ic</w>
out line</w>
On ce</w>
hepat oma</w>
Lin ear</w>
per icardial</w>
galacto sidase</w>
be at</w>
Memb rane</w>
V F</w>
intraper itoneally</w>
in ations</w>
schem es</w>
stal k</w>
ord inary</w>
acetab ular</w>
trans fusions</w>
de stro
bi os
aden ocarcinomas</w>
concentr ate</w>
fo s</w>
recycl ing</w>
re tain</w>
it an</w>
RE T</w>
loc omotion</w>
my ot
2 93</w>
F I</w>
j aw</w>
disp osition</w>
S TI
manufac ture
flavon oids</w>
lute in
re th
Psych i
zot ocin</w>
B 4</w>
gel atin</w>
mal e
mic s</w>
sk eleton</w>
moist ure</w>
hepat ectomy</w>
plant ar</w>
H GF</w>
adap tations</w>
0.7 1</w>
st ated</w>
0.7 9</w>
d a
W al
0. 18</w>
enter ing</w>
catechol amines</w>
G ran
op y</w>
phil is</w>
l ich
ACh E</w>
post prandial</w>
L u
se q</w>
os exual</w>
hel ped</w>
ur nal</w>
F R
repeat edly</w>
ho using</w>
hol ding</w>
o chemical</w>
kne es</w>
ag gra
F os</w>
psychi atry</w>
F K
swe red</w>
K ey</w>
wor ms</w>
el ution</w>
dic ine</w>
1 P</w>
arg um
gro o
stake holders</w>
14 3</w>
granul osa</w>
vi tis</w>
ang l
methyl transferase</w>
alpha -</w>
tr apping</w>
w .
confoun ders</w>
ith elial</w>
h il
multi plex</w>
depri ved</w>
cruc iate</w>
chemo kines</w>
A z
U til
lactam ase</w>
entrop y</w>
sin us
symptom atology</w>
ou abain</w>
Dem ographic</w>
1 75</w>
out lined</w>
extr av
LO G
0. 65</w>
preser ve</w>
enke phalin</w>
le gs</w>
av en
jug ular</w>
replic ate</w>
iz ers</w>
l ay</w>
B N</w>
pharmac ology</w>
co astal</w>
mim ic
in expensive</w>
hom olog</w>
uniform ly</w>
SE N
earli est</w>
0.7 3</w>
bacte remia</w>
le ph
quen ching</w>
et een</w>
dig esti
occup ied</w>
con tra
in er
Combin ation</w>
Is ra
an swered</w>
tw elve</w>
am yl
BR CA1</w>
Rep u
approxim ate</w>
susp ended</w>
dec id
C G
re actor</w>
de ox
for d</w>
autom atically</w>
Carb on</w>
g au
wash ing</w>
tic ks</w>
rest enosis</w>
anis otropy</w>
14 7</w>
app end
bro th</w>
j aun
benz yl</w>
l enti
S AR</w>
od ing</w>
prote ome</w>
py rene</w>
ec ond</w>
1.0 3</w>
rel ates</w>
syn cy
post traumatic</w>
gon dii</w>
Distr ibution</w>
f air</w>
carri age</w>
hydro cephalus</w>
Em base</w>
di ce</w>
OR s</w>
F N</w>
medic ally</w>
hum eral</w>
Prov ince</w>
C 5</w>
MR T</w>
consol idation</w>
in door</w>
rib ose</w>
constr ained</w>
r at
dent ate</w>
mis sense</w>
usi tis</w>
car ing</w>
hy pop
PT P</w>
oc ar
per mitted</w>
F ox
scat tered</w>
1 53</w>
Ch i</w>
de aling</w>
stand ardis
lo l</w>
K Y</w>
ad duct</w>
do t</w>
ev ity</w>
mon omers</w>
c ass
AC s</w>
deliver ing</w>
H L
0. 17</w>
An tim
bio films</w>
r ights</w>
con v
specific ities</w>
ag encies</w>
do ts</w>
anomal ous</w>
intram olecular</w>
B K</w>
os urg
int olerance</w>
cap top
S exual</w>
ac id
e icos
disc ord
i ans</w>
Au th
carbox ylic</w>
enroll ment</w>
10 ,
C 2
Stud ent</w>
continu um</w>
ys in</w>
orthop edic</w>
app earing</w>
sho ot</w>
tra p</w>
dis advantages</w>
refl ec
bab y</w>
K leb
0. 50</w>
amp ing</w>
w et
IC H</w>
plic ity</w>
oper on</w>
y go
cultiv ated</w>
Compar ing</w>
mu sic</w>
or ch
rom ycin</w>
st ably</w>
ex chang
emph ys
pri v
search ing</w>
F c
ag arose</w>
System s</w>
in dependence</w>
liter acy</w>
s orb
Hyper tension</w>
rec over</w>
H un
radio frequency</w>
sk olin</w>
cut ting</w>
A or
re operation</w>
CD D</w>
re test</w>
phosphodi esterase</w>
onch ial</w>
met aph
fa ec
fre ely</w>
scoli osis</w>
13 6</w>
obste tr
reperto ire</w>
yl es</w>
id us</w>
robu st
c ing
intra hepatic</w>
s elling</w>
itone um</w>
sho t</w>
cit abine</w>
elev ations</w>
lig am
modul ators</w>
coll ective</w>
F E
I BS</w>
ero sion</w>
ys mal</w>
mast ectomy</w>
beg in</w>
expl aining</w>
conven ience</w>
pec ul
J un</w>
under goes</w>
HR P</w>
rif amp
Throm b
Pre par
ultr y</w>
it er</w>
ari atric</w>
CD 44</w>
I ll
immun oblotting</w>
explo ited</w>
retro peritoneal</w>
pig lets</w>
c s</w>
1.0 5</w>
zym es</w>
aggreg ated</w>
sh rin
etr y</w>
gland ular</w>
lif es
cortis one</w>
ophthal mic</w>
g rap
o ks</w>
psych opathology</w>
R B</w>
Oxid ative</w>
out growth</w>
arb itr
Aut om
li tis</w>
ex tends</w>
em ma</w>
V A
nit us</w>
ar ises</w>
pur ch
amylo idosis</w>
equ iv
occa sions</w>
2 nd</w>
P PV</w>
com pares</w>
ob sc
cel i
Op en</w>
4 A</w>
u be</w>
De f
c age</w>
cul ating</w>
el abor
thyro xine</w>
V al</w>
gonad al</w>
glomerul onephritis</w>
Mo use</w>
An n
De termin
char ts</w>
mut ational</w>
neutr alization</w>
predn isone</w>
un explained</w>
T ow
1, 0
n ous</w>
attrac ted</w>
typh imurium</w>
p ir
con ve
initi atives</w>
chlo rophyll</w>
K E
lact ose</w>
oc cult</w>
search es</w>
approxim ation</w>
micro fluidic</w>
radi o</w>
Anim al</w>
mel ting</w>
0.00 9</w>
5 6
Con t
5 62</w>
15 4</w>
thal iana</w>
0. 20</w>
Kleb siella</w>
know led
chem otactic</w>
e NOS</w>
in yl</w>
desensi tization</w>
electr ons</w>
ud ine</w>
s i</w>
dur ations</w>
1.0 4</w>
o pro
mechan ically</w>
dissec ted</w>
dig it
otox ins</w>
top ois
ph er
C an</w>
re fined</w>
bund les</w>
bup ivacaine</w>
eosinoph il</w>
audi t</w>
II b</w>
sugg estions</w>
opportun istic</w>
c ast</w>
Perc utaneous</w>
impair s</w>
m .</w>
li poly
gam e</w>
per mis
BM T</w>
fram es</w>
lay ered</w>
CB T</w>
lat ex</w>
chloro plast</w>
el ings</w>
oste ocl
di electric</w>
Gen es</w>
Sev erity</w>
marri ed</w>
dispens able</w>
per s</w>
resid ency</w>
Physi cians</w>
ribonucle ic</w>
induc er</w>
ti fication</w>
expl ains</w>
14 1</w>
be red</w>
blo od
distor tion</w>
Wh it
rib osome</w>
mon omeric</w>
dis closed</w>
- based</w>
am phen
rever sibly</w>
N ucle
til l</w>
Pat tern
apprais al</w>
facil itation</w>
de hydration</w>
C SA</w>
sho p</w>
at e
h n
F TIR</w>
o yl
om ial</w>
D ual</w>
yn chron
kin je</w>
or us</w>
c im
cot ton</w>
lea ve</w>
for ty</w>
O 4</w>
uve itis</w>
aim ing</w>
Intrav enous</w>
fra ilty</w>
Mech anical</w>
3 rd</w>
DF S</w>
tw o
lnc RNA</w>
&apos; t</w>
s .</w>
modul ator</w>
anore xia</w>
au x
B 12</w>
gastr itis</w>
m erg
tes tinal</w>
glycol ysis</w>
A im</w>
combin es</w>
3, 5</w>
Signific antly</w>
cal orimetr
Reg ister</w>
hal operidol</w>
meth icillin</w>
tryp tamine</w>
ESR D</w>
C 1
DO X</w>
oti tis</w>
Mitochond rial</w>
K s</w>
este em</w>
obl ast
di ethyl
Las er</w>
Meas ures</w>
ar abin
ol us</w>
N R</w>
Ph il
ox yl
0. 67</w>
Pregn ancy</w>
ventil ated</w>
del ta
0.0 25</w>
M Hz</w>
F ri
Repu blic</w>
ac clim
recep tive</w>
oth ane</w>
thym ocytes</w>
dec lines</w>
e ve</w>
Recover y</w>
transmit ters</w>
E thi
mul tin
bir th
dra w</w>
polys accharides</w>
chori onic</w>
t os
iso electric</w>
re paired</w>
Ar thro
mo ieties</w>
veter inary</w>
friend ly</w>
benzodi azepine</w>
P ress
GABA ergic</w>
umb er</w>
Pur kinje</w>
0. 72</w>
8 6
fund us</w>
nich e</w>
Onc ology</w>
T ext</w>
lac ked</w>
15 2</w>
par a</w>
v imentin</w>
ic ile</w>
y olk</w>
arthro scopic</w>
M CA</w>
theore tically</w>
S odium</w>
NSAI Ds</w>
effici encies</w>
ver sions</w>
14 6</w>
one y</w>
amphen icol</w>
pro poses</w>
cle an</w>
excre ted</w>
post mortem</w>
ging i
B ilateral</w>
cor onal</w>
Recombin ant</w>
1 1.5</w>
F us
li st
stric tly</w>
polymorph onuclear</w>
po pl
e ae</w>
M W
PR P</w>
ev ac
C ost</w>
II a</w>
R ho
B CL</w>
synap t
cap saicin</w>
osensi tivity</w>
crow n</w>
lit ter</w>
wel fare</w>
5 th</w>
emerg ent</w>
ad versely</w>
pa uc
n arrative</w>
roti zing</w>
par kin
docum ents</w>
Surve illance</w>
chem il
albumin uria</w>
ca vities</w>
sic s</w>
Epidemi ology</w>
antagon ism</w>
expec tedly</w>
ch ap
fif ty</w>
under graduate</w>
mi x</w>
atri oventricular</w>
Clinic al
or ylation</w>
qu ick</w>
k Hz</w>
stra ight</w>
Aut o
str ips</w>
Nur ses</w>
rap amycin</w>
erythropo ietin</w>
p ens
pur ine</w>
co incid
chloro quine</w>
meth oxy</w>
chrom ium</w>
TI MP</w>
Con ventional</w>
pyr imidine</w>
ME T</w>
im otor</w>
0. 22</w>
E US</w>
ail ing</w>
Con di
Nan op
in qu
veget ation</w>
abdom y
not able</w>
pig mented</w>
F 4</w>
lo os
I schem
T c
e g</w>
perme able</w>
di uretic</w>
pl ot</w>
imid azol
ap ex</w>
ep tic</w>
Tr p</w>
two fold</w>
S ho
di ch
hum idity</w>
at resi
all ografts</w>
sion ed</w>
prim itive</w>
de polar
A K</w>
lys ates</w>
C ry
NH S</w>
Recom m
poly po
Med line</w>
Neon atal</w>
ww w.
character s</w>
Centr e</w>
M Pa</w>
tri pl
D anish</w>
con dyl
0. 70</w>
Com preh
D on
B AL</w>
ove restim
evac izumab</w>
sarcom as</w>
reser vation</w>
H U
multi factorial</w>
chic ks</w>
it a</w>
CP B</w>
electro magnetic</w>
B PD</w>
ag ree</w>
ac ic</w>
suppl ied</w>
tubercul ous</w>
pi x
j et</w>
cyt ometric</w>
s er</w>
dis playing</w>
rota virus</w>
me ga
phag ocytic</w>
navig ation</w>
an in</w>
0. 33</w>
PA Hs</w>
cl av
idel ity</w>
Inter actions</w>
n out</w>
t agged</w>
oc ap
paren ting</w>
contra dic
every day</w>
AR DS</w>
resembl ing</w>
meth acrylate</w>
E s
inter facial</w>
parathyro idism</w>
Q TL</w>
immunoglob ulins</w>
I HC</w>
Diab etic</w>
atin e</w>
contex tual</w>
neuro degeneration</w>
spac er</w>
HM G
carb on
atis m</w>
pl au
op en
wor ked</w>
col le
off ering</w>
16 8</w>
Spec ial</w>
elast ase</w>
vent ro
TH E
O K
ou ts</w>
mor al</w>
Po is
clar ified</w>
del irium</w>
Serv ices</w>
Ne ural</w>
Fr ac
L p</w>
Frequ ency</w>
spir al</w>
d welling</w>
ac ia</w>
thromb oxane</w>
anastom otic</w>
wri ting</w>
d re
altern ating</w>
F 3</w>
analy tes</w>
energ etic</w>
sist er</w>
nos ocomial</w>
CI S</w>
bi ogenesis</w>
th y
re min
supr am
pal p
drop ped</w>
CI s</w>
me als</w>
en ses</w>
infer red</w>
5 a</w>
glutam ic</w>
anti le</w>
exten sor</w>
N AME</w>
intra -</w>
co st
harv esting</w>
m ur
con stipation</w>
long evity</w>
st atins</w>
mit ogenic</w>
intrac erebral</w>
cho ose</w>
L U
influenz ae</w>
acet one</w>
ob r
1 D</w>
P ak
AP S</w>
NH L</w>
po ultry</w>
discrep ancies</w>
O CD</w>
CP T</w>
V L</w>
carri es</w>
sub cortical</w>
0. 21</w>
hydroxy apatite</w>
micro bes</w>
atmosph ere</w>
orn ith
Stre ptom
Fluoresc ence</w>
Hosp it
th ec
centr ic</w>
Cri tical</w>
hydro carbon</w>
d ang
sy philis</w>
diff icile</w>
br uc
d in</w>
nig ra</w>
veter ans</w>
poin ted</w>
pluripot ent</w>
HR QoL</w>
vis ually</w>
secre tions</w>
AP 1</w>
phosph on
collagen ase</w>
me iotic</w>
belong s</w>
sit ting</w>
oc clusive</w>
si fied</w>
impl ying</w>
G li
trou t</w>
d ressing</w>
Anti bodies</w>
Al ph
inferen ce</w>
cent ro
dextr in</w>
car c
eli oma</w>
nor ms</w>
leuk otri
maxim ize</w>
oph en</w>
ann ually</w>
D o</w>
lob es</w>
vasodi lation</w>
oste oblast</w>
Vib rio</w>
fo am</w>
di chro
in otropic</w>
ob ia</w>
hel ic
Guid elines</w>
Dis c
th igh</w>
thi o
es h</w>
l asted</w>
eosin ophilic</w>
MI P</w>
D .</w>
fa ecal</w>
0. 24</w>
an hydr
sal inity</w>
p raz
B CR</w>
l ers</w>
extr insic</w>
k et</w>
DE S</w>
pestic ide</w>
neuro genic</w>
phot ocat
itu ximab</w>
regar ds</w>
Th r</w>
m ass
ph atic</w>
Press ure</w>
er mal</w>
atresi a</w>
Pro vid
T ren
H G
ap ha
H G</w>
parkin son
Che m</w>
ca p</w>
psych otherapy</w>
REVI EW</w>
epith elia</w>
gen omics</w>
degrad ing</w>
ox azole</w>
V O2</w>
ist an</w>
fil tering</w>
g ases</w>
V LDL</w>
ad ine</w>
Health care</w>
R M</w>
olig o
sw allowing</w>
obut yric</w>
ke ep</w>
strepto zotocin</w>
VE L</w>
form aldehyde</w>
trache a</w>
Val idation</w>
Sw iss</w>
pos ity</w>
efflu ent</w>
im pul
R ac
flex or</w>
umb ens</w>
tr ain</w>
f eces</w>
em ent
col oc
Thyro id</w>
Th i
idi a</w>
gra ins</w>
UT R</w>
top ography</w>
W eight</w>
Ir on</w>
Nor way</w>
li que</w>
Tech niqu
incre ment</w>
co enzyme</w>
Differen ti
ser ous</w>
ter re
Sc ot
prob ing</w>
scann er</w>
descrip tions</w>
dropl et</w>
r ater</w>
in bred</w>
35 S</w>
R u
B PA</w>
embry ogenesis</w>
Modi fied</w>
recogn ised</w>
tor sion</w>
Sup port</w>
2 1
T O</w>
bas olateral</w>
ox ia</w>
AI S</w>
emphasi zes</w>
retar ded</w>
sequ e
calcul ating</w>
F etal</w>
amp icillin</w>
IF N
neutr on</w>
robust ness</w>
morph ometric</w>
ho c</w>
R elev
adop t</w>
g us</w>
dispers al</w>
im pe
bi g</w>
D r
pa y</w>
il ic</w>
cle an
Targ eting</w>
thromb olysis</w>
T 2D</w>
Mex ican</w>
corro bor
R ot
feren tial</w>
res ections</w>
0. 19</w>
con ti
ass ing</w>
ti dine</w>
su itability</w>
sav ings</w>
af en
uter o</w>
Mid dle</w>
S ea</w>
in ed</w>
D aily</w>
a f</w>
predisp osing</w>
M UC
0. 32</w>
cal cin
sub population</w>
expl ants</w>
s m
V 2</w>
Ont ario</w>
z eta</w>
H i
Q RS</w>
A .</w>
immunomod ulatory</w>
Phot o
predisp osition</w>
fair ly</w>
D 4</w>
T KA</w>
hydrox ylation</w>
EM I</w>
b i</w>
micr on
0. 23</w>
cros sing</w>
HF D</w>
bil aterally</w>
C U
migr ant</w>
T S
R emo
harb oring</w>
ev ap
acetyl transferase</w>
PT C</w>
lin gness</w>
Strateg ies</w>
mes ang
5 A</w>
Sev enteen</w>
E ry
perturb ations</w>
LE V
s aving</w>
d ying</w>
an ase</w>
Gen omic</w>
an der</w>
my c
G DM</w>
hemat ocrit</w>
vari eties</w>
Sch iz
sh ips</w>
fe elings</w>
l ar</w>
appendic itis</w>
M otor</w>
j apon
chem otaxis</w>
19 79</w>
2 C</w>
ch air</w>
abstin ence</w>
g ation</w>
propi onate</w>
jaun dice</w>
pig mentation</w>
M ain</w>
y lob
ell ate</w>
0. 55</w>
brachy therapy</w>
my x
M etal</w>
1.0 6</w>
anos oma</w>
9 00</w>
ro ll
ati zed</w>
0. 68</w>
Ac t</w>
EC TION</w>
Concentr ations</w>
perc ei
tric uspid</w>
dissoci ated</w>
CF TR</w>
an cre
correspon d
L 4</w>
f t
k 1</w>
conf ers</w>
Chlamy dia</w>
fail s</w>
Seph arose</w>
easi er</w>
dos ages</w>
es h
iti vely</w>
Pancre atic</w>
A PO
0.0 00</w>
dilu ted</w>
0. 66</w>
end onuclease</w>
PC NA</w>
li sted</w>
ulin um</w>
prostagland ins</w>
Mod els</w>
desi re</w>
exce eding</w>
xen ografts</w>
em it
per icardi
effec tors</w>
cl ient</w>
V ic
advanc ement</w>
est rous</w>
eti ologies</w>
en icity</w>
N GS</w>
multi modal</w>
profes sion</w>
rec re
ore duc
orth opaedic</w>
epis odic</w>
ascor b
diver ticul
cataly zes</w>
it ates</w>
os elec
chlor inated</w>
alg inate</w>
sulf ide</w>
Effec tiveness</w>
ca emic</w>
AR CH</w>
ass urance</w>
d t</w>
andi bular</w>
po l</w>
I so
P il
neighb oring</w>
veget able</w>
a vid
el emental</w>
D VT</w>
hyper parathyroidism</w>
and a</w>
Tryp anosoma</w>
kary otype</w>
od ont
ke to</w>
RF LP</w>
mim ics</w>
Cer vical</w>
O d
cap sid</w>
sensor imotor</w>
B er
on idazole</w>
dener vation</w>
sensiti vities</w>
bri de
Tr ac
E v
T esting</w>
stret ching</w>
E PR</w>
ul ic</w>
o roph
er ine</w>
disc s</w>
T om
Ti O2</w>
as best
16 3</w>
7 9
es --
po uch</w>
ga thered</w>
kine sia</w>
comp any</w>
0 ,
low -</w>
N it
et axel</w>
Op tical</w>
m sec</w>
radiolab eled</w>
ta z
RE LEV
M SM</w>
O ff
phosph ates</w>
14 8</w>
orth og
Dep end
predomin ance</w>
0. 63</w>
sig moid</w>
tr y</w>
ta urine</w>
ut roph
Malign ant</w>
t ent
transc ranial</w>
Cd c
vaso active</w>
K er
integr ative</w>
spea king</w>
substanti a</w>
quar ter</w>
C ES</w>
cl usal</w>
tic ation</w>
evalu ates</w>
restor ations</w>
Coun ty</w>
conver gence</w>
ocy stis</w>
Adv ances</w>
15 1</w>
In ternal</w>
et opo
flu xes</w>
o plasma</w>
ju ana</w>
hemisph eric</w>
l acti
for skolin</w>
occup ation</w>
encap sulation</w>
0. 56</w>
cre te</w>
RELEV ANCE</w>
e GFR</w>
20 5</w>
tr ust</w>
psych ology</w>
loc alize</w>
chol era</w>
gen otyped</w>
cy tic</w>
MM C</w>
a rent</w>
quanti fying</w>
controver sy</w>
in distinguishable</w>
ex port</w>
D BS</w>
ery thromycin</w>
Mod ulation</w>
C .
tri ed</w>
N itr
0. 69</w>
ob viously</w>
Streptom yces</w>
bacterioph age</w>
el lip
h on
R CT</w>
rein forced</w>
s outh</w>
immun ogenic</w>
Impro ving</w>
cru zi</w>
B en
caud ate</w>
ch ew
em ias</w>
succin ate</w>
antagon ized</w>
Reg ion</w>
D oc
immunocom promised</w>
18 F</w>
di urnal</w>
T X</w>
wil d
or ide</w>
vit amins</w>
For m</w>
sh ed
har monic</w>
mid w
32 P</w>
alpha 1</w>
Pattern s</w>
wed ge</w>
T ex
etopo side</w>
fr ont
a OR</w>
0. 28</w>
op eptide</w>
chol ic</w>
0. 64</w>
osi dase</w>
lig ase</w>
ylob acter</w>
E qu
sub acute</w>
par v
anaes thetic</w>
im bur
y ros
phot osynthesis</w>
micr on</w>
s ounds</w>
intr ag
G raph
u ght</w>
15 6</w>
coll ec
fresh ly</w>
k ill</w>
0. 26</w>
C on</w>
pattern ing</w>
un ted</w>
eng ra
ec k
proto zo
omat erials</w>
s entinel</w>
Intrac ellular</w>
H PA</w>
ad one</w>
ycl ic</w>
ew es</w>
aden o
d .</w>
ke ting</w>
3 60</w>
i o</w>
Anti body</w>
nano structures</w>
poly cystic</w>
discrimin ant</w>
RE S</w>
Th ail
poly unsaturated</w>
anti platelet</w>
pro thrombin</w>
ingredi ents</w>
hal othane</w>
Inter ventions</w>
Hem at
Phyl ogenetic</w>
im etic</w>
multi focal</w>
Optim al</w>
bi ocompatibility</w>
g lo
cal ibr
stress ful</w>
Sm ad
Sw it
Arter ial</w>
herpes virus</w>
Thail and</w>
perme ation</w>
do ing</w>
mul tim
Atl antic</w>
mo sis</w>
Em erg
B RAF</w>
lys osomes</w>
red ness</w>
man eu
transp osition</w>
bo ok</w>
adequ acy</w>
par adox
Transi ent</w>
attend ance</w>
ash es</w>
parti tion</w>
as on</w>
antin oc
Sch wan
explan ations</w>
uni qu
allevi ate</w>
me ters</w>
photo receptor</w>
int enti
In t
autonom ous</w>
Th or
ACh R</w>
SE ARCH</w>
elas ticity</w>
astro cyt
re fu
M am
i tic</w>
re ferences</w>
gen tly</w>
ket o
noc iceptive</w>
ap point
MAL DI</w>
St atus</w>
LE VEL</w>
cu st
0. 62</w>
po ver
emerg e</w>
nemat ode</w>
Maxim um</w>
interrup ted</w>
5 3
soph is
lam ellar</w>
topois omerase</w>
opo rous</w>
oph armac
U ro
mess ages</w>
he al</w>
. ..</w>
W I
electrocardi ogram</w>
inter cal
olig omers</w>
iso flurane</w>
amin ophen</w>
filam entous</w>
pea ked</w>
tur ned</w>
occlud ed</w>
6 6
con sequent</w>
I ran
PC L</w>
bi ases</w>
ol ive</w>
ensur ing</w>
h ips</w>
A di
prob abilities</w>
coron avirus</w>
M .</w>
reconstruc tions</w>
parti tioning</w>
recogn izing</w>
py raz
ulcer ation</w>
absc esses</w>
5 9
h a</w>
in one</w>
pre v
5 8
1 A1</w>
M ag
p 16</w>
J oint</w>
2, 6</w>
oscop e</w>
insp ired</w>
V as
7 7
n ary</w>
po d
ear man</w>
te g
M o</w>
bar ley</w>
g raph</w>
b cl</w>
D B
granul ocytes</w>
secre te</w>
auton omy</w>
as e
pe ers</w>
Bi ol</w>
bio informatics</w>
qu ercetin</w>
le tic</w>
promp ted</w>
G h
adi posity</w>
ou red</w>
lat encies</w>
cr is
q RT</w>
4 3
fil tered</w>
Child hood</w>
ocyan ate</w>
emphys ema</w>
H SCT</w>
tacti le</w>
R 3</w>
diaphrag matic</w>
atro genic</w>
en te
ach ol</w>
seroton ergic</w>
chlor amphenicol</w>
be ams</w>
compreh ension</w>
multi functional</w>
acc umbens</w>
al im
Comput er</w>
dev oid</w>
fol ds</w>
sy l
implic ation</w>
Repe ated</w>
RO M</w>
19 5</w>
CP P</w>
In dependent</w>
la b</w>
bride ment</w>
pre clud
in ward</w>
en o
Correc tion</w>
tin nitus</w>
malon dialdehyde</w>
poin ting</w>
leph rine</w>
nan om
Apop tosis</w>
peri odic
muc ous</w>
ultra structure</w>
dou b
alkal oids</w>
pa st
br y
ide as</w>
ch ymo
auto immunity</w>
M U
gu ar
R ates</w>
Schwan n</w>
S AS</w>
bel ief</w>
E I</w>
ing ested</w>
B 7</w>
plan es</w>
lutein izing</w>
un successful</w>
ap p</w>
re distribution</w>
beta 2</w>
incid ences</w>
mess age</w>
Ag ing</w>
n ish</w>
infec tivity</w>
g al</w>
b ath</w>
Ab normal</w>
eukary otes</w>
em atics</w>
A .
V O</w>
En d</w>
str ands</w>
f idelity</w>
constitu ent</w>
neph ritis</w>
minim izing</w>
ig uous</w>
broncho alveolar</w>
Hy bri
ma ster</w>
fist ulas</w>
hem agglutinin</w>
mas ked</w>
kn esses</w>
at or
am ox
adhe sions</w>
Electr onic</w>
it um</w>
sci ences</w>
F ibr
anc ient</w>
E SI</w>
L TP</w>
c DNAs</w>
E u
E PA</w>
Compreh ensive</w>
reconstruc tive</w>
pl eth
List eria</w>
C 18</w>
ornith ine</w>
a ids</w>
cat abolism</w>
G ene
0. 36</w>
frame works</w>
T N</w>
ion izing</w>
lact one</w>
con du
x ic</w>
bir d</w>
L C
IC S</w>
impl antable</w>
m ates</w>
Uni variate</w>
jejun al</w>
Bet a</w>
un less</w>
shif ting</w>
vill i</w>
re pressed</w>
swit ched</w>
adrenoc eptors</w>
mon oc
phosphor yl
Sp earman</w>
opi ate</w>
im per
f en</w>
fici ency</w>
ro pol
CD 11
ab iotic</w>
par tur
ov sk
dichro ism</w>
Wil ey</w>
ol inium</w>
if ies</w>
ster oid
adju stments</w>
14 9</w>
glu con
H 1
H P
pin eal</w>
p ra
lab ile</w>
s ement</w>
EC MO</w>
ine ural</w>
rostr al</w>
neuro lep
glucos amine</w>
ac on
19 2</w>
ar one</w>
ascorb ate</w>
orb idity</w>
Al most</w>
0. 27</w>
Oxy gen</w>
p 1</w>
repeti tion</w>
comb at</w>
ob lique</w>
anti gen
G ood</w>
brid ging</w>
cing ulate</w>
el es</w>
glycos amin
gener al
B I
4 2
trim eth
g ad
awa ke</w>
dis si
con flu
Recur rent</w>
rib osomes</w>
encoun ter</w>
thalass emia</w>
lifes pan</w>
deliver ies</w>
A d</w>
D HE
ov ulatory</w>
de uter
Thir d</w>
Endo thelial</w>
0. 30</w>
parall eled</w>
reflex es</w>
inter disciplinary</w>
reg imes</w>
seas ons</w>
restric tions</w>
vibr ational</w>
ej ac
0. 38</w>
Abstr act
1. 73</w>
int ent</w>
17 4</w>
neuro developmental</w>
lact ating</w>
0. 48</w>
im ine</w>
wil lingness</w>
Y AG</w>
Tre g</w>
fo ve
metabol ized</w>
osom iasis</w>
pro kary
immun ob
O G</w>
intra epithelial</w>
rig orous</w>
squ ares</w>
eth eless</w>
heal ed</w>
sched ules</w>
od or</w>
emplo y</w>
L 3</w>
osurg ery</w>
oin osi
F As</w>
neo vascularization</w>
the tical</w>
micro glial</w>
sen ior</w>
pen dic
sym path
Traum a</w>
di z
eff eren
ag eous</w>
top ological</w>
an ide</w>
el ig
coun selling</w>
pol lin
de sis</w>
SV 40</w>
nanoc ryst
nanos cale</w>
S 3</w>
morb id</w>
F oc
blind ness</w>
0. 58</w>
neuro genesis</w>
od ine</w>
NI H</w>
vesi cal</w>
at l
cl ade</w>
Ac cum
0. 42</w>
inter fe
re imbur
work load</w>
par s</w>
relig ious</w>
Descrip tive</w>
shed ding</w>
su tures</w>
solubil ized</w>
multicentr e</w>
detox ification</w>
u ps</w>
P le
D CS</w>
no vation</w>
ex empl
hyper insulin
An t
afen ib</w>
dic ation</w>
0. 34</w>
ovari ectomized</w>
deform ities</w>
se a
here sis</w>
Predic tion</w>
acetyl cholinesterase</w>
or h
lepro sy</w>
d an
Camp ylobacter</w>
stere otactic</w>
us crip
1.0 7</w>
tolu ene</w>
r ad
de acetyl
18 5</w>
Fam il
homolog ue</w>
c ep
oc clusal</w>
ar tic
her bic
caroten e</w>
Abstract Text</w>
19 75</w>
B row
RNA i</w>
celi ac</w>
shor tly</w>
ste atosis</w>
amb iguous</w>
bio diversity</w>
vol ution
IN G</w>
L BP</w>
allo steric</w>
mosquit oes</w>
S um
T im
Ch alleng
00 0
M BP</w>
top ology</w>
0. 61</w>
venti lator</w>
Temper ature</w>
S pl
S he
Reg ression</w>
1.0 8</w>
L ack</w>
um b</w>
pec tor
flo x
optim izing</w>
ME S</w>
G ender</w>
im posed</w>
av alin</w>
sub scales</w>
bul b</w>
hypo phy
veget ative</w>
quinol ine</w>
mo ved</w>
train ees</w>
iter pen
id ate</w>
AT P
gene ic</w>
R e</w>
be sides</w>
pho to</w>
II Ia</w>
S 100
yl amine</w>
granul omatous</w>
mesang ial</w>
el vic</w>
at ar
non coding</w>
g ian</w>
bur g</w>
miti gate</w>
HR s</w>
gem citabine</w>
Ac tin
spi kes</w>
sym metrical</w>
ti me
Kin etic</w>
w ine</w>
in clusions</w>
0. 54</w>
k it
En zyme</w>
trif luoro
ap heresis</w>
M ob
el uted</w>
st ation</w>
RI A</w>
fac tion</w>
ari ans</w>
Re action</w>
Compar isons</w>
ir rit
crystall ization</w>
in still
icul us</w>
A A
ter ol</w>
manip ulated</w>
un event
0. 52</w>
0. 60</w>
d ac
pop ul
Mal ay
restr aint</w>
hex a
chap ter</w>
dam aging</w>
au to</w>
Pur ification</w>
Prote ins</w>
hypercholesterol emia</w>
advant ageous</w>
as simil
hu ge</w>
al bin
in digenous</w>
lo oking</w>
op yr
Inc ub
13. 5</w>
at able</w>
THE SIS</w>
f uro
t ate</w>
chic ine</w>
ob liter
perform s</w>
con currently</w>
wor ker</w>
enz a</w>
11. 1</w>
oste omyelitis</w>
AL A</w>
hum an
s angu
ex osomes</w>
prim e</w>
exce ed</w>
inter neurons</w>
coll ections</w>
Fi eld</w>
SS c</w>
buff ered</w>
at erials</w>
odop sin</w>
pat ernal</w>
Clinical Tri
Morph ological</w>
ar um</w>
constitu ted</w>
Decre ased</w>
ol ith
fol ic</w>
it eal</w>
cou ple</w>
Rh od
N IR</w>
Mechanis m</w>
inte rested</w>
bio assay</w>
termin ated</w>
0. 31</w>
ground water</w>
terre strial</w>
li thi
idi tis</w>
dig oxin</w>
osp asm</w>
anti convuls
trim ethyl
C ho
TH A</w>
mid azolam</w>
S AM
Consi der
M ig
acet onitrile</w>
Ig G1</w>
Ga ussian</w>
dis til
ST EMI</w>
streptoc occi</w>
imetr y</w>
Chang e</w>
om b
trac hom
co ffe
er i</w>
osph ere</w>
AM PA</w>
pre requisite</w>
co stly</w>
tol i</w>
extrap ol
man uscrip
ER D</w>
.0 2</w>
sial ic</w>
b an
set t
ch al
ri amycin</w>
cephal ospor
cle aning</w>
projec ted</w>
PC C</w>
Develop mental</w>
pl u
pedi atr
tic um</w>
yo u</w>
a esthetic</w>
il es</w>
In tensive</w>
cre d
clos ing</w>
De ep</w>
t ude</w>
amb igu
exacerb ations</w>
DM SO</w>
c ited</w>
less ons</w>
cap ital</w>
super vision</w>
fr ic
possess ing</w>
distr action</w>
fa ther</w>
migr atory</w>
SO 4</w>
3 20</w>
mirro r</w>
id o</w>
17 7</w>
i ens</w>
w ann
im mor
consul tations</w>
oxal ate</w>
Veter ans</w>
restric tive</w>
pack aging</w>
harv est</w>
standardis ed</w>
0. 53</w>
0. 43</w>
res emble</w>
anth ocyan
W BC</w>
sic k</w>
b evacizumab</w>
tryp an
CA L</w>
se w
B E
pare sis</w>
M an</w>
Recomm end
small est</w>
19 78</w>
rh abdomy
transpor tation</w>
ER G</w>
GT Pase</w>
TRA IL</w>
intrac table</w>
0. 40</w>
der m</w>
CI N</w>
gradu ates</w>
0. 46</w>
lys ate</w>
Iran ian</w>
AN ALY
Effici ent</w>
en a</w>
ab rup
i aceae</w>
puls atile</w>
chaper one</w>
b ariatric</w>
retin ol</w>
yto in</w>
assum e</w>
antagon istic</w>
adjunc tive</w>
intr at
dev ast
Antim icrobial</w>
Aor tic</w>
G d</w>
thrombo embolic</w>
0. 44</w>
in significant</w>
crib ed</w>
0. 57</w>
un translated</w>
S patial</w>
an ne
E SR</w>
is omer</w>
Smo king</w>
the astern</w>
gen otoxic</w>
13. 3</w>
H H</w>
Tradi tional</w>
Tur key</w>
is in</w>
Mod eling</w>
radionuc lide</w>
I OL</w>
olip id</w>
derm is</w>
TL R</w>
reth ral</w>
ra ft</w>
is oc
canc erous</w>
s an
pat ellar</w>
analge sics</w>
synchron ization</w>
com pressive</w>
tem po
PD A</w>
ure ter
infrequ ent</w>
nec rotizing</w>
review ers</w>
m ite</w>
no ea</w>
ag ulation</w>
adip ocyte</w>
He ad</w>
nephro tic</w>
fibrill ar</w>
PA S</w>
liqu ids</w>
cyt ological</w>
disrup t</w>
lipo xy
Sh ig
alge sia</w>
calorimetr y</w>
W KY</w>
oc ation</w>
chamb ers</w>
S SR
P DE
bot t
0. 59</w>
In testinal</w>
G BS</w>
0. 37</w>
orph in</w>
LVE F</w>
six th</w>
erythem a</w>
Per son
l ingu
off set</w>
w are</w>
PA D</w>
i ously</w>
my opia</w>
reconstitu tion</w>
acin ar</w>
dig ested</w>
leth ality</w>
C le
it real</w>
pe a</w>
t an</w>
0. 29</w>
Ch i
oc utaneous</w>
ME NT</w>
micro structure</w>
tris omy</w>
INTERVEN TION</w>
l av
Nin eteen</w>
loc ate</w>
sequ entially</w>
ke y
electro spray</w>
oder ma</w>
port able</w>
guid ing</w>
Ab dom
s ate</w>
re jec
trac ing</w>
sic kness</w>
asbest os</w>
mono amine</w>
conduc tive</w>
robo t</w>
neur ite</w>
R eli
erec tile</w>
deox yn
PC 12</w>
bi ophysical</w>
captop ril</w>
20 20</w>
Ser toli</w>
rab ies</w>
H SA</w>
Per s
My el
W C</w>
PT X</w>
ic il
me gal
V ery</w>
UD P</w>
dent ure</w>
norm ative</w>
con ferred</w>
lead ers</w>
nor th</w>
pheny lephrine</w>
inf antile</w>
mega kary
Remo val</w>
P sy
consi ders</w>
ol im
immunocyto chemistry</w>
hem olysis</w>
advanc ing</w>
Pois son</w>
trachom atis</w>
12 ,
UT I</w>
CRE B</w>
anti proliferative</w>
Rhe um
in ol</w>
ogen ously</w>
TI ON
negl ected</w>
flox acin</w>
coun ted</w>
th aw
remain der</w>
chec ked</w>
O P
cont our</w>
AN G</w>
o b</w>
ER P</w>
arri val</w>
over night</w>
bi otechn
CA S</w>
gin sen
Alter ations</w>
r umin
SI R
intra thecal</w>
z yg
M ain
h s</w>
b ach</w>
ob ium</w>
acr ylic</w>
hard ness</w>
adren al
hel ping</w>
alcoh ols</w>
O vari
D ip
Man n</w>
2, 5</w>
ac ral</w>
In si
A my
hydrox ide</w>
denti sts</w>
at uration</w>
air s</w>
contrac eption</w>
son ographic</w>
coffe e</w>
O X
cyan ide</w>
Amin o</w>
b .
0. 47</w>
I E</w>
con azole</w>
il is</w>
surroun ded</w>
ple as
s aph
B PH</w>
myel o
im possible</w>
yn e</w>
S can
ir is</w>
ClinicalTri als.gov</w>
od ys
immunocom pet
on y</w>
thor ax</w>
granul oma</w>
B is
C PAP</w>
end or
0. 39</w>
f asci
H CO
pep tic</w>
opin ions</w>
PL A2</w>
P BS</w>
an ni
S ing
en oid</w>
hyper calc
param agnetic</w>
if ers</w>
parox ysmal</w>
tran ce</w>
tal k</w>
absorb ance</w>
ascer tained</w>
6 5
phot osensi
Vi et
eo chrom
0. 51</w>
is lands</w>
0. 41</w>
infer tile</w>
bre ed</w>
Cir culating</w>
og lo
AP D</w>
crani ofacial</w>
standardi zation</w>
Spec ies</w>
relap sing</w>
pr ice</w>
v oid
off s</w>
Pe ak</w>
in ogen</w>
ed ges</w>
bar ic</w>
val pro
e uc
ex it</w>
macrom olecules</w>
hom ozyg
tet anus</w>
An terior</w>
ap ril</w>
Paren ts</w>
15 8</w>
A rea</w>
Dis ability</w>
of ur
C ha
ureth ane</w>
orig inate</w>
mid brain</w>
hall mark</w>
P Y
A trial</w>
mo tions</w>
or ange</w>
sist ant</w>
py el
ca ve
GF AP</w>
su stain</w>
transp arent</w>
Adolesc ents</w>
o estrogen</w>
belong ed</w>
hydr ated</w>
syn geneic</w>
az epam</w>
immer sion</w>
min us</w>
R u</w>
m Abs</w>
se where</w>
ch or
pe ti
tw itch</w>
mari juana</w>
ac o</w>
co vers</w>
D ynamics</w>
sym bi
sha ft</w>
man nit
yl transferase</w>
16 6</w>
sophis ticated</w>
osteoc last</w>
R D
PE C</w>
elig ibility</w>
f alling</w>
entr ic</w>
ag inal</w>
iter ative</w>
2 80</w>
Poly morph
vi an</w>
TE XT</w>
Predic tors</w>
doc etaxel</w>
ga ze</w>
S ite</w>
Identi fying</w>
no ur
0. 49</w>
yl yl</w>
res veratrol</w>
ro ds</w>
splen ectomy</w>
de bridement</w>
prote oglycan</w>
tin a</w>
visu alize</w>
Cas 9</w>
ten sor</w>
r onate</w>
equ ipped</w>
17 2</w>
E MS</w>
thous and</w>
1.0 9</w>
50 6</w>
CD C</w>
Ex tr
fibr illary</w>
RESUL T</w>
sub mucosal</w>
tun n
on asal</w>
meth adone</w>
it ly</w>
th ing</w>
amin oglyco
mon o</w>
di g</w>
pauc ity</w>
16 4</w>
M PO</w>
az o
20 6</w>
hypo plasia</w>
he ads</w>
R os
T K</w>
elev en</w>
so y</w>
AR C</w>
CXCR 4</w>
KE Y</w>
MA O</w>
cl oz
B ene
CO S</w>
t ons</w>
thorac otomy</w>
eyel id</w>
Assess ing</w>
lign in</w>
re organization</w>
encour aged</w>
INTER PRE
Mac roph
jejun um</w>
Al together</w>
infiltr ate</w>
fe el</w>
A sp
M 3</w>
implic it</w>
flow ering</w>
my ometr
phosph oinosi
op tera</w>
Sa har
ap tam
carb achol</w>
Abdom inal</w>
M Ab</w>
ventr icles</w>
enter al</w>
sand w
live stock</w>
As th
wash ed</w>
T ask</w>
mannit ol</w>
er as</w>
sup er</w>
fac ile</w>
af lat
a vir
B ank</w>
mater n
Rh iz
leishman iasis</w>
melan omas</w>
ti m</w>
cal oric</w>
prevent able</w>
CD s</w>
RN P</w>
str ated</w>
nucle ation</w>
w ind</w>
b erry</w>
16 2</w>
S us
PC B</w>
st ore</w>
l arynx</w>
lab els</w>
pe red</w>
copolym er</w>
a a</w>
gre y</w>
ket one</w>
ad vis
S en
Str ain</w>
dys lipidemia</w>
instruc tions</w>
gh relin</w>
fa thers</w>
My c</w>
F abr
ol uminescence</w>
scat ter</w>
wor th</w>
compan ies</w>
H M</w>
saf er</w>
read ers</w>
Clin ically</w>
Radi o
e IF
compens ated</w>
wash out</w>
Ethi opia</w>
caver nous</w>
bi og
mar keting</w>
neuro psychiatric</w>
2 30</w>
AR F</w>
synap se</w>
negl ect</w>
mon oxide</w>
in struction</w>
vi d</w>
hel ices</w>
appe tite</w>
F as
pres chool</w>
Whit ney</w>
tic ism</w>
H PV
u tively</w>
hypo thetical</w>
mut ual</w>
S j
go at</w>
el sewhere</w>
C ong
auth en
hydroph ob
2 O</w>
am y
D eli
inv ited</w>
PRE SEN
dynam ical</w>
un identified</w>
son i</w>
ro oms</w>
nucle ase</w>
vic inity</w>
INTERPRE TATION</w>
s r
sal mon</w>
bac ks</w>
gau ge</w>
L ep
correc ts</w>
rough ness</w>
basi lar</w>
ch lamy
he ated</w>
lik re
10. 3</w>
Targ eted</w>
C enters</w>
An es
pi ece</w>
pit ch</w>
M P
Li kewise</w>
vasodi lator</w>
at ally</w>
s h</w>
Pro long
mat ches</w>
ri b</w>
elim inating</w>
acet aminophen</w>
fer ro
ST Z</w>
n ess
c c</w>
ar rested</w>
c ocul
cl ot</w>
ver ification</w>
Intra operative</w>
oglo bin
C 3H</w>
ble omycin</w>
en sed</w>
pa w</w>
alcohol ism</w>
Extrac ellular</w>
Mut ation</w>
motoneur ons</w>
y er</w>
ic o
appro ached</w>
spermat ogenesis</w>
adj ust</w>
D G
chrom atic</w>
car pal</w>
rom andibular</w>
G a</w>
k Pa</w>
op ent
z ers</w>
fav ored</w>
eti dine</w>
tr u
Mem ory</w>
jour nal</w>
hall uc
um s</w>
ropol itan</w>
C .</w>
op ened</w>
be ds</w>
devast ating</w>
K i
H RT</w>
igh ten
Cr iter
e ast</w>
di valent</w>
sp ore</w>
re ticular</w>
aspar ag
fe eling</w>
De ath</w>
Prepar ation</w>
veh icles</w>
Haem ophilus</w>
Pro cess
inter molecular</w>
S eg
con es</w>
chol ate</w>
ep icardial</w>
Li qu
ard ous</w>
K ne
gre en
hy ph
osyl transferase</w>
m ar</w>
xim e</w>
p A</w>
Eg yp
infra structure</w>
propos al</w>
l umb
P b
tin ent</w>
electr ically</w>
orthog onal</w>
Gra ves</w>
st ains</w>
br ight</w>
ox ic</w>
ca v
Pol y</w>
her oin</w>
Sch ist
cadaver ic</w>
Incub ation</w>
uro thelial</w>
be gun</w>
ac ne</w>
A AV</w>
AL K</w>
CON TEXT</w>
amo eb
di pine</w>
amph oter
co atings</w>
em itting</w>
pre conditioning</w>
spl itting</w>
w r
inf est
sol eus</w>
fer tile</w>
am a</w>
al be
Sci ences</w>
ophag y</w>
res sions</w>
Sym p
Pu bl
20 4</w>
vaso constric
Den mark</w>
we an
CN Ts</w>
ti ps</w>
preced ented</w>
PRESEN TATION</w>
E .
her bi
cyclospor in</w>
16. 7</w>
pri orities</w>
ven tive</w>
disco ver
omy cosis</w>
intim al</w>
reas oning</w>
graph s</w>
underestim ated</w>
trans formations</w>
on ec
Sur ge
narrow ing</w>
divid ing</w>
bre eds</w>
or rhea</w>
15 9</w>
plau sible</w>
dis aster</w>
evol ve</w>
neighbor hood</w>
Vir al</w>
neigh bo
deplo yment</w>
DR G</w>
C ateg
u a</w>
hy brid
PAR P</w>
pri on</w>
s ap
H U</w>
yr onine</w>
UV B</w>
disp arity</w>
NL R</w>
Protec tion</w>
kin ematics</w>
ANALY SIS</w>
medias tin
aug ment</w>
M Ps</w>
peroxis ome</w>
F u
T X
ou d</w>
er ate</w>
it ely</w>
Un til</w>
L 5</w>
L at
di a
Gre ater</w>
evalu able</w>
Sim ple</w>
connec ting</w>
NE L</w>
compar atively</w>
cho osing</w>
per t</w>
stric ture</w>
HD AC
ello sis</w>
18 6</w>
oscill atory</w>
util izes</w>
hid den</w>
cros sed</w>
yl ene</w>
F NA</w>
Symp tom</w>
L ey
haem odynamic</w>
th west</w>
fic ially</w>
renew al</w>
as in</w>
set up</w>
br is</w>
2, 000</w>
bul l
eti ologic</w>
wh ites</w>
hem ostasis</w>
c amp
beg ins</w>
clinic opathologic</w>
denat uration</w>
ren dered</w>
os oph
t oral</w>
consec utively</w>
suppl emental</w>
mag net
particip ates</w>
Psych ological</w>
trans form
carbox y</w>
rot ator</w>
st omy</w>
S l
sl ides</w>
onc ogenes</w>
W D</w>
Ser ial</w>
Hor mon
ectom ies</w>
m Glu
CD 14</w>
L atin</w>
Im age</w>
arom atase</w>
M ad
CD 40</w>
carbo platin</w>
Chem otherapy</w>
J our
distric ts</w>
abro gated</w>
LOG Y</w>
m ist
1. 11</w>
inve stment</w>
P rec
can als</w>
ag onal</w>
fing ers</w>
e sia</w>
sp ic
sur prisingly</w>
zo on
ful filled</w>
fibrin olytic</w>
1. 12</w>
L ond
R ight</w>
orth otopic</w>
inflam ed</w>
cl op
far mers</w>
on co
ion ophore</w>
10. 2</w>
m A</w>
Emerg ing</w>
resembl es</w>
de tom
ros ity</w>
inser t</w>
pover ty</w>
fail ing</w>
EC 50</w>
A qu
St at
lipoxy genase</w>
G H
justi fied</w>
tun able</w>
S an</w>
r ituximab</w>
im i
plasm on</w>
ros ome</w>
ol one</w>
amphoter icin</w>
pneum othorax</w>
inspec tion</w>
ca st
spong e</w>
assum ing</w>
t ou
Ep id
as tically</w>
Transpl antation</w>
S TS</w>
la ws</w>
e tra
-- --
isot opic</w>
detom idine</w>
Tol l</w>
A ir
ti an</w>
3 3.3</w>
inter ven
Br d
um oral</w>
E U</w>
AD L</w>
Res on
S W</w>
20 2</w>
sh ut
R h</w>
chemil uminescence</w>
r als</w>
not es</w>
Q I</w>
st aged</w>
IM T</w>
cloz apine</w>
dis proportion
1. 10</w>
andro gens</w>
Combin ing</w>
n ationally</w>
nec rop
15 00</w>
cl eral</w>
brady cardia</w>
L ess</w>
P 450
disabl ed</w>
H CT</w>
compul sive</w>
or age</w>
n yst
Ex tensive</w>
k ain
antr al</w>
Myco plasma</w>
synerg istically</w>
ocycl ic</w>
AF M</w>
o flurane</w>
1. 15</w>
spati otemporal</w>
Gre en</w>
Epidemi ological</w>
IgG 4</w>
di pole</w>
o estradiol</w>
an yl</w>
spectro meter</w>
Recommend ations</w>
acidi fication</w>
hol low</w>
im pression</w>
l ati
ag enesis</w>
injec ting</w>
psycho tics</w>
str atum</w>
carcin ogen</w>
Por tu
19 9</w>
ME K</w>
N G
AD A</w>
18 2</w>
cl ass
ist ering</w>
paradig ms</w>
lipos ome</w>
. The</w>
14. 5</w>
brid ges</w>
conver t</w>
dro ps</w>
random ization</w>
arbitr ary</w>
s and</w>
trans duced</w>
SI I</w>
pic tures</w>
yros ine</w>
16 1</w>
rich ness</w>
porph yrin</w>
ib u
ot ec
Glc NAc</w>
ind ol
fig ure</w>
prot ons</w>
dyst roph
gen i
choro id</w>
parac rine</w>
HC s</w>
S qu
micro circulation</w>
techn ically</w>
relap ses</w>
14. 3</w>
iod oth
Gener ation</w>
bur nout</w>
Psy c
H ong</w>
ko v</w>
or ship</w>
rel ess</w>
permis sive</w>
c f
h ir
ol i</w>
T yr
T emporal</w>
k el
Sahar an</w>
h exam
P SCs</w>
ad esh</w>
syn cope</w>
groo ve</w>
we ed</w>
V P
be e</w>
m ole</w>
ti tre
simul ating</w>
O B</w>
pa d</w>
c ies</w>
Inf ants</w>
compens ate</w>
pur pur
mesoth elioma</w>
tr apped</w>
it rate</w>
Kne e</w>
di morph
therap ist</w>
saph enous</w>
in sem
I VI
Intr a</w>
H3 K
h ot
r umen</w>
Pro b
neon ate</w>
in ergic</w>
18 8</w>
cyt ologic</w>
b anding</w>
Lond on</w>
equi val
amin obutyric</w>
deline ate</w>
M b</w>
lin oleic</w>
likre in</w>
hy per</w>
NL R
et tes</w>
mer cap
congru ent</w>
V H</w>
PBM Cs</w>
g as
Ley dig</w>
Q Ds</w>
19 77</w>
in in</w>
For ce</w>
G 6
glomerul i</w>
hel min
TN M</w>
am ing</w>
tripl et</w>
uz umab</w>
E ye</w>
T h</w>
d b</w>
nerv osa</w>
AT CC</w>
de vised</w>
if f</w>
bra e</w>
Sign aling</w>
fri ends</w>
4 a</w>
un altered</w>
ore sistance</w>
disco ver</w>
herni ation</w>
main tains</w>
estr al</w>
shrin kage</w>
an oid</w>
ax es</w>
v an</w>
St ar
un precedented</w>
can cell
cl otting</w>
Con cer
Fin land</w>
assemb lies</w>
sp .</w>
id ene</w>
10. 6</w>
ure mic</w>
pr ur
N U
tempor ally</w>
He at</w>
thin k</w>
RB Cs</w>
i atrogenic</w>
AC R</w>
ater ial</w>
1. 13</w>
D TPA</w>
plas min</w>
2 60</w>
over dose</w>
Ap pl
Tr iton</w>
B U
sur pr
muc inous</w>
 m</w>
LI F</w>
ag ues</w>
a dex</w>
CYP 3
O lig
10. 4</w>
thyro idectomy</w>
re acting</w>
er h
sarco plasmic</w>
PD E</w>
1. 14</w>
troph oblast</w>
cy ste
0 01</w>
2 D3</w>
nan omaterials</w>
incid ental</w>
in i</w>
cust om</w>
10. 8</w>
x 2</w>
electrol ytes</w>
TU NEL</w>
k ish</w>
0.0 15</w>
18 3</w>
Coun c
H er</w>
im aged</w>
t ness</w>
ec ia</w>
k ingly</w>
li ons</w>
to uch</w>
ens emble</w>
per idone</w>
sha res</w>
La ke</w>
pharmac odynamic</w>
myel inated</w>
re modelling</w>
ir con
rec tus</w>
sec ond
syn ucle
dou bling</w>
re placing</w>
cylin dr
CT X</w>
dimer ic</w>
20 3</w>
in ia</w>
bio degradable</w>
emp ty</w>
mut ans</w>
autoradi ography</w>
un folding</w>
N L</w>
a ver</w>
19 76</w>
PA T</w>
F ull</w>
phot odynamic</w>
cat ast
- deoxy
mi an</w>
def ence</w>
substitu ents</w>
A sc
G 3</w>
azep ines</w>
biosens or</w>
of loxacin</w>
gri d</w>
publ ic
rim al</w>
ses sive</w>
Mi xed</w>
16 7</w>
Invol vement</w>
orimetr ic</w>
lac tam</w>
B lue</w>
si bling</w>
aver aging</w>
ar by</w>
transf ers</w>
ep razole</w>
extr usion</w>
SR S</w>
B asal</w>
resc ued</w>
ing ton</w>
rhyth mic</w>
y ch
ul ph
join ing</w>
G E
f lex</w>
specific ation</w>
tac rolimus</w>
ran ked</w>
discipl ines</w>
Wil le
strateg ic</w>
SC ID</w>
legis lation</w>
IN FO</w>
ip olar</w>
of en
19 70</w>
P ren
or bit</w>
al a</w>
7 50</w>
Del ayed</w>
hyal uron
sol ids</w>
rub ber</w>
8 01</w>
den s</w>
un ic
haz ardous</w>
popl iteal</w>
six ty</w>
r ash</w>
At tention</w>
Cr on
reg ister</w>
2 70</w>
TH P</w>
Impl ementation</w>
su n</w>
K L
c ock
tur b
CEN T</w>
Pol and</w>
K 562</w>
f im
an o</w>
Col orectal</w>
16 9</w>
N B
l ut
6 9
ev acu
is othi
K ong</w>
but yr
associ ates</w>
phen ytoin</w>
sem ide</w>
W ar
kin d
CN T</w>
ta g</w>
Wille brand</w>
gover ning</w>
amph ib
ti i</w>
anti arrhythmic</w>
fluor o</w>
p 65</w>
asth enia</w>
d ating</w>
metallo proteinases</w>
deoxy glucose</w>
CA 2</w>
Di et</w>
Pro gram
di am
di one</w>
Est abl
AD H</w>
re aches</w>
uniqu ely</w>
dec lining</w>
t z</w>
speci ation</w>
moti le</w>
stra ight
The ore
A 5</w>
elucid ation</w>
cre ates</w>
interpre ting</w>
anch ored</w>
qui escent</w>
HM G</w>
post er
phosph onate</w>
am el
per pendic
pl ei
moun ted</w>
b ig
Disc ussion</w>
H 7</w>
in clin
8 -</w>
PC T</w>
enanti omers</w>
A TION</w>
X a</w>
equi valence</w>
w i
loc king</w>
f ishes</w>
for amen</w>
PO RT</w>
alc in</w>
coord inates</w>
om eth
neuro cognitive</w>
4 th</w>
instill ation</w>
N I</w>
plank ton</w>
adv ent</w>
corro sion</w>
Counc il</w>
W H</w>
f eline</w>
pharmac otherapy</w>
Det ailed</w>
de bris</w>
ep tives</w>
An at
b arium</w>
de er</w>
is ser
check list</w>
objec tively</w>
sinus oidal</w>
W ol
c ari
isop ren
Ti O</w>
y cle</w>
op ter
anc e
2, 3,
naph thal
Traum atic</w>
gynec ologic</w>
tem plates</w>
RE CENT</w>
hol es</w>
electrocardi ographic</w>
ac a</w>
MR S</w>
semiconduc tor</w>
w arr
my opathy</w>
N Y
lo bectomy</w>
arteri oles</w>
CR H</w>
AD AM
R R
drin kers</w>
HA ART</w>
membran ous</w>
Pro lifer
Organ ic</w>
AR E</w>
ti fied</w>
situ ated</w>
comp uting</w>
Wor king</w>
Y ear</w>
amelior ated</w>
in novation</w>
C e
Lim ited</w>
statis tic</w>
tun ed</w>
os sification</w>
aut ocrine</w>
X RD</w>
Alph a</w>
imper ative</w>
waveleng ths</w>
emul sions</w>
broil er</w>
A ir</w>
F at
orb it
Techn ology</w>
myco bacterial</w>
neur o</w>
ser ov
chromo ph
su perim
bot ulinum</w>
2 H</w>
pro gnos
multi dimensional</w>
annot ation</w>
bur sts</w>
morph ogenetic</w>
im pulse</w>
S ter
albe it</w>
phen obarbital</w>
psori atic</w>
digesti bility</w>
mem bered</w>
bifur cation</w>
vag in
flavon oid</w>
heterozyg osity</w>
or dering</w>
phyl ogeny</w>
resembl ed</w>
analy zer</w>
superi ority</w>
cris tine</w>
H amil
naph th
1 C</w>
S cal
pro biotic</w>
micr onucle
mas king</w>
tern ary</w>
Nan o
in cur
col chicine</w>
neuro fibrom
resi ding</w>
Ac ross</w>
Gl n</w>
sor tium</w>
ide ation</w>
D O</w>
pres ently</w>
Hal f</w>
mimic ked</w>
Tum ors</w>
me detomidine</w>
U g
our ce</w>
10. 7</w>
elong ated</w>
hyper thyroidism</w>
re programming</w>
Scan ning</w>
alg al</w>
neuro transmitters</w>
C CA</w>
Asth ma</w>
con fusion</w>
per tinent</w>
Tr ich
staphyloc occal</w>
vacu oles</w>
pow ered</w>
PU FA</w>
Fib ro
Biom ar
cer tainty</w>
G DP</w>
pul sion</w>
L if
Sol id</w>
occup ancy</w>
bov is</w>
meta plasia</w>
pe l</w>
z oster</w>
concep tu
Mic ha
de emed</w>
Accur ate</w>
vis co
A beta</w>
E volution</w>
iti dis</w>
on i
 o</w>
ab normally</w>
po rosity</w>
un met</w>
Inflam mation</w>
warr ant</w>
E .</w>
dri ves</w>
ic tal</w>
1 1,
With out</w>
cre am</w>
x ation</w>
orph ine</w>
carb ap
ygo tic</w>
nanow ires</w>
mod ular</w>
one uro
qu it</w>
immunocompet ent</w>
dic s</w>
tend ons</w>
j i
comput ation</w>
ome res</w>
path ogenetic</w>
neuro transmission</w>
scar ring</w>
li sten
s tive</w>
g ates</w>
conver gent</w>
si l</w>
ser a
sub traction</w>
integr ins</w>
Oc cu
gly can</w>
contrac eptives</w>
Ne isser
Selec tion</w>
phil osoph
og u
t osp
har mon
Ne o
ric eps</w>
ure ter</w>
shap ing</w>
Psychi atric</w>
coun ty</w>
AL E</w>
affor ded</w>
f mol</w>
m entary</w>
- 3
stat ements</w>
wa ke</w>
ori entations</w>
sp oro
S ud
s phen
- 2.
ac illin</w>
K r
kal likrein</w>
Compo unds</w>
c up</w>
inf lation</w>
rh o</w>
titre s</w>
19 6</w>
immunocyto chemical</w>
compl aint</w>
sera dish</w>
yl ine</w>
re ared</w>
oly b
biom aterials</w>
pl ating</w>
efferen t</w>
P PAR</w>
m i</w>
Pro toc
wor thy</w>
verte brae</w>
sch wann
l ass</w>
andro st
metr onidazole</w>
SP E</w>
occa sional</w>
g aining</w>
bil ayers</w>
equiv ocal</w>
hair pin</w>
cod ons</w>
prov oked</w>
Fus arium</w>
sin uses</w>
bub ble</w>
Proc ed
ud ed</w>
0.0 0</w>
18 4</w>
intran asal</w>
l em
u ality</w>
ac k
abil istic</w>
L HRH</w>
anticoagul ants</w>
synchron ized</w>
suppl ementary</w>
de af
II A</w>
icro bi
oligos accharide</w>
phosph o</w>
Compo und</w>
at rophic</w>
qu ater
commit ted</w>
AR s</w>
METHO DO
S CLC</w>
end ym
concomit antly</w>
ter r
amelior ate</w>
di ode</w>
17 6</w>
m ate</w>
int entional</w>
infec ting</w>
N erve</w>
erh ans</w>
Inter view</w>
princ ip
CB CT</w>
Sam ple</w>
Arab ia</w>
od or
phot ographs</w>
clim atic</w>
inser tions</w>
at ed
initi ative</w>
17 1</w>
op enic</w>
G O
Rec ognition</w>
ac o
gastro esophageal</w>
18 1</w>
lim bic</w>
23 187</w>
Sequ encing</w>
tum oral</w>
Mat rix</w>
Immuno histochemistry</w>
fluctu ation</w>
precip itated</w>
rec ap
expec t</w>
tin ct</w>
osteopo rotic</w>
di phosphate</w>
contr asting</w>
ep ist
birth weight</w>
G PI</w>
The ory</w>
lymphaden opathy</w>
trans ection</w>
neuro surgical</w>
refer rals</w>
ma z
germin al</w>
conc an
sk y</w>
abstr act</w>
Vari ation</w>
compl eting</w>
common est</w>
Clin icians</w>
gre n</w>
Ste re
co existence</w>
en ucle
T Y
short -</w>
on egative</w>
tho roughly</w>
1. 16</w>
t ospor
alkal i</w>
M ICs</w>
anesthe tics</w>
el ite</w>
streng thening</w>
6 8
id er</w>
gen ation</w>
endo tracheal</w>
b at
e osin</w>
stat ement</w>
11. 4</w>
il ance</w>
H K</w>
sac ral</w>
0.0 12</w>
OR F</w>
bronch itis</w>
Po or</w>
C are
flu oxetine</w>
F OR</w>
hydroly zed</w>
A 2
p ene</w>
migr ating</w>
G le
P f
colle agues</w>
uc e</w>
trop in</w>
albin o</w>
famil i
Neisser ia</w>
dimer ization</w>
invari ant</w>
ti az
thi o</w>
mo x
streptoc occal</w>
I PV</w>
P eptide</w>
sub family</w>
6 J</w>
eu than
dou bled</w>
PL GA</w>
J AK
di phenyl
s aid</w>
b lu
anc estral</w>
AD R</w>
infiltr ates</w>
Path way</w>
2 12</w>
recogn izes</w>
work shop</w>
inter vertebral</w>
oxyl in</w>
- mediated</w>
R ate</w>
I G
cardi over
rig idity</w>
b ib
ot ax
unevent ful</w>
accum ulating</w>
al izes</w>
distor ted</w>
ag ency</w>
re ti
olip ids</w>
lead er</w>
Integr ated</w>
vig orous</w>
loc k</w>
encephal ic</w>
Ca P</w>
ibu profen</w>
H en
af il</w>
immun o</w>
d yn
d osis</w>
brea king</w>
al li
pre menopausal</w>
R ib
bed side</w>
hy ster
compl ementation</w>
F lor
ana plastic</w>
thous ands</w>
fav our</w>
Al k
PI s</w>
meth amphetamine</w>
ex ocytosis</w>
E SCC</w>
osy stem</w>
hypot ensive</w>
par asym
chol er
h im
illo facial</w>
Lang erhans</w>
A -</w>
S AP</w>
ir s</w>
tis tic</w>
man ually</w>
phosphor ylase</w>
phthal ate</w>
Adolesc ent</w>
dec ided</w>
sy l</w>
anti psychotics</w>
Isl and</w>
D 6</w>
ente sis</w>
sew age</w>
anti epileptic</w>
Pres ence</w>
invasi veness</w>
dyst onia</w>
inter ruption</w>
intim a</w>
trac ted</w>
bio chemistry</w>
ec ules</w>
benz oate</w>
B angl
p r</w>
PK C
re absorption</w>
bio activity</w>
Re tin
osmol ality</w>
G G
M PA</w>
peri oste
lithi asis</w>
cul turally</w>
om i
supram olecular</w>
2 25</w>
a .
Altern ative</w>
sc anned</w>
ham pered</w>
iodoth yronine</w>
Ken ya</w>
de fibrill
S to
carcin ogens</w>
commit tee</w>
op ancre
transc atheter</w>
Anti biotic</w>
st ature</w>
anch or</w>
w ash</w>
suspici ous</w>
streng then</w>
bo ost</w>
pher om
log arith
n ings</w>
out lines</w>
ome ters</w>
hepat otoxicity</w>
ac ea</w>
A HL</w>
Th 17</w>
cou mar
h sp
Seph adex</w>
AC P</w>
11. 8</w>
Ta king</w>
od om
Prolong ed</w>
Go og
viol ent</w>
dis closure</w>
as cribed</w>
e zing</w>
modul atory</w>
v able</w>
E AE</w>
di visions</w>
dex tro
elas tin</w>
y litis</w>
E ss
glycol ytic</w>
lec tins</w>
HN SCC</w>
let ter</w>
Up per</w>
salic ylic</w>
obr onchial</w>
Min i</w>
ear ances</w>
addi tives</w>
im port</w>
dop ing</w>
mil dly</w>
Ovari an</w>
work force</w>
discrim inating</w>
ureth ra</w>
imag ery</w>
nephro toxicity</w>
prospec ts</w>
calc ified</w>
cl avian</w>
cyclohex imide</w>
leth anolamine</w>
op ens</w>
perf ec
seque stration</w>
hyp ogly
con ference</w>
xen obi
de grade</w>
M W</w>
11. 3</w>
ph eochrom
dr astically</w>
Tren ds</w>
co ar
Occu pational</w>
ost at</w>
Li ving</w>
to ur
CR S</w>
O -</w>
toxic ological</w>
oc ephal
c ist
PC Bs</w>
pepti dase</w>
Wor k</w>
econ omically</w>
L DL
outw ard</w>
min d
te en
at ography</w>
fo etal</w>
my ogenic</w>
her ds</w>
METHODO LOGY</w>
W B</w>
asc ent</w>
judg ment</w>
K RAS</w>
18. 5</w>
m .
r ams</w>
oglob ulin</w>
In jection</w>
gluc an</w>
S ph
al t</w>
Tox oplasma</w>
CD DP</w>
decom pens
CYP2 C
tri age</w>
gl ot
le aching</w>
00 2</w>
emph ig
compreh en
L AD</w>
re form</w>
G yn
weigh ing</w>
convul sive</w>
ph ages</w>
Ch lor
L ith
oste ogenesis</w>
F FA</w>
c c
com b</w>
R ati
cyclo dextrin</w>
B P1</w>
rest oring</w>
read er</w>
tumorig enic</w>
er vical</w>
epi phy
on omy</w>
concan avalin</w>
S etting</w>
p p</w>
fib ros
intrav itreal</w>
propyl ene</w>
Hun ting
1. 17</w>
K ir
pr us
tetrac h
mill im
U R</w>
intr ons</w>
ab domin
row ing</w>
ubiquitin ation</w>
irr itation</w>
PG E</w>
esophag itis</w>
ye asts</w>
O 157</w>
ac knowled
SE L
1 0.1</w>
fun ded</w>
id og
oscill ation</w>
w ar</w>
17 3</w>
judg ments</w>
glut ar
perme abil
out let</w>
osteocl asts</w>
CN V</w>
Recon struction</w>
19 74</w>
S on
ak i</w>
h ens</w>
se al
odop a</w>
y --
x 1</w>
str ing</w>
re ds</w>
in dispensable</w>
ic eption</w>
g um</w>
viri ons</w>
K ar
os oma</w>
atr ac
sp asm</w>
der ma</w>
prepar ing</w>
ur ate</w>
h an</w>
re traction</w>
col o
answ ers</w>
esti n</w>
ca stration</w>
Mil d</w>
CL A</w>
DR B1</w>
S pe
fer ment
remn ant</w>
trans activation</w>
mig rate</w>
crystall ographic</w>
intram edullary</w>
auth orities</w>
intrav entricular</w>
wor st</w>
Ter m</w>
vit rectomy</w>
ap eptide</w>
lit ers</w>
VE GF
J u
Trans fer</w>
ter t</w>
C ost
f asted</w>
co iled</w>
2 4.
Goog le</w>
is o</w>
contrac ted</w>
ER CP</w>
har bo
AP s</w>
macrom olecular</w>
P TH
Enter ococcus</w>
read ings</w>
eosin ophilia</w>
prus side</w>
inequ alities</w>
at o
p a</w>
bu d</w>
17 8</w>
var ices</w>
fore sts</w>
perin eal</w>
di ap
pa yment</w>
Sim ulation</w>
restor ative</w>
mem ories</w>
motiv ated</w>
Se q</w>
obstac les</w>
h us
thromb olytic</w>
ac i
regi stries</w>
gad olinium</w>
acycl in</w>
ang itis</w>
otyp ically</w>
myri state</w>
P BL</w>
tr i</w>
if era</w>
s na
over looked</w>
obacter iaceae</w>
smo ked</w>
surfac tants</w>
anc ement</w>
hydrophob icity</w>
si aly
ul line</w>
aer ob
herbi v
F ast</w>
T u
hyper lipidemia</w>
Ex p
con crete</w>
Lab el</w>
DE X</w>
en yl</w>
Isra el</w>
b inge</w>
O SCC</w>
lipo philic</w>
be et
G AD</w>
straight forward</w>
TP 53</w>
inflam mas
DO I</w>
Pharmac ological</w>
Ech ocardi
reimbur sement</w>
S AM</w>
t etro
ser ogrou
w earing</w>
peri vascular</w>
s pro
mom ents</w>
manip ulations</w>
D DM</w>
sw abs</w>
cord ant</w>
centr ally</w>
Liqu id</w>
am enable</w>
Ca M</w>
 ll
eng aging</w>
T ES</w>
sev oflurane</w>
counter part</w>
l iz
re finement</w>
out door</w>
ket t
disp osal</w>
nor adrenergic</w>
flow ers</w>
k yph
nour ished</w>
sp ra
D BA</w>
y og
pul l</w>
V 3</w>
ep iness</w>
inter medi
ur gently</w>
acet amol</w>
lingu istic</w>
Reson ance</w>
Multi variable</w>
N early</w>
cataly ze</w>
in correct</w>
at ergic</w>
2 56</w>
dr ift</w>
A cin
b ank</w>
infec t</w>
end orphin</w>
act one</w>
her d</w>
D ri
R us
N d</w>
educ ators</w>
tub al</w>
vin cristine</w>
repeat ability</w>
cent rom
u ation</w>
myocardi tis</w>
idog rel</w>
d am</w>
CD 25</w>
SC N</w>
6 4
arter itis</w>
A m</w>
j i</w>
h oney</w>
vascul arized</w>
le sioned</w>
R are</w>
1. 18</w>
it ual</w>
Ther mal</w>
leukotri ene</w>
appreci ated</w>
am ne
detec tors</w>
en ol</w>
per taining</w>
campa ign</w>
ab an</w>
in completely</w>
au xin</w>
20 9</w>
meningi oma</w>
Pak istan</w>
tiaz em</w>
Criter ia</w>
re uptake</w>
frag ile</w>
10. 9</w>
imetr ic</w>
el ementary</w>
Differenti ation</w>
leaf let</w>
el uting</w>
de fl
j ing</w>
ecta sia</w>
CA 3</w>
Con nec
poly cyclic</w>
back grounds</w>
glut en</w>
aldehy des</w>
mon os
D SS</w>
A h
o kinin</w>
ig enic</w>
om n
aly zed</w>
3 </w>
c nem
FV C</w>
19 8</w>
l axis</w>
faec alis</w>
c 2</w>
AC A</w>
M ass
ep endym
my cel
adren ocortical</w>
ip ple</w>
E F
agricul ture</w>
review ing</w>
di version</w>
sc ars</w>
B enz
mon oph
sub scale</w>
ell ae</w>
TI s</w>
P he
con dom</w>
inform al</w>
Em bry
ST AT</w>
Ch ic
qual ified</w>
inc enti
otec an</w>
a g</w>
gluc osidase</w>
intrac or
ab ut
11. 6</w>
Accur acy</w>
pre existing</w>
fer ric</w>
classi fications</w>
7, 8</w>
re generating</w>
ur tic
confir matory</w>
lith o
Mac ro
prost acyclin</w>
fasc ia</w>
tr in
ox al</w>
Ap plications</w>
ly ase</w>
melan in</w>
anis otropic</w>
I MRT</w>
o .</w>
rid ge</w>
l ot
ox ib</w>
fe deral</w>
get ting</w>
Inter fer
Non etheless</w>
exec ution</w>
ogene tically</w>
ad el
n s
k its</w>
benz yl
ag er</w>
perpendic ular</w>
ch in</w>
f in</w>
on ide</w>
p etro
sub divided</w>
arg ued</w>
retin oblastoma</w>
hor seradish</w>
E PS</w>
Pr P</w>
S per
19 7</w>
M SI</w>
C ON</w>
h un
stitu tion</w>
smar t
TN BC</w>
Der mat
trans aminase</w>
Micro bial</w>
cop enia</w>
ardi ac</w>
head aches</w>
DN ase</w>
Valu e</w>
me iosis</w>
Al tered</w>
B asic</w>
Re ference</w>
T uberculosis</w>
R est
ex am</w>
vin ces</w>
sym b
tonsi ll
ti vitis</w>
gen otypic</w>
F ab</w>
vi al</w>
serop re
long est</w>
Cl oning</w>
iev ing</w>
nicotin amide</w>
inte rests</w>
Re tinal</w>
5 4
tig mine</w>
defin es</w>
them atic</w>
hab di
Mater ial</w>
enc h</w>
quinol ones</w>
in c</w>
press ors</w>
lat ors</w>
Gastro intestinal</w>
public ly</w>
il tration</w>
arbox ylic</w>
Dig ital</w>
ospec ific</w>
ogen in</w>
mit omycin</w>
bor on</w>
om atic</w>
op on
encoun ters</w>
MM Ps</w>
fluoro scopy</w>
Bri ef</w>
introduc es</w>
maxim ally</w>
l an
tain ties</w>
scav enger</w>
Tex as</w>
Contr ary</w>
ut y</w>
Uni on</w>
ith romycin</w>
contin ent</w>
inter acted</w>
di hydro</w>
Psyc INFO</w>
pol yn
percei ve</w>
im migrants</w>
leng thening</w>
lac tin
P PD</w>
si mian</w>
b ad</w>
ref ers</w>
sc ene</w>
dang erous</w>
Ne ph
s lowing</w>
ref er</w>
palp able</w>
h i</w>
11. 7</w>
spac ing</w>
d ases</w>
cl aim</w>
L atin
id omide</w>
E G</w>
un covered</w>
en tion</w>
immunohisto chemically</w>
EV s</w>
kn ock</w>
nitro prusside</w>
endocardi al</w>
Trans mission</w>
metaph ase</w>
Nanop articles</w>
equival ents</w>
stro kes</w>
pum ps</w>
di cl
er us</w>
vin yl
in conclusive</w>
soci eties</w>
De fin
miner als</w>
S cop
W ales</w>
1. 21</w>
Ar gen
blast ocyst</w>
encomp assing</w>
drin k</w>
tempo romandibular</w>
casc ades</w>
Cryst al</w>
lay ing</w>
S ha
Deli very</w>
val is</w>
ech an
persist s</w>
Repor ting</w>
lin k
Prof ile</w>
us ate</w>
sc ru
ear th
Del etion</w>
wave form</w>
la ev
cry o
synucle in</w>
ow ad
p 2</w>
Rou tine</w>
Eng ine
l ides</w>
H an</w>
Jour nal</w>
K I</w>
marg inally</w>
al istic</w>
ocompati ble</w>
ID DM</w>
ometr ically</w>
com a</w>
ren ic</w>
K u
cylindr ical</w>
R ad
accid ental</w>
T CDD</w>
AP A</w>
v ice</w>
anastom oses</w>
la ke</w>
Ac tion</w>
extrav as
thre e
B ra
Develop ing</w>
f ission</w>
chymo trypsin</w>
owad ays</w>
brom o</w>
CB 1</w>
quad riceps</w>
c ar</w>
M uch</w>
onc ological</w>
ap ple</w>
sandw ich</w>
dam s</w>
syn ergy</w>
 mol</w>
G el</w>
HO MA</w>
sh allow</w>
immor t
P h</w>
tr ate</w>
compl i
D WI</w>
PR A</w>
Cron bach</w>
20 7</w>
sugg estion</w>
R N</w>
polypo sis</w>
insul t</w>
furo semide</w>
fer mented</w>
g t</w>
17 9</w>
b ine</w>
oc clusions</w>
lymphaden ectomy</w>
prolifer ator</w>
cnem ius</w>
H ome</w>
hand le</w>
ST I</w>
al th</w>
1 c</w>
alcohol ics</w>
chemoradi otherapy</w>
oz ym
anil ine</w>
sustain ability</w>
dosi metry</w>
tetra zol
fluo roph
pass ing</w>
de als</w>
In duc
res um
ra inf
calc ifications</w>
chem opre
at eness</w>
ell ularly</w>
Pren atal</w>
Cor relations</w>
to oth
arth ritic</w>
R M
classi fier</w>
home ostatic</w>
oselec tivity</w>
path ologically</w>
m atism</w>
disrup ting</w>
PE P</w>
contribut or</w>
environ mentally</w>
B ay</w>
Ac qu
Physi ological</w>
eff usions</w>
prin ts</w>
HC MV</w>
gangli onic</w>
Gle ason</w>
li ximab</w>
k a
complex ed</w>
Transcrip tion</w>
tro chan
work flow</w>
ad o</w>
b an</w>
mor bidities</w>
ex agg
15. 5</w>
ran king</w>
li t</w>
Es ophag
void ing</w>
er ul
educ ated</w>
t PA</w>
OV X</w>
w ires</w>
un resectable</w>
El derly</w>
bac illi</w>
p om
Tran sl
si ans</w>
H ip</w>
In di
deman ding</w>
CD I</w>
sh ad
re as</w>
ill es</w>
E stro
vox el</w>
l uminescence</w>
compet ency</w>
19 4</w>
hyper algesia</w>
phosphat ases</w>
ti go</w>
Hunting ton</w>
op eptides</w>
unc tional</w>
R o</w>
ear able</w>
rh od
CY P</w>
W all
war ning</w>
met ropolitan</w>
gastroenter itis</w>
at ous</w>
hydro dynamic</w>
sub clavian</w>
cim etidine</w>
9 37</w>
18 9</w>
hab it</w>
chew ing</w>
us cul
se eded</w>
assemb le</w>
r ide</w>
oc ene</w>
iss ure</w>
P 3
ho g</w>
hydroxy tryptamine</w>
uro kinase</w>
19 1</w>
follow up</w>
ff er</w>
Met abol
N ative</w>
T ib
tran su
compl ained</w>
man soni</w>
parasym pathetic</w>
1 7.5</w>
MR A</w>
pro lactin
rec tom
cyto keratin</w>
explic itly</w>
men ting</w>
incorpor ates</w>
A 23187</w>
L IN
ar k
bl y
immuno assays</w>
EC D</w>
H1 N1</w>
ten s</w>
DE Gs</w>
an ut</w>
anti thrombin</w>
tub ul
myel operoxidase</w>
l ose</w>
three fold</w>
C aco</w>
TH C</w>
VE C</w>
cin nam
K e
lipos omal</w>
om eprazole</w>
gon orrho
modi fiable</w>
surg e</w>
0.0 13</w>
a ke</w>
onec rosis</w>
0.0 16</w>
conjunc tivitis</w>
meningi omas</w>
in habit
avir in</w>
fe at
S GA</w>
l eton</w>
n ex
av a</w>
I SO</w>
glyc ans</w>
12. 3</w>
hard ware</w>
Surge ons</w>
re ment</w>
ep ide
o kinase</w>
ab er
intenti ons</w>
transpos on</w>
hyper polarization</w>
end arte
ev o
Meth yl
habdi tis</w>
calibr ated</w>
organis ation</w>
expec tation</w>
haemat ological</w>
motiv ational</w>
Import ance</w>
In corpor
collo id</w>
olys in</w>
warran ts</w>
man n
HE V</w>
st ellate</w>
Aca demic</w>
anaesthe tized</w>
os up
phosphoinosi tide</w>
ne bul
mig rated</w>
bus iness</w>
pharmac ist</w>
gel atin
par ap
Adhe rence</w>
G ERD</w>
Qu e
loos ening</w>
inter course</w>
reg ressions</w>
mu g</w>
abstr acts</w>
smo oth
c r</w>
ell er</w>
PD AC</w>
Sec re
reproduc e</w>
il le</w>
ser ologic</w>
0.0 14</w>
1. 23</w>
por ts</w>
ti ometry</w>
IK V</w>
ser onegative</w>
Inf ec
Tox icity</w>
E IA</w>
19 3</w>
z ircon
k J</w>
Fl ex
o u</w>
1. 19</w>
hydra ulic</w>
terr itory</w>
met atar
spe eds</w>
bronch oscopy</w>
esc ens</w>
AS 1</w>
Or ig
d oxin</w>
colli sion</w>
p assi
bio tin
ather ogenic</w>
manuscrip t</w>
reflec tance</w>
T ob
gluc opyran
Inf ections</w>
Met abolism</w>
appreci able</w>
Im paired</w>
sec ure</w>
re produced</w>
sk illed</w>
air borne</w>
j ump</w>
bil lion</w>
12. 8</w>
er ization</w>
S ul
V CAM</w>
deaf ness</w>
endoc rin
R L</w>
rot ating</w>
Dru gs</w>
g in</w>
12. 2</w>
K T</w>
th enium</w>
Swit zer
To ol</w>
non diabetic</w>
E con
F a
bl unted</w>
blo ts</w>
I b</w>
2 2.
M PS</w>
oper able</w>
thro at</w>
trans late</w>
c oc
diver sification</w>
Wil cox
Stand ardi
Nitr ic</w>
itr y</w>
extra hepatic</w>
ol aryng
carbam azepine</w>
H ER</w>
13. 2</w>
in sured</w>
re feren
batter ies</w>
un a</w>
seropre valence</w>
lac to
denti stry</w>
characteris ation</w>
nit rous</w>
I AP</w>
B on
dys functions</w>
pecul iar</w>
ker atitis</w>
loc ked</w>
cost al</w>
Quanti fication</w>
sulf oxide</w>
um n</w>
hyal uronic</w>
scre ens</w>
admin istering</w>
ro t</w>
ev ening</w>
Switzer land</w>
Auth ors</w>
haem odialysis</w>
Arter y</w>
In s</w>
p est</w>
B ul
Meth od
tryp tic</w>
NI DDM</w>
spec ulate</w>
multi level</w>
2 alpha</w>
Inhib itors</w>
soci etal</w>
discord ant</w>
inter net</w>
identi fiable</w>
lib itum</w>
exacerb ated</w>
hyper cap
Contr ast</w>
as perg
1. 20</w>
W ash
es el</w>
uc tal</w>
atri sts</w>
in -</w>
y algia</w>
Initi ally</w>
H cy</w>
neuro toxic</w>
DHE A</w>
cl amping</w>
St ability</w>
con gen
question ed</w>
analy te</w>
ru g
Re pair</w>
.0 3</w>
3 7.5</w>
in ae</w>
de tr
Protec tive</w>
oper ators</w>
Acc ess</w>
dys functional</w>
Targ et</w>
glycer in</w>
be ha
i ensis</w>
comprehen sively</w>
13. 6</w>
P it
K v
blood stream</w>
dur able</w>
Wilcox on</w>
c iti
hist ones</w>
SC F</w>
Im pair
cont acted</w>
al ert</w>
en al
col orimetric</w>
ec z
spir ation</w>
cross linking</w>
kine sis</w>
oder m</w>
A im
ca esarean</w>
5 D</w>
H SC</w>
m E
G ro
C ob
MI S</w>
physi otherapy</w>
exc iting</w>
icrobi als</w>
li er</w>
flav one</w>
ev en
TR PV
ang eal</w>
7 3
ere b
pul l
chemo attrac
pol es</w>
insul a</w>
2 3.
worsen ed</w>
Str ong</w>
myco bacteria</w>
Per sistent</w>
T CM</w>
CO L
proce eds</w>
ligam ents</w>
exp ense</w>
V PA</w>
B AT</w>
R AD
pig e
glutam atergic</w>
pro vo
C 4
per ovsk
at tainment</w>
Hist opathological</w>
hy pos
indu stries</w>
Syn thetic</w>
ad ds</w>
recover ies</w>
DM D</w>
quinol one</w>
SH 2</w>
annot ated</w>
benzodi azepines</w>
ost om
zin ess</w>
R S
gastro cnemius</w>
conflic ts</w>
2 22</w>
in ant</w>
carc ass</w>
D end
hund reds</w>
omorph ine</w>
l ated</w>
han dic
K C</w>
aneurys mal</w>
adver tis
const antly</w>
12. 1</w>
T TP</w>
enor m
prote oglycans</w>
princip ally</w>
T ax
anth in</w>
ing ent</w>
ste adily</w>
aw s</w>
Con comit
fer rom
pro long</w>
dise qu
sep tic
Mul tic
in tu
vol tam
R es</w>
sec tors</w>
ighten ed</w>
L S
epididym al</w>
insectic ide</w>
anticonvuls ant</w>
sten oses</w>
t rough</w>
ag mus</w>
op rim</w>
L and
neuro physiological</w>
D B</w>
is omerase</w>
Sup pression</w>
e ip
C ore</w>
allo ys</w>
econ omy</w>
fum ig
be ar</w>
val ine</w>
exchang er</w>
plas monic</w>
constr aint</w>
fric tion</w>
1. 22</w>
fibrin olysis</w>
sea water</w>
lin s</w>
Tur kish</w>
radi ograph</w>
otroph in</w>
v itr
mm 2</w>
interpre tations</w>
galact os
2 14</w>
a es
R O</w>
Tric ho
D eri
dam ages</w>
co variance</w>
for aging</w>
co m</w>
draw ing</w>
te es</w>
amox icillin</w>
Fat ty</w>
h rs</w>
re taining</w>
gr as
obut amine</w>
SE P</w>
di p
condu it</w>
form ulas</w>
PT CA</w>
c ulation</w>
k 2</w>
dis infection</w>
choler ae</w>
tetrazol ium</w>
I on</w>
ery th
PT A</w>
fer rin</w>
Hybri d</w>
compet e</w>
excep tional</w>
12. 6</w>
ser iously</w>
Electr ical</w>
cortic es</w>
tit udes</w>
5 000</w>
DO PA</w>
ba g</w>
steril ization</w>
wa it</w>
oval bumin</w>
CB D</w>
incid ents</w>
C ushing</w>
Y 1</w>
un ra
expendit ures</w>
di phenyl</w>
et obacter</w>
l ax
E Q</w>
f ection</w>
rel and</w>
En dom
Dep ending</w>
B AC</w>
az o</w>
e ased</w>
Par tic
stac king</w>
uncer tainties</w>
z ona</w>
hyp no
r al
if er</w>
CO OH</w>
din ucleotide</w>
engra ft
enorm ous</w>
lev odopa</w>
Mon oclonal</w>
ultrason ographic</w>
laev is</w>
u pr
micro arrays</w>
d oll
exha ustion</w>
F X
po d</w>
circu itry</w>
pro vinces</w>
gener ator</w>
Lym e</w>
20 8</w>
ph os
et ching</w>
a 1</w>
v ac
de aminase</w>
physic s</w>
st ations</w>
sti n</w>
purpur a</w>
M apping</w>
- N</w>
schist osomiasis</w>
bur g
dop a</w>
correspond ence</w>
splic ed</w>
combin atorial</w>
prob abilistic</w>
arthro scopy</w>
Ac tivities</w>
r uled</w>
6 2
Is su
ff in</w>
sp ines</w>
Mel an
eli ac</w>
absorp tiometry</w>
anthrop ogenic</w>
Techn ical</w>
ester ol</w>
HMG B1</w>
Ca enor
l ic</w>
LI MI
engraft ment</w>
tr id
Com pon
cass ette</w>
w illing</w>
redund ant</w>
respon der</w>
id ated</w>
9 8
ut ter</w>
cle ared</w>
p 27</w>
diure tics</w>
carcin oid</w>
St .</w>
recre ational</w>
p I</w>
equ ilib
N N
metabol omics</w>
Path ology</w>
inf er</w>
19 73</w>
quater nary</w>
clu es</w>
withdraw n</w>
Re habilitation</w>
Enter obacteriaceae</w>
coar se</w>
iso zymes</w>
4, 4</w>
D am
trem end
resol ving</w>
Path ological</w>
Inv asive</w>
poly p</w>
por ation</w>
C yp
gly caemic</w>
h anded</w>
ofen ac</w>
bronch odi
poly styrene</w>
ic it</w>
f 1</w>
intim ate</w>
In don
sh rim
CS C</w>
r 2</w>
FI TC</w>
F v</w>
Caenor habditis</w>
wh el
1. 24</w>
mac aques</w>
Ep ithelial</w>
phot ore
Incre ases</w>
HR QOL</w>
Av ail
0.0 11</w>
Heter ogene
a eg
succ e
HC A</w>
im pregn
Nor we
allevi ated</w>
empir ically</w>
deoxyn ucle
in t</w>
ST R</w>
st yles</w>
Acin etobacter</w>
par av
AN S</w>
SO UR
2 23</w>
escal ation</w>
b abo
en ever</w>
hydro cortisone</w>
Bar ri
12. 0</w>
stric tures</w>
sc rip
Modi fication</w>
K B</w>
6 3
2 21</w>
s chol
de bil
din itro
sa w</w>
bever ages</w>
Le sions</w>
or g</w>
suc tion</w>
p un
n ation</w>
work up</w>
varic ella</w>
refu ge
d y</w>
di asis</w>
sub dural</w>
Pro bl
A ther
lu ted</w>
chondro itin</w>
end o</w>
special ties</w>
z ole</w>
P ig
hat ching</w>
coun ties</w>
Mar kov</w>
in tub
Be ing</w>
cannabin oid</w>
Gener ally</w>
pal atal</w>
n am</w>
E 7</w>
am iod
bi directional</w>
3 B</w>
R y
p emphig
in ev
p. o.</w>
omet abolic</w>
Ultra structural</w>
cryop reservation</w>
e tings</w>
fo rec
ter rit
mus h
Sep ar
air flow</w>
ed es</w>
th umb</w>
contrac ture</w>
1, 1</w>
tur bul
ing ing</w>
St able</w>
chloro form</w>
V enous</w>
minim ized</w>
ex ocrine</w>
I reland</w>
Z inc</w>
su staining</w>
d G</w>
ori e</w>
cyst ectomy</w>
c Tn
fo ster</w>
bub bles</w>
l es
eme dicine</w>
prolifer ate</w>
hep t
amiod arone</w>
ogene tics</w>
T od
th ened</w>
path s</w>
or ific
ou rea</w>
ep ic
prim or
V ar
las ers</w>
S SI</w>
p ts</w>
poly amine</w>
oc ta
psych omotor</w>
sup posed</w>
induc tive</w>
glucuron ide</w>
H HV</w>
sin usitis</w>
volunte er</w>
ifer ous</w>
c et
4 80</w>
rh am
IC E</w>
ex presses</w>
dynam ically</w>
conserv atively</w>
ch in
Influ enza</w>
sing leton</w>
Hydro xy
AN CA</w>
proton ated</w>
Loc alization</w>
practi cing</w>
synchron y</w>
L act
Hist ologic</w>
11. 9</w>
T CP</w>
cre di
Moder ate</w>
conti gu
ri es</w>
F oun
immunob lot</w>
bud ding</w>
en de
analy sing</w>
Perc eived</w>
w alled</w>
ta iled</w>
V DR</w>
G las
th western</w>
PM Ns</w>
dist ension</w>
aspar tic</w>
G L</w>
hyper plastic</w>
gingi valis</w>
Ob ste
g est</w>
n u</w>
G AP</w>
p ie
persist ently</w>
therm ally</w>
p tive</w>
dicl ofenac</w>
uni or</w>
AT 2</w>
synthesi zing</w>
S in
inflammas ome</w>
methyl prednisolone</w>
shar ply</w>
g m</w>
cad aver</w>
cul turing</w>
em in
cor al</w>
soci ally</w>
myel odys
reconstruc t</w>
St reng
arti fact</w>
Nu tritional</w>
Ne utroph
fel low
metast asi
cil ia</w>
ent gen
SC P</w>
NO D</w>
aflat oxin</w>
Schist osoma</w>
eip t</w>
he ifers</w>
V entricular</w>
Ch est</w>
C MR</w>
jejun i</w>
path ies</w>
hemat uria</w>
osp inal</w>
at en
Exc ept</w>
antim icrobials</w>
MT 1</w>
D AT</w>
RE PORT</w>
PA M</w>
fl our</w>
k an
function alization</w>
As n</w>
mas titis</w>
rel ia</w>
spectro metric</w>
rifamp icin</w>
mar king</w>
Brd U</w>
ret t</w>
estro genic</w>
CT C</w>
erup tion</w>
path ologists</w>
oroph aryngeal</w>
cholest asis</w>
N MD
us ability</w>
che ese</w>
S po
flu conazole</w>
ther ing</w>
Pl us</w>
W L</w>
N ep
c m
ac ul
anaphy laxis</w>
Theore tical</w>
ar c</w>
practi cally</w>
plas mac
h older</w>
4 D</w>
H SP</w>
evid ences</w>
X 3</w>
Gre at</w>
C utaneous</w>
at om
im printed</w>
inhabit ants</w>
ster nal</w>
vers a</w>
X Y</w>
d otoxin</w>
thou ghts</w>
dil tiazem</w>
emphasi zing</w>
T AC</w>
max illa</w>
anne aling</w>
ast ly</w>
mis use</w>
NA SH</w>
m ant
Deri ved</w>
out puts</w>
Cul ture</w>
A gency</w>
12. 7</w>
poly phenols</w>
fer ring</w>
cycl ine</w>
Leg ion
str ip</w>
pleg ic</w>
auto antibody</w>
acetyl ated</w>
ir a</w>
pred ator</w>
Rec ei
Br uc
co inc
Medi ated</w>
ST s</w>
glyco sides</w>
d uty</w>
Angi otensin</w>
3 000</w>
mit es</w>
compli ant</w>
ol ia</w>
non steroidal</w>
omy ces</w>
VO 2
fac et</w>
he d
sulf hydr
I di
GL UT
glyc ation</w>
is ure</w>
E mp
ris ky</w>
TA TIONS</w>
a ural</w>
arthro sis</w>
palmit ate</w>
an ser
ne arby</w>
need les</w>
scho ol
communic ating</w>
A II</w>
exac tly</w>
lig ated</w>
ann ular</w>
under pin
chol angitis</w>
disequ ilibrium</w>
ne o</w>
fac eted</w>
but yl
L PL</w>
distinc tly</w>
ie u</w>
dep ths</w>
us or</w>
inhib in</w>
NLR P3</w>
a pro
lympho proliferative</w>
og ran
nyst agmus</w>
C um
benz oic</w>
tym pan
AC TI
W ell</w>
sub mandibular</w>
S atis
cat abolic</w>
dig it</w>
Sp 1</w>
cy tidine</w>
tic es</w>
re aring</w>
shor tage</w>
ten sin</w>
A part</w>
favor ably</w>
phot onic</w>
Inf ra
gp 120</w>
thi one
14 ,
un recognized</w>
vas ospasm</w>
S pi
or ization</w>
af luoro
lo ts</w>
on t</w>
Neuro logical</w>
H a</w>
D CM</w>
pr ag
electron ics</w>
T yph
sul fam
pi eces</w>
H V
og luc
E 6</w>
f urthermore</w>
W A</w>
clop idogrel</w>
dys plastic</w>
qual ities</w>
pel lets</w>
Bo ard</w>
TNF alpha</w>
go w</w>
denat ured</w>
Bacter ia</w>
hy pon
Predic ting</w>
nemat odes</w>
1. 26</w>
intern alized</w>
toc occus</w>
on ad
predisp ose</w>
o vid
T es
ch ose</w>
ju x
dor m
fir m</w>
discus sing</w>
Norwe gian</w>
rec ti
al er
Wor k
swe et</w>
m ography</w>
c uc
be es</w>
obsc ure</w>
fet oprotein</w>
let ters</w>
Pol ic
pup il</w>
anes thesi
land marks</w>
er ase</w>
reg s</w>
Post erior</w>
inoc ulum</w>
I PF</w>
Re active</w>
obarb it
osteoc alcin</w>
cogn ate</w>
geni stein</w>
Den sity</w>
CIN AHL</w>
t ogenic</w>
SM D</w>
sp astic</w>
glycol ip
er in</w>
ex ome</w>
Metast atic</w>
pector is</w>
otom ies</w>
PT B</w>
alop ecia</w>
O ri
fo od
I H</w>
Di strict</w>
cor rhiz
immun ophen
all o</w>
n ut</w>
C PA</w>
sti l
U TP</w>
al ia</w>
ser ology</w>
TM J</w>
paradox ical</w>
un satisfactory</w>
requ ested</w>
G 4</w>
ri d</w>
Ra ther</w>
kil ob
stimul ator</w>
ap illary</w>
pyro phosphate</w>
H ost</w>
descrip tors</w>
al azine</w>
miner alized</w>
Categ ory</w>
R om
s n</w>
S ig
implic ate</w>
pip eline</w>
og astric</w>
un ts</w>
bro ken</w>
D SA</w>
S n</w>
end os
fer i</w>
D an
0.0 17</w>
pa ste</w>
1, 6</w>
Estim ation</w>
evap oration</w>
N PV</w>
swe at</w>
NSAI D</w>
ro unds</w>
satur able</w>
AP I</w>
ith in</w>
R and
hyper tonic</w>
a 2</w>
Optim ization</w>
Glas gow</w>
M t
Rel ease</w>
di ph
V M</w>
TL C</w>
24 h</w>
I RS</w>
ul ator</w>
GW AS</w>
retur ning</w>
simul ator</w>
as phy
per itoneum</w>
I .
alpha 2</w>
d aughter</w>
16. 5</w>
rib o
Appro pri
wee k
Te aching</w>
in ii</w>
13 ,
ot on
Fr ame
Fr ag
Sequ ential</w>
pix el</w>
endarte rectomy</w>
U rine</w>
CO D</w>
trac ers</w>
trich loro
coincid ed</w>
proce ed</w>
ac ies</w>
bl acks</w>
hol istic</w>
dia stere
y stitis</w>
hex idine</w>
Sci enti
BM SCs</w>
tr ap
op posing</w>
ong side</w>
1. 27</w>
orph an</w>
er sin
metabol ically</w>
t ables</w>
12. 9</w>
re r</w>
F B
gen ders</w>
ap e</w>
eur in</w>
oxy cycline</w>
Evalu ating</w>
incenti ves</w>
thyro iditis</w>
invasi vely</w>
CM C</w>
kin ematic</w>
2 51</w>
correl ating</w>
GT T</w>
me etings</w>
ep oxide</w>
par acetamol</w>
AT M</w>
En doc
Ug anda</w>
bac ter</w>
controll able</w>
c ubic</w>
Prof es
C 6
concentr ates</w>
es sively</w>
co ils</w>
circum ferential</w>
prefer able</w>
co existing</w>
anc est
Tom ography</w>
T at</w>
f ted</w>
t ann
com pressed</w>
aff ord
ster ols</w>
Q L</w>
N 3</w>
3 75</w>
associ ative</w>
Fin nish</w>
hin dered</w>
encephal omyelitis</w>
Maxim al</w>
an y
ion ized</w>
calcul i</w>
pre maturity</w>
V ide
L B</w>
Cer tain</w>
cann ula</w>
transcrip tionally</w>
elucid ating</w>
sl ide</w>
den sit
Bangl adesh</w>
ne al</w>
In clusion</w>
RA TION
pan ze
elic its</w>
S r</w>
h ur
ho used</w>
astig matism</w>
oxidi zing</w>
Am pl
AI R</w>
C ou
carbox ylate</w>
Ischem ic</w>
wea ther</w>
thyro tropin</w>
30 8</w>
keratin ocyte</w>
B ot
no xi
numer ically</w>
H N</w>
refl ective</w>
Depend ent</w>
k B</w>
li d</w>
stre p
lip id
munic ipal</w>
cent red</w>
dec or
ther to</w>
mal ate</w>
produc ers</w>
amil oride</w>
RAN KL</w>
13. 1</w>
8 7
incre ments</w>
1. 28</w>
condyl ar</w>
separ ating</w>
explo it</w>
c enti
Col om
xyl ose</w>
HY PO
Ge org
Hydro gen</w>
W B
ar i</w>
ti bi
Ear th</w>
deg ran
Bar rett</w>
dra in</w>
P SS</w>
F ine</w>
rib avirin</w>
morph ologies</w>
intes tin
12. 4</w>
ribonucle ase</w>
a e
CA A</w>
Flor ida</w>
gener alization</w>
teach er</w>
n evertheless</w>
edi atr
termin i</w>
Re stric
thromb i</w>
ha i</w>
osi tivity</w>
incis ors</w>
T ERT</w>
Sing ap
trache ostomy</w>
agg res
de phosphorylation</w>
orph yrin</w>
My o
institu tion
photo receptors</w>
hepar an</w>
rel ational</w>
a sion</w>
trans dermal</w>
FA K</w>
B ab
LIMI TATIONS</w>
C i</w>
rub ella</w>
H UV
event ual</w>
astro cyte</w>
v ol</w>
Infec tious</w>
az id</w>
or b</w>
GAB AA</w>
stre ptom
n ial</w>
dow s</w>
sub sp</w>
requ est</w>
Viet nam</w>
cholecyst okinin</w>
R FA</w>
spond ylo
agg ing</w>
sus pec
demyel inating</w>
plei otropic</w>
13. 8</w>
O pi
categor ical</w>
refer ring</w>
Er b
at oid</w>
Jo hn</w>
micro particles</w>
PO 2</w>
arcom as</w>
PE I</w>
ellul ose</w>
develop mentally</w>
ad riamycin</w>
di d
RATION ALE</w>
M .
11. 0</w>
re acts</w>
determin ate</w>
bench mark</w>
1. 35</w>
d est</w>
hypox emia</w>
evolution arily</w>
inter ior</w>
lamin ar</w>
gr ating</w>
inv entory</w>
un predictable</w>
Con serv
sati va</w>
un cover</w>
em pathy</w>
lev er</w>
h it</w>
E 4</w>
met amorph
con cordant</w>
CD 28</w>
Ter min
granul omas</w>
syncy tial</w>
ak a</w>
cal pain</w>
mm 3</w>
sc rap
bin ocular</w>
ab is
my ocl
dor feri</w>
g ar</w>
S ulf
uni vers
pe anut</w>
call osum</w>
E co
chlor ine</w>
sle eping</w>
IV C</w>
instrum ented</w>
slow ed</w>
p ell
comfor table</w>
menis cus</w>
fl ash</w>
candi diasis</w>
deacetyl ase</w>
conden sed</w>
neuro science</w>
achiev es</w>
SC E</w>
recru it</w>
cochle a</w>
sing let</w>
oph ores</w>
altern atively</w>
dimin ish</w>
MM SE</w>
ated ness</w>
6 6.7</w>
en thal
micro dialysis</w>
3 30</w>
homolog ues</w>
emul sification</w>
y al</w>
pe t</w>
ch ief</w>
pro to</w>
ear th</w>
M IN
hex ane</w>
anti thrombotic</w>
disper sive</w>
P yr
ound ly</w>
syn onymous</w>
Sch iff</w>
qu er
cycl ization</w>
4, 6</w>
B ei
itud inally</w>
ob sessive</w>
oc arb
epide mics</w>
den itr
harb or</w>
amy otrophic</w>
ab ra
gam bling</w>
um ps</w>
sc ro
viri on</w>
insem ination</w>
t DCS</w>
pro xy</w>
H g
ess ness</w>
MY C</w>
inter ro
Pil ot</w>
induc ers</w>
di esel</w>
con spic
lac Z</w>
weigh ed</w>
SL N</w>
3 b</w>
1 I</w>
burg dorferi</w>
M Abs</w>
Observ ational</w>
cl aimed</w>
ac cordingly</w>
0.0 18</w>
ec centric</w>
reason ably</w>
cardiomy ocyte</w>
immun ologically</w>
y es</w>
t amp
w ells</w>
cer vic
oxid oreduc
deline ated</w>
collec tively</w>
Enh ancement</w>
hem ostatic</w>
transcrip tomic</w>
colon ized</w>
extravas ation</w>
staphyloc occi</w>
ec k</w>
2 15</w>
homolog s</w>
PR ACTI
us ly</w>
CA G</w>
glutar aldehyde</w>
popul arity</w>
fat ality</w>
zoon otic</w>
propan e</w>
im ported</w>
C FA</w>
k i</w>
re act
p t</w>
F B</w>
sal ient</w>
sel dom</w>
PG s</w>
Foun dation</w>
A edes</w>
10 th</w>
dys regulated</w>
concentr ic</w>
phosphati dy
ipl atin</w>
gyn a
apos i</w>
br a</w>
Statis tically</w>
tr aps</w>
sl iding</w>
noxi ous</w>
run s</w>
mid ine</w>
HI T</w>
communic ate</w>
stoichi ometry</w>
s ows</w>
un folded</w>
pro x
sim vastatin</w>
upr ight</w>
tel omeric</w>
Bacter i
hist omorph
Thor acic</w>
H an
T anz
SN R</w>
avi um</w>
I le</w>
diz ziness</w>
E PI</w>
B CL
Ery thro
des cent</w>
syndrom ic</w>
vacc inia</w>
we alth</w>
Ep ilep
T1 D</w>
sy n</w>
duc tus</w>
yr s</w>
c 1</w>
D HT</w>
to e</w>
ag s</w>
PG I2</w>
tetr a</w>
cholec ystitis</w>
shel f</w>
hind limb</w>
back ward</w>
tap e</w>
M ll
2 13</w>
A X</w>
demyel ination</w>
fib ril</w>
deterior ated</w>
K aposi</w>
im atinib</w>
ox es</w>
PC S</w>
alkal oid</w>
U I</w>
Rem ark
M AC
T 7</w>
T CA</w>
D Q</w>
dem y</w>
discrimin ative</w>
Malay sia</w>
d d
illo sis</w>
st aff
pig ments</w>
M AT</w>
litho trip
bio degradation</w>
lac rimal</w>
conv inc
care rs</w>
N ET</w>
Spec i
m olyb
Ch eck
thermo philic</w>
advoc ated</w>
tetr adec
neur aminidase</w>
Expl oring</w>
SC A</w>
b y
trans locations</w>
Sj 
m ati
post treatment</w>
hemat opoiesis</w>
disabl ing</w>
TE E</w>
over whel
D S
hypon at
Hypo xia</w>
D TI</w>
facilit ators</w>
seg mented</w>
ap omorphine</w>
pu rely</w>
hom odi
ex changes</w>
An y</w>
Sus cepti
abl ative</w>
AD M</w>
ur ic
dialy sate</w>
tre otide</w>
n t
NAD P</w>
Relationsh ips</w>
M os
antim al
represent atives</w>
Predic tive</w>
lipoly sis</w>
ren orphine</w>
ma zine</w>
guid es</w>
M oun
under took</w>
appropri ateness</w>
A NF</w>
Comput ational</w>
au tistic</w>
temper ate</w>
N et</w>
bi an</w>
put amen</w>
reservo irs</w>
el iness</w>
prof oundly</w>
op rine</w>
E BP</w>
con tain
1. 33</w>
thin ning</w>
G old</w>
oligodendro cytes</w>
nam es</w>
Condi tions</w>
pent obarbital</w>
M LP</w>
attrib ute</w>
J ur
grou ping</w>
un responsive</w>
M SH</w>
0.000 5</w>
N M</w>
str um</w>
1 --</w>
radi osurgery</w>
helic ase</w>
Dis co
Autom ated</w>
C SCs</w>
os tigmine</w>
my oglobin</w>
stain less</w>
sal mon
Proc ess</w>
ox ins</w>
frag mented</w>
Prog ression</w>
is otropic</w>
2 16</w>
nanocryst als</w>
Person ality</w>
PA A</w>
occu pati
Cl 4</w>
- .
yr in
I SS</w>
F MD</w>
13. 4</w>
di hedral</w>
ic ol
cryp t</w>
occ idi
A ra
be ad</w>
O X</w>
gastr o</w>
E A
arti ficially</w>
inc eption</w>
vill ages</w>
alk ylation</w>
drin ks</w>
Probl ems</w>
pleth ys
he ightened</w>
rel ieve</w>
ver tigo</w>
1. 5
melan ocytes</w>
w asting</w>
al o</w>
ox amine</w>
Scop us</w>
6 A</w>
si ed</w>
SO C</w>
gra zing</w>
psych otropic</w>
Em plo
dor sol
bene fici
inequ ality</w>
Challeng es</w>
Chol esterol</w>
Insi ghts</w>
link ages</w>
l ac</w>
P MMA</w>
An dro
ampl ify</w>
R Y
an abolic</w>
T en
sulf ated</w>
tric ho
CD 45
Bi o</w>
justi ce</w>
thre ats</w>
re generated</w>
complic ating</w>
CT P</w>
2 35</w>
infarc ts</w>
Throm bo
ch ar</w>
M MR</w>
c eption</w>
tur ning</w>
spi ked</w>
des m
H am
der ang
Be h
onc ologic</w>
discipl ine</w>
Ach illes</w>
I TS</w>
apha sia</w>
shi el
row s</w>
raph e</w>
26 4.7</w>
Famil ial</w>
H and</w>
viro logical</w>
15. 4</w>
T d
pot ently</w>
Ultras on
pharmac euticals</w>
vit ell
correc ting</w>
compet encies</w>
F AS</w>
intr igu
myel ination</w>
ro l
IC SI</w>
relax ed</w>
Neur onal</w>
trimeth oprim</w>
oph ytes</w>
w ant</w>
prob ands</w>
8 5
y z
A TI
re mediation</w>
leuk o
8 9
assess es</w>
oin tim
O cular</w>
iso enzyme</w>
T ACE</w>
iv a</w>
Activ ated</w>
Mes enchymal</w>
M ay
ereb ellar</w>
chim panze
contr asts</w>
organ elle</w>
optim ally</w>
ici ting</w>
Bir th</w>
en umer
s cleral</w>
co oking</w>
potenti ate</w>
re alize</w>
rec eipt</w>
ac rom
un tary</w>
W is
et us</w>
archa e
reduc tive</w>
cos tim
Bet ter</w>
Brow n</w>
chloro plasts</w>
Sj gren</w>
A reas</w>
un il
stre ams</w>
Up take</w>
encephal on</w>
mil ieu</w>
abrup t</w>
E pig
rel atedness</w>
sub total</w>
oc ean</w>
embol i</w>
toxic ology</w>
B le
TNF </w>
K a</w>
lex ical</w>
transu rethral</w>
D SC</w>
Ra f</w>
aff iliated</w>
4 B</w>
neuro peptides</w>
Ar th
injec table</w>
1 200</w>
homogen ate</w>
athi oprine</w>
hem o
R GD</w>
respon ds</w>
insi cally</w>
ecz ema</w>
ex y</w>
Dem entia</w>
pit falls</w>
antinoc iceptive</w>
ati co
MT s</w>
contigu ous</w>
met agen
exce eds</w>
cho w</w>
sev enty</w>
green house</w>
iform is</w>
AL I</w>
shrim p</w>
ex foli
1. 32</w>
Rever se</w>
d obutamine</w>
trans loc
S 4</w>
tr ast
end op
obser ving</w>
ad here</w>
L ateral</w>
H 5
hy n
cong estion</w>
Repor ted</w>
A SC</w>
M ach
R ed
un diagnosed</w>
insectic ides</w>
pen is</w>
CF S</w>
dev oted</w>
smar t</w>
D ow
sle epiness</w>
ec um</w>
hierarch y</w>
cholangi ocarcinoma</w>
Au tism</w>
str ip
iso enzymes</w>
con to
R a</w>
ip enem</w>
oplas mosis</w>
manufacture rs</w>
y our</w>
echan ics</w>
a h
Protoc ol</w>
squ ared</w>
trans thoracic</w>
SER S</w>
G as</w>
Caucasi ans</w>
des tin
M PTP</w>
F G</w>
car p</w>
ir al</w>
pheochrom ocytoma</w>
Ro ot</w>
y ne
ser s</w>
ox azol
RF S</w>
mut ually</w>
pair wise</w>
c uring</w>
sim plicity</w>
pol luted</w>
dra ft</w>
Commun ication</w>
IC G</w>
un labeled</w>
Reli ability</w>
am plic
util isation</w>
n ascent</w>
hum erus</w>
e V</w>
del ib
cardio respiratory</w>
radi ologist</w>
14. 2</w>
econ omical</w>
hemisph eres</w>
Interfer on</w>
termin ally</w>
14. 6</w>
S tri
ig no
vill ous</w>
ym ic</w>
titr e</w>
re ads</w>
recur red</w>
carbox ylase</w>
un usually</w>
aden ylyl</w>
embed ding</w>
G SK
In s
DE AE</w>
obacter ial</w>
In strum
Tob acco</w>
micron utri
imi pramine</w>
lin a</w>
anxi ous</w>
metabol izing</w>
ren der</w>
perf usate</w>
cal orie</w>
distil led</w>
CB A</w>
.0 4</w>
end azole</w>
ochond ral</w>
iti dine</w>
stop ping</w>
GT P
photocat alytic</w>
list ening</w>
2 S</w>
sl opes</w>
DI C</w>
Impair ment</w>
detr usor</w>
copolym ers</w>
M TH
Cor tical</w>
c ian</w>
ER S</w>
Ar c
ge hog</w>
substitu ent</w>
anser in</w>
m ou
hi therto</w>
O ld</w>
har dly</w>
system ically</w>
rele ases</w>
Hist ologically</w>
2 11</w>
str ate</w>
sp on
max illofacial</w>
electr o</w>
Y outh</w>
g out</w>
T RE
L OH</w>
star ts</w>
geometr ies</w>
ol actone</w>
lys ed</w>
long itudinally</w>
ill icit</w>
quadr ant</w>
justi fy</w>
Recur rence</w>
U re
Vari ations</w>
partur ition</w>
micro globulin</w>
organ izing</w>
S ide</w>
Q Tc</w>
chondro cyte</w>
promis es</w>
corne as</w>
pass ages</w>
argum ents</w>
o regional</w>
Phosph orylation</w>
Bei jing</w>
dent ures</w>
N M
a rest</w>
C re</w>
Dim en
H SCs</w>
rec t
ful min
acceler ates</w>
G CS</w>
SIR T1</w>
bol a</w>
intral uminal</w>
S ir
MI F</w>
sil k</w>
calc ane
X X</w>
op ost
Mic ros
1. 29</w>
3 40</w>
obstac le</w>
C CN
ris es</w>
al ongside</w>
oun ded</w>
umin escent</w>
cros ses</w>
assimil ation</w>
HUV ECs</w>
3 T</w>
re tin</w>
ance stry</w>
lich en</w>
offic ial</w>
m d
read missions</w>
merg ed</w>
ign s</w>
I TP</w>
visi ting</w>
W H
read iness</w>
bic eps</w>
diph ther
di x</w>
6 a</w>
ori ent
ocortico id</w>
gover ned</w>
den afil</w>
recap it
X R
Ex ternal</w>
hybridi zed</w>
kal emia</w>
occ er</w>
vag ina</w>
Te tra
c ic
her itability</w>
199 0s</w>
RE SEARCH</w>
hom o
mo tional</w>
asth m
HB e
Meas uring</w>
restr ained</w>
trast uzumab</w>
aren cy</w>
posi tives</w>
C 7</w>
bi ocompatible</w>
pro biotics</w>
reson ances</w>
yr ight</w>
5, 6</w>
ann exin</w>
r arity</w>
li a</w>
Par ameters</w>
accum ulates</w>
drain ing</w>
en su
13. 7</w>
2 18</w>
transf used</w>
mes h
ali phatic</w>
T regs</w>
sna ke</w>
g ang
l on
catech ol</w>
1. 31</w>
G PR
G over
end odontic</w>
ester ified</w>
well being</w>
K ine
b 1</w>
detec ts</w>
SEL ECTION</w>
esophag ectomy</w>
Estro gen</w>
le isure</w>
HSP 70</w>
el is</w>
j unior</w>
B V
lob ular</w>
mu si
deplo yed</w>
f all
L TR</w>
rel ieved</w>
per it
sulfhydr yl</w>
2 26</w>
chel ating</w>
initi ates</w>
cl ades</w>
alog ue</w>
ren dering</w>
surpr ising</w>
os si
tre hal
hum or</w>
praz osin</w>
2 5.
ver sities</w>
part nership</w>
S cat
conc ussion</w>
ES BL</w>
spir itual</w>
I B
Incre ase</w>
P ic
I l
un resolved</w>
top ically</w>
initi o</w>
Pl ants</w>
P VA</w>
Org an</w>
J A</w>
f ile</w>
ex tubation</w>
ME D</w>
Rho A</w>
retro virus</w>
fur an</w>
hypercalc emia</w>
en em
Idi opathic</w>
K yo
autophag ic</w>
CL P</w>
caroten oids</w>
v WF</w>
Shig ella</w>
Oper ative</w>
it abine</w>
child birth</w>
Dec ision</w>
beta -</w>
D Y
ro entgen
14. 8</w>
x aban</w>
c ab
ir y</w>
lo id</w>
sur al</w>
bas oph
h os
dec eased</w>
deb ated</w>
Top ical</w>
un selected</w>
so red</w>
scler osing</w>
myel opathy</w>
D e</w>
exagg erated</w>
HYPO THESIS</w>
phosphon ates</w>
fl oral</w>
ont ology</w>
comp ute</w>
persi sting</w>
In surance</w>
reson ant</w>
ul ose</w>
victim ization</w>
L astly</w>
Signific ance</w>
In clud
ben th
ch itin</w>
abor tions</w>
ul ous</w>
gyn ecological</w>
splen ocytes</w>
15. 6</w>
osper mia</w>
z in</w>
Recor d</w>
rip ening</w>
phen ol
PW V</w>
H SD</w>
C los
b ru
mes oporous</w>
SOUR CES</w>
D or
Bacter oides</w>
D ays</w>
S 6</w>
m ec
C ad
AL Y</w>
ma ffin</w>
R ic
di acylglycerol</w>
tre x
mol l
bib li
Reduc ing</w>
cen sus</w>
Oste o
propi onic</w>
Diff usion</w>
aneu ploidy</w>
p ing
-- the</w>
cann ulation</w>
me rely</w>
P .
m eri
4 E</w>
ne tium</w>
H IF
Ag ainst</w>
ob iliary</w>
loc alisation</w>
pH i</w>
ne u</w>
in o
vasoconstric tor</w>
1. 30</w>
00 00
G M1</w>
gam es</w>
il in</w>
o ting</w>
mo re
ant ec
iso ther
nan oro
er ly</w>
chrom es</w>
Tr ig
an oic</w>
fl atten
ta p</w>
end ers</w>
yl osing</w>
1, 3
hypoglyc emic</w>
expon entially</w>
entr ap
rh odopsin</w>
pharmac ologically</w>
17 beta</w>
sho ots</w>
a h</w>
m as</w>
Inhib itory</w>
prokary otic</w>
rejec ted</w>
30 4</w>
F al
adrenal ectomy</w>
enzym atically</w>
ch en
des er
biom olecules</w>
in activating</w>
ersin ia</w>
Dis tinct</w>
Peri odic
dorsol ateral</w>
um ping</w>
certi fied</w>
am i</w>
M AS</w>
c t
prur itus</w>
pre incubation</w>
1. 34</w>
trig lyc
acro megal
impul sivity</w>
herni as</w>
O V</w>
lo ose</w>
- beta</w>
fos sil</w>
Kyo to</w>
ul aris</w>
B ovine</w>
accommod ate</w>
on ade</w>
demonstr able</w>
neuro inflammation</w>
sub species</w>
establ ishes</w>
og lut
met ab
sensor ineural</w>
y early</w>
electromy ography</w>
CCR 5</w>
blast ocysts</w>
ar ine</w>
leuc ocyte</w>
est u
anth ine</w>
spond ylitis</w>
ip 1</w>
F S
lo fen</w>
P ER
prob ed</w>
pollut ant</w>
A 6</w>
Ev ans</w>
play er</w>
replic ative</w>
bud s</w>
AB O</w>
ED 50</w>
cryp tic</w>
mach ines</w>
Col um
sero conversion</w>
mT OR
crim inal</w>
ar abine</w>
ob ac
IC Us</w>
ag itation</w>
in ert</w>
acet aldehyde</w>
T e</w>
ul ary</w>
photo chemical</w>
P oint</w>
polys omn
B i</w>
T it
t ar</w>
Fr anc
ore doxin</w>
- 20</w>
call us</w>
P SP</w>
pneumon itis</w>
leuc ocytes</w>
c v</w>
bis phosphate</w>
ff s</w>
pre fer</w>
pal m</w>
opost erior</w>
L -</w>
k at</w>
ure sis</w>
Th ai</w>
3 R</w>
SE A</w>
microm olar</w>
deoxy uridine</w>
neuro vascular</w>
where in</w>
si ght</w>
destro yed</w>
tr al</w>
urtic aria</w>
ecto dermal</w>
- alpha</w>
IN R</w>
Od ds</w>
aber ration</w>
tremend ous</w>
modi fies</w>
ad ol</w>
thorac oscopic</w>
olig omeric</w>
t z
ik a</w>
2 O3</w>
Singap ore</w>
D XA</w>
lit ter
them e</w>
baro reflex</w>
deriv ation</w>
appro aching</w>
re polarization</w>
pursu it</w>
observ able</w>
198 0s</w>
asp inal</w>
polym y
dos ed</w>
H DL
res ur
br ings</w>
sor afenib</w>
construc ting</w>
Hol stein</w>
1. 36</w>
L uc
m U</w>
ax one</w>
ch us</w>
opath ogenic</w>
os acral</w>
Tre ated</w>
c ence</w>
di ary</w>
G SK</w>
NF 1</w>
14. 7</w>
acon azole</w>
PM L</w>
vascul ar
od a</w>
co al
thermo phil
Sub st
stimul ant</w>
wh enever</w>
enter o
.00 2</w>
deriv atization</w>
Pr EP</w>
E x</w>
is th
inter observer</w>
nanocom posite</w>
ho ods</w>
epider mi
evacu ation</w>
anti oxidative</w>
2 6.
cur rence</w>
BM C</w>
Reg ulatory</w>
ocor tex</w>
ab and
n ul
later ally</w>
B u</w>
6 00
ba um
uniform ity</w>
wave forms</w>
- 4
lev er
bur ning</w>
apo E</w>
c k</w>
campa igns</w>
for amin
contamin ant</w>
mutag enicity</w>
ac eous</w>
commun ications</w>
2 54</w>
at ria</w>
tri iodothyronine</w>
aven ues</w>
cir cle</w>
d oxycycline</w>
com ments</w>
oco agulation</w>
T ests</w>
t ful</w>
neuro troph
am er</w>
co oper
htt ps</w>
Pharmaco kinetics</w>
Inf ant</w>
O t
or is</w>
as tine</w>
Wash ington</w>
an odine</w>
nec ro
1, 4,5</w>
adop ting</w>
C ros
sp ending</w>
HBe Ag</w>
fra il</w>
entrap ment</w>
HC M</w>
un wanted</w>
DL BCL</w>
acc ept</w>
In ten
Clu ster</w>
et etra
RA GE</w>
interfe res</w>
epidermi dis</w>
Medic ation</w>
PE G
fertil ized</w>
os ylation</w>
B ey
SV R</w>
rec an
RO P</w>
di pl
1 A2</w>
hem ic
b 2</w>
Cycl ic</w>
debil itating</w>
Com mission</w>
lu x</w>
Cryp tospor
chemoattrac tant</w>
nucle olar</w>
perfor ated</w>
aden omatous</w>
smart phone</w>
HT 1A</w>
ari thromycin</w>
car cer
up ward</w>
immort alized</w>
S ten
dic ations</w>
 M</w>
oph ytic</w>
1, 4
M ur
in k</w>
glucon e
E bola</w>
d ap
Y ersinia</w>
tyros inase</w>
W P</w>
An gel
nanot ube</w>
py re
pro hib
chond ral</w>
appro x</w>
ST D</w>
5 50</w>
MEASU RE</w>
inf low</w>
transm ural</w>
extr am
ole ate</w>
Ch loro
hypo thermic</w>
udg et</w>
conflu ent</w>
retin oid</w>
Th r
PPAR </w>
fl ame</w>
ent a
co ast</w>
E Ds</w>
A sians</w>
Hepat ocellular</w>
Ass ay</w>
out standing</w>
erc ept</w>
o hex
tur ns</w>
Initi ative</w>
7 -</w>
3 90</w>
flu idity</w>
ad ate</w>
M CA
prog ressing</w>
isch er</w>
b erg
te re
Sign al</w>
con finement</w>
ati de</w>
os a
TI A</w>
Bi oin
ac ylation</w>
un stimulated</w>
inst ant
hemangi oma</w>
ker nel</w>
z a</w>
aggres siveness</w>
rain bow</w>
un expectedly</w>
13. 9</w>
ad vised</w>
PV N</w>
resi de</w>
Schiz ophren
Ap p
Rati o</w>
S oil</w>
quantit ated</w>
pro BNP</w>
Aca demy</w>
chlor hexidine</w>
calcin eurin</w>
HB s</w>
Dis crim
as ynchron
cyt olytic</w>
Disco very</w>
atten d</w>
ingredi ent</w>
oste oblastic</w>
emplo ys</w>
SI L</w>
1. 45</w>
d anger</w>
intrigu ing</w>
un desirable</w>
ep oxy</w>
anti inflammatory</w>
g avage</w>
EX P
pre pubertal</w>
alumin ium</w>
aeg yp
emit ted</w>
val gus</w>
psychi atrists</w>
phosphatidyl serine</w>
dener vated</w>
gran ulation</w>
Endom e
ul o</w>
cardi ogenic</w>
CO M
in emia</w>
as eptic</w>
si ves</w>
superim posed</w>
metac ar
y i</w>
Wh ere</w>
glutam yl</w>
ul trac
14. 1</w>
F N
pro mazine</w>
infrequ ently</w>
pig ment
spin ning</w>
re volution
depolar izing</w>
u PA</w>
1, 5</w>
Tran sport</w>
incis or</w>
dys kinesia</w>
bal ances</w>
cryop reserved</w>
M AR</w>
en jo
sub maximal</w>
Cop per</w>
olec ule</w>
thi azide</w>
Perc ep
sc aled</w>
discover ies</w>
un modified</w>
nor ing</w>
contradic tory</w>
c ages</w>
Rand om</w>
streptom ycin</w>
dy le</w>
ol ite</w>
pri ori</w>
anz apine</w>
dec on
Ex amin
heter osexual</w>
F at</w>
nitro glycerin</w>
R ay
6 2.5</w>
7 4
o tics</w>
am ole</w>
e ens</w>
itu ation</w>
sk i</w>
Anti oxidant</w>
ul f</w>
enhanc ers</w>
z om
19 72</w>
my asthenia</w>
oph ene</w>
od ed</w>
over coming</w>
Pr inc
Sec ond
pherom one</w>
compl emented</w>
cur ved</w>
integr ates</w>
Gh ana</w>
Pro phyl
tri axone</w>
13 1I</w>
umin a</w>
trans esophageal</w>
Fl av
analy zes</w>
end ings</w>
il ia</w>
neurolep tic</w>
b are</w>
Util ization</w>
anth rene</w>
Techniqu e</w>
c iv
high -</w>
el iciting</w>
transi ents</w>
2 0.0</w>
K up
is omerization</w>
cros stalk</w>
F ung
Import ant</w>
lacti s</w>
dur ability</w>
hydra z
No .</w>
AB L</w>
se eding</w>
om on
lic ensed</w>
con fron
N O2</w>
3, 3</w>
hype re
affor d</w>
Bey ond</w>
Al g
sub class</w>
N l
transp arency</w>
transl uminal</w>
a plastic</w>
ne arest</w>
par an
di pyrid
regul arity</w>
matern ity</w>
C CT</w>
sh unting</w>
denat uring</w>
mind fulness</w>
15. 3</w>
H ir
tensi ves</w>
sacc ades</w>
more over</w>
Valu es</w>
prev ailing</w>
cl au
Kn ock
Anti gen</w>
eth ane</w>
pepti d
struc turing</w>
leuk emias</w>
eigh ty</w>
res ins</w>
N ear</w>
at ech
nar co
med ul
hex agonal</w>
Et OH</w>
7 th</w>
S ize</w>
N 0</w>
1. 37</w>
l .
pto sis</w>
ex tran
chol ed
emergen cies</w>
L PA</w>
clos est</w>
le gi
yto plasmic</w>
Fe atures</w>
per fluoro
sh unts</w>
ol ide</w>
low ers</w>
pro drug</w>
hydroxy vitamin</w>
ple omorphic</w>
neuro protection</w>
15. 2</w>
ocor tic
caroten oid</w>
valu ed</w>
W R</w>
dil emma</w>
band width</w>
Car ib
Resp ond
o vi
eth an
Hist ory</w>
proton ation</w>
str ingent</w>
innerv ated</w>
Spectr um</w>
r is</w>
A wa
P ON
a -</w>
nanocom posites</w>
asym metr
spas ticity</w>
tri als.gov</w>
phosphatidy lethanolamine</w>
T l</w>
CS S</w>
vacu olar</w>
M SA</w>
Relev ance</w>
fa eces</w>
30 2</w>
n ight
bar k</w>
ang ulation</w>
unc oupling</w>
posi t</w>
thione in</w>
fif teen</w>
sar col
er ness</w>
fram esh
Gam ma</w>
less ness</w>
activ in</w>
mon ocytic</w>
propri oc
ow l</w>
PL D</w>
presum ptive</w>
L O</w>
toler ate</w>
ili ation</w>
aper ture</w>
dis advantage</w>
doll ars</w>
myel ogenous</w>
Eth anol</w>
pall adium</w>
H 4
on ality</w>
SC H</w>
End ogenous</w>
intrac lass</w>
PV P</w>
ul ent</w>
acqu iring</w>
ach oline</w>
sent ence</w>
anni i</w>
contribut ors</w>
14. 4</w>
lo vir</w>
A maz
defin itely</w>
accommod ation</w>
R un
1. 43</w>
Ad ren
Periodic als</w>
rainf all</w>
coagul ant</w>
mediastin um</w>
gra vis</w>
an ode</w>
nano fibers</w>
Bor relia</w>
2 90</w>
los artan</w>
re fin
is oni
inter phase</w>
Argen tina</w>
otyp ical</w>
par ag
spea kers</w>
1. 38</w>
propri a</w>
un explored</w>
viv ax</w>
vag otomy</w>
spectrophot ometric</w>
st ocks</w>
p M</w>
Flu oro
st ag
0.0 19</w>
neuro chemical</w>
frac tured</w>
gluc oside</w>
anch oring</w>
bo oks</w>
TL R2</w>
1. 75</w>
weigh ting</w>
marri age</w>
hypogly caemia</w>
CA C</w>
R inger</w>
munic ip
pl asi
bas in</w>
thi amine</w>
silic ate</w>
Indic ations</w>
obstruc ted</w>
fo vir</w>
O PN</w>
Pur ified</w>
x 10</w>
D y
carb onic</w>
actin omyc
bio chemically</w>
t yline</w>
inf liximab</w>
fir stly</w>
M ol
15. 8</w>
W eb
actu arial</w>
o y
pattern ed</w>
poli ovirus</w>
Com peti
rib ozym
D -</w>
CD11 b</w>
ant a</w>
dec ide</w>
N asal</w>
S chol
trac ed</w>
Frame work</w>
micro surgical</w>
my oblasts</w>
E HR</w>
acceler ating</w>
wild life</w>
spac ed</w>
S -</w>
E ST</w>
N ICU</w>
AT R</w>
lys ophosph
Fas L</w>
ab duction</w>
mer its</w>
super vis
gly caemia</w>
swe et
explan atory</w>
PGF 2</w>
par amount</w>
ot onic</w>
G N
yl choline</w>
ac cred
az athioprine</w>
4 000</w>
ma il</w>
oly tica</w>
nes ota</w>
poly aden
Transcrip tional</w>
e der</w>
D PP</w>
G PC
molec ularly</w>
Re placement</w>
sar copenia</w>
15 ,
retin itis</w>
pe g
gonorrho eae</w>
T f
con dyle</w>
anthrac ene</w>
op olym
25 -</w>
rom a</w>
Adju v
photosensi ti
Vol ume</w>
s wa
Peri operative</w>
7 8
D NP</w>
K it</w>
hyper tensives</w>
arc tion</w>
re pairs</w>
counter act</w>
Bi och
Min istry</w>
is y</w>
ultraf iltration</w>
F RET</w>
y ou
olip in</w>
dyst rophic</w>
B ut
vol ati
deline ation</w>
hemat oxylin</w>
web site</w>
R U
ym ents</w>
fo uling</w>
re placements</w>
Mn 2</w>
P BC</w>
C 8</w>
chrom ic</w>
pseud ot
ac idity</w>
mo unt</w>
cryst al
G N</w>
ir relevant</w>
non smokers</w>
flu ency</w>
ul i</w>
Im mediate</w>
hosp ice</w>
T PO</w>
conclud es</w>
Nec k</w>
F atigue</w>
uro logical</w>
S ox
AC H</w>
male imide</w>
g il
4 86</w>
sed ative</w>
hal ogen
opro lol</w>
C b
cephal ic</w>
Ano ph
mon y</w>
L ED</w>
P ho
L t
APO E</w>
R II</w>
ho u</w>
Subjec tive</w>
myelodys plastic</w>
pl ated</w>
le in</w>
AB R</w>
pa redness</w>
vag us</w>
de his
oc kets</w>
menis cal</w>
f as
ul opathy</w>
tag s</w>
S J
om el
fove al</w>
infest ation</w>
Nic o
tamp onade</w>
B Ps</w>
P 5</w>
run ners</w>
s c</w>
w earable</w>
Bruc ella</w>
C i
glob ular</w>
sig mo
D il
D ar
M ACE</w>
ot a
baum annii</w>
actin omycin</w>
DD T</w>
res orb
There after</w>
PV R</w>
orific e</w>
grad ation</w>
p ush</w>
mis diagnosed</w>
mar c
influ ential</w>
op sies</w>
fu si
stri kingly</w>
m g.
Z V</w>
replic ating</w>
Tanz ania</w>
un biased</w>
ep sia</w>
crystall in</w>
p 3</w>
intra operatively</w>
P ent
triglyc eri
L FA</w>
st oma</w>
p ins</w>
Scot land</w>
Econ omic</w>
Ex am
asthm atics</w>
o prost
T MP</w>
complex ation</w>
comb ustion</w>
T SP</w>
apo B</w>
Coll agen</w>
- 3.
N Z
bup renorphine</w>
Hospit als</w>
manufac tured</w>
suppl ies</w>
Prog ressive</w>
Rep orts</w>
on a
loc alised</w>
al loc
C our
iso zyme</w>
F U
asperg illosis</w>
N ucleotide</w>
O phthal
pred ators</w>
o embryonic</w>
form atics</w>
be have</w>
acti on
cardi ology</w>
lam p</w>
L am
sp ous
mi R
dig iti
B a</w>
access ed</w>
ph en</w>
kerat oplasty</w>
anhydr ase</w>
cadaver s</w>
I AA</w>
C ath
ph in</w>
vi z</w>
suc kling</w>
loc oregional</w>
radi olig
E GFP</w>
enter otoxin</w>
biore actor</w>
pro fit</w>
no vel
elast ography</w>
heterozyg otes</w>
l anth
2 24</w>
2 17</w>
pum ping</w>
bio transformation</w>
habit ual</w>
Sol u
S keletal</w>
Aim s</w>
y .
arch e</w>
LO D</w>
absorb able</w>
authen tic</w>
mant le</w>
inf eri
classi fying</w>
caregi ving</w>
ure t
listen ers</w>
J .</w>
rac es</w>
he el</w>
denti tion</w>
comm is
pan els</w>
morph ometry</w>
appl ies</w>
top ographic</w>
Br assi
bac ul
c ept</w>
PL S</w>
roll ing</w>
pre dation</w>
andro sterone</w>
aptam er</w>
tri ad</w>
pel let</w>
ag inous</w>
glut aminase</w>
T x</w>
architec tures</w>
iv ary</w>
SI V</w>
dich otom
Ess ential</w>
manip ulate</w>
wean ed</w>
end ocytic</w>
Q A</w>
arg on</w>
bul bar</w>
my ocyte</w>
II B</w>
T ak
trac es</w>
pertur bed</w>
degran ulation</w>
capac itance</w>
SP 1</w>
disrup ts</w>
Transi tion</w>
Altern atively</w>
glyc ated</w>
ol dest</w>
col ic</w>
hospit alisation</w>
prec au
cardi ometabolic</w>
G GT</w>
corrhiz al</w>
2 7.
cor p
o plastic</w>
p ace</w>
Ch ag
F ischer</w>
CYP3 A4</w>
form erly</w>
lip tin</w>
carr age
scler oderma</w>
NE Ts</w>
N umber</w>
G o</w>
nucle osome</w>
in compatible</w>
frac tal</w>
notic eable</w>
Com posite</w>
dex medetomidine</w>
mom entum</w>
phen otypically</w>
sen ile</w>
12 4
in vertebrates</w>
ro l</w>
arthro desis</w>
enal april</w>
isoni azid</w>
energ etics</w>
oxal iplatin</w>
un ding</w>
fib rate</w>
cor ds</w>
adap ting</w>
astrocyt oma</w>
si der
guan idine</w>
en th
al ty</w>
AM s</w>
Ro yal</w>
Regar dless</w>
K re
ads orbent</w>
deep ly</w>
V iv
st ump</w>
frag ility</w>
hil ar</w>
dihydroxy vitamin</w>
c asp
Radi otherapy</w>
9 5
discrim inated</w>
Cum ulative</w>
oxidoreduc tase</w>
ph ones</w>
crystall ography</w>
S SA</w>
cholester yl</w>
heter ocyclic</w>
ir id
C z
en chym
arteri ography</w>
isot onic</w>
Mo thers</w>
EG CG</w>
P SD</w>
P ower</w>
Qu antum</w>
iod inated</w>
Scienti fic</w>
K et
16 ,
ator vastatin</w>
bi variate</w>
phal angeal</w>
e ze</w>
p ill
memb ership</w>
orth ostatic</w>
se em
ne ocortex</w>
ograph ies</w>
EN T</w>
geometr ical</w>
eng th</w>
trex one</w>
om us</w>
TL s</w>
1. 42</w>
Fe deral</w>
ag le</w>
oc treotide</w>
dystroph in</w>
acet amide</w>
adop tive</w>
dissi pation</w>
A gro
50 ,000</w>
mac ro</w>
K CN
mono -</w>
C 5
N TR</w>
Z ika</w>
18. 2</w>
perovsk ite</w>
acclim ation</w>
Respond ents</w>
L ar
AD s</w>
NO 3</w>
phon ological</w>
Selec ted</w>
Appropri ate</w>
epididym is</w>
Pharmaco kinetic</w>
3 22</w>
at oxin</w>
ph arynx</w>
J D</w>
Gra ft</w>
n adi
re war
al ist</w>
Flu id</w>
LV H</w>
sev enth</w>
tos econd</w>
tel emedicine</w>
el ong</w>
unc h</w>
M Cs</w>
V an
tax onomy</w>
CA PD</w>
anti trypsin</w>
gener ational</w>
E H</w>
P SI</w>
u ti
connec t</w>
2 2.5</w>
ore sis</w>
iod o
sub si
mu st
stabil izes</w>
op tically</w>
dam ycin</w>
3 01</w>
prag matic</w>
z ens</w>
str aw</w>
expos ing</w>
mini ature</w>
Anoph eles</w>
sr c</w>
Suscepti bility</w>
E specially</w>
N Cs</w>
Ta q
incid entally</w>
per oxides</w>
im migrant</w>
M LC</w>
70 s</w>
f an</w>
fil ari
sul cus</w>
crow ns</w>
d m
ac hy
pathophysi ologic</w>
manufacture r</w>
ar tem
anat omically</w>
ta ils</w>
str abis
midw ives</w>
om ethyl</w>
b yst
solubil ization</w>
L G</w>
gen otoxicity</w>
vide os</w>
down ward</w>
beta 3</w>
or o</w>
hem ophilia</w>
kin et
Cryptospor idium</w>
Ab s
stere o
bene ath</w>
ann abin
intr insically</w>
D X
Micro RNAs</w>
alkyl ating</w>
om ic
thi azol
Biomar kers</w>
T 3
ne ointim
pre hospital</w>
gangli oside</w>
if i
enter ica</w>
Graph ene</w>
it ter</w>
Gran ul
G AT
SI s</w>
amid o</w>
ur us</w>
sh RNA</w>
therapeu tically</w>
Dop amine</w>
FV III</w>
elim inates</w>
Awa reness</w>
com promising</w>
Caro lina</w>
17. 6</w>
or ized</w>
odont ogenic</w>
G AG</w>
iso propyl
M OF</w>
Stand ards</w>
fu els</w>
cylin der</w>
id um</w>
deoxy cholic</w>
amp ed</w>
ble aching</w>
a ks</w>
sh ocks</w>
pol ice</w>
h es
visi bility</w>
myel ocytic</w>
responsi bilities</w>
5 1
Man ual</w>
inc ap
PC D</w>
venti onally</w>
V SMC</w>
TR s</w>
de methylation</w>
ow ed</w>
supr ac
crani otomy</w>
ru thenium</w>
G 0</w>
mer ic</w>
cl ath
epitheli oid</w>
tin y</w>
Int ell
ep il
rest ores</w>
famili arity</w>
dis locations</w>
P ol</w>
be ating</w>
quadr atic</w>
break through</w>
appen dix</w>
So ft</w>
omen cl
micro flora</w>
attemp ting</w>
innov ations</w>
gl it
radi osensi
A ud
impl ied</w>
Caro tid</w>
class room</w>
zom ib</w>
o protective</w>
is obut
tr uly</w>
di hydroxy</w>
contr asted</w>
10 -</w>
phot ons</w>
thym ocyte</w>
Jur kat</w>
K inase</w>
on ts</w>
At ten
ho ur
f ene
es .
edi ble</w>
sec tioned</w>
ore active</w>
aur icular</w>
t ones</w>
ta ught</w>
am enor
CD 45</w>
instruc ted</w>
neph ron</w>
Arti ficial</w>
bal ancing</w>
polymer ases</w>
SN AP</w>
P IN
oph yte</w>
estr one</w>
In stitu
O DC</w>
sist ed</w>
Con sensus</w>
im printing</w>
LO X</w>
f ish
phil icity</w>
hom in
mar kets</w>
fl are</w>
re fraction</w>
Pan el</w>
Ste p</w>
tunn eling</w>
ann ulus</w>
convul sions</w>
bronchi olitis</w>
our ces</w>
olym ph</w>
igno red</w>
chem o</w>
r P</w>
R as
G all
coll iculus</w>
am bly
ag r
direc ting</w>
epilep ticus</w>
opa que</w>
quar ters</w>
1. 39</w>
13. 0</w>
B ond</w>
termin ology</w>
Fe asibility</w>
pr ick</w>
ak ia</w>
cl ay</w>
F AD</w>
practi ced</w>
inv ading</w>
ME C</w>
L angu
def ensive</w>
PR O</w>
PAC AP</w>
re alization</w>
col ectomy</w>
parkinson ism</w>
P ap</w>
arc tic</w>
Legion ella</w>
mes oderm</w>
In digenous</w>
benefici aries</w>
Sub stance</w>
thyro globulin</w>
Bi opsy</w>
t ably</w>
ure ase</w>
d h
PG E1</w>
r atic</w>
S RE
E O</w>
Frac ture</w>
M H
comm entary</w>
ant ations</w>
tel angi
promp tly</w>
TA M</w>
icul ate</w>
r TMS</w>
myco sis</w>
electromy ographic</w>
anch orage</w>
appoint ment</w>
at oma</w>
v s.</w>
Kup ffer</w>
dermat ology</w>
ur gency</w>
Pa O2</w>
U VA</w>
an onymous</w>
aer ial</w>
spiro metry</w>
bre vi
fentan il</w>
ap ps</w>
re bound</w>
P .</w>
C max</w>
ry anodine</w>
acycl o
lithotrip sy</w>
oneph rosis</w>
tend erness</w>
E motional</w>
O I</w>
av ul
ness ed</w>
M CT</w>
s occer</w>
Q C</w>
cl arithromycin</w>
sper mine</w>
spher oids</w>
b orders</w>
Investig ations</w>
Pro st
N CI</w>
ill umin
16. 3</w>
fumig atus</w>
T D
hydro thermal</w>
ocyan in</w>
im a</w>
W A
serov ar</w>
nor m</w>
Micro RNA</w>
Gu inea</w>
transm it</w>
R MS</w>
V D
ph renic</w>
ad venti
inten sified</w>
c ecal</w>
qu ail</w>
w rap
pot encies</w>
CC 1</w>
spi king</w>
flag ell
parav entricular</w>
Carib bean</w>
qu oti
at traction</w>
ent ate</w>
CH OP</w>
PO D</w>
pac k</w>
fav oring</w>
I O</w>
ti sts</w>
sim pler</w>
Process ing</w>
exer tion</w>
intrac erebro
dil ute</w>
micro liters</w>
correc tions</w>
G A
W ide</w>
ore tic</w>
cortic otropin</w>
salic ylate</w>
spl anch
hyper glycemic</w>
time -</w>
an one</w>
inci sions</w>
od u
Appl ying</w>
un determined</w>
aegyp ti</w>
un ified</w>
car inii</w>
Th y</w>
rhe ological</w>
th en
2 39</w>
diverticul um</w>
z able</w>
cephal y</w>
in carcer
us able</w>
citr ic</w>
f ast
yst olic</w>
Pres ent</w>
G ATA</w>
S ta
 2</w>
RO I</w>
draw backs</w>
DO C</w>
aux iliary</w>
Remark ably</w>
I CI</w>
on us</w>
stress or</w>
Aden osine</w>
sy ll
Prolifer ation</w>
exist ent</w>
taz idi
school children</w>
W at
hon ey
mening ococcal</w>
reinfor cing</w>
ph i
li ps</w>
SD F</w>
D uration</w>
plasm as</w>
rel ied</w>
T ATA</w>
ser ially</w>
imp ing
7 6
dec el
sent ences</w>
E lig
in determinate</w>
IC R</w>
Concentr ation</w>
b at</w>
in ization</w>
az a</w>
her bs</w>
pre optic</w>
Neur ons</w>
2 32</w>
CD 20</w>
Pregn ant</w>
in efficient</w>
Per in
Rev ised</w>
T MD</w>
prog resses</w>
PATIEN T</w>
P -</w>
extern ally</w>
sn ail</w>
controll er</w>
duc tor</w>
hom eless</w>
bac eous</w>
la un
le um</w>
fulmin ant</w>
e ing</w>
tim ed</w>
comp iled</w>
Hist or
phag ocytes</w>
dis satisfaction</w>
main stay</w>
Ag NPs</w>
S ma
ulin emia</w>
CS T</w>
De fic
dig ree</w>
stom atitis</w>
Ab original</w>
re ally</w>
hemorrh ages</w>
Min nesota</w>
ac y
yn u
sp rin
2 p</w>
plas tics</w>
j a</w>
H earing</w>
SC S</w>
oc alization</w>
speci alization</w>
n ap
Th rough
haemorrh agic</w>
F asting</w>
vi l</w>
attenu ating</w>
Adjuv ant</w>
SV M</w>
2 75</w>
R ussian</w>
aminoglyco side</w>
ic lovir</w>
te bral</w>
post ulate</w>
Integr ation</w>
v as</w>
BO LD</w>
Esophag eal</w>
A CL
en sures</w>
Ex trem
l ich</w>
Ac celer
hydrox yl
n id
C CI</w>
wa x</w>
but anol</w>
H ung
2 2.2</w>
5 S</w>
av oids</w>
non sense</w>
pul sive</w>
oly ticus</w>
acti onal</w>
1. 40</w>
U 937</w>
hydroly tic</w>
zz y</w>
join ed</w>
IU GR</w>
Ill umina</w>
plasmac yt
glucuron idase</w>
def ault</w>
Hamil ton</w>
bi phenyl</w>
sex uality</w>
C 12</w>
- independent</w>
eth oxazole</w>
vill age</w>
bur gh</w>
NY HA</w>
multi plex
E DS</w>
con sen
our inary</w>
V ZV</w>
po ds</w>
AL D</w>
ig o</w>
os tim
anti phospholipid</w>
O wing</w>
anter oposterior</w>
ovid uc
ca sts</w>
an thus</w>
ox ime</w>
col ored</w>
ti er</w>
go iter</w>
cy stitis</w>
vacu ol
cr ic
coord in
VA TS</w>
precip itate</w>
TE A</w>
Agg reg
def enses</w>
Col labor
po x</w>
16. 6</w>
tazidi me</w>
ME NT
break age</w>
ri an</w>
2 M</w>
the tically</w>
man ure</w>
A th
Pol ish</w>
C erebro
B if
DN A
cyan obacteria</w>
hyper baric</w>
thi oredoxin</w>
Cx 43</w>
I b
HU VEC</w>
ribo flavin</w>
otroph s</w>
Solu ble</w>
Chag as</w>
epider moid</w>
audi o</w>
nom inal</w>
od y
poly neuropathy</w>
anxi olytic</w>
aphy seal</w>
op tics</w>
an oids</w>
categor ization</w>
B H</w>
her itable</w>
14. 9</w>
Numer ical</w>
I LD</w>
syring e</w>
papill oma</w>
C CD</w>
3 10</w>
st ays</w>
V SMCs</w>
plasi as</w>
str u
ic am</w>
E ph
ac ial</w>
whe y</w>
exud ate</w>
g lobe</w>
ast atin</w>
S 6
dis continuous</w>
tain ly</w>
y le
HD AC</w>
D ra
PK D</w>
Sens ory</w>
M as
sk ew
under score</w>
naphthal ene</w>
H LH</w>
col lim
Gi ant</w>
S CA
4 20</w>
UR E</w>
Observ ations</w>
s lit</w>
t ad
defibrill ator</w>
ris peridone</w>
ket ones</w>
ep im
tox oplasmosis</w>
PE EP</w>
15 N</w>
o esophagus</w>
3 &apos;
ST N</w>
log ists</w>
EG TA</w>
cultiv ar</w>
aminop yr
sper midine</w>
L TB
6 th</w>
R K
meth acholine</w>
achiev able</w>
aver sive</w>
bul lying</w>
A de
multi plication</w>
mes enchym
aut umn</w>
trans mis
ac anth
CD 19</w>
ont ogeny</w>
char d</w>
wa ke
Statis tics</w>
Accum ulation</w>
mil lions</w>
A neur
shor test</w>
pepti dyl</w>
peroxis omal</w>
investig ator</w>
form e</w>
sol utes</w>
per mitting</w>
Micro bi
micro biology</w>
Ser a</w>
phot osystem</w>
l akes</w>
u ate</w>
15. 7</w>
op r
bruc ei</w>
maneu ver</w>
1, 5
ginsen g</w>
20 ,000</w>
a viruses</w>
re t</w>
at tain</w>
Colum bia</w>
can al
projec ting</w>
19. 5</w>
Gover n
anti diabetic</w>
Ob structive</w>
19 71</w>
view point</w>
hypo thyroid</w>
deoxy ribonucleic</w>
2 66</w>
Chrom osome</w>
bott len
n ipple</w>
g ay</w>
hydroxy butyrate</w>
Ca regi
U P</w>
b li
IN S</w>
PI P</w>
L et
oc rip
neuro biological</w>
os patial</w>
seed ling</w>
oll en</w>
fac iens</w>
iter pene</w>
Re sistant</w>
P ros
ri st
v um</w>
th ri
the tics</w>
Cont act</w>
0.000 2</w>
question able</w>
adap tor</w>
Tod ay</w>
ph or
an no
initi ator</w>
Langu age</w>
thro p
c uret
3 65</w>
F ar
angi opathy</w>
micro scopically</w>
ga g</w>
AP L</w>
gro unded</w>
mac aque</w>
i. d.</w>
Engine ering</w>
replic ates</w>
H aving</w>
relax ant</w>
k en
sim us</w>
mechan o
st ory</w>
en cl
enro l
Prog ress</w>
cycl o</w>
Separ ation</w>
His pan
recan alization</w>
surviv in</w>
S m</w>
Z IKV</w>
2 19</w>
Co ord
BC VA</w>
yn itr
aut ograft</w>
can e</w>
tetro dotoxin</w>
8 7.5</w>
J ew
al fa</w>
acknowled ged</w>
nom ogram</w>
Moder n</w>
dysp epsia</w>
2 28</w>
oc occi</w>
17 ,
C Cl4</w>
Su b</w>
moder ated</w>
adhe red</w>
itr e</w>
antimal arial</w>
herbic ide</w>
aeros ols</w>
contrain dications</w>
ac rine</w>
thal lium</w>
G AP
odi pine</w>
im ipenem</w>
in um</w>
w a</w>
micro scop
gl asses</w>
BAL F</w>
con ferring</w>
At t
Bec k</w>
st osis</w>
part ner
cr ack</w>
AD E</w>
Fem ales</w>
t ases</w>
sh ops</w>
Tow ard</w>
kain ate</w>
mos a
anti neoplastic</w>
ed ent
tran sist
oxid ases</w>
- 0.0
Q D</w>
priv acy</w>
W W
for c
p anc
cl oud</w>
identi ties</w>
amelior ates</w>
adi c</w>
VO2 max</w>
y led
poly amines</w>
Ki 67</w>
vi remia</w>
1. 41</w>
Con tent</w>
PRO CE
le sional</w>
Schizophren ia</w>
le -</w>
L ow
miti gation</w>
br um</w>
diag ram</w>
val ences</w>
bre ad</w>
au d</w>
hyper oxia</w>
Sou theast</w>
bur dens</w>
indu stri
bel t</w>
mobil ized</w>
non human</w>
ma res</w>
tris phosphate</w>
c p
ib ly</w>
pep sin</w>
visco elastic</w>
JAK 2</w>
W ound</w>
isol euc
cer ul
sen escent</w>
end osomes</w>
T am
U ter
mic ellar</w>
is co</w>
h en</w>
C1 q</w>
micro injection</w>
histor ically</w>
Contro ll
even ly</w>
PG C</w>
15. 0</w>
v illus</w>
comput ationally</w>
Se as
c emented</w>
ocrip tine</w>
lu xation</w>
grap e</w>
C MS</w>
pancre atico
tric yclic</w>
V itro</w>
exerc ised</w>
antec ed
igh ting</w>
over lying</w>
Q S</w>
pre defined</w>
nanow ire</w>
spond yl
asparag ine</w>
multi faceted</w>
competi tively</w>
D 4
gonad otrop
G ulf</w>
SL C
form ans</w>
wi reless</w>
form ate</w>
papill a</w>
argum ent</w>
hom ing</w>
Cor neal</w>
3 25</w>
CH 3</w>
terat oma</w>
B T
cephalospor ins</w>
pp b</w>
A SC
enedi one</w>
ma iled</w>
1. 44</w>
perioste al</w>
6 50</w>
Bu il
certi fic
R G</w>
ta x</w>
rein force</w>
complet eness</w>
ush ed</w>
aor t
lu br
P ES</w>
16. 2</w>
dend rim
histi ocytosis</w>
Adap tive</w>
H aw
Indon esia</w>
penetr ate</w>
mon ey</w>
- like</w>
dipyrid amole</w>
in ite</w>
Bl adder</w>
D o
anti al</w>
amphi philic</w>
atl as</w>
di oxin</w>
b udget</w>
oc entesis</w>
As sisted</w>
r amycin</w>
C TS</w>
mid gut</w>
lac un
chro maffin</w>
Pat tern</w>
fim bri
advanc ements</w>
multi cellular</w>
PL P</w>
Pers onal</w>
m g
gen u
CD 2</w>
MD M2</w>
under lies</w>
de methyl
G HRH</w>
heterodi mer</w>
mass age</w>
ferrom agnetic</w>
P 9</w>
15. 1</w>
consum e</w>
flo ating</w>
Arth ritis</w>
2 38</w>
my opic</w>
M 0</w>
P NA</w>
car go</w>
ub ular</w>
E SC</w>
for cement</w>
20 th</w>
seem ingly</w>
M ill
non significant</w>
ra e</w>
f le
cef triaxone</w>
st en</w>
On line</w>
mal treatment</w>
19 66</w>
tran sep
Fe eding</w>
sor ted</w>
el ian</w>
AN C</w>
d .
d 1</w>
M CL</w>
5 &apos;
Second ly</w>
ho uses</w>
Vari ability</w>
apo A</w>
restric t</w>
F inal</w>
col pos
win dows</w>
photo period</w>
3 C</w>
immunosup pressed</w>
al ol</w>
U SP
sym biotic</w>
c ach
crow ding</w>
2 68</w>
Un ilateral</w>
Der iv
MT A</w>
arteri olar</w>
CYP2 D6</w>
medic ated</w>
At temp
Ex pert</w>
vic tim</w>
Latin o</w>
ap es</w>
extrac ting</w>
T AP</w>
O PG</w>
F usion</w>
myot ubes</w>
E SS</w>
am er
M ax
ar ic</w>
c. v.</w>
H ill</w>
Gre ece</w>
fl un
.00 5</w>
N em
B CC</w>
Eff orts</w>
hyp om
whe el
aminop eptidase</w>
1. 50</w>
coll ater
gr ass
AP T</w>
gen ases</w>
d ae</w>
Cal cul
doub t</w>
De pressive</w>
enucle ation</w>
ophthalm itis</w>
mod elled</w>
modi fier</w>
dis ks</w>
admin ister</w>
den tine</w>
immuno fluorescent</w>
ca strated</w>
E ating</w>
explo iting</w>
sphing osine</w>
L ei
met oprolol</w>
vig ilance</w>
ecta sis</w>
ad nex
Dow n
ter pen
g ill</w>
Mil k</w>
acyclo vir</w>
f us
athl ete</w>
30 5</w>
rot ations</w>
Aud itory</w>
Y ears</w>
be ans</w>
char coal</w>
oxygen ated</w>
Ex tended</w>
halluc inations</w>
ore mentioned</w>
phant oms</w>
Con sec
steroid ogenesis</w>
mercap to
M agne
c asting</w>
yr amine</w>
0.0 23</w>
Rev e
B CS</w>
gam m
Ann ual</w>
tri tion</w>
norm als</w>
Physi cian</w>
lif t</w>
vasodi latation</w>
m c
ogr ade</w>
trop ic</w>
bif unctional</w>
in vertebrate</w>
ob s</w>
potenti ates</w>
chromoph ore</w>
langu ages</w>
Dip tera</w>
synapt osomes</w>
glit azone</w>
2 45</w>
M ales</w>
adjuv ants</w>
iz ability</w>
to id</w>
zircon ia</w>
orch estr
Satis faction</w>
end otox
int us
pro top
2 42</w>
- positive</w>
aly st</w>
Ma king</w>
nin ety</w>
E wing</w>
vertebr a</w>
Ass emb
En zym
buff ers</w>
access ing</w>
1. 56</w>
Ra dical</w>
biotin ylated</w>
Inter pre
fix ing</w>
univers ally</w>
spectrophot ometry</w>
dic t
ut h</w>
PT FE</w>
af orementioned</w>
0.0 21</w>
glycosamin oglycans</w>
d aun
art z</w>
S AA</w>
duplic ated</w>
s ol</w>
ith iasis</w>
omy osin</w>
thrombocyt openic</w>
fac ets</w>
12 3
communic able</w>
diphther ia</w>
de feren
Ta u</w>
periodic ally</w>
on ella</w>
embry onal</w>
1. 46</w>
ol anzapine</w>
I HD</w>
S hor
pro vi
15 0
la id</w>
nam ing</w>
trehal ose</w>
congen ers</w>
co incident</w>
A H
aff ir
Pu er
P 300</w>
irr itable</w>
anth ra
E X</w>
hydroxy proline</w>
S GL
B 16</w>
k al</w>
rever sibility</w>
Obste tr
neo formans</w>
hypercap nia</w>
F ra
yst rophy</w>
ref ine</w>
chrom atid</w>
op son
uc cin
ath letic</w>
Wh y</w>
valpro ate</w>
pharmac ies</w>
pseudo aneurysm</w>
T etr
ventro lateral</w>
8 8
sal but
aw a</w>
th yl
el i</w>
et ast
Estim ates</w>
ge ographically</w>
scap ular</w>
ol ding</w>
In ter</w>
Net works</w>
four fold</w>
re actors</w>
on eal</w>
separ ations</w>
Transpl ant</w>
ow nership</w>
benz o
olig omerization</w>
biosens ors</w>
s apon
sem ic
st ar</w>
scop olamine</w>
def ec
parkinson ian</w>
prepar ative</w>
bic ycle</w>
salbut amol</w>
divid e</w>
mis e</w>
os ulf
ver m
1. 47</w>
lacto ferrin</w>
Res ear
Coh en</w>
Kine tics</w>
Vis u
Prog nosis</w>
pyrro lid
N EC</w>
st u
neg ativity</w>
magne tization</w>
1. 48</w>
photo electron</w>
v oid</w>
un healthy</w>
hom ogenous</w>
si s
manip ulating</w>
brid ged</w>
lif elong</w>
tempor arily</w>
 L</w>
Str ains</w>
li ability</w>
T MA</w>
A HI</w>
splanch nic</w>
den um</w>
Treat ments</w>
Paren tal</w>
Le ad</w>
intus sus
eng ers</w>
fibrom yalgia</w>
0.0 24</w>
sub stitutes</w>
S b</w>
Hsp 70</w>
chen ne</w>
ip ient</w>
arg ues</w>
transcrip tom
ensi tive</w>
instant aneous</w>
28. 6</w>
oun ding</w>
throm bectomy</w>
intrat umoral</w>
ex tant</w>
phosph og
pa y
0.0 28</w>
1. 67</w>
com ings</w>
Hispan ics</w>
Ter tiary</w>
de af</w>
typ ed</w>
Com m
Res ection</w>
SY N
Q 1</w>
is otype</w>
2 52</w>
onc ologists</w>
far ming</w>
PO RT
break fast</w>
p eren
dro w
prov ocation</w>
PL E</w>
Zn 2</w>
depic ted</w>
G B
G Cs</w>
E O
clin es</w>
br ushing</w>
v in</w>
micro vessels</w>
aut ogenous</w>
ste ep
pyrid yl</w>
electro physiologic</w>
y -</w>
PM C</w>
re tains</w>
ag al
MR P</w>
serogrou p</w>
Ac anth
poly chlorinated</w>
G AL
ur inol</w>
id ov
necrop sy</w>
fabr icate</w>
PRACTI CE</w>
dehis cence</w>
ME P</w>
reli ance</w>
diure sis</w>
equ ity</w>
dimen sion
M CC</w>
her b</w>
pyr imid
co oled</w>
sw ollen</w>
C la
mat ous</w>
cancell ous</w>
cellul arity</w>
Wil d</w>
OH DA</w>
arteri osus</w>
tym panic</w>
diff usi
alg a</w>
- 5
fu zzy</w>
ocor tin</w>
hyd atid</w>
multi layer</w>
iso propyl</w>
stabil ities</w>
in activity</w>
- O</w>
N Ac
ap er</w>
In stitutes</w>
astro cytic</w>
quadru pole</w>
cogn itively</w>
adeno viral</w>
peptid oglycan</w>
BR CA2</w>
bacteri ological</w>
p age</w>
pl ings</w>
Nep al</w>
isopren aline</w>
un n
isothi ocyanate</w>
join tly</w>
S v</w>
3 beta</w>
Q ALY</w>
Suc c
an oxic</w>
Don or</w>
Au NPs</w>
2 48</w>
thic knesses</w>
Ab err
E hr
Res olution</w>
Pres entation</w>
comp elling</w>
Wil ms</w>
schwann oma</w>
ren ders</w>
prob and</w>
in stitute</w>
AM S</w>
PO 4</w>
D T
st ear
CR 1</w>
K 3</w>
ar cu
hypo thesi
omencl ature</w>
In du
Fac il
magn ification</w>
oc e
az ithromycin</w>
benz oyl</w>
Intrac ranial</w>
bever age</w>
Standardi zed</w>
ch ances</w>
cardi otoxicity</w>
2 34</w>
g lue</w>
b ats</w>
cycl opent
AV R</w>
tion ality</w>
Rus sia</w>
over growth</w>
cyst atin</w>
o val</w>
pharmac odynamics</w>
C is
1. 55</w>
proce eded</w>
At titudes</w>
DE NV</w>
Experi ences</w>
sacc ade</w>
3 70</w>
h GH</w>
un bound</w>
bot tle</w>
hair y</w>
trochan teric</w>
anten na</w>
Dys function</w>
end osomal</w>
Du chenne</w>
Concomit ant</w>
micro l</w>
exten sions</w>
17. 2</w>
Rac 1</w>
hyaluron an</w>
I G</w>
Util izing</w>
scal able</w>
bul ky</w>
- free</w>
mul tiv
Un expectedly</w>
17 A</w>
Exam ples</w>
R L
ardi a</w>
U GT
hyponat remia</w>
F ocal</w>
S AD</w>
it z</w>
Contro ls</w>
Vic tor
A HR</w>
are ly</w>
n est</w>
microm eter</w>
c ements</w>
extrac ranial</w>
ib encl
fec und
Q TLs</w>
A gr
it ably</w>
2 43</w>
NI RS</w>
trabec ul
asphy xia</w>
con sin</w>
multi plicity</w>
Al lo
am ik
oc cosis</w>
vir tu
lif ting</w>
bur ned</w>
A U</w>
S cores</w>
wid ths</w>
Hem odynamic</w>
ent orial</w>
secre tin</w>
thi ols</w>
carcin oembryonic</w>
hydra zine</w>
om icro
graph ical</w>
nanos he
go ti
O DN</w>
D CIS</w>
ol or</w>
clin damycin</w>
PA G</w>
en an</w>
B ase</w>
if os
Col or</w>
allo dyn
T SA</w>
ne goti
PTH rP</w>
Fac ial</w>
Fluoresc ent</w>
f issure</w>
3 1P</w>
Pt d
w ish</w>
ME G</w>
IN H</w>
ly ophil
CT D</w>
ty ly</w>
PI C</w>
metallo thionein</w>
Polym erase</w>
N 2O</w>
denti st</w>
omer ular</w>
avoid able</w>
w etting</w>
ibencl amide</w>
2 3.5</w>
ca ve</w>
omal acia</w>
pleas ant</w>
st asis</w>
Radi ographic</w>
di sh
AT G</w>
transduc ers</w>
M ich
broil ers</w>
micro organism</w>
tri acylglycerol</w>
swa b</w>
2 27</w>
pre paredness</w>
aper itoneal</w>
0.0 22</w>
T AT</w>
PE R</w>
cr ash</w>
16. 4</w>
mou th
Rou x</w>
trac ked</w>
g n</w>
erb al</w>
Co operative</w>
co oked</w>
Im ages</w>
spor ulation</w>
pe digree</w>
hydr ide</w>
Col on
gro in</w>
certi fication</w>
ST M</w>
A gre
G6 PD</w>
Endo th
C aspase</w>
entr ifug
od ular</w>
16. 1</w>
vid in</w>
ig an</w>
lob ar</w>
Soci o
elabor ate</w>
8 3.3</w>
clinic al
M CS</w>
H SS</w>
Wis consin</w>
b om
Dis ruption</w>
see ks</w>
Al a
Consec utive</w>
st on</w>
non alcoholic</w>
cardio protective</w>
resc ine</w>
Environ ment</w>
chron ological</w>
fir m
interven ing</w>
nadi r</w>
Gener alized</w>
Gen Bank</w>
Aut ophagy</w>
inter connected</w>
D U</w>
A mp
suspec t</w>
threat ened</w>
ecto derm</w>
Recei ver</w>
car d</w>
sw im</w>
De gradation</w>
Syn erg
0.0 26</w>
asym pto
i. c.v.</w>
PD s</w>
assign ments</w>
pec tin</w>
asym metrical</w>
Micha elis</w>
abund ances</w>
exha us
orth olog
IR I</w>
SI R</w>
Hem orrh
dar kness</w>
heter otopic</w>
con tract</w>
man ia</w>
1. 54</w>
re conc
cr ime</w>
flav or</w>
lea ks</w>
A r</w>
o int
Egyp t</w>
O 2-</w>
A typical</w>
direc tors</w>
extr as
3 80</w>
modi fiers</w>
cyto chal
eu thyroid</w>
2 36</w>
rhod amine</w>
17. 4</w>
ex ia</w>
gonad otrophin</w>
y o</w>
C Cs</w>
cryp toc
SS G</w>
en trance</w>
Cys tic</w>
non pregnant</w>
PI D</w>
2 29</w>
P J
pur ities</w>
och lor
por in</w>
cin ti
land mark</w>
ol ence</w>
ad ox</w>
pat ella</w>
ker t</w>
Tow ards</w>
2 5.0</w>
e at</w>
xim al</w>
off enders</w>
butyr yl</w>
ran itidine</w>
fer rous</w>
lymph edema</w>
B ol
iv udine</w>
AV M</w>
N ar
evo ke</w>
R .</w>
T ru
sten otic</w>
Oc currence</w>
voltam metry</w>
ti r
S lo
Spec imens</w>
X 4</w>
E vents</w>
orig inates</w>
imping ement</w>
y n</w>
E TS</w>
B K
s acchar
graph ite</w>
R ural</w>
B max</w>
gol den</w>
gal ectin</w>
Sep sis</w>
ser ver</w>
is tin</w>
poly cy
visc ous</w>
g ab
all yl</w>
epi androsterone</w>
Nur se</w>
hol o
Ver sus</w>
de generate</w>
oct adec
2 55</w>
predomin ated</w>
accep tors</w>
t led</w>
duplic ate</w>
Ex traction</w>
ocon azole</w>
f ound
ar tom
form ulate</w>
en ox
Partic ularly</w>
isot opes</w>
invari ably</w>
ot str
lec ithin</w>
atic a</w>
H AV</w>
O 6</w>
ter ized</w>
T PN</w>
18. 8</w>
Intr am
Revie ws</w>
treat able</w>
se y</w>
disper se</w>
amik acin</w>
Q 10</w>
red oxin</w>
hour ly</w>
ass ault</w>
ag end
l or</w>
An throp
sup pur
Mic ro</w>
Vacc ination</w>
Re v</w>
lab yrin
monit ors</w>
T rop
SP C</w>
pac ed</w>
Dr .</w>
O m
hem agglutination</w>
ple uro
mE q</w>
app earances</w>
1. 49</w>
Mo vement</w>
Dic ty
n NOS</w>
ac ity</w>
ps i</w>
micro villi</w>
N ile</w>
co eliac</w>
Con current</w>
AF 1</w>
per pe
mo s</w>
2 65</w>
pon tine</w>
F ore
ol umbar</w>
adren ocortic
n is</w>
Nl m
bo di
eth anolamine</w>
Nlm Category</w>
k ynu
0.0 27</w>
ynitr ite</w>
T GA</w>
neurofibrom atosis</w>
pa di
hall marks</w>
E Z
em mal</w>
estim ations</w>
manufac ture</w>
Macroph ages</w>
D DP</w>
semi quantitative</w>
14. 0</w>
genit ourinary</w>
multi tude</w>
pyel onephritis</w>
C ent
Strateg y</w>
Hi erarch
aco emulsification</w>
go t</w>
dur a</w>
alop ram</w>
Di versity</w>
Dam age</w>
alog y</w>
ach ments</w>
unc ou
Re as
NH 3</w>
advoc ate</w>
fo res
lic ted</w>
biom echanics</w>
intrac ytoplasmic</w>
ati dyl
0.0 35</w>
13 0
Sub group</w>
segreg ated</w>
implic ating</w>
Leuk emia</w>
pie zo
r uminal</w>
sho ul
TK I</w>
G AD
5 ,000</w>
kerat osis</w>
sub classes</w>
RT I</w>
oblig ate</w>
c ili
disp arate</w>
P in
Dev ice</w>
activ ations</w>
conc eived</w>
mush room</w>
finger print</w>
synth eses</w>
par ty</w>
sp un</w>
index ed</w>
novel ty</w>
wake fulness</w>
hem oglobin
du plications</w>
endoscop e</w>
G AS</w>
fib er
15. 9</w>
ank ylosing</w>
Air way</w>
Foc us</w>
cardi o</w>
recover ing</w>
MTH FR</w>
ds RNA</w>
nic k</w>
AM A</w>
B B
OUTCO MES</w>
sac ro
Ex pan
vascul arity</w>
enanti omer</w>
r CBF</w>
el et
arc tation</w>
tr ying</w>
I MP</w>
ud in</w>
cath ode</w>
caus ality</w>
Ade qu
P d
S t</w>
predic tability</w>
C BP</w>
ass er
CT Cs</w>
F ul
cos me
Check list</w>
bl end</w>
contrac ting</w>
serop ositivity</w>
E ur
Vacc ine</w>
Osteo arthritis</w>
A NA</w>
re oxygenation</w>
T CR
auto regulation</w>
Un usual</w>
jejun ostomy</w>
f ting</w>
Res ting</w>
ob let</w>
pro ficiency</w>
post s</w>
tel omeres</w>
intern ally</w>
urb an
over production</w>
lumin ance</w>
P ag
S 1P</w>
dr astic</w>
SO D1</w>
o yst
am adol</w>
rec ir
nucle osides</w>
arthro pathy</w>
neuro surgery</w>
muc ositis</w>
4 R</w>
hetero chromatin</w>
fibros arcoma</w>
C U</w>
V en
nanom olar</w>
PC V</w>
cl arity</w>
Vide o</w>
2 64</w>
0.0 10</w>
bac lofen</w>
e thers</w>
in accurate</w>
exc epti
HC G</w>
aten olol</w>
IVI G</w>
deuter ium</w>
neuro toxin</w>
TL E</w>
h s
ERI A</w>
emb ran
den sely</w>
n es</w>
co us
cer tainly</w>
fluctu ating</w>
ds DNA</w>
power ment</w>
dextro se</w>
Tr p
n im
Epidemi ologic</w>
S U</w>
nal trexone</w>
Ex ogenous</w>
short comings</w>
chemoradi ation</w>
te zomib</w>
M atr
trap ez
N N</w>
bar rel</w>
gam et
- 12</w>
ure ly</w>
av al
Del phi</w>
pro collagen</w>
ure thro
Techniqu es</w>
protozo an</w>
ch y</w>
casp ases</w>
L ater</w>
Sho ulder</w>
ent olamine</w>
plas tin</w>
cef tazidime</w>
OR Fs</w>
cra ving</w>
erythropo iesis</w>
transform ants</w>
ist ers</w>
Fe der
wor th
E MR</w>
V ie
diam ond</w>
immer sed</w>
propag ated</w>
em powerment</w>
1, 6
cap ping</w>
Mal aria</w>
conver ts</w>
g ig
scro tal</w>
Sy rian</w>
con ventionally</w>
D AS</w>
4 31</w>
Sh ang
hybrid oma</w>
medul lo
AT RA</w>
aspec ific</w>
T an
O T
immun operoxidase</w>
Publ ished</w>
trans vaginal</w>
av ascular</w>
as aki</w>
NH 4</w>
2 </w>
VE P</w>
govern ance</w>
explo itation</w>
synovi tis</w>
S earch</w>
encomp asses</w>
enol ase</w>
S SR</w>
9 6
in clusive</w>
o to</w>
Portu gu
sa ve</w>
cl ip</w>
17. 8</w>
Gre ek</w>
heavi er</w>
intrag astric</w>
Larg er</w>
magnit udes</w>
e uro
C W</w>
N ature</w>
hyper triglyceri
3 15</w>
opo ietin</w>
an tine</w>
ipl eg
Ben ign</w>
cat ch
angi oma</w>
phenomen ological</w>
non surgical</w>
Atl as</w>
inferen ces</w>
mesenchym e</w>
Nit rogen</w>
1. 52</w>
ell ites</w>
gover n</w>
sorb itol</w>
D na
V AD</w>
H op
ic ill
an orectal</w>
Re productive</w>
Elec troph
2 47</w>
g 1</w>
Con fir
ra d</w>
ut amide</w>
Ex isting</w>
9 7
arcu ate</w>
mic ity</w>
mis carriage</w>
advant aged</w>
oc h</w>
ophosph orylation</w>
palli ation</w>
Br it
antr um</w>
Relev ant</w>
L ou
W ar</w>
Inhib itor</w>
chro tron</w>
T Y</w>
key words</w>
mi tic</w>
neur algia</w>
30 3</w>
LTB 4</w>
or yz
electroencephal ogram</w>
ach loro
alle y</w>
Epilep sy</w>
Polym er</w>
shut tle</w>
G el
op olysaccharide</w>
b ench</w>
immunosup press
To k
Knock down</w>
e de</w>
Indi ans</w>
an oxia</w>
Immun ization</w>
opac ity</w>
oligodendro cyte</w>
post translational</w>
EC S</w>
Heterogene ity</w>
fo relim
resear ches</w>
iz ine</w>
ip ients</w>
ut ation</w>
1. 65</w>
vul var</w>
mo de
bronch us</w>
G est
1. 53</w>
Princ ipal</w>
mer it</w>
far nes
varic eal</w>
E SD</w>
ec tor</w>
ass a</w>
S can</w>
Ep o</w>
isoleuc ine</w>
ic ides</w>
es ulf
ocul omotor</w>
B DI</w>
dis placements</w>
Abs ence</w>
mic ally</w>
ap sular</w>
h ang
chem oresistance</w>
perfor ations</w>
character izes</w>
Trans genic</w>
elabor ated</w>
Th ym
fi ve
to ol
ste ers</w>
2 0.5</w>
em an
uron ium</w>
maxim a</w>
androst enedione</w>
hapl oid</w>
you ths</w>
J er
ass or
ad er</w>
inten si
11 C</w>
custom ized</w>
clath rin</w>
bloc kage</w>
insec urity</w>
gall stones</w>
Z P</w>
fib ular</w>
emerg es</w>
chim eras</w>
bacul ovirus</w>
Viv o</w>
PG A</w>
un planned</w>
mes o
trim eric</w>
ancest or</w>
multi pl
Endo vascular</w>
Care ful</w>
dys lex
bl astine</w>
Spectr al</w>
recru iting</w>
curricul a</w>
idov udine</w>
b a</w>
ta uro
res or
R AR
M urine</w>
rad on</w>
inter specific</w>
mon onucle
colo strum</w>
Portugu ese</w>
ro ll</w>
tech netium</w>
cer am
invol untary</w>
catast rophic</w>
F lo
for age</w>
Appro aches</w>
Phen otypic</w>
- 11</w>
Ox ide</w>
2 98</w>
chaper ones</w>
b ites</w>
infarc ted</w>
gl enoid</w>
e --
K o
L C3</w>
a C</w>
LN CaP</w>
broad band</w>
g ium</w>
met e
appreci ation</w>
epsil on
O GTT</w>
Colom bia</w>
Main tenance</w>
dec ont
P U</w>
M CF
squ ir
ligh ting</w>
3 00
flag ellar</w>
kyph osis</w>
2 33</w>
2 41</w>
R SA</w>
iso thermal</w>
ep sy</w>
spec ify</w>
mal to
des atur
ju n</w>
biotechn ology</w>
coumar in</w>
ir in
Th al
Al t
Barri ers</w>
VE GFR</w>
Li po
PC O2</w>
at trition</w>
yl line</w>
av icular</w>
S MS</w>
appoint ments</w>
bi osis</w>
. com</w>
sle eve</w>
FK 506</w>
uter i</w>
PM 2.5</w>
Adju sted</w>
infiltr ated</w>
lumb osacral</w>
mil der</w>
roc k</w>
ag liptin</w>
cal ving</w>
fibrobl astic</w>
streng thened</w>
MT C</w>
cap tive</w>
- binding</w>
I P3</w>
- activated</w>
1. 51</w>
AB I</w>
bull ous</w>
qu artz</w>
oth re
S Q</w>
C Ps</w>
R ub
R LS</w>
biom aterial</w>
star tle</w>
fem tosecond</w>
correc tive</w>
e ters</w>
ospor a</w>
osper m</w>
Kre bs</w>
E very</w>
He ad
Polic y</w>
u ing</w>
17. 3</w>
perman ently</w>
preced es</w>
ch yl
Determin ants</w>
igen in</w>
web sites</w>
Multic enter</w>
ion toph
star ved</w>
Sum mary</w>
wea knesses</w>
aly sts</w>
strabis mus</w>
2 61</w>
phen oxy
MD P</w>
coagul opathy</w>
u ters</w>
vasodi l
m it</w>
al -</w>
um es</w>
CS P</w>
mim etic</w>
insul ts</w>
stom atal</w>
oblast omas</w>
Vir tual</w>
ten ing</w>
sin ensis</w>
conc ei
Li kert</w>
oler ant</w>
Memb ers</w>
am it
Assemb ly</w>
In direct</w>
u bin
Phy to
os able</w>
oper itoneum</w>
con tu
od en
Immun ocyto
osa hexa
C lim
under weight</w>
ac rosome</w>
DIN G</w>
Schol ar</w>
rap e</w>
comm ens
transc utaneous</w>
propan ol</w>
immun ology</w>
triti ated</w>
retin as</w>
Pen icil
P 6</w>
te thered</w>
Cop yright</w>
T g
hem odi
CT LA</w>
allerg ies</w>
d on</w>
J AK</w>
intub ated</w>
finger printing</w>
bronch opulmonary</w>
0.000 01</w>
wavel et</w>
16. 8</w>
tw o-</w>
radiolig and</w>
Ch ile</w>
absorp tive</w>
excepti onally</w>
gran d
em etic</w>
SN s</w>
H .</w>
MM F</w>
op ed</w>
tow n</w>
M end
omy elin</w>
ome dicine</w>
Hsp 90</w>
aspir ates</w>
P elvic</w>
pyl oric</w>
precau tions</w>
par at
rac emic</w>
yl us</w>
plu g</w>
ar id</w>
Par t
an tee</w>
sun light</w>
stil b
ca pro
hydr onephrosis</w>
TA G</w>
cys tine</w>
hyper polar
elev ision</w>
40 2</w>
conspic uous</w>
P PS</w>
in sular</w>
dem ented</w>
smo ker</w>
T 0</w>
cru st
ter tile</w>
ax anthin</w>
CM s</w>
Agro bacterium</w>
allop ian</w>
be c</w>
thaw ed</w>
cross linked</w>
sp ider</w>
S omat
rumin ants</w>
K .</w>
Meth yl</w>
micro L</w>
excep tions</w>
cl ick</w>
clon ogenic</w>
intrac ardiac</w>
PD MS</w>
resear cher</w>
LV AD</w>
citr us</w>
G e</w>
physi co</w>
TR P</w>
SM I</w>
fist ulae</w>
glot tic</w>
Ca MK
hyper sensitive</w>
un adjusted</w>
E SW
GL U
append ectomy</w>
mic elle</w>
phen e</w>
catar acts</w>
deferen s</w>
19 70s</w>
2 46</w>
Rel ation</w>
pr ices</w>
l is
gangli osides</w>
corrobor ated</w>
Post operatively</w>
Sym ptomatic</w>
tetram er</w>
S o</w>
in spiration</w>
en tive</w>
ocar pine</w>
surviv orship</w>
intrad ermal</w>
H p</w>
spec ulated</w>
pi one
thick ened</w>
2 1.3</w>
sub lethal</w>
Incorpor ation</w>
hib ern
3 3.
PM I</w>
hab ituation</w>
hu b</w>
hyperinsulin emia</w>
17. 1</w>
Hormon e</w>
Impro vements</w>
ex cur
PT T</w>
e worthy</w>
cast le</w>
2 37</w>
M ong
a king</w>
partner ships</w>
or ative</w>
guan ylate</w>
yl on</w>
pow ders</w>
E2 F</w>
c i</w>
fluor ine</w>
am end
glycosamin oglycan</w>
S OS</w>
ti da</w>
de fibrillation</w>
fal fa</w>
all ine</w>
19. 4</w>
oper ates</w>
drom ic</w>
dys morph
B est</w>
oste onecrosis</w>
F ran
an aerob
CH 2</w>
MV D</w>
L F
Prost agland
AV F</w>
per v
quar tiles</w>
dom s</w>
wave guide</w>
colum nar</w>
Fir stly</w>
un ipolar</w>
ethyl enedi
if ier</w>
thaw ing</w>
C p</w>
z on
refl ections</w>
Pro ton</w>
fluoro scopic</w>
oblast oid</w>
four teen</w>
absorb ing</w>
padi as</w>
2 58</w>
por k</w>
17. 9</w>
W G</w>
run off</w>
P ep
. -
grow s</w>
Brassi ca</w>
H ex
G in
tr ains</w>
Micro scopic</w>
T est
S clerosis</w>
uro genital</w>
Lt d</w>
i .</w>
D CA</w>
palmit oyl</w>
pe de
cytochal asin</w>
cap turing</w>
2 500</w>
reti rement</w>
H -</w>
osi c</w>
disproportion ately</w>
TI C</w>
accompl ish</w>
F 5</w>
ER </w>
shiel ding</w>
Pa ulo</w>
ch ips</w>
intra oral</w>
I r</w>
erb B</w>
ush es</w>
cu ti
ful le
necess itating</w>
b ears</w>
K 4</w>
accur acies</w>
Diff icul
guar antee</w>
ass ed</w>
abil is</w>
nev us</w>
Avail able</w>
lin ol
Con jug
bul ls</w>
Neph ro
cere al</w>
Ur ban</w>
inci sional</w>
P ACT</w>
thym ine</w>
co factors</w>
PF GE</w>
intrac ellularly</w>
sh ells</w>
ach i
olys accharides</w>
olig o</w>
exacerb ate</w>
cere us</w>
h sa</w>
o sterol</w>
conf identi
pac hy
end ophthalmitis</w>
osom atic</w>
S har
L e</w>
ham artom
vagin alis</w>
j as
RN FL</w>
amne sia</w>
Immuno fluorescence</w>
Cor yne
ji ang</w>
hypox anthine</w>
m old</w>
op ty
resi st</w>
Pal li
los ing</w>
L umbar</w>
U D</w>
t ut
employ ee</w>
bo oster</w>
ster on
practi c
2 1.4</w>
glyco side</w>
bim odal</w>
sp ind
G J
3 42</w>
nul li
c itations</w>
thir teen</w>
pneum ophila</w>
ocon us</w>
arg in</w>
Con struction</w>
te ach</w>
cry o</w>
ic ism</w>
18 S</w>
Pa ste
t -</w>
whe ezing</w>
whe el</w>
y anine</w>
ex haled</w>
ine -</w>
requ ests</w>
Con sortium</w>
MD MA</w>
iz o
sion ing</w>
spl eens</w>
no on</w>
hy stere
AM H</w>
rever sing</w>
ile us</w>
uni versities</w>
spectr in</w>
con sangu
spro uting</w>
PS Ps</w>
g all</w>
de posit</w>
framesh ift</w>
ed ings</w>
path ologist</w>
sulf onate</w>
territ ories</w>
U niqu
cat ch</w>
angi o
re tic
character ise</w>
impregn ated</w>
B N
co t</w>
od enal</w>
produc er</w>
EC P</w>
V o
on ite</w>
ot olaryng
collater als</w>
cataly tically</w>
GD NF</w>
ota xime</w>
j e
co variate</w>
bilir ubin
il eg
Pul se</w>
s ingly</w>
E I
hyper responsiveness</w>
Kr us
enthal py</w>
N OR</w>
mis matched</w>
lear ners</w>
per oneal</w>
fl at
nev i</w>
ra fts</w>
shoul ders</w>
os arcomas</w>
DM N</w>
Wall is</w>
ox imetry</w>
DP PH</w>
X L</w>
Cor d</w>
LD 50</w>
amoeb a</w>
fecund ity</w>
Oste opo
ALY s</w>
g ib
M ent
CL s</w>
1, 2,4</w>
L ength</w>
c M</w>
ER Ps</w>
aqu at</w>
moun tain</w>
stri ated</w>
des aturation</w>
Not ch
1 G</w>
wast es</w>
be re
ju dic
ogu an
inter individual</w>
CR IT
2 63</w>
S mar
bul im
16. 9</w>
atyp ia</w>
concer t</w>
g un
re arranged</w>
1. 58</w>
Ar ch
2 44</w>
mul tis
him bine</w>
Ex p</w>
16. 0</w>
Sim ulations</w>
h um</w>
E FS</w>
thic ker</w>
a o</w>
18. 6</w>
intu itive</w>
5 Y</w>
trans located</w>
hex yl</w>
put rescine</w>
re habil
ag u
co erul
AZ T</w>
b ach
A 9</w>
y clines</w>
ast ers</w>
I on
I RR</w>
Mich igan</w>
1. 57</w>
Acc ep
pain less</w>
r il
K 3
N SE</w>
De ficiency</w>
homozyg otes</w>
poster olateral</w>
Infra red</w>
M AR
cr ashes</w>
conto urs</w>
ind welling</w>
S AT</w>
hyper methylation</w>
19. 2</w>
TT X</w>
c resc
prot amine</w>
L AB</w>
harbo red</w>
HB G</w>
orth o</w>
bio distribution</w>
petro leum</w>
Analy tical</w>
P Q</w>
CRIT ERIA</w>
peri ventricular</w>
F ont
. 1</w>
F 344</w>
qui et</w>
t ul
clinical trials.gov</w>
Collabor ative</w>
l i</w>
50 8</w>
swit ches</w>
M ath
vi til
AC HE</w>
mis oprost
w as
de activation</w>
met ach
vul us</w>
gas eous</w>
hem ipleg
long us</w>
acyl glycer
Mig ration</w>
pu er
gu est</w>
porph yr
Mel atonin</w>
opty sis</w>
I 1</w>
brom ocriptine</w>
he ights</w>
repe ating</w>
centro id</w>
itr aconazole</w>
AD T</w>
ano ate</w>
ou tre
micro albuminuria</w>
Ab normal
enanti oselective</w>
P c</w>
x er
str adiol</w>
buff ering</w>
Gu ang
ob ox</w>
40 5</w>
break points</w>
contin gent</w>
ar bo
misoprost ol</w>
qu asi
inferi ority</w>
sil denafil</w>
Spectro scopy</w>
p en</w>
clav ul
har ms</w>
12 10</w>
Ather osclerosis</w>
miner al
LA K</w>
myometr ial</w>
pre test</w>
I le
C 5a</w>
40 L</w>
chi ro
alga m</w>
irin otecan</w>
H 9
Vari ables</w>
Opi oid</w>
NK T</w>
polymer ized</w>
addi tions</w>
electroencephal ography</w>
el essness</w>
ic k
chlamy dial</w>
dimorph ism</w>
er ally</w>
gen iculate</w>
collag enous</w>
Acqu ired</w>
s oma</w>
- K</w>
mel t</w>
2 57</w>
dy ads</w>
Br onch
adi po
sulfam ethoxazole</w>
uro spor
2 1.1</w>
hydrox ylated</w>
anthrac ycline</w>
lo dipine</w>
cyto static</w>
am algam</w>
isol ating</w>
oc ked</w>
t uration</w>
Q SAR</w>
acces sions</w>
E r</w>
fluor inated</w>
intracor onary</w>
ov a</w>
Gi ardia</w>
V WF</w>
F AP</w>
Inter views</w>
adop ts</w>
New castle</w>
E SCs</w>
Dimen sional</w>
determin istic</w>
olec tomy</w>
splen omegaly</w>
ep ir
sp ur
Psych osocial</w>
A RE
dou ble
del aying</w>
Fo rest</w>
opath ogenesis</w>
auth ority</w>
Prote us</w>
remn ants</w>
de dness</w>
GTP ases</w>
man ic</w>
I PC</w>
inter professional</w>
Sc i</w>
DM BA</w>
metatar sal</w>
ai red</w>
TRPV 1</w>
s tic
c m3</w>
5 0.0</w>
Am bul
myometr ium</w>
vas omotor</w>
Off ice</w>
oglut arate</w>
staff ing</w>
B O</w>
transpor ting</w>
Ther mo
22 q
Program me</w>
phen otyping</w>
teg mental</w>
un favourable</w>
mut h</w>
ti des</w>
18. 4</w>
ac ellular</w>
L eb
Meas ure</w>
b us</w>
carcin ogenicity</w>
mTOR C1</w>
cl omi
ap noea</w>
tic atory</w>
J ak
1, 7
CD 56</w>
N AA</w>
phyl ogenetically</w>
cooper ativity</w>
Minim al</w>
M BC</w>
concep tions</w>
2 73</w>
H arr
gu il
acetyl cysteine</w>
PO P</w>
eme sis</w>
tend er</w>
Frac tures</w>
S .</w>
Fac ulty</w>
Metast asis</w>
rifamp in</w>
o ocysts</w>
l pr</w>
supra ventricular</w>
kit t</w>
g oblet</w>
dis course</w>
phen idate</w>
anticip ate</w>
poly urethane</w>
ac company</w>
leiomy oma</w>
b ell</w>
architec tural</w>
hypoc alc
Shang hai</w>
h olog
ari us</w>
ME M</w>
R och
Pneum ocystis</w>
past ure</w>
ot ens
acromegal y</w>
R AR</w>
es onide</w>
GLUT 4</w>
ophyl l
lo d
in ulin</w>
ap enta
Mor ris</w>
Ear lier</w>
lox ane</w>
occa sion</w>
offic ers</w>
synerg ism</w>
rec alled</w>
CD H</w>
japon ica</w>
vol ta
F EV</w>
Bel gium</w>
outre ach</w>
ane oplastic</w>
dy ne
AE Ds</w>
artic ulation</w>
ona dism</w>
inser ts</w>
U M</w>
18. 3</w>
S AP
M PP</w>
ML R</w>
vacu ole</w>
dal tons</w>
lor dosis</w>
pre implantation</w>
var us</w>
quoti ent</w>
hydro peroxide</w>
neuro pathies</w>
mal tose</w>
inc entive</w>
re par
res us
Sil ver</w>
DM F</w>
kn ife</w>
Rheum atoid</w>
CH B</w>
B 27</w>
ox o
intussus ception</w>
B 3
Sem i</w>
orh inal</w>
J am
fibrom a</w>
br inging</w>
as ka</w>
sl augh
Ul tim
s ay</w>
c us
form ats</w>
Lym ph</w>
bis -</w>
sn ails</w>
In patient</w>
lep tosp
Tum our</w>
m W</w>
inter pol
recei ves</w>
fi re
ocycl ine</w>
p ill</w>
bur ied</w>
SH V</w>
Epig en
E MA</w>
I SR
doc yanine</w>
im purities</w>
ph ys
Seas onal</w>
fum arate</w>
avid in</w>
bio char</w>
must ard</w>
o oph
nar rati
pa yments</w>
Rev ision</w>
spermat og
Bal ance</w>
lo zin</w>
carrage enan</w>
allodyn ia</w>
R U</w>
disrup tive</w>
ent orhinal</w>
Epid ermal</w>
2 1.5</w>
inten sively</w>
Aer omonas</w>
litter mates</w>
gly cin
SI K</w>
T CC</w>
comp uters</w>
pal pation</w>
Arc tic</w>
ri vers</w>
ato hepatitis</w>
MD CK</w>
II IA</w>
semin iferous</w>
L os</w>
CB Z</w>
 1</w>
i. m.</w>
chol este
endoscop ically</w>
su ite</w>
mal nourished</w>
MD R1</w>
B ost
pro myelocytic</w>
can opy</w>
9 9.
50 s</w>
Cyto kine</w>
gr ac
proto plasts</w>
aqu educ
inclin ation</w>
TR AP</w>
oscill ator</w>
Bur kitt</w>
Jo hn
redund ancy</w>
O SAS</w>
vin blastine</w>
ur anium</w>
break point</w>
radi osensitivity</w>
Ab sorption</w>
sporo zo
C yst
recip itation</w>
HE K
marg in
E vent</w>
Ox idation</w>
si le</w>
electro physiology</w>
Ser ies</w>
ph acoemulsification</w>
post surgical</w>
Streng th</w>
k d</w>
min ated</w>
av al</w>
Lew y</w>
PS 1</w>
Resi dual</w>
forc eps</w>
1. 3
compart ment
thyl ak
Mob ile</w>
enzym ic</w>
not omy</w>
DE P</w>
T1 DM</w>
nanoro ds</w>
steroid ogenic</w>
peri stal
cys tic
19. 6</w>
coord inating</w>
hype remia</w>
oc tan
non selective</w>
ant oin</w>
radi ologically</w>
E osin
re generate</w>
F und
ab used</w>
ob acillus</w>
ampl ing</w>
sub lingual</w>
administr ations</w>
ful fill</w>
haem olytic</w>
immunoprecip itated</w>
PV C</w>
sol di
infarc tions</w>
in ning</w>
anes ulf
gl abr
AG Es</w>
ab ulary</w>
parv um</w>
Aberr ant</w>
W i
foc us
in gens</w>
gl ibenclamide</w>
EB P
inter im</w>
phosph ot
remin is
30 9</w>
E H
min g
ox i
Wil li
sh ire</w>
D .
D CE</w>
T x
diffusi vity</w>
anc iclovir</w>
O il</w>
sl aughter</w>
R SD</w>
bio assays</w>
circum flex</w>
cav itation</w>
AT L</w>
M IC
ver tically</w>
Ch E</w>
ten sions</w>
P r</w>
Agre ement</w>
EG G</w>
Path ways</w>
vir gin</w>
rec alc
transfer ring</w>
V AP</w>
7 20</w>
H az
assi gn</w>
b omb
men arche</w>
Org anis
epti form</w>
thi ophene</w>
vitil igo</w>
mening eal</w>
.00 3</w>
Penicil lium</w>
PR S</w>
Radi ological</w>
reser pine</w>
non union</w>
GI ST</w>
0.0 29</w>
hi m</w>
F TD</w>
lign oc
pon der
pancre atectomy</w>
L ine</w>
acc ru
util ised</w>
chel ator</w>
K P</w>
quin ones</w>
cor ner
afford able</w>
e ders</w>
thi op
curet tage</w>
Cycl in</w>
S O2</w>
Specific ity</w>
b un
ann ul
PD H</w>
oro usly</w>
C old</w>
lymph oblastoid</w>
Diff use</w>
convinc ing</w>
ph ia</w>
E MENT</w>
R .
fi tinib</w>
placent as</w>
tod d
B Z
Con version</w>
hypo perfusion</w>
advoc acy</w>
disc er
17. 7</w>
tent atively</w>
A 
ultrac entrifug
2 88</w>
atech in</w>
neurolog y</w>
cave olin</w>
rop ic</w>
Ch emo
pl otted</w>
30 6</w>
RAN TES</w>
in compatibility</w>
fuc ose</w>
osahexa enoic</w>
F ish</w>
aug ments</w>
Lig and</w>
2 49</w>
aff e
MUC 1</w>
entr al</w>
earth qu
18 ,
W E</w>
o viruses</w>
clim bing</w>
2 62</w>
thym oma</w>
pre determined</w>
wr ong</w>
s ins</w>
P SII</w>
sub retinal</w>
Perc eption</w>
b pm</w>
pal mitic</w>
T ro
le ar</w>
assum es</w>
b athing</w>
mes enter
2 7.5</w>
Fib rosis</w>
sc ribed</w>
end ang
II IB</w>
D ex</w>
pur ple</w>
muscul ature</w>
3 11</w>
ur chin</w>
u ximab</w>
Coryne bacterium</w>
or d</w>
glucone ogenesis</w>
 et</w>
PD R</w>
Echocardi ography</w>
Mechanis tically</w>
Contr ibution</w>
hom osexual</w>
in activate</w>
c Gy</w>
er v
itu it
issu ed</w>
C PS</w>
Pre ventive</w>
Hol ter</w>
landscap es</w>
spous es</w>
B IS</w>
AC D</w>
pur ulent</w>
Resear chers</w>
restric ting</w>
rhiz osphere</w>
2 53</w>
Eth ics</w>
S olution</w>
hy aline</w>
administr ators</w>
Gene tics</w>
inqu iry</w>
centrom ere</w>
acyl transferase</w>
Ischem ia</w>
tr is</w>
ester ases</w>
edent ulous</w>
cap it
nucle oti
no stosis</w>
An .</w>
Par as
mis leading</w>
p K</w>
C Y</w>
DQ B1</w>
biom imetic</w>
g ents</w>
intra thoracic</w>
foot ball</w>
G PCR</w>
MR C</w>
sil enced</w>
ec tic</w>
odynam ically</w>
Observ ation</w>
multin ucle
Lith ium</w>
Con sumption</w>
4 32</w>
ri ol</w>
hydroxy steroid</w>
sphing omyelin</w>
propos als</w>
TA VI</w>
amphib ian</w>
un defined</w>
Re actions</w>
citi zens</w>
e igen
Mi R</w>
ym ph
bo otstr
gli osis</w>
im olar</w>
imp acting</w>
osin usitis</w>
Surve ys</w>
fel low</w>
Bost on</w>
2 71</w>
depress ant</w>
T DP</w>
phot ocoagulation</w>
occup ying</w>
cha otic</w>
AN ES</w>
Beh et</w>
K ing</w>
olig omer</w>
obi ology</w>
pediatr icians</w>
en ing
an ate</w>
1. 63</w>
Per spective</w>
neur ites</w>
in operable</w>
mal adaptive</w>
Practi cal</w>
stoichi ometric</w>
bi olog
Dem on
Pre clinical</w>
Cyto chrome</w>
dec iding</w>
S HBG</w>
perox ynitrite</w>
L H
cartil aginous</w>
H eli
M U</w>
ph entolamine</w>
ocat alytic</w>
l op
mag lob
Cor tico
Im plant</w>
ap entin</w>
H ippocamp
TC GA</w>
Pro ducts</w>
rever ses</w>
u an</w>
c idin</w>
ovari ectomy</w>
physi o
atr an</w>
3 6.
align ments</w>
en v</w>
wh it
ru it</w>
concer ted</w>
verm ectin</w>
IM PORT
protr usion</w>
S or
s lip
b outs</w>
dis infec
bl ank</w>
prog estin</w>
mode stly</w>
nanot echn
phal an</w>
eg o</w>
tetradec ano
ec ule</w>
phot oc
lam ivudine</w>
gr atings</w>
l ement</w>
mark eted</w>
hap ten</w>
org hum</w>
pyro lysis</w>
ster ility</w>
stre am
d ress
deci sive</w>
Ap gar</w>
guan id
S MR</w>
mat ters</w>
G ross</w>
B owel</w>
aver sion</w>
rhabdomy osarcoma</w>
D W</w>
post graduate</w>
paran asal</w>
H ind
SC L</w>
pren atally</w>
Dist al</w>
inter costal</w>
ob a</w>
1. 66</w>
N Q
fundam entally</w>
cohe sion</w>
Er ro
bu terol</w>
clau dication</w>
sol vation</w>
overestim ated</w>
th emia</w>
dosi metric</w>
T .</w>
LA SIK</w>
per fr
osup pression</w>
2 1st</w>
cataly sed</w>
lys osome</w>
1 20
intra vesical</w>
Simult aneously</w>
phen olate</w>
anc ers</w>
ur ve
fam ide</w>
P As</w>
em py
0.0 36</w>
bo ost
he art
pre valences</w>
Ch lo
anc erous</w>
toxic osis</w>
discrimin atory</w>
satisfac tor
ophysi ological</w>
Aneur ys
rom e</w>
HO X
2 72</w>
organis ations</w>
neutr alized</w>
at opy</w>
en one</w>
cl oth
AP ACHE</w>
re positioning</w>
Car bo
T 8</w>
K aw
De pl
edi tion</w>
sulfon yl
1. 64</w>
Injur ies</w>
pr ison</w>
multi component</w>
PA L</w>
T olerance</w>
ig ence</w>
Im mediately</w>
F it
is inin</w>
bin omial</w>
sal ping
ultra thin</w>
rot ated</w>
mono valent</w>
passi vely</w>
plethys mography</w>
Squ amous</w>
man ometry</w>
CD 5</w>
inten sification</w>
MD s</w>
S Q
ca dic</w>
bi oc
rem if
tri angular</w>
mit ogens</w>
pen sion</w>
sk elet
z idovudine</w>
chlor promazine</w>
thorac olumbar</w>
exc i
AD Rs</w>
thrombo plastin</w>
man no
or ib
vesti bul
Star ting</w>
G PS</w>
tin ine</w>
reg ressed</w>
tri vial</w>
excre tory</w>
urospor ine</w>
con val
- stimulated</w>
0.0 32</w>
Krus kal</w>
my o</w>
Uter ine</w>
E l</w>
olim us</w>
peri or</w>
phot oluminescence</w>
manifest s</w>
conjunctiv a</w>
ten o
Suppl ementation</w>
com positional</w>
ventro medial</w>
C el
dis sections</w>
tur key</w>
Le uc
neuro pathological</w>
HCO 3-</w>
k V</w>
di benzo</w>
RE E</w>
resp ir
adel phia</w>
ros ette</w>
bodi ly</w>
rel ying</w>
cap ita</w>
propag ating</w>
sam ine</w>
circum c
Ps ori
Con f
O ry
ure ment</w>
M ari
pati ent
electro poration</w>
2 3.3</w>
4 S</w>
blo c</w>
fav ors</w>
reticul ocyte</w>
metamorph osis</w>
Mac aca</w>
Consider able</w>
t elevision</w>
L Q</w>
tin ase</w>
tain able</w>
chel ation</w>
st ands</w>
Hep arin</w>
L Y</w>
3 5.
Val idity</w>
septic emia</w>
o v</w>
F OR
th inner</w>
piezo electric</w>
s lip</w>
K I
uc ulline</w>
sup pressors</w>
p ubic</w>
con serving</w>
par adox</w>
un trained</w>
aggra vated</w>
sti r
vi bri
uro dynamic</w>
mono oxygenase</w>
prec ede</w>
anter ograde</w>
lit azone</w>
un available</w>
acet am</w>
Elig ible</w>
sal va</w>
opon tin</w>
lif lozin</w>
Particip ation</w>
carbox yp
r uc
adju stable</w>
r ust</w>
toler able</w>
Com plexes</w>
Cz ech</w>
Mar kers</w>
transf ec
.0 00
volu tional</w>
Mach ine</w>
teen agers</w>
Ultrason ography</w>
2 3.1</w>
cal ories</w>
histopath ologically</w>
obliter ation</w>
F UN
n ations</w>
le ach
M eg
py ogenes</w>
wheel chair</w>
phospho protein</w>
ton ian</w>
Font an</w>
O mp
ex ogenously</w>
S ham</w>
P Y</w>
Phil adelphia</w>
exhaus tive</w>
us et
ha y</w>
institu ted</w>
re visions</w>
at e-</w>
ph aryng
2 67</w>
0.0 45</w>
C ef
suppl ying</w>
cardiover ter</w>
m 1</w>
EXP ERI
X I</w>
mo ves</w>
neur itis</w>
ic ola</w>
tubercul in</w>
2 59</w>
n omenclature</w>
al falfa</w>
later alis</w>
n AChR</w>
mal absorption</w>
stre et</w>
Po oled</w>
ello femoral</w>
str is</w>
as sion</w>
spec kle</w>
S ystolic</w>
Immun ological</w>
SY 5Y</w>
hyn chus</w>
os ep
tumorig enicity</w>
V HL</w>
resi stive</w>
B land</w>
Su stained</w>
Her pes</w>
MD CT</w>
gall stone</w>
philosoph y</w>
angi ograms</w>
six teen</w>
opr amide</w>
entan il</w>
Controll ing</w>
satisfactor ily</w>
L .
fl ank</w>
60 s</w>
coagul ase</w>
Tr is</w>
an ian</w>
inter genic</w>
broncho constriction</w>
su turing</w>
rec ession</w>
inter ing</w>
B e</w>
Di vision</w>
H 5</w>
intr atrac
pheny ls</w>
k r
hypo plastic</w>
2 85</w>
PD I</w>
amin obenz
IMPORT ANCE</w>
Dom ain</w>
priv ileg
acceler ometer</w>
Al ong</w>
3 4.
do ors</w>
3 2.
c on</w>
pom be</w>
Alg orith
Phy s</w>
pyrid inium</w>
wit nessed</w>
Melan oma</w>
In activation</w>
poly phenol</w>
TB ARS</w>
Contr ib
L ess
fl utter</w>
k o</w>
ic on</w>
ster notomy</w>
acr idine</w>
PA 1</w>
ne ocortical</w>
R 0</w>
SU V</w>
gar lic</w>
Isl ands</w>
O x</w>
parti te</w>
r ons</w>
Dend ritic</w>
s ong</w>
intern alizing</w>
br an</w>
PA N</w>
GPC Rs</w>
wa king</w>
stret ched</w>
CH S</w>
Aff airs</w>
p ons</w>
N W</w>
Mll er</w>
f usc
Inf arction</w>
Auto immune</w>
ta vidin</w>
sens ations</w>
spati o</w>
inc ial</w>
Su icide</w>
Con ference</w>
CH C</w>
yog a</w>
L CA</w>
ad or</w>
stitu ted</w>
othre itol</w>
F ACS</w>
gl os
post transplant</w>
Cul tured</w>
Th in</w>
inhe rently</w>
Enter obacter</w>
R CA</w>
gastro stomy</w>
organ ize</w>
angi ogram</w>
plas tid</w>
Electro chemical</w>
Determin ing</w>
radi ographically</w>
r IL</w>
bi um</w>
nitro phenyl</w>
2 95</w>
Ch IP</w>
Trans forming</w>
L eptin</w>
oint ment</w>
Pa CO2</w>
cef otaxime</w>
osmol arity</w>
Buil ding</w>
Enzym atic</w>
expan ds</w>
Mal aw
broad ening</w>
Per itoneal</w>
tob ramycin</w>
anter olateral</w>
Uniqu e</w>
Y AP</w>
di ous</w>
mal occlusion</w>
corne um</w>
X anth
ch oc
compart mental</w>
Lymph oma</w>
arch es</w>
9 -</w>
d A</w>
8 th</w>
1. 62</w>
sum mation</w>
P 7</w>
war d
supr a</w>
W el
I x
Uni versal</w>
intern ationally</w>
1, 8
Gl c</w>
f ats</w>
enol pyruvate</w>
x i</w>
2 76</w>
u ated</w>
Ga g</w>
Profes sional</w>
perfr ingens</w>
re wards</w>
L ag
mat ured</w>
ge ts</w>
r an</w>
PO C</w>
refuge es</w>
byst ander</w>
lin ic</w>
multi forme</w>
achiev ements</w>
bi ogenic</w>
quin ine</w>
Com p
s 1</w>
V enti
Ec topic</w>
Minim ally</w>
z ip
N K1</w>
T TR</w>
P orph
relax ing</w>
Alt man</w>
gra vit
pseud om
MD V</w>
el min
ost elium</w>
PE F</w>
ocl opramide</w>
A udi
y fish</w>
P ow
l one</w>
V TA</w>
profes sions</w>
Z r</w>
rel ieving</w>
des min</w>
disp osable</w>
SB RT</w>
it ted</w>
pro tracted</w>
MR L</w>
disper sions</w>
glycos yl
Sto kes</w>
OR R</w>
retin oids</w>
Chang ing</w>
pro active</w>
d P</w>
S ource</w>
vers ati
fill er</w>
Wil son</w>
re mitting</w>
3 93</w>
ir o</w>
bre ad
Struc tured</w>
ur ing
F 6</w>
B MS</w>
se ated</w>
h inge</w>
In sec
macro lide</w>
S an
B m
molyb denum</w>
controver sies</w>
G EN
19 60</w>
R -</w>
ero sive</w>
dehydro epiandrosterone</w>
Typh imurium</w>
C e</w>
minim ization</w>
para plegia</w>
b oxes</w>
30 7</w>
obstetr ics</w>
Meth ylation</w>
administr ated</w>
Par allel</w>
Gol d
telangi ectasia</w>
Ver o</w>
abol ish</w>
neuro tensin</w>
ss DNA</w>
str ipping</w>
E ti
Ah R</w>
CB S</w>
inv aded</w>
Y el
18. 9</w>
V alley</w>
ec top
Bi ology</w>
cyto kinesis</w>
co arctation</w>
0.0 31</w>
DM AR
ach uset
tri azole</w>
T Fs</w>
at ellite</w>
ac ar
renew ed</w>
bronchi ectasis</w>
B il
J i
hypog onadism</w>
May o</w>
1. 4
PA O</w>
HCO 3</w>
ns 0</w>
hepat obiliary</w>
thermophil us</w>
clinic o</w>
Cost s</w>
S. D.</w>
T a</w>
ow ners</w>
hydro static</w>
child bearing</w>
18. 7</w>
neuro filament</w>
ometr ics</w>
S 100</w>
B CI</w>
nanoc arri
dilu tions</w>
al asia</w>
inf inite</w>
ten e</w>
eth oxy
transep ithelial</w>
os ting</w>
achuset ts</w>
2 74</w>
S till</w>
Inf ected</w>
ref used</w>
p ockets</w>
immuno chemical</w>
SP T</w>
pericardi tis</w>
duc k</w>
S DH</w>
un intended</w>
Amy loid</w>
MCA O</w>
virtu e</w>
Sp ace</w>
pericardi um</w>
pre mat
Al ber
Conserv ative</w>
cl earing</w>
extern alizing</w>
ste ep</w>
phot ography</w>
Anat omical</w>
econ omics</w>
epig astric</w>
D AP</w>
ester ification</w>
HE TE</w>
loc alizes</w>
Mass achusetts</w>
hydroxy dopamine</w>
quin idine</w>
im eter</w>
1. 85</w>
fasc icul
car trid
m ex
18. 1</w>
estim ator</w>
lamin ae</w>
T W
rip tyline</w>
C PC</w>
expos e</w>
permeabil ized</w>
p 24</w>
0.0 37</w>
Ble eding</w>
p it</w>
Str ong
bet aine</w>
shor ten</w>
6 19</w>
Sm ith</w>
van adate</w>
str ata</w>
echocardi ogram</w>
19 69</w>
chr ys
comp action</w>
vol vulus</w>
pal mar</w>
epil eptiform</w>
Me V</w>
amoun ted</w>
juven iles</w>
lu tide</w>
sat ellites</w>
MV PA</w>
m ated</w>
Par k</w>
Ara b</w>
enter itis</w>
ultraf ast</w>
ul inic</w>
Neutroph il</w>
post eri
mas ticatory</w>
R APD</w>
un protected</w>
sto ols</w>
ylo xy</w>
andro genic</w>
sensiti zing</w>
cat abol
Feder ation</w>
sa ved</w>
E TH
ox ine</w>
dos e-</w>
Wh o</w>
bar bit
chori o
melan ocytic</w>
ab users</w>
hyper uric
neutrop enic</w>
Adap tation</w>
new s</w>
pecul i
intr as
40 7</w>
mini atur
ath ymic</w>
sk inf
preser v
Abnormal ities</w>
Gre en
Dicty ostelium</w>
A SCs</w>
ende av
cyto chromes</w>
al arm</w>
con idia</w>
c em
O v
hem opoietic</w>
gon ads</w>
synthesi sed</w>
uc k</w>
CYP 1A1</w>
FO L
non toxic</w>
aqu ap
Hierarch ical</w>
Fo ot</w>
end ogenously</w>
ac king</w>
bran ch
Apo E</w>
V .</w>
docum enting</w>
maneu vers</w>
Compon ent</w>
Attemp ts</w>
ar is
Emp ir
deter gents</w>
pen icill
B 19</w>
1. 59</w>
Spe ech</w>
mol es</w>
B arr
resist ances</w>
at ever</w>
1 10
tr ies</w>
B .
HPV 16</w>
Educ ational</w>
b id
gro ss
inev itable</w>
ses qu
function alities</w>
4 60</w>
5 00
od ystrophy</w>
PR IS
bre ath
raz ine</w>
versati lity</w>
TA VR</w>
ste atohepatitis</w>
I MA</w>
oviduc t</w>
coerul eus</w>
B 6
nig er</w>
U 1</w>
den ly</w>
fertil izer</w>
M ec
U se
sp ora</w>
&# 124
&#124 ;</w>
gre l</w>
hex adec
emin ence</w>
2 0.8</w>
AC T
Sper m</w>
keratin s</w>
0.0 38</w>
CR E</w>
agend a</w>
but yric</w>
se aling</w>
Lim itations</w>
m PFC</w>
Lang mu
ome dial</w>
Oc ean</w>
under stand
fe eds</w>
disc ern
Non invasive</w>
myo fibroblasts</w>
Pag et</w>
ic ing</w>
ath ion</w>
necess itates</w>
im pressive</w>
Govern ment</w>
a --
In fusion</w>
ne ovascular</w>
anc illary</w>
f ight</w>
TK Is</w>
g A</w>
0.0 34</w>
Re fl
hom os
charg ing</w>
ACh Rs</w>
Cycl o
kilob ase</w>
W nt
are r</w>
19. 3</w>
EC C</w>
2 7.3</w>
Ad ding</w>
recommend s</w>
amb ulation</w>
F BS</w>
ic ating</w>
s u</w>
CM E</w>
periodic ity</w>
W O
non responders</w>
fac ul
T b
scler otherapy</w>
K IT</w>
tend encies</w>
R UN
vir idae</w>
ce ased</w>
t .
GP x</w>
4 10</w>
for th</w>
sin ogen</w>
CL S</w>
N itro
youn gest</w>
tan k</w>
A J
E OC</w>
lo s</w>
parall els</w>
conve x</w>
T EN
yo himbine</w>
T EC</w>
ch able</w>
k ins</w>
F LI
1. 60</w>
Val ve</w>
viro logic</w>
us en</w>
agre ements</w>
ubiquit ously</w>
micro liter</w>
inst all
vor tex</w>
Cong o</w>
ar ticul
1. 61</w>
T UR
rel ay</w>
In jec
B ud
Mut ant</w>
Struc tures</w>
hystere sis</w>
tr amadol</w>
T al
linol enic</w>
2 4.5</w>
Glut athione</w>
en etetra
micro vessel</w>
erg ometer</w>
ure teric</w>
se aled</w>
Wh ilst</w>
phyto hemagglutinin</w>
r t</w>
Fung al</w>
G CT</w>
gross ly</w>
electro retin
hir su
chemopre ventive</w>
asymmetr ies</w>
uni directional</w>
l ou
et ch</w>
mas cul
cach exia</w>
P aired</w>
t RNAs</w>
ol gus</w>
dis advantaged</w>
Con text</w>
Puer to</w>
A SI
CN N</w>
in breeding</w>
dress ings</w>
S As</w>
gal anin</w>
fro gs</w>
s way</w>
lor ide</w>
G ab
CM P</w>
plas ties</w>
nano structured</w>
Ox ford</w>
hin der</w>
mill is
Adequ ate</w>
form yl</w>
p ine
kerat oconus</w>
p end
ab ies</w>
pil ocarpine</w>
3 8.5</w>
occur rences</w>
abund antly</w>
P PA</w>
lo tinib</w>
per ip
P NS</w>
tail or</w>
ab sol
hybri dis
Mend elian</w>
t les</w>
erb erine</w>
enteroc occi</w>
cobal amin</w>
lon eliness</w>
peri apical</w>
a j
w .</w>
pheny leth
Langmu ir</w>
agon istic</w>
enteroc olitis</w>
dyne in</w>
Ad sorption</w>
odi a</w>
AP 2</w>
H AM</w>
AT E</w>
sud denly</w>
MV C</w>
Cryp tococcus</w>
antigen icity</w>
W T1</w>
colli sions</w>
disc ectomy</w>
mesoth elial</w>
Subst antial</w>
Su pr
Aut ologous</w>
H PC</w>
IN K
intracerebro ventricular</w>
mg. kg</w>
equ imolar</w>
CD 38</w>
phosph ine</w>
troph oblastic</w>
eigh th</w>
s ors</w>
centrifug al</w>
normo xic</w>
1 S</w>
s ure</w>
Li pos
19. 8</w>
5 B</w>
i ol</w>
HI P</w>
rac em
assembl ages</w>
nanoshe ets</w>
P TS</w>
muc o
lax ity</w>
C av
home obox</w>
A ED</w>
R oles</w>
B atter
ser osal</w>
aneu ploid</w>
1. 68</w>
endor sed</w>
precip itating</w>
Through out</w>
iz z
al ex
os tin</w>
spec ts</w>
Out patient</w>
vibr ations</w>
B LM</w>
Sequ ences</w>
ron utri
omy ositis</w>
PPAR gamma</w>
assembl ing</w>
S et
be ings</w>
scin til
C itr
Wa ve</w>
adip ogenesis</w>
ch ord
me sial</w>
nucle ophilic</w>
Ps A</w>
bruc ellosis</w>
A UC
oci ous</w>
extrapol ation</w>
crystal lin
occupati ons</w>
cuti cle</w>
corpor a</w>
aur a</w>
O CT
conver s
Def ects</w>
un acceptable</w>
2 77</w>
CO P</w>
flav ones</w>
EC A</w>
Anes thesia</w>
On set</w>
beet le</w>
leaf lets</w>
Bioin formatics</w>
un detected</w>
glauc omatous</w>
- monophosphate</w>
dihydro testosterone</w>
ynchron ization</w>
mening itidis</w>
SB s</w>
O F
E u</w>
prox en</w>
D ON</w>
de ad
b out</w>
Sensi tive</w>
se at</w>
K M</w>
resi des</w>
Cy clos
h TERT</w>
DE s</w>
Micro scopy</w>
ulf an</w>
cl ipping</w>
Min or</w>
incub ating</w>
Palli ative</w>
practi c</w>
Estim ated</w>
Pers ons</w>
y x</w>
P el
K appa</w>
CN P</w>
narrati ves</w>
tric eps</w>
11 1
uscul arly</w>
p ads</w>
allevi ating</w>
Ri o</w>
er ism</w>
FUN DING</w>
di oxygenase</w>
acul ture</w>
2 6.7</w>
commens al</w>
aro xaban</w>
MR s</w>
G ut</w>
d n
inv ag
19 68</w>
th uring
for tified</w>
hydrol ases</w>
benth ic</w>
ad in</w>
ameli oration</w>
peren nial</w>
M AG
3 7.
azol es</w>
c iliated</w>
PO MC</w>
Perin atal</w>
PRIS MA</w>
cap ped</w>
2 1.2</w>
metab otropic</w>
ur ge</w>
classi fiers</w>
RE D</w>
Scal es</w>
nich es</w>
th ings</w>
ul ant</w>
B SI</w>
ocyt openia</w>
lympho kine</w>
l ing
PC 3</w>
aspir ate</w>
PP 2A</w>
E pi
dy nor
0.0 33</w>
overl apped</w>
bor tezomib</w>
hydroxy urea</w>
ri v
my corrhizal</w>
Wa als</w>
vol t
recru its</w>
CM T</w>
Eco RI</w>
know ing</w>
H2 S</w>
consul tant</w>
M 4</w>
pup ils</w>
Com position</w>
logarith mic</w>
reg rowth</w>
dissec ting</w>
an am
ad ders</w>
ero sions</w>
2 69</w>
3 98</w>
Ab solute</w>
E PCs</w>
pre formed</w>
urg ical</w>
primor dial</w>
C GH</w>
um -</w>
pro ves</w>
Gu ided</w>
CO LL
bl ur
Aqu eous</w>
L ES</w>
pursu ed</w>
ple ura</w>
as matic</w>
Sp A</w>
l ice</w>
ultracentrifug ation</w>
constitu ting</w>
deci ph
hypno tic</w>
tol l</w>
empir ic</w>
ul ators</w>
18 0
induc tively</w>
stere oselective</w>
ter in</w>
GR F</w>
Comm erc
T able</w>
bat ches</w>
fem oris</w>
archa eal</w>
tex ts</w>
t at
ide ally</w>
astrocyt omas</w>
reser ves</w>
tonsill ectomy</w>
Per spectives</w>
Ob ese</w>
se tron</w>
met all
inst ar</w>
un ve
eng ine</w>
he ur
anti angiogenic</w>
angi otens
CO M</w>
dig its</w>
rect angular</w>
g anciclovir</w>
ri tical</w>
vide ot
Val salva</w>
Haw ai
od al
8 5.7</w>
wor n</w>
vascular isation</w>
aut ophosphorylation</w>
xenobi otic</w>
tour niqu
oz ol
Typ ical</w>
cont ag
SS B</w>
MD I</w>
not eworthy</w>
Ill ness</w>
allop urinol</w>
neighbo uring</w>
legi tim
Gly co
X PS</w>
on om
di peptide</w>
de polarized</w>
Electro physiological</w>
Exc essive</w>
I SI</w>
AR I</w>
obarbit uric</w>
M d
pol is</w>
immun isation</w>
col ors</w>
mamm ographic</w>
oblig atory</w>
parv ovirus</w>
6 R</w>
ma y
ke V</w>
thuring iensis</w>
Mechanis tic</w>
bi phenyls</w>
H ym
co exist</w>
Resi dents</w>
elev ate</w>
ation --
M PV</w>
aver ages</w>
mel phalan</w>
avid ity</w>
2 78</w>
2 86</w>
sub luxation</w>
calc it
lap s</w>
CD 18</w>
diff us
nucle oli</w>
ST A</w>
3 8.
4 40</w>
D exam
inv ade</w>
1. 72</w>
strep tavidin</w>
N ow</w>
ec oxib</w>
p asses</w>
aryn go
RA DS</w>
intram uscularly</w>
Fr am
deser ves</w>
7 1.4</w>
Di ver
kinet och
W GA</w>
hist ogram</w>
hemat omas</w>
- C</w>
au er</w>
SR C</w>
L ib
PD GF
im mobility</w>
og old</w>
ath ic</w>
periph erally</w>
rs 10
We e
A e.</w>
Sub cutaneous</w>
Tox ic
CH 2
granul omatosis</w>
s els</w>
ac ros
circ RNAs</w>
det ached</w>
B lin
An th
exempl ified</w>
galactos amine</w>
etr on</w>
Epigen etic</w>
alumin a</w>
U .
tri am
rat ers</w>
dis similar</w>
Brit ain</w>
decompens ated</w>
tun e</w>
C SE</w>
Ver sion</w>
hypertriglyceri demia</w>
A stro
Nic oti
inf ested</w>
pos itory</w>
cy nom
sacrific e</w>
empy ema</w>
2, 0
trunc ation</w>
gen in</w>
Con sist
e sional</w>
19. 7</w>
am lodipine</w>
CD 16</w>
A spir
C ot
k ening</w>
no isy</w>
met am
Hist one</w>
Isol ates</w>
myri sto
cholangi opancre
2 96</w>
ne sts</w>
pa ste
syn chrotron</w>
relax ations</w>
appreci ably</w>
Macroph age</w>
D SB</w>
2 6.5</w>
zym osan</w>
narco tic</w>
inter -</w>
en forcement</w>
CD 40L</w>
ambul ance</w>
anti cholinergic</w>
exp ired</w>
ben z</w>
distor tions</w>
CR PC</w>
rhin osinusitis</w>
electr icity</w>
P PP</w>
m t</w>
di bular</w>
Ar tem
ket oconazole</w>
L up
consul ted</w>
aldo steron
bud esonide</w>
Se iz
IR F</w>
ooph o
de pot</w>
Reg ular</w>
C CC</w>
1. 69</w>
ay a</w>
compan ion</w>
Up date</w>
A bl
9 80
co iling</w>
VO Cs</w>
S ib
ion omer</w>
os sy
Gal NAc</w>
3 12</w>
T NP</w>
bis phosphonates</w>
sec tomy</w>
recur ring</w>
cre ative</w>
og litazone</w>
Bioch em</w>
gil ts</w>
R AP</w>
di ethyl</w>
co incidence</w>
mat h</w>
P x</w>
un reliable</w>
antagon ize</w>
Syn ech
hyph ae</w>
Z O</w>
CI D</w>
parag angli
di polar</w>
co expression</w>
col istin</w>
pre molars</w>
ather ogenesis</w>
Si O2</w>
IF A</w>
dithi othreitol</w>
og el</w>
anti apoptotic</w>
2 1.7</w>
peri kary
di butyryl</w>
ent on</w>
Here ditary</w>
T Z</w>
Y east</w>
lim e</w>
phot otherapy</w>
anhydr ide</w>
Ju ven
MENT AL</w>
cot yled
purch ase</w>
R 5</w>
affor ds</w>
0.0 48</w>
C igaret
W in
9 3
Rel ap
in let</w>
prog est
um or</w>
Al ex
Depl etion</w>
T AA</w>
my ositis</w>
ter ro
17. 0</w>
SH 3</w>
Effici ency</w>
Bal b</w>
effec ted</w>
SE C</w>
co tinine</w>
st ories</w>
Mam malian</w>
b os
ne ts</w>
rop ivacaine</w>
ham string</w>
vast us</w>
qu is
CD 36</w>
rot ary</w>
un reported</w>
F ecal</w>
grou p
fat alities</w>
offic in
cri tic
ch a</w>
Pro fil
ing ham</w>
CV C</w>
dimin ishes</w>
O TC</w>
fa una</w>
on ian</w>
approxim ated</w>
ne eding</w>
D TH</w>
recombin ants</w>
co de
therapeu tical</w>
Hy al
Morph ology</w>
1. 76</w>
dis ulph
leuk openia</w>
Restric tion</w>
E uc
T ST</w>
A GA</w>
mosa icism</w>
pris on
arith metic</w>
musi cal</w>
Nicoti ana</w>
40 4</w>
Percep tions</w>
par aquat</w>
papill ae</w>
extra ordinary</w>
glyco si
in atus</w>
on ych
inten sely</w>
G ib
nucle ocap
rewar ding</w>
laun ched</w>
S ed
He avy</w>
t ang
Ch arg
az ines</w>
O k
mac ula</w>
under line</w>
R DS</w>
un familiar</w>
tel em
19. 1</w>
rip tan</w>
Expl oratory</w>
2 2.7</w>
7 T</w>
M ann
rom atic</w>
Ag ents</w>
cas u
Dexam ethasone</w>
j obs</w>
Cul tures</w>
bic uculline</w>
sin k</w>
29 4
incub ations</w>
PR F</w>
z umab</w>
opac ities</w>
L an
PA N
benz othi
trop omyosin</w>
Recor ds</w>
PU FAs</w>
N SCs</w>
T uni
2. 25</w>
auto fluorescence</w>
retro viruses</w>
un exposed</w>
PC M</w>
Na F</w>
e ut
el ap
micro algae</w>
y ls</w>
ap sig
Per fusion</w>
polysomn ography</w>
monoph y
oryz ae</w>
1. 78</w>
finger prints</w>
Concer ning</w>
DO M</w>
lab oration</w>
call ing</w>
ob tur
CD 133</w>
m ock</w>
cyto protective</w>
na ked</w>
pup illary</w>
encephal y</w>
photo thermal</w>
human ized</w>
night time</w>
pter yg
NMD AR</w>
cu ts</w>
pack ages</w>
yn es</w>
st ut
as king</w>
visu ospatial</w>
T un
post test</w>
feat uring</w>
G la
forelim b</w>
2 2.3</w>
mon ocular</w>
ble ph
uc ker</w>
LM WH</w>
n .
nas oph
varic ose</w>
peri plasmic</w>
cf u</w>
2 82</w>
pall idum</w>
de fer
is ogenic</w>
oz ygotic</w>
later alization</w>
t k</w>
Cis platin</w>
P MS</w>
An der
S 9</w>
D 88</w>
tr iterpen
phag ocyt
log 10</w>
fluoro deoxyglucose</w>
S cler
5 40</w>
it ant</w>
strepto kinase</w>
S ca
fluoro quinolones</w>
E lim
on ase</w>
dimin ution</w>
f is
ind ole
so as</w>
cocul ture</w>
cy r
organ ophosph
cyan o
ag lutide</w>
ph r
neuro behavioral</w>
sal es</w>
t ently</w>
TH F</w>
FF R</w>
un suitable</w>
frag ilis</w>
valid ating</w>
predisp osed</w>
C -</w>
T ub
amput ations</w>
lactam ases</w>
s onic</w>
Z h
hospit alised</w>
zol id</w>
re tr
bio feedback</w>
fore head</w>
to thec
Cha in</w>
tim olol</w>
eti r
ight ness</w>
non parametric</w>
T m</w>
J ord
SP M</w>
AD D</w>
F ever</w>
Ambul atory</w>
T -</w>
appl iance</w>
impair ing</w>
PL L</w>
cra b</w>
rup tures</w>
mal le
V P1</w>
basoph ils</w>
R v
anthocyan in</w>
Fi g</w>
on ous</w>
bio inform
xenobi otics</w>
In ser
CD 31</w>
n ails</w>
ap i
homocy ste
s ine</w>
G ar
acter ium</w>
v imetric</w>
b on</w>
it arian</w>
fun do
beha ved</w>
2 83</w>
CO MT</w>
pene trance</w>
STAT 1</w>
intestin es</w>
vacc inations</w>
SO X
autoradi ographic</w>
D PAT</w>
consist encies</w>
N SC</w>
entr apped</w>
Tri ple</w>
weak ened</w>
M PI</w>
V SV</w>
F CM</w>
under way</w>
U su
ti zing</w>
per ine
pos tis
exec uted</w>
B 5</w>
12 th</w>
Sp ir
trop ism</w>
stimul ants</w>
fur n
histor ic</w>
en ig
0.0 46</w>
AN N</w>
ozol omide</w>
Kaw asaki</w>
H T2</w>
un employment</w>
foun der</w>
complic ate</w>
icon azole</w>
Inten sity</w>
con son
pluripot ency</w>
trans gender</w>
art um</w>
babo ons</w>
absol utely</w>
S anger</w>
t actic</w>
F 0</w>
U E</w>
CP E</w>
immunos tim
Gu ill
Hb A</w>
tun g
discord ance</w>
clo ac
al ar
Ch AT</w>
Mar ked</w>
B omb
biotechn ological</w>
n owadays</w>
E di
igen es</w>
2 1.6</w>
r um</w>
phyto plankton</w>
extrapol ated</w>
fast est</w>
2 99</w>
ph le
herbic ides</w>
C ann
al o
lamin ectomy</w>
sil age</w>
d T</w>
quantit ate</w>
Op portun
sc Fv</w>
pre malignant</w>
ici ous</w>
tetr afluoro
Polymorph isms</w>
al ists</w>
N oc
ner i</w>
ir reversibly</w>
Cyt otoxicity</w>
H ed
genit alia</w>
A tomic</w>
lenti viral</w>
1. 74</w>
exam s</w>
Mi x
osse o
recalc itr
ven ting</w>
intram ural</w>
Portu gal</w>
CH 3
helmin th</w>
hepat ocarcin
p c
M BL</w>
Ve si
hypos padias</w>
V V</w>
sper mati
pyrid oxal</w>
Sch ed
conf ident</w>
5, 5</w>
expl ant</w>
COLL ECTION</w>
un aware</w>
MT B</w>
G i</w>
tail oring</w>
examin er</w>
othor acic</w>
dec la
fasci itis</w>
classi cally</w>
- cyclic</w>
overwhel ming</w>
collag ens</w>
To oth</w>
am ant
particip atory</w>
but ter
sist ence</w>
amer ic
S SE
cr ush</w>
1. 95</w>
D RE
Chi ari</w>
al is
van adium</w>
apsig argin</w>
V ision</w>
di op
hemangi omas</w>
si loxane</w>
ster n
regul arities</w>
illustr ating</w>
clar ification</w>
TM Z</w>
refr ig
spind les</w>
sp aw
conform al</w>
tibi alis</w>
pemphig us</w>
M ST</w>
d f</w>
P ax
us s</w>
4 70</w>
dis assembly</w>
can is</w>
floc ks</w>
S Z</w>
f lowing</w>
thal idomide</w>
in sensitivity</w>
Pot enti
Adhe sion</w>
preclud e</w>
ribozym e</w>
PS G</w>
antinoc iception</w>
P 0</w>
il ization</w>
hydroxy ethyl</w>
F ig
IU D</w>
A ph
Investig ating</w>
L AMP</w>
m ogenic</w>
B am
i PSCs</w>
fin ished</w>
disrup tions</w>
perfec tly</w>
G Hz</w>
Minim um</w>
os al
doc osahexaenoic</w>
Bac k</w>
Pro duc
E volution
si rolimus</w>
ot onin</w>
dis agreement</w>
conf used</w>
sp otted</w>
Fol l
ligh ts</w>
N V
ar res
Men ing
1. 71</w>
non operative</w>
B art
con tainment</w>
V ul
no tification</w>
contrain dicated</w>
fluoro metric</w>
on olactone</w>
ob vi
Pa rent</w>
tax on</w>
voc abulary</w>
investig ational</w>
op sin</w>
crystall ized</w>
se af
ver ing</w>
Na OH</w>
nig ro
turbul ence</w>
mis diagnosis</w>
hel ium</w>
O LT</w>
ha plo
bl ends</w>
hype rex
if ery</w>
chloro thiazide</w>
interfe red</w>
hyper glycaemia</w>
PO AG</w>
choleste atoma</w>
HI AA</w>
alim umab</w>
pre ponder
repres s</w>
anth elmin
2 3.8</w>
C PD</w>
bis exual</w>
Bur k
H .
constitu tional</w>
azol amide</w>
abl ated</w>
E 1A</w>
Enh ancing</w>
im pulses</w>
phosphog lycer
si li
concentr ating</w>
perv asive</w>
satis fy</w>
cour t</w>
extrac table</w>
SC R</w>
neighbo ur
ph lo
St abil
trans glutaminase</w>
lo ad
SP L</w>
C ran
hyper prolactin
haem ophilia</w>
radionuc lides</w>
nanotechn ology</w>
crystallin ity</w>
M CD</w>
C CA
PL R</w>
kil odal
2 5.5</w>
2 0.6</w>
sil yl</w>
O K</w>
biop olym
2 81</w>
ur onate</w>
if olia</w>
bin din</w>
electroencephal ographic</w>
oc tion</w>
U s
ist ed</w>
v ign
om as
cuc umber</w>
Re plication</w>
renew able</w>
tele ost</w>
con genit
mum ps</w>
Sal ivary</w>
4 01</w>
n ights</w>
cel ecoxib</w>
mon as</w>
S of
aqu aculture</w>
DO T</w>
gelatin ase</w>
Succ ess</w>
D ogs</w>
S ic
in osine</w>
ra p</w>
neutroph ilic</w>
rati a</w>
2. 00</w>
cl aud
substanti ated</w>
E K</w>
lab ial</w>
anticip ation</w>
yr amidal</w>
d war
oli tica</w>
EZ H2</w>
gol d
leiomy osarcoma</w>
tem s</w>
bene f
spermati ds</w>
M orbidity</w>
hex okinase</w>
neurotroph in</w>
cle fts</w>
autom ation</w>
abut ment</w>
N RS</w>
azol ine</w>
N al
ph ox</w>
R ice</w>
reg isters</w>
lep rae</w>
neighb or</w>
s tick</w>
En v</w>
S omatic</w>
SU D</w>
phot olysis</w>
unc ul
ribonucle otide</w>
educ ate</w>
chec king</w>
eradic ate</w>
C lear
in ized</w>
si RNAs</w>
E PC</w>
ech inoc
H ES</w>
rs 2
3 35</w>
complex ities</w>
prevent ative</w>
ys tic</w>
J IA</w>
decre ment</w>
immuno regulatory</w>
pen icil
Victor ia</w>
ging iva</w>
 n</w>
prim i
cum ulus</w>
odon tics</w>
nes tic</w>
in noc
nitro samine</w>
occup y</w>
dis integration</w>
op ene</w>
A SP</w>
AM R</w>
anti social</w>
astig otes</w>
ambigu ity</w>
obi ological</w>
op ic
plan us</w>
T yrosine</w>
Trans formation</w>
c ow
dis appear</w>
0.0 39</w>
econ ium</w>
micro structural</w>
ven ules</w>
sil ane</w>
glob us</w>
preser ves</w>
cephalospor in</w>
A AV
ont ally</w>
meg a</w>
2 0.4</w>
ec itabine</w>
ap ed</w>
photo volta
poly propylene</w>
su tured</w>
spin ach</w>
stake holder</w>
1, 9
rectom ized</w>
DD D</w>
C Q</w>
sapon ins</w>
vari ances</w>
80 3</w>
th aw</w>
por cel
imp rec
Ca uses</w>
sac k
Ser otonin</w>
micro vasculature</w>
enteroc olitica</w>
acc ent
h ip
temper ament</w>
calcul us</w>
one -</w>
ge fitinib</w>
adhe sives</w>
mes o</w>
ser ologically</w>
ev al
Sph ing
L en
in adver
oro facial</w>
ogran in</w>
R up
AS M</w>
in arily</w>
ric kett
l ag
Me Hg</w>
MR D</w>
Anes thesi
cal end
carbap enem</w>
col ytic</w>
sol it
ach alasia</w>
Adi pose</w>
Angel es</w>
monol ith
decont amination</w>
D ex
am ps</w>
myocl onus</w>
ch ase</w>
i vermectin</w>
3 84</w>
Con ver
ceram ics</w>
pol yc
ful filling</w>
Co ul
methyl phenidate</w>
Bio chemistry</w>
otox ic
Prophyl actic</w>
H ab
Ar m</w>
Eth ical</w>
M ang
multicentr ic</w>
Sma d</w>
2 4.3</w>
peroxis omes</w>
aph ase</w>
fluoroph ore</w>
V SD</w>
0.0 47</w>
Pl an</w>
asc in</w>
premat urely</w>
H PS</w>
i g</w>
in ear</w>
Cyt otoxic</w>
fl or
Youn ger</w>
post al</w>
oste osynthesis</w>
N 6</w>
N AT</w>
EV AR</w>
T .
sh ade</w>
ab a</w>
caud a</w>
2 92</w>
A PAP</w>
ig nor
wet land</w>
g ut
SW I</w>
5 b</w>
I ON</w>
q 21</w>
b ags</w>
ne omycin</w>
il li
che ap</w>
AT s</w>
magne t</w>
19 65</w>
enti tled</w>
multi ply</w>
ane diol</w>
lev ofloxacin</w>
- 15</w>
eri ous</w>
qu es</w>
over use</w>
ant o
dec oding</w>
g ic</w>
er ations</w>
endo derm</w>
S par
Hist ology</w>
diff u
mil est
ens or</w>
fin ishing</w>
thi obarbituric</w>
it orial</w>
im oto</w>
addic ts</w>
p t
an ting</w>
experim entation</w>
bis phosphonate</w>
artem isinin</w>
com et</w>
inter view
chromat osis</w>
2 79</w>
t oglobin</w>
em mas</w>
xy lem</w>
y m</w>
TB S</w>
C atheter</w>
GAP DH</w>
piper azine</w>
Osteopo rosis</w>
wor sen</w>
hypocalc emia</w>
ud inal</w>
phosph oro
meth rin</w>
tw e
T ME</w>
Pl anning</w>
G ir
- 4.
pap ain</w>
inst alled</w>
food borne</w>
benef ited</w>
4 18</w>
wh is
micro graphs</w>
cle av
bis phenol</w>
e at
P PIs</w>
cl ed</w>
inter body</w>
por ter</w>
uni tinib</w>
Cu 2</w>
avul sion</w>
Scat chard</w>
X II</w>
work shops</w>
Tradi tionally</w>
PC 1</w>
Random ised</w>
l acc
coll ar</w>
AF B1</w>
S 1
i PSC</w>
4 30</w>
satis fying</w>
allo t</w>
vis cer
ER alpha</w>
alph ab
sphen oidal</w>
 3</w>
micro gravity</w>
GR P
guar ante
A sh
z wit
catast roph
et an</w>
L 1210</w>
des mo
bronch i</w>
CD 68</w>
rever sion</w>
P g
NC S</w>
ym ia</w>
ante grade</w>
Ultim ately</w>
C 9</w>
sati lity</w>
Juven ile</w>
AU D</w>
kin esin</w>
syst ole</w>
radi opharmac
maxim izing</w>
- related</w>
sci sic</w>
plan in</w>
hair s</w>
acycl ic</w>
hyper bilirubin
ca ught</w>
C3 b</w>
Autom atic</w>
calcit riol</w>
aminoglyco sides</w>
b c
cat fish</w>
ul ans</w>
pop ulated</w>
for cing</w>
dr illing</w>
pack aged</w>
2 0.3</w>
P eptides</w>
five fold</w>
or chi
RA W
sp ans</w>
RI P
a etiological</w>
pre load</w>
tw ard</w>
51 Cr</w>
c ecum</w>
re visited</w>
op elvic</w>
fi l</w>
prol yl</w>
Glut amate</w>
AS L</w>
CD 1</w>
H VA</w>
oplas min</w>
uve al</w>
eg al</w>
her tz</w>
Stro op</w>
cra ft</w>
re mic</w>
AI D</w>
scop ing</w>
secre tag
analog y</w>
conn exin</w>
amit riptyline</w>
chem ic</w>
P HC</w>
ow ned</w>
uro logy</w>
ni x</w>
clea ve</w>
endang ered</w>
de stabilization</w>
cann ulated</w>
Practi ces</w>
pall idus</w>
phospho enolpyruvate</w>
dimension ality</w>
nitr ide</w>
spec tac
n ymph
B -</w>
Un its</w>
ejac ulation</w>
met oclopramide</w>
pige ons</w>
Orth opaedic</w>
j udge</w>
crust ace
remo ves</w>
Cap e</w>
Tur ner</w>
op enem</w>
1. 82</w>
de regulation</w>
stac ked</w>
Si O</w>
bread th</w>
amenor rhea</w>
medullo blastoma</w>
P la
gener alised</w>
densit ometry</w>
m oth</w>
el aboration</w>
genu ine</w>
intr icate</w>
cellul ase</w>
IL 6</w>
apenta enoic</w>
cholangiopancre atography</w>
el eph
min ocycline</w>
ho id</w>
pu tida</w>
sta urosporine</w>
abra sion</w>
B ran
qu ery</w>
oste openia</w>
bar s</w>
mass eter</w>
advis able</w>
bomb esin</w>
lumin escent</w>
B ic
de generated</w>
Egyp tian</w>
LIN C
p add
ple ur
D enti
assist ants</w>
am ended</w>
ag liflozin</w>
kin ins</w>
pat ellofemoral</w>
us sions</w>
loc alizing</w>
0.000 3</w>
D TC</w>
unra vel</w>
prec ocious</w>
nitros ourea</w>
choled och
w ol
asympto tic</w>
N as
19. 9</w>
HD V</w>
remif entanil</w>
comm enced</w>
OR S</w>
magnet o
fasc ial</w>
2 6.3</w>
kind ling</w>
govern mental</w>
der ia</w>
CD P</w>
not ch</w>
circum scribed</w>
xen o
amin ol
nu triti
k no
R P
aden osyl
aldosteron ism</w>
CI A</w>
sub chondral</w>
Mitochond ria</w>
termin ate</w>
potenti ating</w>
2 91</w>
CE M</w>
HT N</w>
sun flower</w>
- containing</w>
Su gg
wor ry</w>
NCT 00
equilib ration</w>
EXPERI MENTAL</w>
un characterized</w>
polyaden ylation</w>
v owel</w>
micro sphere</w>
Regi stration</w>
o rest</w>
fil ls</w>
tor sional</w>
18. 0</w>
piper acillin</w>
A OM</w>
G rowing</w>
co activator</w>
acetyl glucosamine</w>
indol ent</w>
corner stone</w>
a plasia</w>
uro logic</w>
cTn I</w>
Nico tine</w>
Pen n
1. 70</w>
AG s</w>
123 I</w>
pos ting</w>
de par
micronucle i</w>
I ris
me 3</w>
sub merged</w>
adnex al</w>
r po
adi ene</w>
secretag og
I GT</w>
sati ety</w>
prefer ably</w>
azol in</w>
micro electrode</w>
financ ing</w>
cynom olgus</w>
S c</w>
C er</w>
impul sive</w>
H NE</w>
t ances</w>
Per u</w>
min orities</w>
bi ting</w>
spong es</w>
2 2.6</w>
Nig erian</w>
after noon</w>
kynu ren
2 89</w>
p Ka</w>
oro logical</w>
2 84</w>
sw ing</w>
Compu terized</w>
polic y
7 A</w>
w in</w>
ab ig
SI DS</w>
AL D
vascul opathy</w>
J anus</w>
in dium</w>
con sortium</w>
Phil ipp
NU MB
incur red</w>
C CS</w>
pa stor
hist olytica</w>
Adv ant
Reas ons</w>
Ric kett
ga ther</w>
abstr acted</w>
institution alized</w>
tor ch
Fabr y</w>
decla red</w>
phosphor ib
coloc alized</w>
di vor
Res ource</w>
Mar ine</w>
en closed</w>
en ema</w>
ass ure</w>
lip oma</w>
Compl iance</w>
dihydro pyridine</w>
dynor phin</w>
AI P</w>
sac cadic</w>
Ap o</w>
rein nerv
catch ment</w>
N owadays</w>
iner tial</w>
TR AF
dimorph ic</w>
x an</w>
exerc ising</w>
hum ic</w>
MI D</w>
mar mos
ex pedi
ad mixture</w>
Cat al
fundo plication</w>
G au
T s
tion ary</w>
tetrach loro
NS 1</w>
St ent</w>
dys ph
reminis cent</w>
M ol</w>
am pull
po oling</w>
dehydro genases</w>
append age</w>
k led</w>
sh ore</w>
K an
Ar gin
opter in</w>
am ib
gingi vitis</w>
costim ulatory</w>
cellul itis</w>
poli o</w>
Ch ondro
ediatr ics</w>
entr ant</w>
gra ined</w>
PD L</w>
tis ed</w>
chimpanze es</w>
ca val</w>
bre asts</w>
cin olone</w>
myelo proliferative</w>
3 45</w>
mot or
than ks</w>
endop eptidase</w>
protop orphyrin</w>
manif esting</w>
Malaw i</w>
Ch it
2 0.7</w>
.00 4</w>
hemi paresis</w>
G V</w>
sym metr
bur sting</w>
tor tu
macro globulin</w>
Cir cular</w>
V eg
sl er</w>
resus cit
p c</w>
Chrom osomal</w>
ambly opia</w>
John son</w>
di amine</w>
s noring</w>
bra sili
under take</w>
decid uous</w>
1. 96</w>
annabin oid</w>
Con form
psych ophysical</w>
excit on</w>
SR P</w>
hr an</w>
p ests</w>
per pet
Cat alyzed</w>
oc ine</w>
glomerul osclerosis</w>
rec to
2 94</w>
ov an
U PR</w>
plas mal
phen anthro
accep ting</w>
Sho uld</w>
fusi form</w>
contin ental</w>
Func tioning</w>
sub surface</w>
tur bin
chlor ite</w>
plex iform</w>
2 4,
sh eds</w>
le ptom
eclamp tic</w>
D engue</w>
p 75</w>
san itation</w>
re presses</w>
Repe at</w>
on idine</w>
chim erism</w>
on eous</w>
Con cep
Con st
Par is</w>
2 97</w>
AB I
hemat ology</w>
supr as
n ylon</w>
Austr ia</w>
4 90</w>
ophthalm ology</w>
anten n
cinti graphy</w>
iso kinetic</w>
prospec t</w>
kan amycin</w>
non fatal</w>
endoth eli
dimin ishing</w>
U tility</w>
1 L</w>
1. 77</w>
u el
he ard</w>
abstr action</w>
Lep tosp
ore tin
off ici
glo ves</w>
Test osterone</w>
Harr is</w>
m IU</w>
og e
na proxen</w>
cell ence</w>
hy oid</w>
form ally</w>
G SSG</w>
ord inate</w>
an ks</w>
si de
V a
ag glomer
thermod ynamics</w>
retur ns</w>
ER O</w>
uro ra</w>
Lymph ocyte</w>
P ut
Q M</w>
re medi
sl ing</w>
mineral ocorticoid</w>
front otemporal</w>
ill ation</w>
war ts</w>
noc iception</w>
compl ement
Chic ago</w>
Burk hol
2 2.1</w>
- 6
2 87</w>
H US</w>
un paired</w>
Isra eli</w>
gyna ecological</w>
C DS</w>
p ic</w>
T rim
0.0 42</w>
phil a</w>
dec o
Establ ishment</w>
bronchodi lator</w>
Jew ish</w>
err oneous</w>
mic tur
Col laboration</w>
CT Ls</w>
transmis sible</w>
moun ting</w>
C oupling</w>
li kewise</w>
Guill ain</w>
1. 86</w>
2 2.4</w>
D AG</w>
RA W</w>
per chlor
CA H</w>
F CS</w>
hydro genation</w>
H and
ore tinal</w>
n us</w>
end onucle
10 A</w>
exp enses</w>
14 0
underestim ate</w>
op ing</w>
micro cephaly</w>
AM Ps</w>
y osin</w>
V ene
bis muth</w>
BU N</w>
P GF</w>
post ures</w>
HC O</w>
Issu es</w>
impe de</w>
l anding</w>
Mon o
cyto chemical</w>
tac kle</w>
2 8.5</w>
k is
L BW</w>
Z im
lo oks</w>
in homogeneous</w>
op razole</w>
extr actions</w>
am y</w>
1. 6
main stream</w>
arsen ite</w>
ar ding</w>
trans rectal</w>
phon on</w>
osph eres</w>
dissec t</w>
ensu ing</w>
al ign</w>
PC E</w>
Rec ru
lati tude</w>
micronucle us</w>
faec ium</w>
sprin t</w>
S it
par aneoplastic</w>
u d</w>
ain ide</w>
vas op
CYP2 E1</w>
2 4.1</w>
3 2.5</w>
Ser ratia</w>
Angi ography</w>
counter acted</w>
Estim ating</w>
scaveng ers</w>
Que bec</w>
augh ters</w>
un fractionated</w>
eth idium</w>
k new</w>
4 3.
L AP</w>
tr uth</w>
Sup por
succ essively</w>
acylglycer ols</w>
Evolution ary</w>
P ituitary</w>
non ionic</w>
transpl antations</w>
gh ing</w>
step ping</w>
pyre thro
0.0 43</w>
resc ence</w>
conver sions</w>
RI F</w>
inter section</w>
haemat opoietic</w>
abol ishes</w>
M ir
expan sions</w>
Rec tal</w>
ylo xy
en yl
Cigaret te</w>
ag enic</w>
tex tile</w>
fruc to
cardio plegia</w>
9 29</w>
efflu ents</w>
im pressions</w>
Endome trial</w>
el ic</w>
tr ium</w>
con doms</w>
Con sul
ori enting</w>
Obstetr ics</w>
ver a</w>
sc arc
LA TION</w>
gonadotrop ins</w>
dorm ancy</w>
em es</w>
Pro ximal</w>
Por cine</w>
terat ogenic</w>
al dol
Ar teri
1. 83</w>
an ders</w>
ec o</w>
iton avir</w>
prolong ing</w>
3 33</w>
b ody
T AS</w>
there of</w>
HE K</w>
buff alo</w>
b arely</w>
che ek</w>
G US</w>
Gen otype</w>
Hy dr
GI P</w>
micro extraction</w>
osph ing
tro pic
glycolip id</w>
s IL</w>
R ana</w>
et an
Con stitu
her ing</w>
ocy anine</w>
decompens ation</w>
succe eded</w>
S AC</w>
di ox
ren s</w>
chem osensitivity</w>
hal ide</w>
ast e</w>
paste ur
cortic ospinal</w>
and able</w>
Gla uc
CA F</w>
ci vil</w>
Sr i</w>
N 4</w>
u ates</w>
K al
k A</w>
0.0 49</w>
aven ue</w>
ste aro
electrocardi ography</w>
U preg
W id
wo od
Immun oglobulin</w>
tetr ap
hybridis ation</w>
U B
All ergic</w>
chondro sarcoma</w>
duc ks</w>
val bumin</w>
CD C
Rever sible</w>
lip ogenesis</w>
PD C</w>
normo xia</w>
prolifer ated</w>
D 5</w>
J H</w>
Con duc
sou theastern</w>
illu sion</w>
ozo ites</w>
in docyanine</w>
trim er</w>
p 21
S p</w>
T on
orp tive</w>
Ann exin</w>
A cr
respec ts</w>
chol angiography</w>
an emic</w>
ed le</w>
hydro gen
ob e
Ch l</w>
disp ensing</w>
Tre ating</w>
on tium</w>
os clerotic</w>
contrac tures</w>
Bloc kade</w>
N TP</w>
epiphy seal</w>
P assive</w>
com ment</w>
ore activity</w>
mon op
amylo id
Cam ero
comput ations</w>
CD 95</w>
etr ic</w>
til l
nucle ated</w>
adip ogenic</w>
P ure</w>
or amic</w>
og al
nan ometer</w>
com pres
fr onto</w>
tourniqu et</w>
br ightness</w>
ger an
en er</w>
Practi tion
B ow
HB c</w>
semi structured</w>
nulli parous</w>
co transporter</w>
miti gated</w>
L epid
q 13</w>
Q s</w>
met azo
intr aspecific</w>
psych ologists</w>
endotox emia</w>
after wards</w>
3 13</w>
c ement
hypo vol
12 9
am idine</w>
F 10</w>
- untranslated</w>
or f
flu ence</w>
pneum atic</w>
neurolep tics</w>
decor ated</w>
lec ture</w>
benz ofur
cet uximab</w>
w rin
posi um</w>
anis m</w>
B .</w>
Impro ve</w>
SE D</w>
NUMB ER</w>
ur in
sal ience</w>
hand led</w>
HF R</w>
ile oc
Ophthal m
SO M</w>
40 3</w>
L LC</w>
gastro duodenal</w>
haemat oma</w>
psycho active</w>
an nel</w>
ress ors</w>
H ep</w>
P ICU</w>
DA SH</w>
myri ad</w>
Yel low</w>
secre tase</w>
propor tionally</w>
T BP</w>
exha ust</w>
r icin</w>
dis close</w>
still birth</w>
brevi ated</w>
associ ating</w>
Questionn aires</w>
For m
Compl ementary</w>
R PA</w>
un corrected</w>
DM I</w>
ATP ases</w>
U F</w>
c aly
muc os
pseud op
tetrach loride</w>
inter viewing</w>
ther mot
Pre -</w>
trabecul ectomy</w>
F ABP</w>
pec tomy</w>
ribonucle oprotein</w>
re tail</w>
trac ks</w>
Tu key</w>
gab apentin</w>
ph obia</w>
sp ared</w>
L ank
dor si</w>
ed rine</w>
Agr icul
b in</w>
ro oted</w>
drain ed</w>
ron i</w>
inv alu
E OR
1. 87</w>
Met formin</w>
Sub stitution</w>
oste olysis</w>
under scores</w>
sal is</w>
CT GF</w>
penicill amine</w>
Pre term</w>
plasm apheresis</w>
son ication</w>
antr one</w>
En rich
B ile</w>
ti st</w>
Descrip tion</w>
wid ening</w>
M Z</w>
neuro p
enter ocytes</w>
coinc ides</w>
S ST</w>
er cosis</w>
ME L</w>
Fem oral</w>
interfer ons</w>
pro viral</w>
invalu able</w>
tap ered</w>
mo tives</w>
op t
Ste p
P article</w>
G .</w>
yl ates</w>
R ich
remo vable</w>
PT P
haem olyticus</w>
Cur cumin</w>
glycer aldehyde</w>
1. 79</w>
Ar a</w>
AN T</w>
laryng oscopy</w>
We ek</w>
pip ette</w>
de formations</w>
ver b
PR RSV</w>
t apping</w>
spon sored</w>
ox yl</w>
un equal</w>
ther mol
voc ational</w>
ore xin</w>
P CD
J .
opto electronic</w>
spiro ch
heterodi mers</w>
ot o
AD CC</w>
cel lo
stem ness</w>
T DF</w>
rec al
ess or</w>
pediatr ics</w>
scen es</w>
firm ly</w>
V aginal</w>
spo ken</w>
em atical</w>
it ching</w>
3 17</w>
form ic</w>
t elec
hyper ventilation</w>
0.0 41</w>
19. 0</w>
Taiw anese</w>
di -</w>
SH P</w>
drop out</w>
ol is
amplic on</w>
oc al
sev er
odom ain</w>
dermat ological</w>
dist ally</w>
Le af</w>
I CT</w>
conn ex
C CP</w>
Trans fection</w>
industri alized</w>
japon icum</w>
G eriatric</w>
es cul
coloc alization</w>
f allopian</w>
om ies</w>
Ster oid</w>
glabr ata</w>
an teri
supr ag
Flex ible</w>
G K</w>
- 9
hydro ps</w>
ISR CT
angi ographically</w>
cor n
emb rane</w>
Car ri
vir als</w>
spo use</w>
cardiover sion</w>
2 3.4</w>
Burkhol deria</w>
3 38</w>
D un
gen ol</w>
Mo tion</w>
Endoc rine</w>
DE HP</w>
tin in</w>
cap tures</w>
domin ate</w>
cannabin oids</w>
rel s</w>
ST 2</w>
ap arin</w>
em et
immun olab
gal lium</w>
diver ged</w>
w ives</w>
fe e</w>
aller genic</w>
0.0 20</w>
pro coagulant</w>
1. 81</w>
assi sting</w>
carc asses</w>
R RT</w>
omen ing
7 a</w>
U PLC</w>
im umab</w>
Includ ed</w>
foot print</w>
baro receptor</w>
bor ate</w>
simpl ify</w>
repor tedly</w>
ag al</w>
aph id</w>
stimul ations</w>
Path ogenesis</w>
later ality</w>
A As</w>
protein emia</w>
5 01</w>
p S</w>
dal ton</w>
lipi demic</w>
W AT</w>
organis ational</w>
soldi ers</w>
te am
ac ylated</w>
SSR Is</w>
P Z
ophen yl</w>
la w
perin uclear</w>
est yles</w>
1. 84</w>
sl ur
F allot</w>
al ties</w>
deoxy cholate</w>
Fib er</w>
Ar sen
intrad uctal</w>
Synerg istic</w>
histo chemically</w>
PV I</w>
scinti graphic</w>
underestim ation</w>
R BP</w>
idi otypic</w>
Qu in
ali qu
rel uc
TR IM
no thing</w>
in sti
dom onas</w>
sul fo
6 B</w>
G M
fluo rene</w>
oper ant</w>
pat chy</w>
II I
19 50</w>
0. 125</w>
Me dium</w>
vit ality</w>
denitr ification</w>
dil emmas</w>
pos th
disc ol
rin se</w>
I SH</w>
ol uc
PI K3
tetr as
Ultr a</w>
Maj ority</w>
- flanking</w>
porcel ain</w>
tal ar</w>
stor m</w>
Ga N</w>
non obese</w>
epig ene
Institu tional</w>
on itis</w>
tin gu
3 9.
pneumon ectomy</w>
T ou
Path ologic</w>
S SCP</w>
5 12</w>
hex os
provo ke</w>
intr onic</w>
Accum ulating</w>
bi tis</w>
New ly</w>
Clim ate</w>
Pr inci
pix els</w>
R ank
Te hran</w>
mas ks</w>
g ills</w>
is os
gold fish</w>
PC SK
opac ification</w>
asp ing</w>
cholest atic</w>
T CD</w>
T b</w>
an setron</w>
sec tioning</w>
water shed</w>
6 20</w>
conc e
cr ises</w>
ograph ed</w>
laryng ectomy</w>
contain ers</w>
calend ar</w>
F MS</w>
S low</w>
de duc
therm ogenesis</w>
c ub
980 59</w>
Cir cadian</w>
varic ocele</w>
J C</w>
th apsigargin</w>
prec ancerous</w>
Spi ro
H T3</w>
de alt</w>
normal ize</w>
oxif ylline</w>
ud ing</w>
MI BG</w>
Cyt ogenetic</w>
TGF </w>
s arc
fem in
exp iration</w>
on wards</w>
C 16</w>
TL Rs</w>
abig atran</w>
P ast</w>
bil s</w>
oguan idine</w>
ap ia</w>
2 c</w>
F enton</w>
Con struc
He aling</w>
schizophren ics</w>
un published</w>
bo ards</w>
inhal er</w>
Spectro metry</w>
eno humeral</w>
mc g</w>
An kle</w>
hist ograms</w>
allo on</w>
Pa ediatric</w>
advertis ing</w>
Gen otyping</w>
b all
ey e
Bloc k</w>
Fri ed
Prostagland in</w>
ca uter
g ris
de g</w>
estro l</w>
W NV</w>
3 43</w>
up dating</w>
Vari able</w>
6. 25</w>
ovi position</w>
A AT</w>
CH 4</w>
3 26</w>
N av
ov aginal</w>
TR AL</w>
lute um</w>
Sal t</w>
poly genic</w>
PE A</w>
precip itates</w>
ad an</w>
prescrib e</w>
P W</w>
govern ments</w>
19 ,
MT D</w>
lipoly tic</w>
um inated</w>
top ographical</w>
Co he
ped al</w>
1. 89</w>
dou bly</w>
NS 3</w>
Bene fits</w>
2 n</w>
intercal ated</w>
G ri
noc ic
CDK N
prop idium</w>
og els</w>
H ash
al um</w>
oste ochondral</w>
SYN THESIS</w>
1. 80</w>
Bur den</w>
phosphoryl ates</w>
euthan ized</w>
reg ressive</w>
pigment osa</w>
standardi ze</w>
foramin al</w>
re missions</w>
ile ostomy</w>
fav oured</w>
kerat o
glut aryl</w>
L 6</w>
2 4.2</w>
M CH</w>
sphinc ter
obstetr ical</w>
3 73</w>
1. 88</w>
K EGG</w>
C JD</w>
T PP</w>
cho ol
Cardi ology</w>
radiolab elled</w>
fl ushing</w>
Tran sp
D SBs</w>
P v
proprioc eptive</w>
mel i
oopho rectomy</w>
X P</w>
penetr ated</w>
al en</w>
N Ts</w>
ex onuclease</w>
ent ails</w>
sum ing</w>
n ailing</w>
Dis sem
S impl
pa ins</w>
ag A</w>
ve g
ME N</w>
b ore</w>
2 1.8</w>
ond ansetron</w>
Rec eptors</w>
Sens or</w>
pul mon
ML H1</w>
re folding</w>
ine ous</w>
o at</w>
cul min
depend encies</w>
2. 15</w>
Post natal</w>
Chlamy domonas</w>
intrap artum</w>
O f
re ef</w>
Integr ating</w>
Tor onto</w>
carboxyp eptidase</w>
immuno deficient</w>
immun odom
biop sied</w>
IM PACT</w>
cyan obacterial</w>
Ant arctic</w>
am ed</w>
cl amped</w>
gel ation</w>
3 14</w>
br ace</w>
oval e</w>
L RP</w>
transpos ons</w>
syl van
euthan asia</w>
brac kets</w>
riv aroxaban</w>
Ar my</w>
capro lactone</w>
fol ia</w>
tuber cle</w>
typh oid</w>
recep tion</w>
ing rowth</w>
mac ronutri
F D
T 6</w>
Sub strate</w>
My D88</w>
PE O</w>
sulf onyl</w>
unra vel
Aspir in</w>
blin k</w>
CI C</w>
si i</w>
suic ides</w>
biog e
st -</w>
end osperm</w>
s orbent</w>
om ata</w>
pre molar</w>
50 5</w>
quadru plex</w>
monoph asic</w>
co operate</w>
fib ula</w>
di alogue</w>
Mo roc
psych o</w>
dec entr
Amaz on</w>
cre tion</w>
En cephal
si ds</w>
granul ocytic</w>
Impl antation</w>
Fre und</w>
con ferences</w>
re use</w>
AN IM
pal in
p 62</w>
cl ips</w>
analy tically</w>
ambi a</w>
grac ilis</w>
compl aining</w>
Bif id
CYP2C 19</w>
pol yl
see ing</w>
O TA</w>
pursu e</w>
mor tal
i rosis</w>
ut z
satur ating</w>
scarc ity</w>
o estrus</w>
propo s</w>
chondro genic</w>
hed gehog</w>
cu ps</w>
c up
re ven
si ll
tou gh
ad ural</w>
4 88</w>
contrain dication</w>
H AP</w>
t .</w>
reg ained</w>
nor theastern</w>
pep per</w>
activ eness</w>
i eld</w>
p -</w>
kine tically</w>
phosphot yrosine</w>
end obronchial</w>
H ome
or hin
encomp ass</w>
protozo a</w>
I DA</w>
my enteric</w>
repeti tions</w>
arachid onate</w>
osp ond
B is</w>
PC Ps</w>
ependym al</w>
D in
MB q</w>
hop ed</w>
per if
ig el</w>
TE s</w>
1. 92</w>
tox oid</w>
duoden ectomy</w>
Pro mo
HR CT</w>
Extrac ts</w>
hy men
mill il
A HA</w>
car ds</w>
pro insulin</w>
aband oned</w>
H K
F g
un ity</w>
k i
I tems</w>
appl i
gall ate</w>
perc ritical</w>
hand grip</w>
Prog esterone</w>
Issu e</w>
phenol ics</w>
st at</w>
non invasively</w>
Transcrip tome</w>
dish es</w>
H all</w>
5 HT</w>
op exy</w>
ari etal</w>
poly vinyl</w>
Er r
quer ied</w>
- 8
SP F</w>
r 1</w>
elev ating</w>
O DI</w>
un ate</w>
anaphy lactic</w>
Tok yo</w>
od d</w>
H ard
pro ving</w>
ub a</w>
N TG</w>
GI S</w>
deriv atized</w>
m s
qu e
co done</w>
lar va</w>
ho ok</w>
Lin kage</w>
m Health</w>
- treated</w>
Por tal</w>
asci tic</w>
k not</w>
sp end</w>
nucle osomes</w>
distingu ishes</w>
trib ut
D ox
Wor kers</w>
well ness</w>
2 0.2</w>
Hist amine</w>
dysp noea</w>
pollin ation</w>
pres sur
om uc
cyclo addition</w>
cryp torch
si as</w>
o acetate</w>
I PD</w>
ha em</w>
T ween</w>
aden oid</w>
ME LD</w>
valpro ic</w>
3 16</w>
T ME
sw allow</w>
circum vent</w>
diarrhe al</w>
aptam ers</w>
m econium</w>
L PO</w>
K 5</w>
IV US</w>
T ER
miti gating</w>
eigh teen</w>
porphyr ins</w>
M aster</w>
Z o
hal ogen</w>
SE T</w>
tam er</w>
ever olimus</w>
P NP</w>
ech oic</w>
tw isted</w>
Pu gh</w>
diffus ely</w>
le u
collo ids</w>
dac tyly</w>
ib izumab</w>
bl ade</w>
an ec
uro graphy</w>
aph th
intellig ent</w>
ron ous</w>
M 
pat ern
Cat alytic</w>
robu stly</w>
oste opontin</w>
Tes ticular</w>
T n</w>
In nov
up dates</w>
hypot onic</w>
onco protein</w>
extram edullary</w>
8 4
D ry</w>
pow ers</w>
anticip atory</w>
L Ns</w>
E U
T DI</w>
bo ur
carb amate</w>
Radi ology</w>
horiz on</w>
tw ist</w>
identi fier</w>
s ort</w>
ex t
Li ve</w>
Gr ad
arom a</w>
Glyc ine</w>
s kin
PT V</w>
at tract</w>
A cous
hyper thyroid</w>
di ving</w>
bl a
otrop h</w>
Agg ressive</w>
inter position</w>
palmit oyl
Str ati
a head</w>
happ y</w>
P ha
code ine</w>
im ino</w>
ress or</w>
2 1.9</w>
cyt opathic</w>
fac tor
3 D
L AM</w>
dre w</w>
accred itation</w>
aug menting</w>
x ide</w>
de regulated</w>
p its</w>
den ing</w>
PK 1</w>
d C</w>
par g
H2 AX</w>
m es</w>
op us</w>
Prob lem</w>
ifos famide</w>
B iliary</w>
ac tom
Prote omic</w>
in hab
thi ol
G PA</w>
et ched</w>
anthocyan ins</w>
co infection</w>
pe el</w>
dor si
relig ion</w>
melan ocyte</w>
mis s</w>
lam ellae</w>
ser y</w>
bl astic</w>
d aughters</w>
entr ain
chi sis</w>
flag ella</w>
Pharmac eutical</w>
EOR TC</w>
K Y
H ox</w>
phospho choline</w>
fellow ship</w>
4 4.
acin i</w>
mal arial</w>
P ND</w>
hep cidin</w>
intra renal</w>
2 2.8</w>
A ge
G .
P P1</w>
lat tices</w>
CD 30</w>
i ors</w>
c un
pe tic</w>
30 ,000</w>
me ant</w>
Pro per</w>
NH ANES</w>
Te am</w>
tet anic</w>
los sal</w>
tur tle</w>
rhabdomy olysis</w>
p o</w>
6 000</w>
inv al
clav icle</w>
we ap
poly pharmacy</w>
di lol</w>
ev asion</w>
out performed</w>
atic ity</w>
archa ea</w>
F el
40 9</w>
L Q
In take</w>
PW S</w>
3 24</w>
fl avi
quad ri
at rist</w>
isol e</w>
Ste ady</w>
2 5.6</w>
dis asters</w>
P c
eth onium</w>
Fram ingham</w>
3 23</w>
V is</w>
Bon fer
steril ized</w>
neointim al</w>
2 7.8</w>
t ography</w>
in suff
gam bi
O S
lact ams</w>
neighbor hoods</w>
19 60s</w>
transfec tants</w>
STAT EMENT</w>
Me dia</w>
LE Ds</w>
5 20</w>
neuro fibrillary</w>
R XR</w>
dis ap
phospho transferase</w>
ic ks</w>
ver si
ep i</w>
dis cour
esti s</w>
5 7.1</w>
V AT</w>
om itted</w>
contu sion</w>
on yl
fa ult</w>
Perc ent
H DR</w>
r hom
O E</w>
al og</w>
20 ,
Micro array</w>
pacema kers</w>
econ ds</w>
D ro
cc RCC</w>
O FF</w>
er lotinib</w>
basi cally</w>
em e</w>
ind olol</w>
diff usive</w>
Par ticular</w>
S ons</w>
aspir ated</w>
bac illus</w>
LU TS</w>
A Y
pos it
employ ers</w>
sug ar
asynchron ous</w>
un supervised</w>
p ant
X S</w>
Th resh
cere als</w>
cle aves</w>
volt ages</w>
D ox</w>
leuk ocytosis</w>
An omal
cou plings</w>
micronutri ent</w>
H Q</w>
metabol omic</w>
oc king</w>
ve dilol</w>
PO A</w>
CEN TRAL</w>
val vul
CA N</w>
W MD</w>
p idus</w>
ali ke</w>
AC I</w>
pancre at
entr ies</w>
PO IN
OR F
P2 X
assist ant</w>
pre incubated</w>
alk anes</w>
SN S</w>
Cyt os
Ba P</w>
aort as</w>
A AC</w>
multi system</w>
P osi
moder ating</w>
P PE</w>
4 4.4</w>
E ither</w>
const ell
peculi arities</w>
idi al</w>
immuno diffusion</w>
urban ization</w>
G CA</w>
pleth ora</w>
Cle ar</w>
L ind
specific ations</w>
GI T</w>
Rob ust</w>
biolog ics</w>
P yro
immunost ained</w>
sc r
mus cim
un balanced</w>
Syn chron
plas tic
mes encephalic</w>
kain ic</w>
pedi grees</w>
a plasma</w>
d amp
in forming</w>
quin tile</w>
FI GO</w>
life times</w>
B rom
de hydr
rib osylation</w>
Ab l</w>
PI A</w>
CE US</w>
Bloc king</w>
tubul o
ethan olic</w>
flow metry</w>
hydra zone</w>
2 0.9</w>
clu sively</w>
mutag ens</w>
som ata</w>
prov incial</w>
mill ig
t agging</w>
et allic</w>
ep ri
HEK 293</w>
5 alpha</w>
ad hering</w>
Cerebro spinal</w>
W o
M AM</w>
hydro genase</w>
SC Cs</w>
Differen ce</w>
out performs</w>
parox etine</w>
GLU T1</w>
ent om
CT R</w>
od on</w>
Cl 3</w>
plant arum</w>
pell ucid
CN Vs</w>
a rene</w>
est rel</w>
exc imer</w>
lipid aemia</w>
X yl
Trac king</w>
recalcitr ant</w>
F ro
eth ing</w>
CD R</w>
2, 7
caus ation</w>
s ocket</w>
U bi
infiltr ative</w>
beet les</w>
defl ection</w>
Per man
CP M</w>
chim era</w>
pip e</w>
astr in</w>
flatten ed</w>
des ert</w>
r as
se baceous</w>
Con focal</w>
An emia</w>
muscim ol</w>
pro apoptotic</w>
deri ving</w>
digit orum</w>
E AC</w>
fe eder</w>
postis chemic</w>
p 38
qu orum</w>
kary otypes</w>
scann ers</w>
Examin ing</w>
ab at
lin kers</w>
aer ation</w>
centrom eric</w>
resear ched</w>
2.0 5</w>
ol ae</w>
Cdc 42</w>
me ticul
CL E</w>
Col on</w>
Ga it</w>
perfor ator</w>
metacar pal</w>
perim etry</w>
40 8</w>
swe ating</w>
o chr
par si
Rab bit</w>
at razine</w>
Wh ites</w>
ad versity</w>
ospor ium</w>
MO Fs</w>
Su perior</w>
confron ted</w>
I d</w>
V erbal</w>
yn ess</w>
Inter sti
argin ase</w>
chir ality</w>
coinc ide</w>
AB C
eb a</w>
cle aving</w>
claud in</w>
resembl ance</w>
D MA</w>
9 4
op al
extrem es</w>
chiro practic</w>
S BS</w>
piper idine</w>
20 1
recogn izable</w>
re pairing</w>
electro spun</w>
A symmetric</w>
mess engers</w>
achi asmatic</w>
per methrin</w>
motiv ations</w>
e ism</w>
- UTR</w>
veter in
3 G</w>
ow a</w>
equ atorial</w>
foun ded</w>
hun ger</w>
p ies</w>
F PG</w>
att ach</w>
3 36</w>
2. 5
HC Cs</w>
r p
SK F</w>
un loading</w>
suff ers</w>
Pot assium</w>
Cy an
LY P</w>
s orghum</w>
lyc opene</w>
histi ocytic</w>
turb idity</w>
hex ose</w>
DR 4</w>
Prec ision</w>
ith ymia</w>
bl a</w>
U m
psych ologic</w>
4 2.9</w>
O Cs</w>
phenanthro line</w>
4 5.5</w>
p ou
megakary ocytes</w>
1 B1</w>
flex ural</w>
verte bro
ur on</w>
hem optysis</w>
An k
triam cinolone</w>
Physi ology</w>
29. 4</w>
beha ves</w>
inf lated</w>
intersti tium</w>
osteocl ast
j umping</w>
Cl ose</w>
Bonfer roni</w>
T SC</w>
Al aska</w>
EC L</w>
Col or
ar athyro
phyto chemical</w>
un described</w>
flan ked</w>
erec tion</w>
Magne sium</w>
mill ing</w>
pul satility</w>
S pati
M AD
Ar ray</w>
Cryst all
ec ologically</w>
Less ons</w>
indic a</w>
R en
ellip so
3 19</w>
E W
C As</w>
3 28</w>
SU Vmax</w>
w ounding</w>
hydro lysate</w>
neuro kinin</w>
PI N</w>
2 4.4</w>
A Q</w>
Hist opathology</w>
gri ef</w>
gang rene</w>
ol .
yn yl</w>
oste otomies</w>
Immun otherapy</w>
exud ative</w>
3 0.0</w>
Alber ta</w>
succ ession</w>
Doc um
X i
phosphor ylate</w>
spor um</w>
Arti cles</w>
Sud an</w>
diverticul itis</w>
Sy d
moll us
inter ictal</w>
micro be</w>
PRO M</w>
S ection</w>
N iss
loc alities</w>
H3 N2</w>
T f</w>
Wh ich</w>
marc escens</w>
id ylate</w>
itu ality</w>
T CS</w>
neurolog ically</w>
- 30</w>
a ked</w>
ro ad
p 63</w>
col ostomy</w>
TI PS</w>
C oma</w>
D 2
aver ine</w>
ze olite</w>
exp andable</w>
7 2
g ym
ocyt omas</w>
Frequ ent</w>
Ampl ification</w>
re hydration</w>
oper ation
Bi g</w>
at entorial</w>
ther mos
annot ations</w>
hap toglobin</w>
Psori asis</w>
an aphase</w>
ifer ol</w>
Long er</w>
conver ge</w>
acr on</w>
Typ es</w>
E TA</w>
scap hoid</w>
gyn ecology</w>
Sud den</w>
EN aC</w>
2 2.9</w>
M SP</w>
lif estyles</w>
spl in
dig est</w>
T CE</w>
im migration</w>
al ising</w>
Fox p3</w>
L AS</w>
cock ro
fac tant</w>
TR PM
aris en</w>
success es</w>
bran ds</w>
Regi stered</w>
skew ed</w>
i o
p 300</w>
diast ole</w>
Peri od
ambigu ously</w>
C GP</w>
centur ies</w>
onc ogenesis</w>
Col e
3 55</w>
p ub
enter pr
earthqu ake</w>
P 8</w>
r itonavir</w>
cry otherapy</w>
sing le-</w>
ic ho
te l</w>
ir one</w>
natur alistic</w>
AT G
L ayer</w>
micro capsules</w>
ore sistant</w>
Nor mal
aldol ase</w>
h its</w>
bif ida</w>
AI T</w>
Dec om
Intersti tial</w>
bo ar</w>
flo od</w>
appli ances</w>
resc rip
subjec tively</w>
Pres enting</w>
amni ocentesis</w>
Interpre tation</w>
dwar f</w>
i qu
4 6.
B t</w>
det ella</w>
gly oxal</w>
ver ruc
13 7
p. i.</w>
nigro striatal</w>
L AA</w>
H ip
G em
sing ular</w>
E t</w>
titr ated</w>
transp eptidase</w>
inter cept</w>
Pro grams</w>
Man ip
Suppl ementary</w>
aden o</w>
pyr role</w>
accoun tability</w>
plank tonic</w>
fem oro
pod ocytes</w>
ger bils</w>
Anti bacterial</w>
exce ed
FL T3</w>
ter y</w>
tetram ethyl
Secre tion</w>
bach ia</w>
4 00
minim izes</w>
spermat ocytes</w>
3 6.4</w>
1. 98</w>
radi ative</w>
2 3.2</w>
L ec
4 b</w>
hal o</w>
C affe
i x
4 5.
si t</w>
lam b</w>
sulph ur</w>
cap ecitabine</w>
g or
Mar fan</w>
Empir ical</w>
ation -</w>
hyp o</w>
stem ic</w>
cist er
bioinform atic</w>
tan gen
- 80</w>
electron ically</w>
H5 N1</w>
o frontal</w>
M J</w>
mod ulations</w>
Famil ies</w>
Lim b</w>
en sured</w>
eg u
ND V</w>
J ones</w>
phos ate</w>
intr af
Ca Cl2</w>
F ES</w>
hem olymph</w>
T ot
resum ption</w>
gras p</w>
W er
AR A</w>
3 18</w>
F MR
cl ots</w>
bin der</w>
im balances</w>
GL UT</w>
P DS</w>
ot us</w>
chel ate</w>
M im
dic tion</w>
E mission</w>
peri prosthetic</w>
lit ters</w>
ad alimumab</w>
d ane</w>
z ein</w>
hydro chlorothiazide</w>
Syd ney</w>
d UTP</w>
1. 7
111 In</w>
cu ed</w>
SP I</w>
chron otropic</w>
A1 C</w>
Cyto kines</w>
Hippocamp al</w>
Conf idence</w>
naph tho
plasm atic</w>
PR IN
8 50</w>
B ipolar</w>
brasili ensis</w>
f ishing</w>
M ellitus</w>
triti um</w>
C en
tri angle</w>
buil dings</w>
arthro plasties</w>
calib er</w>
Bor detella</w>
rectom ies</w>
SM AD
C ER
end ronate</w>
sub threshold</w>
corrobor ate</w>
A SE</w>
H 19</w>
I PS</w>
pre diabetes</w>
V el
PS MA</w>
inf inity</w>
I E
expon ent</w>
RG Cs</w>
benz imidazole</w>
ampull ary</w>
N .
no s</w>
sched uling</w>
N PS</w>
ent a</w>
direc ts</w>
2, 4,6</w>
compl ements</w>
1, 25-</w>
Polymorph ism</w>
fo reg
zz le</w>
myc otoxins</w>
integr ase</w>
l af
T ab
Nan o</w>
Cop ing</w>
2 0.1</w>
yl and</w>
Rel ax
DP PC</w>
mon ozygotic</w>
peric ytes</w>
dec ap
Abl ation</w>
PRO SP
Or b
ad duction</w>
6 30</w>
NI S</w>
SR s</w>
2 3.6</w>
eb all</w>
294 002</w>
sh all</w>
cycl op
cent rosome</w>
re rs</w>
diag rams</w>
fer redoxin</w>
hem in</w>
PT s</w>
mel it
ord inal</w>
pun ishment</w>
multi step</w>
atr ic
Cl ar
PM T</w>
nitro so</w>
deform ability</w>
rep ell
shad ow</w>
otrop ia</w>
cataly zing</w>
sap onin</w>
olis thesis</w>
B F
Ser ological</w>
perpe tr
un conscious</w>
1. 93</w>
40 6</w>
hot spots</w>
sel f
D TT</w>
2.0 4</w>
symbi osis</w>
S et</w>
as ks</w>
meth ion
M ALT</w>
oph obia</w>
transl ating</w>
cystic ercosis</w>
4 35</w>
b am
ti ed</w>
tec tum</w>
pod ocyte</w>
PI 3</w>
continu ally</w>
arbox ylate</w>
extrap yramidal</w>
phosph oc
percenti les</w>
Lat ent</w>
pige on</w>
Al u</w>
rib s</w>
ward ship</w>
H ous
ex o
ven oms</w>
bul king</w>
Tra it</w>
gl ing</w>
pi oglitazone</w>
Cardi omy
municip alities</w>
t angles</w>
Sol anum</w>
selen ite</w>
1. 94</w>
- phosphate</w>
read out</w>
hypothesi sed</w>
fi ref
diag onal</w>
PC O</w>
hybrid omas</w>
a 3</w>
5 60</w>
immuno electrophoresis</w>
pre motor</w>
SO CS
dist ention</w>
desatur ase</w>
draw s</w>
C uc
om ental</w>
mer openem</w>
addic tive</w>
insul ator</w>
DE N</w>
CK 2</w>
cock tail</w>
provi sional</w>
transmit ting</w>
gra vid
Neuro spora</w>
am id</w>
bromo deoxyuridine</w>
Georg ia</w>
2 4.6</w>
1, 500</w>
tap eptide</w>
cm H2O</w>
ni an</w>
R ange</w>
O vid</w>
glycer o</w>
Ehr lich</w>
nasoph arynx</w>
ch ore
SI P</w>
oid ectomy</w>
iod o</w>
Character istic</w>
PCSK 9</w>
cl onic</w>
fo als</w>
nat ally</w>
seas onality</w>
A AS</w>
ar ab
2 9.5</w>
C ause</w>
ill uminated</w>
Cap illary</w>
disproportion ate</w>
dipl opia</w>
ar as
biom olecular</w>
am per
Al ve
mean ings</w>
m eval
pro st</w>
numer ary</w>
oc ally</w>
0.0 44</w>
chemo embolization</w>
d na
P PG</w>
radio iodine</w>
Saf e</w>
mal function</w>
isth mus</w>
P p
Chrom atin</w>
Gest ational</w>
PL T</w>
chyl omic
fulle rene</w>
preponder ance</w>
multi stage</w>
Que ens
ogen omics</w>
tothec in</w>
un specific</w>
j aws</w>
am isole</w>
tom ized</w>
retri eve</w>
ac cul
SR BC</w>
S and
tr aline</w>
me ets</w>
sp ina</w>
tab ac
3 1.5</w>
r Hu
homin is</w>
neuro ticism</w>
ocul tural</w>
CL D</w>
pre medication</w>
IC M</w>
postin ter
ag og
consul tants</w>
Lif estyle</w>
3 ,000</w>
psych osomatic</w>
radic ular</w>
Proced ures</w>
C as</w>
Ex ec
Sh h</w>
L u</w>
D HFR</w>
ac s</w>
ad aic</w>
hor ase</w>
DE SC
bul l</w>
synth ases</w>
Cro ati
mictur ition</w>
Compl ement</w>
mast oid</w>
L TD</w>
Av oid
Hash imoto</w>
t uce</w>
cul in</w>
SE ER</w>
resum ed</w>
f owl</w>
4 25</w>
R K2</w>
Q ALYs</w>
Wol bachia</w>
ph obic</w>
techn icians</w>
ref usal</w>
digiti zed</w>
3 4.5</w>
e fully</w>
re infection</w>
parasi tism</w>
con vol
micro -</w>
MM PI</w>
pu st
oth yro
t mann
ST ATI
L ET</w>
teri onic</w>
exud ates</w>
gl enohumeral</w>
1. 8
mis matches</w>
ho ok
UD CA</w>
dorm ant</w>
12 -</w>
parathyro idectomy</w>
u rella</w>
Pro c</w>
fluoro quinolone</w>
p. m.</w>
Glauc oma</w>
i osity</w>
SU MO</w>
Muc osal</w>
ni volum
nucle olus</w>
polymy xin</w>
comm and</w>
allevi ates</w>
amid o
disulph ide</w>
p is
Pop ulations</w>
suscepti bilities</w>
4 54</w>
b ath
ide um</w>
Ray n
id ality</w>
con volutional</w>
amelior ating</w>
pea king</w>
nucleoti dase</w>
CH X</w>
Bas in</w>
pneum operitoneum</w>
stri ate</w>
S tra
I ra
p f
decid ual</w>
volati les</w>
nivolum ab</w>
H 7
inter related</w>
relax in</w>
MAP Ks</w>
no dos
M un
ST E</w>
IL 2</w>
Head ache</w>
Queens land</w>
ro unded</w>
2 3.7</w>
L y</w>
it i</w>
po ts</w>
chemopre vention</w>
Taq Man</w>
AN G
Tox ic</w>
NG AL</w>
lyophil ized</w>
entrain ment</w>
anti hist
emo tionally</w>
supr achiasmatic</w>
p O2</w>
O sc
over laps</w>
CM I</w>
be er</w>
load ings</w>
conver sely</w>
p 40</w>
applic ants</w>
health ier</w>
at roph
V B</w>
complement arity</w>
Mu LV</w>
Jer sey</w>
b out
V p</w>
Iris h</w>
AC TION</w>
micro circulatory</w>
Demon stration</w>
sh ru
DM 1</w>
ANIM ALS</w>
Gl n
ho p</w>
Elev ation</w>
fin ds</w>
Memb ran
M NC</w>
b ounded</w>
ex otic</w>
bac tam</w>
ond yl
MG MT</w>
millim eter</w>
Intell igence</w>
di odes</w>
symb olic</w>
mar in</w>
accompan ies</w>
C ast
- specific</w>
tem ozolomide</w>
happ iness</w>
ex pressive</w>
por phy
jur is
S BA</w>
I PA</w>
Mo Ab</w>
Morph ine</w>
C Z
under taking</w>
PG D</w>
S RT</w>
el ders</w>
P EC
bl adders</w>
glycol ic</w>
FF M</w>
polyn omial</w>
fi x</w>
PR s</w>
discern ible</w>
n m
st oring</w>
K G</w>
defin itively</w>
explo sive</w>
Mus cul
ox antrone</w>
Sp ine</w>
T SS</w>
i ers</w>
end ophytic</w>
func tioned</w>
synovi um</w>
Matr igel</w>
4 2.
ogn athic</w>
prokary otes</w>
Pit ts
- nitro</w>
Di alysis</w>
bulim ia</w>
3 0.8</w>
X O</w>
3. 75</w>
e dics</w>
pro -</w>
cardi ologists</w>
morb idly</w>
sub tropical</w>
ga thering</w>
edi a</w>
RY GB</w>
j er
implic ates</w>
cloth ing</w>
As suming</w>
degrad ability</w>
menstr uation</w>
D ST</w>
TH z</w>
Hist opathologic</w>
H o</w>
str ide</w>
enol one</w>
adi ab
Aff inity</w>
1. min</w>
ede matous</w>
babo on</w>
L TC</w>
As n
surro und</w>
Ac ids</w>
.S .</w>
Rob otic</w>
4 T</w>
judg ement</w>
wh atever</w>
spas ms</w>
T end
gu st
nur sery</w>
17 0
k les</w>
mon ensin</w>
den oted</w>
attr activeness</w>
lacc ase</w>
D ur
MI A</w>
Ad j
mag na</w>
bro minated</w>
2 5.8</w>
P PT</w>
ta sis</w>
1. 97</w>
50 3</w>
tum or
Com pet
organ ochlor
CaMK II</w>
at elec
defec ation</w>
D eg
O AB</w>
re activities</w>
prop ion</w>
ex o</w>
gl um
examin ers</w>
TIV E</w>
mon t
alim entary</w>
fac tual</w>
main land</w>
multinucle ated</w>
efficac ies</w>
invol ution</w>
dichotom ous</w>
gl ass
fr active</w>
dissoci ative</w>
Rank in</w>
Re produc
cyan o</w>
glycolip ids</w>
abor tus</w>
R od
R ac</w>
de formed</w>
min ent</w>
Al li
epilep togenic</w>
Cul ex</w>
E GF
Typ ically</w>
X en
nar col
Deriv atives</w>
del inqu
B W
Reve als</w>
S ti
conc ise</w>
tur keys</w>
car d
ab scisic</w>
CF C</w>
Ig AN</w>
cler k
alli ed</w>
b ent</w>
m C</w>
invari ance</w>
S PO
3 32</w>
SD B</w>
p CR</w>
tor iness</w>
Franc isco</w>
Hem oglobin</w>
Classi cal</w>
Wal ker</w>
A y
N IV</w>
z hou</w>
SR IF</w>
circumc ision</w>
Camero on</w>
rex ia</w>
N ocardi
suppur ative</w>
tr y
cri st
sh op
t enth</w>
un ambiguously</w>
un intentional</w>
SL P</w>
arathyro idism</w>
acet azolamide</w>
c occus</w>
citr ulline</w>
strati fy</w>
CCL 2</w>
routin es</w>
A urora</w>
heter otrophic</w>
trig ine</w>
SL T</w>
n i</w>
H AI</w>
Dist urb
cist ern
N Y</w>
u tional</w>
arthro pod</w>
Ep is
leptom ening
ox acillin</w>
surviv or</w>
2 5.3</w>
som ething</w>
bit ter</w>
Profil ing</w>
ot er</w>
ang led</w>
2.0 3</w>
e ably</w>
chori ocarcinoma</w>
m ative</w>
su p</w>
Ar cha
S ampling</w>
yl phorbol</w>
19 67</w>
ethyl maleimide</w>
ante l</w>
DESC RIP
tr a</w>
consul ting</w>
is otypes</w>
Rayn aud</w>
CF s</w>
imidazol ium</w>
pan oramic</w>
transpos able</w>
on itoring</w>
adap tability</w>
neuro pathology</w>
ket on
under served</w>
H AT</w>
e IF</w>
decel eration</w>
Lei den</w>
end ole
CYP 1A2</w>
hypercholesterol emic</w>
Rep eti
Ir radiation</w>
M PM</w>
actinomyc et
16 0
IgG 2a</w>
N ationwide</w>
3 1.3</w>
sarcol emmal</w>
w af
cir c</w>
met h</w>
promin ently</w>
leg ume</w>
cryp ts</w>
fimbri ae</w>
caver nos
rin one</w>
ubi quinone</w>
impe ded</w>
Ory za</w>
A poli
micro surgery</w>
Sk ills</w>
MCF 7</w>
8 a</w>
organ ogenesis</w>
sin onasal</w>
elap sed</w>
s artan</w>
a hertz</w>
CA 125</w>
equiv ocally</w>
Gau cher</w>
S olar</w>
aff iliation</w>
f ears</w>
de an</w>
mas tig
s -</w>
1. 00
worth while</w>
in ding</w>
process or</w>
diap horase</w>
todd lers</w>
hem olysin</w>
inser ting</w>
tent ative</w>
lav icular</w>
hyaluron idase</w>
ospond in</w>
ex changed</w>
arch i
ar ded</w>
ace us</w>
Ret ention</w>
install ation</w>
I K</w>
pro drom
midw ifery</w>
amphib ians</w>
ph leb
1. 90</w>
uro lithiasis</w>
stere ois
resorb able</w>
in correctly</w>
ba ic
A 10</w>
F un
CD 44
P rescrip
uni ons</w>
Nor theast</w>
B SE</w>
re treatment</w>
at oes</w>
ic ed</w>
ME N
MM T</w>
Reg ions</w>
Rhiz obium</w>
1. 91</w>
ax on
neurolog ists</w>
Fe wer</w>
pl akia</w>
k cat</w>
- 0.5</w>
1, 3,5</w>
herbiv ores</w>
Hum ans</w>
desi pramine</w>
u in</w>
b 5</w>
ul ants</w>
peri anal</w>
cardi olipin</w>
emul si
m ally</w>
lam in</w>
2.0 2</w>
Pro l
MI BI</w>
alc iferol</w>
pare tic</w>
man o
wo ol</w>
med itation</w>
fiber optic</w>
Meth an
45 Ca</w>
DL S</w>
2 6.6</w>
mar sup
Porph yro
sub epithelial</w>
aphy sis</w>
turbul ent</w>
amin ic</w>
RB F</w>
L em
W u
I BM</w>
sub mucosa</w>
prost atitis</w>
opi ates</w>
osyl ceramide</w>
- 7
el o
optim ism</w>
Qu estions</w>
aquap orin</w>
micro electrodes</w>
AE P</w>
destro y</w>
O HD</w>
otom ized</w>
si r
Hormon al</w>
c oco
therm o</w>
P 53</w>
allo xan</w>
dermat ologic</w>
hygi enic</w>
quen ched</w>
Hung ary</w>
in ella</w>
ep ine</w>
py razole</w>
endometri oid</w>
deoxynucle oti
teno fovir</w>
m ere</w>
cryst allo
St orage</w>
ag us</w>
y co
D DS</w>
intim ately</w>
L amin
irrit ability</w>
F .</w>
K g</w>
Man aging</w>
team work</w>
yr id
glucos aminidase</w>
pl ana</w>
m ell
il age</w>
Bi osynthesis</w>
postin fection</w>
sh ik
50 2</w>
D s
spir onolactone</w>
s unitinib</w>
Syn aptic</w>
extrav ascular</w>
N CAM</w>
immunodom inant</w>
after load</w>
ca ine</w>
pro drugs</w>
stre ptococcus</w>
GR ADE</w>
K K</w>
ul ls</w>
imp utation</w>
Inter mittent</w>
multi modality</w>
Cad mium</w>
3 29</w>
3 0.5</w>
in opathy</w>
AC 1</w>
emp tive</w>
tonsill ar</w>
facul tative</w>
HC Ws</w>
Competi tion</w>
met te</w>
enanti omeric</w>
3 21</w>
pyrro l
isother ms</w>
AV Ms</w>
Pseud o
3 5.7</w>
CO I</w>
ampl ifier</w>
HB O</w>
congru ence</w>
cy pro
cyan obacterium</w>
POIN TS</w>
os ylated</w>
Ch im
Dec i
6, 7</w>
CDK 4</w>
pastor is</w>
Acous tic</w>
glucon ate</w>
spra ying</w>
D rin
pur ify</w>
ophil in</w>
s d</w>
N b</w>
man ag
An tico
q 22</w>
Z r
Af ter
off ices</w>
LI TY</w>
2 5.4</w>
phosphatidyl glycerol</w>
Plac ental</w>
oscill ators</w>
P ip
ur ally</w>
ou ght</w>
Cob b</w>
- associated</w>
il legal</w>
fluoresc ently</w>
1 --
Y 2</w>
Alter ation</w>
- 13</w>
regi str
HR QL</w>
cari ous</w>
h u</w>
C os
att achments</w>
GST M1</w>
Pharmac y</w>
metagen omic</w>
S PA</w>
b ons</w>
ion omycin</w>
AP N</w>
desi c
mam mal</w>
Conform ational</w>
scr atch</w>
delib erate</w>
c occidi
1. 9
NI HSS</w>
Dist ress</w>
M TS</w>
X X
Mar row</w>
W HR</w>
amin ases</w>
atis simus</w>
Neu rom
hat ch
P PH</w>
L AR</w>
acceler ator</w>
collap sed</w>
pemphig oid</w>
special ised</w>
il o
co aching</w>
upreg ulate</w>
tur tles</w>
transist ors</w>
sugar cane</w>
S SS</w>
2.0 8</w>
tu me
On going</w>
Coll ection</w>
mete orological</w>
phyl um</w>
s k</w>
am pu
per il
Mem orial</w>
DO CA</w>
confoun ded</w>
intratrac heal</w>
- bi
Transc ranial</w>
abdomin is</w>
Exp anded</w>
thylak oid</w>
m Sv</w>
d ul
keto acidosis</w>
ME RS</w>
W R
su is</w>
sh ell
aeros ol
16 00</w>
gon ad</w>
Ig G2</w>
metach ronous</w>
can ines</w>
4 8.
B Q</w>
ax ine</w>
micro gram
c er</w>
equ il
lute us</w>
enumer ation</w>
4 7.
El ucid
sub families</w>
Ag ed</w>
M C3
in adequately</w>
over flow</w>
fibrom atosis</w>
l son</w>
Ad renal</w>
Sched ule</w>
Of ten</w>
tri phosphatase</w>
PE s</w>
halogen ated</w>
Bl ast
x L</w>
V 4</w>
Cran i
mus sels</w>
RN s</w>
Fe ed
sn akes</w>
Cou pled</w>
P X</w>
awa kening</w>
osper mic</w>
Lup us</w>
ver tex</w>
rig orously</w>
wet lands</w>
Immunocyto chemical</w>
perikary a</w>
1 s</w>
conflu ence</w>
Ch ip</w>
glyc opeptides</w>
policy makers</w>
V ector</w>
PROSP ERO</w>
P PC</w>
M assive</w>
min ip
17 </w>
grass land</w>
hypo chlorite</w>
regi onally</w>
tar trate</w>
hem odynamically</w>
Barr </w>
STATI STI
form ulae</w>
fil arial</w>
Fer mi</w>
Z ucker</w>
19 th</w>
Mod e</w>
2 6.1</w>
5 4.5</w>
ven om
ber ries</w>
S ex
dyslex ia</w>
phosphoglycer ate</w>
3 41</w>
2 6.8</w>
ag g</w>
asp inatus</w>
skinf old</w>
Char cot</w>
ax y</w>
Ax is</w>
Fabr ication</w>
ext ents</w>
C h</w>
g eal</w>
. org</w>
d -</w>
il ine</w>
4 73</w>
seg ment
handic ap</w>
ir us</w>
eth ox
Transc atheter</w>
2 6.2</w>
meth anesulf
bi valent</w>
CB V</w>
Penn sylvan
ol ium</w>
CC M</w>
hypop nea</w>
MT P</w>
A symptomatic</w>
N os
t yramine</w>
ou b
imp action</w>
lacti de</w>
Color ado</w>
b w</w>
in consistencies</w>
ari ae</w>
Cal mette</w>
ro si
visu alizing</w>
Arthro plasty</w>
Pitts burgh</w>
Sal v
QU ES
Arthro scopic</w>
recir culation</w>
Consist ently</w>
m ural</w>
de pressor</w>
intro g
Sp in</w>
M CV</w>
ar mam
Con sum
y amo
OR E</w>
methyl cellulose</w>
34 a</w>
second arily</w>
En anti
pa res
toph ysin</w>
dermat omyositis</w>
S erious</w>
matern ally</w>
pl ers</w>
op ically</w>
under nutrition</w>
microm etast
2 5.7</w>
T TE</w>
un im
inf l
motoneur on</w>
1, 2,
Radi x</w>
os accharomyces</w>
un equivocally</w>
if loxacin</w>
Ex cellent</w>
pil i</w>
- end</w>
ogen omic</w>
F resh</w>
al d</w>
AI s</w>
Cb l</w>
wor e</w>
R ig
ec t
etan ercept</w>
photosensiti zer</w>
aminol ev
intra abdominal</w>
myx oma</w>
MI T</w>
P gp</w>
9 8.
Br id
Ont ology</w>
seal ant</w>
Method ology</w>
f unds</w>
transduc ing</w>
b py</w>
3 5.5</w>
o ide
is er</w>
separ able</w>
chlamy dia</w>
dis accharide</w>
Ab use</w>
Tr ust</w>
nucleocap sid</w>
P o</w>
F r</w>
O ct</w>
oc eles</w>
cy t</w>
cont acting</w>
dihydro folate</w>
c n
d 2</w>
Re generation</w>
PV s</w>
male ate</w>
scrap ie</w>
d ome</w>
non linearity</w>
trache obronchial</w>
un insured</w>
d otal</w>
conform ers</w>
phosphati dic</w>
Cor on
pir ide</w>
U AE</w>
em ide</w>
L n</w>
apo protein</w>
Math ematical</w>
r A</w>
gn ath
tax ol</w>
tung sten</w>
B ox</w>
3 31</w>
en ec
Angi ogenesis</w>
del im
2.0 7</w>
ad h
han dedness</w>
sphen oid</w>
Zim bab
dec an</w>
hyper active</w>
explo sion</w>
c p</w>
b olic</w>
v us</w>
Pol ys
oxygen ases</w>
aggreg ating</w>
consangu ineous</w>
p 50</w>
Prom otes</w>
ren z</w>
li ties</w>
Pe er</w>
CV S</w>
opro st</w>
semic ir
mur m
Elim ination</w>
comit ans</w>
leukotri enes</w>
re forms</w>
flu i
m TBI</w>
m l.
B ET</w>
appe aling</w>
H ox
CR D4
psychi atrist</w>
in s
per sic
for k</w>
e book</w>
andro gen
6 6.
M r
O XA</w>
om entum</w>
pro peptide</w>
th al</w>
ran ibizumab</w>
Visu alization</w>
co ol</w>
cyste ines</w>
4 2.5</w>
M PC</w>
inter ventricular</w>
col l</w>
lipos arcoma</w>
eicos apentaenoic</w>
excur sion</w>
quin ox
Provid ing</w>
Acanth amoeba</w>
multi parous</w>
angi osarcoma</w>
ESW L</w>
Func tions</w>
neg atives</w>
DM E</w>
immun ogold</w>
CD 86</w>
cr assa</w>
IC F</w>
Aca d</w>
contin gency</w>
Hor iz
A bo
endos ym
G p
ar ism</w>
SSR I</w>
h oma</w>
cam eras</w>
bacterioph ages</w>
Dev ices</w>
phyto chemicals</w>
4 0.0</w>
T ube</w>
el der</w>
auth or
Em bol
dr ill</w>
extran odal</w>
H TS</w>
3 27</w>
ib ration</w>
Const ant</w>
P ichia</w>
tetra ploid</w>
DESCRIP TION</w>
ap position</w>
bi l</w>
PT Z</w>
CN U</w>
hyperuric emia</w>
M itral</w>
semin oma</w>
post transcriptional</w>
incur able</w>
commit tees</w>
S Y</w>
C SD</w>
3 37</w>
mon etary</w>
pyr if
Contin ued</w>
alge sic</w>
ban ks</w>
F an
trans itory</w>
P2 X</w>
Fibro blast</w>
Rickett sia</w>
m itis</w>
acetyl salicylic</w>
transl uc
glucopyran oside</w>
fas cin
ak ic</w>
aut ocor
no ro
CP 2</w>
LE M</w>
Am ph
2.0 6</w>
demethyl ase</w>
te t</w>
CYP2C 9</w>
Cole optera</w>
3 S</w>
aden itis</w>
extra ocular</w>
oreduc tive</w>
Proced ure</w>
ocyt otic</w>
RO CK</w>
sph aer
60 2</w>
underpin ning</w>
S 2
al an
el ithiasis</w>
SI M</w>
Ho ech
Porphyro monas</w>
en esulf
bo osting</w>
metast able</w>
Con taining</w>
Micha el</w>
3 O4</w>
Func tion
Behavi our</w>
yamo ya</w>
M VA</w>
po proteins</w>
dermat ologists</w>
mycel ium</w>
Ch er
exc itable</w>
- triphosphate</w>
anch ors</w>
oxif ene</w>
tmann in</w>
trans genes</w>
ucle otides</w>
perim eter</w>
Promo ting</w>
L AC</w>
sti ff</w>
unil aterally</w>
tom ies</w>
Rel atively</w>
28. 8</w>
Caregi vers</w>
EC Gs</w>
expl anted</w>
thermo stable</w>
isother m</w>
th o</w>
inter mit
hypertroph ied</w>
myo fibrillar</w>
Defin ing</w>
T PS</w>
train ee</w>
E im
Commun ities</w>
heterozyg ote</w>
2 7.6</w>
I -</w>
chrom ogenic</w>
My x
Mod elling</w>
D er</w>
em al</w>
gg ed</w>
Pos itron</w>
u PAR</w>
on ics</w>
Ment en</w>
l ane</w>
Bab esia</w>
bio available</w>
gon i
0.000 4</w>
A 8</w>
S 5</w>
cl earances</w>
Vir gin
hypo phosphat
contribut ory</w>
man ager</w>
10 9
hydroxy methyl</w>
endonucle ases</w>
respon dent</w>
exc itations</w>
op tom
insi pidus</w>
land fill</w>
non competitive</w>
Intr insic</w>
T 4
cal bindin</w>
situ ational</w>
Hir sch
B LA
immuno therapeutic</w>
domin antly</w>
exfoli ation</w>
Notch 1</w>
holog raph
st unting</w>
fur a</w>
Pennsylvan ia</w>
R GC</w>
 2</w>
ethyl ene
foll icul
Smad 3</w>
Err atum</w>
Period ontal</w>
desic cation</w>
ac cord</w>
pres ent
vis itors</w>
3 39</w>
inoc occus</w>
trans forms</w>
SI T</w>
Intr aperitoneal</w>
kynuren ine</w>
AR 1</w>
P ress</w>
non randomized</w>
sarcom ere</w>
s one</w>
3 48</w>
3 51</w>
fri end</w>
el and</w>
2 2.0</w>
N ag
enhanc ements</w>
Aden ocarcinoma</w>
F ts
gun shot</w>
N b
boost ed</w>
C MA</w>
ing ival</w>
ipp o</w>
star ter</w>
sil ence</w>
fix ator</w>
hypog lossal</w>
bott les</w>
S ensing</w>
B rug
und oub
tis ol</w>
Gli oblastoma</w>
S SC</w>
RAW 264.7</w>
AD SCs</w>
hal ation</w>
Vis c
- terminal</w>
home odomain</w>
flav us</w>
laf axine</w>
numb ness</w>
bis pec
2 6.4</w>
ag ro
sep ta</w>
confidenti ality</w>
n els</w>
F K</w>
st ayed</w>
cycl ists</w>
irradi ance</w>
D AF</w>
M WT</w>
ut most</w>
upreg ulating</w>
K SHV</w>
od in</w>
estim ators</w>
HC P</w>
caus ally</w>
f r</w>
5 30</w>
em comitans</w>
cephal ometric</w>
cl ue</w>
Extrac orporeal</w>
Use fulness</w>
s now</w>
- 40</w>
el ly</w>
diff using</w>
oroph arynx</w>
G C
P ene
omod ulin</w>
squir rel</w>
3 0.4</w>
recycl ed</w>
t arily</w>
aph ro
h p
o is</w>
U N</w>
gu ard</w>
methan olic</w>
ico tin
spermatog onia</w>
e w</w>
Ap parent</w>
9, 10</w>
L MA</w>
tetrafluoro ethylene</w>
2 3.9</w>
H NF
Cor relates</w>
ni um</w>
PO PU
plas mosis</w>
RI S</w>
2 4.7</w>
L SD</w>
29. 6</w>
co erc
flo oding</w>
tetradecano ylphorbol</w>
AI H</w>
necess itate</w>
glycos yl</w>
S PS</w>
mir abilis</w>
l end</w>
d abigatran</w>
1. 99</w>
St an
2 5.9</w>
Anti biotics</w>
ens embl
AP PRO
E -</w>
AD PKD</w>
Tr kB</w>
dithi ocarb
Lact ate</w>
te dness</w>
1 ----
Em ph
Cap acity</w>
Termin al</w>
BV DV</w>
sper sed</w>
civ ilian</w>
S HS</w>
d l
are rs</w>
Parkin son
isoc itrate</w>
un answered</w>
in competence</w>
AB T</w>
O L
PC V
pyrif os</w>
Hemat opoietic</w>
pro mastig
B IA</w>
Discrim ination</w>
q i</w>
28. 3</w>
multiplex ed</w>
3 9.5</w>
su pers
SI RS</w>
equ i</w>
Ga As</w>
G SE
E AT</w>
CD K</w>
2 6.9</w>
3 61</w>
to tic</w>
actinomycet emcomitans</w>
N AG</w>
alk enes</w>
adren o
Rest oration</w>
plo ids</w>
tax ane</w>
postinter vention</w>
pyr ine</w>
bacteri uria</w>
multi locus</w>
M ac</w>
sulf atase</w>
hy pol
intercal ation</w>
I de
- sensitive</w>
Tricho derma</w>
Chem istry</w>
2 4.8</w>
o eba</w>
R al
O Cl</w>
di ene</w>
un ambiguous</w>
Cd S</w>
Ber lin</w>
n y</w>
reg ain</w>
C2 C12</w>
irrit ant</w>
Fe 2</w>
engine er</w>
fl ashes</w>
myco phenolate</w>
hyph al</w>
lati t
6 b</w>
An tic
hyperbilirubin emia</w>
29. 2</w>
en g</w>
bi ob
conduc tor</w>
Ur d</w>
narrow er</w>
escal ating</w>
Ad riamycin</w>
Prote obacteria</w>
le es</w>
commerc i
p ills</w>
aval ent</w>
N Ws</w>
in ones</w>
min s</w>
AB S</w>
pris tine</w>
as exual</w>
mil king</w>
IP SS</w>
Vene z
hypophy sis</w>
CRD4 20
ent arium</w>
Oc t
No ise</w>
3 6.5</w>
bi ologists</w>
lot tic</w>
fe til</w>
HC T1
Histor ically</w>
re ts</w>
catar rh
form amide</w>
ach ial</w>
thi azol</w>
poly electrolyte</w>
cyst oscopy</w>
R BD</w>
cl ou
fl um
Jo h
viol ations</w>
intermedi ary</w>
m RS</w>
re bleeding</w>
meth y
haem odynamics</w>
ycl o</w>
general izability</w>
cohe sive</w>
fluoroph ores</w>
om ission</w>
re perfused</w>
bio accumulation</w>
CO RT</w>
Chrom atography</w>
a HR</w>
5 32</w>
E h
b end</w>
enth usi
Alve olar</w>
- 100</w>
bre vis</w>
tub ing</w>
str ontium</w>
inter media</w>
pr ud
Transl ational</w>
ov orin</w>
multi potent</w>
S ources</w>
b age</w>
Inter mediate</w>
are sis</w>
hydr alazine</w>
Vari ants</w>
pre ovulatory</w>
hypo physi
lute in</w>
exceed ingly</w>
audi ometry</w>
S FA</w>
et om
Bifid obacterium</w>
ec centr
low s</w>
mat uring</w>
cr acks</w>
Cd 2</w>
har sh</w>
tetr alogy</w>
g st</w>
un pleasant</w>
ste am</w>
p ial</w>
Shig a</w>
un conventional</w>
du plexes</w>
quit ting</w>
bi refr
CD 80</w>
AD MA</w>
Compon ents</w>
S PAR
compar ator</w>
Cor responding</w>
50 4</w>
pl en
te tran
ess ay</w>
dys men
gr amin
semiconduc tors</w>
D eb
ach ian</w>
fo il</w>
vap our</w>
thalass aemia</w>
TI L</w>
epir ubicin</w>
p icro
cur able</w>
sil k
bo iling</w>
aqueduc tal</w>
I tem</w>
Q LQ</w>
sp r
amni on</w>
Mn SOD</w>
substr atum</w>
tuber ous</w>
Anthrop ometric</w>
cri ti
prioriti ze</w>
Paste urella</w>
eti apine</w>
Cho ice</w>
Mt b</w>
fol k</w>
Per ox
L og</w>
over comes</w>
Sil encing</w>
Scot tish</w>
bi oluminescence</w>
inform ants</w>
2 1.0</w>
6 32</w>
encephal ography</w>
overestim ation</w>
D AA</w>
ep in</w>
poly ke
Neuro psychological</w>
G m
V K
reson ator</w>
CB I</w>
an them
aut oreactive</w>
O GD</w>
emb odi
im pose</w>
posteri orly</w>
ER s</w>
sens u</w>
5, 7</w>
s ore</w>
C in
v i</w>
us tine</w>
cy clin
simpl est</w>
vasodi lators</w>
Loc alized</w>
A ro
b erberine</w>
zip per</w>
hydro quinone</w>
allevi ation</w>
A 7</w>
cl ock
chrom ogranin</w>
holo enzyme</w>
b es
B lacks</w>
Philipp ines</w>
bootstr ap</w>
R ing</w>
E n</w>
sn ow
incap able</w>
monolith ic</w>
3 1.6</w>
18 00</w>
prolong s</w>
lo tho</w>
jour ney</w>
p im
termin ating</w>
dys biosis</w>
spl int</w>
agre es</w>
xyl anase</w>
adiab atic</w>
I MS</w>
mot ors</w>
CS M</w>
ig ilance</w>
oph ora</w>
AM F</w>
lo vastatin</w>
nic ardi
pl ague</w>
am yl</w>
let tuce</w>
C t
c itation</w>
hyper coagul
az ido</w>
PE D</w>
innerv ating</w>
asi an</w>
NE P</w>
om imetic</w>
Andro gen</w>
Argin ine</w>
un safe</w>
heter ogenous</w>
asc ial</w>
Hoech st</w>
3 78</w>
heter ocy
lib eration</w>
Al bumin</w>
enter ovirus</w>
o c</w>
pur inergic</w>
ophen one</w>
Red ox</w>
hymen a</w>
A spects</w>
form ative</w>
2 5.2</w>
4 H</w>
proteas omal</w>
sub sample</w>
she aths</w>
Cy A</w>
3 62</w>
T in
Ne f</w>
my oblast</w>
imid azo</w>
M ood</w>
Mut ants</w>
g B</w>
cit alopram</w>
O PD</w>
angi oedema</w>
Behavi ors</w>
Ec ological</w>
reat ment</w>
UC B</w>
thre ad</w>
Cy cle</w>
O O</w>
Tran s</w>
ellul osic</w>
hypop arathyroidism</w>
calcane al</w>
is omer
anteced ent</w>
mesenter y</w>
hepatocarcin ogenesis</w>
H NC</w>
d iterpen
T 5</w>
leg es</w>
tex t
hip pur
3 46</w>
B os
mos sy</w>
obac illi</w>
L DA</w>
m um</w>
mimic ry</w>
osi ties</w>
psych opathological</w>
fabr ic</w>
Myel oid</w>
di imide</w>
cin ere
instruc tional</w>
HCT1 16</w>
k at
til age</w>
supr atentorial</w>
Phosph ate</w>
G v
E stradiol</w>
CR s</w>
zwit terionic</w>
Plac ebo</w>
4 G</w>
ten ascin</w>
c in</w>
val erate</w>
Orig in</w>
3 34</w>
Bi omedical</w>
Vi olence</w>
phosphati dyl</w>
alli ance</w>
M OR</w>
6 40</w>
su percritical</w>
Chit osan</w>
st un
ell i</w>
thyro idal</w>
nano structure</w>
extrap ulmonary</w>
disap pointing</w>
n ong
Virgin ia</w>
U sed</w>
un conjugated</w>
str aw
HC Ps</w>
ir aglutide</w>
DO PAC</w>
PH Q</w>
in omycin</w>
otax in</w>
x ylo
li ers</w>
nitr ates</w>
Electro cardi
Embry onic</w>
micronutri ents</w>
C ocaine</w>
nicardi pine</w>
ap re
Apoli poprotein</w>
- 5.
si zing</w>
extr uded</w>
ensi bility</w>
phyl a</w>
PGF 1</w>
A bility</w>
4 1.7</w>
inter sec
V an</w>
programm able</w>
mano eu
L abor
rop in</w>
CI P</w>
L aw</w>
bl ended</w>
Neuro imaging</w>
p ag
B CP</w>
CD T</w>
En tam
toxic ants</w>
tryp tase</w>
Cul tural</w>
P is
vul va</w>
compar ability</w>
e k
optim ised</w>
I owa</w>
tal us</w>
Biom echanical</w>
b um
STI s</w>
5 5.6</w>
thri ve</w>
spondyl olisthesis</w>
vasodil atory</w>
M MS</w>
tri phenyl
Char lson</w>
line zolid</w>
radic ulopathy</w>
Recru itment</w>
Neu tr
IC Cs</w>
ethyl amine</w>
g y
c s
induc ibility</w>
lenti virus</w>
3 56</w>
Ca T</w>
papill omas</w>
L K
PD B</w>
ro ads</w>
SIGN ED</w>
inter hemispheric</w>
proc urement</w>
Nor dic</w>
Depend ence</w>
Dra wing</w>
hal lux</w>
ro of</w>
od ors</w>
In sp
abro ad</w>
remedi es</w>
en rich</w>
Pro files</w>
WI TH</w>
B q</w>
ori ous</w>
sulf onic</w>
olip oma</w>
intox icated</w>
acclim ated</w>
I SR</w>
del icate</w>
altern ation</w>
ensembl es</w>
am pul
Par ac
rheumat ology</w>
deuter ated</w>
2. 10</w>
super numerary</w>
dor some
Hous e
erythemat ous</w>
Can ine</w>
V 600
cra yfish</w>
W ell
inf un
neutr alize</w>
B3 LYP</w>
photovolta ic</w>
lob ule</w>
win ding</w>
Am mon
rec A</w>
heter o</w>
cd c2</w>
super conducting</w>
Ly t</w>
tangen tial</w>
Entam oeba</w>
C X</w>
AF S</w>
Aer obic</w>
n ate</w>
3 85</w>
neuro anatomical</w>
Mob ility</w>
microscop ical</w>
fic ally</w>
but aline</w>
orbit als</w>
sigmo id
t RN
mu M</w>
aminopyr idine</w>
un employed</w>
0.9 9
armam entarium</w>
Sec urity</w>
ulf ite</w>
hsp 70</w>
ful l
MM N</w>
ati gu
fol iar</w>
conform ity</w>
BR CA</w>
MI M</w>
40 ,000</w>
multim orbidity</w>
d ence</w>
ex osome</w>
electroph ilic</w>
derang ement</w>
AS SIGNED</w>
A PCs</w>
de ma</w>
AP E</w>
rever ted</w>
nid ulans</w>
mercapto ethanol</w>
a den</w>
elic itation</w>
care ers</w>
PH B</w>
R p</w>
par valbumin</w>
exer ting</w>
in accessible</w>
Gyn ecology</w>
revolution ized</w>
con cave</w>
is omeric</w>
aw aiting</w>
arteri osclerosis</w>
hi o</w>
NT M</w>
ren yl</w>
bl ack
N od
ar rests</w>
radi oluc
aor to
2 .</w>
plas ti
Fi xation</w>
Vol tage</w>
D raft</w>
ap ride</w>
irrig ated</w>
DN R</w>
Step wise</w>
vari ably</w>
pec toral</w>
but ton</w>
1 T</w>
clu b</w>
macro scopically</w>
homogene ously</w>
Hemorrh age</w>
under studied</w>
comp assion</w>
bur sa</w>
RA ST</w>
3 58</w>
T y
bi ocat
ML L</w>
I DE
en o</w>
characteris tically</w>
idi otype</w>
GIST s</w>
happ ens</w>
infec ts</w>
wo ven</w>
CT G</w>
mus sel</w>
Bo NT</w>
logarith m</w>
Transl ation</w>
filari asis</w>
transl ationally</w>
apro tinin</w>
Ander son</w>
Rec A</w>
chron icity</w>
CE TP</w>
2. 01</w>
TI MI</w>
bacter aemia</w>
d amping</w>
M ot
60 9</w>
29. 9</w>
gg le</w>
v ille</w>
ass ment</w>
SC M</w>
Tetra hymena</w>
TF II
off ending</w>
var ial</w>
Q X</w>
9 7.
osulf ate</w>
F AB</w>
Provid ers</w>
symb ol</w>
certific ates</w>
2 7.7</w>
K at
am acrine</w>
calc i
necess itated</w>
blast omas</w>
MI B</w>
Ar ach
inclin ed</w>
DL B</w>
G AT</w>
oscill ating</w>
suic idality</w>
P od
carboxy methyl</w>
fellow s</w>
anteri orly</w>
L PC</w>
ap ne
audi ence</w>
Lepid optera</w>
fic ient</w>
react ants</w>
Endoth elin</w>
re pulsion</w>
de w</w>
V NS</w>
lu x
log MAR</w>
F ace</w>
tonsi l</w>
optim isation</w>
deli vers</w>
F uk
im men
mul toc
a ea</w>
R Rs</w>
Algorith m</w>
Charg e</w>
L B
par af
eph edrine</w>
vesi cou
BD E</w>
id o
EM D</w>
Ha pl
L TA</w>
Tran spor
conv ection</w>
discover ing</w>
6 60</w>
5 10</w>
M u</w>
PRIN CIPA
O le
expect ancies</w>
M PH</w>
pr ism</w>
carbox amide</w>
hyd ati
s wee
SAM PLE</w>
heur istic</w>
chool ers</w>
phlo em</w>
out look</w>
aggra v
un equivocal</w>
AR B</w>
-0. 2</w>
S SD</w>
ifor ms</w>
tropic alis</w>
mo fetil</w>
2. 13</w>
CXCL 12</w>
wh ol
Pro duct</w>
Under going</w>
Inter val</w>
2. 14</w>
sex -</w>
arch ival</w>
Rac ial</w>
un even</w>
sub urban</w>
nov ice</w>
valu ation</w>
detec tability</w>
cal ifor
ophyl l</w>
g ate
ren ovascular</w>
ste wardship</w>
go od
C ode</w>
pap averine</w>
justi fication</w>
feat ured</w>
6 1.5</w>
serov ars</w>
i vir</w>
Ex tra
amb er</w>
oro lac</w>
radi i</w>
bo id</w>
Ver tical</w>
air craft</w>
4 23</w>
Ex change</w>
p ens</w>
end owed</w>
depolar izations</w>
fin s</w>
attrib ution</w>
multoc ida</w>
PRINCIPA L</w>
Amon gst</w>
squ e
IgG 3</w>
wild type</w>
V NTR</w>
stand point</w>
p EF</w>
de hydrated</w>
cor ona</w>
Cul ic
D oses</w>
colon ize</w>
chel ators</w>
predisp oses</w>
PD Z</w>
HI V
bottlen eck</w>
Haz ard</w>
branch ial</w>
Dis charge</w>
Inte rest</w>
VL BW</w>
Tib etan</w>
3 88</w>
4 C</w>
predomin ate</w>
pedi cled</w>
S ports</w>
F AB
t all</w>
av ement</w>
DD E</w>
azo ospermia</w>
APPRO ACH</w>
tr il
23 S</w>
P ed
lact obacilli</w>
MB F</w>
F NAC</w>
2. 75</w>
electro convulsive</w>
ket anserin</w>
3 68</w>
igh ted</w>
P edi
S ites</w>
refrac toriness</w>
legis l
schwann omas</w>
W heat</w>
Assess ments</w>
pent ag
post natally</w>
scaff olding</w>
SRE BP</w>
ocl avicular</w>
5 3.
Mon tre
flui dics</w>
ad ductor</w>
UN ASSIGNED</w>
mid point</w>
EM F</w>
2. 12</w>
al ise</w>
arri ved</w>
LY 294002</w>
sett lement</w>
r udi
star s</w>
perfor in</w>
m ir</w>
be rel
CA R
HA DS</w>
micro satellites</w>
des erve</w>
Sh ape</w>
spher oid</w>
bu oy
cerul oplasmin</w>
D PI</w>
Gn R
C US</w>
pri t</w>
H air</w>
T AR</w>
im perfect</w>
PR V</w>
Z ea</w>
bi ventricular</w>
Br agg</w>
Hed gehog</w>
w iring</w>
dec oction</w>
arthro pods</w>
nu ts</w>
ut a</w>
xen on</w>
Plat form</w>
Int act</w>
daun orubicin</w>
A pl
chi 2</w>
gu ide
SO FA</w>
fl u</w>
ment oring</w>
Nat l</w>
ST EM</w>
alk ylated</w>
convers ations</w>
H h</w>
homogen ization</w>
2 4.9</w>
mortal ities</w>
Eim eria</w>
3, 4,5</w>
str ings</w>
obac tam</w>
POPU LATION</w>
olym phatic</w>
pector alis</w>
4 V</w>
J s</w>
al d
arte facts</w>
oste oid</w>
her m
accum ulations</w>
PV L</w>
Fal se</w>
B cl
0.0 30</w>
loc alizations</w>
fil tr
gam etes</w>
gener ators</w>
spea ker</w>
V RE</w>
SI N</w>
osteoclast ogenesis</w>
E o
fir st-</w>
De sign
aff ection</w>
non verbal</w>
PF O</w>
L ati
N RT</w>
ap hor
ster ically</w>
synap tophysin</w>
age able</w>
L ine
hos tility</w>
exam ic</w>
L amb
gl acial</w>
aut opsies</w>
28. 9</w>
anis h
thyro toxicosis</w>
1 d</w>
b anded</w>
al endronate</w>
organ ophosphate</w>
subtil isin</w>
bleph aro
- 2-</w>
col or
mac ul
Tim ing</w>
o plankton</w>
F US</w>
cTn T</w>
O hio</w>
e h
pa ve</w>
ser traline</w>
conduc tances</w>
gly phosate</w>
3 63</w>
p ond</w>
IV M</w>
amni os</w>
interpol ation</w>
abs orb</w>
hal o
Ob served</w>
f o</w>
r us</w>
ang inal</w>
ca vit
ol ian</w>
resi stin</w>
aph y</w>
tachy arrhythmias</w>
refuge e</w>
double t</w>
 l</w>
la den</w>
Asc aris</w>
degrad es</w>
scintil lation</w>
Abo ve</w>
Res ult</w>
issu res</w>
6 25</w>
ever sion</w>
shell fish</w>
H ib</w>
p 13</w>
ap ath
cy l</w>
3 82</w>
M ess
mesh work</w>
STATISTI CAL</w>
di zation</w>
nucle oprotein</w>
envel oped</w>
sphincter otomy</w>
L yn
osyn aptic</w>
sou thwestern</w>
incarcer ated</w>
P ec
D X</w>
meticul ous</w>
O PC</w>
PK U</w>
l atissimus</w>
inter spersed</w>
cas e
aren a</w>
2 7.2</w>
g luteal</w>
elec ted</w>
top yran
J E</w>
vor iconazole</w>
Ptd Ins</w>
R ome</w>
co expressed</w>
inform ational</w>
angiotens inogen</w>
in coming</w>
prison ers</w>
G ray</w>
e ed</w>
F T
methyl glutaryl</w>
A GS</w>
con genic</w>
Z NF
der gar
hal ves</w>
calcin osis</w>
mit ophagy</w>
neurop il</w>
q 23</w>
Venez uel
4 12</w>
EB RT</w>
gr ant</w>
colpos copy</w>
D a
hot spot</w>
cortic o</w>
pra vastatin</w>
tis ation</w>
Exc ess</w>
-- in</w>
Sec tional</w>
aster ide</w>
T TF</w>
for tification</w>
dec tomy</w>
al pine</w>
ag ly
loc ating</w>
substanti ate</w>
intellig ibility</w>
bl es
Initi ation</w>
N ox
recti fier</w>
l agged</w>
Over weight</w>
We in
P2 Y</w>
Fibr illation</w>
3 52</w>
Ch o</w>
Pre ferred</w>
RD W</w>
Montre al</w>
m assi
form alism</w>
2.0 9</w>
under lines</w>
AM C</w>
repl en
di peptidyl</w>
stear ic</w>
w ines</w>
trans ected</w>
electro mechanical</w>
eti opathogenesis</w>
phy sis</w>
B SP</w>
sub thalamic</w>
big ger</w>
Stri kingly</w>
comp ly</w>
phosphor ic</w>
deoxynucleoti dyl</w>
injur ious</w>
1, 2,3</w>
Le sion</w>
CI T</w>
destin ation</w>
3 96</w>
un ya</w>
ran ks</w>
4 68</w>
ev al</w>
D BT</w>
hypo kalemia</w>
phyl lo
Sep arate</w>
E po
Di verse</w>
dec ol
hyper thermic</w>
para haemolyticus</w>
SC O
flic k</w>
retar d
Morph ometric</w>
y an
hyper reactivity</w>
Sp in
apoli poproteins</w>
v end
M ap</w>
F ear</w>
ab alin</w>
Cyt omegalovirus</w>
gro oming</w>
den uded</w>
Over view</w>
HSP 90</w>
dig ests</w>
hel met</w>
decon volution</w>
3 72</w>
U TIs</w>
rec ur</w>
aden omy
chi tinase</w>
oc iliary</w>
meth ox
id ers</w>
PD D</w>
sc ant</w>
ampl ifying</w>
2 d</w>
en ings</w>
re entrant</w>
lim bal</w>
uro logists</w>
s-- a</w>
LM ICs</w>
pill ar</w>
md x</w>
3 66</w>
adren om
te thering</w>
tum orous</w>
ven e
antin uclear</w>
tonsi ls</w>
pancreatico duodenectomy</w>
l adder</w>
re entry</w>
ocy steine</w>
Qu ad
fec ture</w>
sympath ectomy</w>
N if
max ill
enox aparin</w>
ic idin</w>
ich thy
photo acoustic</w>
clar ifying</w>
V600 E</w>
ov ani</w>
AF F</w>
Nan os
sulfon amide</w>
J 2</w>
Stud ying</w>
amino ethyl</w>
protr usions</w>
weigh t
synapt osomal</w>
M id</w>
eradic ated</w>
Caffe ine</w>
Gen omes</w>
angl ement</w>
teen age</w>
ur so
Method ological</w>
communic ative</w>
3 0.6</w>
in born</w>
SE R</w>
Orth op
H PT</w>
down regulating</w>
Pneum onia</w>
chol anthrene</w>
Schiz osaccharomyces</w>
3 54</w>
cere br
ethyl ammonium</w>
propag ate</w>
Mer kel</w>
ac ked</w>
mon oton
sev enteen</w>
Mil itary</w>
mang ro
anaesthe tics</w>
normal ity</w>
handic apped</w>
til apia</w>
al ene</w>
14 6a</w>
N PH</w>
later alized</w>
Batter y</w>
G EM</w>
un structured</w>
Li poprotein</w>
Vir uses</w>
ED SS</w>
Muscul oskeletal</w>
atelec tasis</w>
5 4.
ma ys</w>
contain er</w>
nymph s</w>
amib i</w>
CO 3</w>
A SP
s ell</w>
CYP 3A</w>
rot um</w>
phen azine</w>
Att achment</w>
f use</w>
Willi ams</w>
spaw ning</w>
Exec utive</w>
manoeu v
stere o</w>
conve y</w>
Mer cur
ch ie
all ant
poly g
1 100</w>
5 80</w>
an icol
eng al</w>
extr adural</w>
iod ination</w>
ap ol
po ro
I VA</w>
Ba 2</w>
condu its</w>
opon tine</w>
f lip</w>
multi valent</w>
chol elithiasis</w>
hom icide</w>
Eth nic</w>
big gest</w>
experi ential</w>
spir ituality</w>
Tes la</w>
nim odipine</w>
9 th</w>
str ained</w>
put atively</w>
homocyste inemia</w>
SC G</w>
olim bic</w>
mitochond ri
mol .
natri uresis</w>
hom ologies</w>
gon ococcal</w>
Meas ured</w>
Vas cul
pent oxifylline</w>
In trig
mes ylate</w>
28. 2</w>
micro angiopathy</w>
RO Is</w>
O ff</w>
enc ycl
CD A</w>
syn tactic</w>
DI s</w>
AR P</w>
re volution</w>
CCA AT</w>
Ex tract</w>
Appl ied</w>
Commerc ial</w>
oph aryn
Impro ves</w>
o h
ure mia</w>
Glc NAc
deriv es</w>
HF pEF</w>
trif lu
vol ar</w>
purch ased</w>
y x
di aries</w>
transcriptom es</w>
re med
sub regions</w>
X e</w>
re inst
novi al</w>
punc tate</w>
S HR
mit oxantrone</w>
glass y</w>
3 81</w>
inter rater</w>
SN ARE</w>
macro cyclic</w>
con i</w>
wal ked</w>
SV C</w>
Multi drug</w>
dendr ite</w>
V in
ofur an
N MMA</w>
organis ed</w>
osy nostosis</w>
nanocarri ers</w>
com post</w>
leach ate</w>
ness ing</w>
A gon
phen anthrene</w>
enop tera</w>
agg rec
Cr uc
Adju stment</w>
prognos es</w>
S f
X pert</w>
ren es</w>
insuff lation</w>
muc ins</w>
to ad</w>
multi channel</w>
Usu ally</w>
5 7.
E J</w>
don ovani</w>
N ations</w>
IC V</w>
micro structures</w>
Per sian</w>
HM W</w>
un itary</w>
immuno therapies</w>
AR M</w>
aqu ine</w>
fove a</w>
i demic</w>
cyt arabine</w>
fl ying</w>
ann els</w>
Sh ock</w>
contamin ating</w>
pa yer</w>
antigen ically</w>
I TC</w>
F asci
stabil izer</w>
dil ection</w>
P u</w>
D OR</w>
Re fer
NL S</w>
Socio economic</w>
surviv als</w>
al anyl</w>
anti emetic</w>
pregn enolone</w>
fibro ids</w>
O HCA</w>
narrow ed</w>
iform es</w>
os pores</w>
AC E2</w>
PS s</w>
lanth anide</w>
3 83</w>
ot gun</w>
rid ges</w>
M arg
inter chang
2. 17</w>
Ex clusion</w>
su it</w>
PC r</w>
some one</w>
tetram eric</w>
pro ficient</w>
alc ogen
3 M</w>
ill ic</w>
AT C</w>
distr actor</w>
ibr ated</w>
Sel enium</w>
v ault</w>
AF B</w>
bacteri ocin</w>
cyclohex ane</w>
F 9</w>
on colytic</w>
og astro
mis folded</w>
poly ester</w>
conver sation</w>
adren als</w>
inter species</w>
ey er</w>
swim mers</w>
wo ody</w>
Mut ational</w>
en il</w>
ven ography</w>
ung unya</w>
stru ggle</w>
oyst er</w>
Lank a</w>
ant al</w>
grad ely</w>
Ig D</w>
O reg
Th o
he i</w>
chr y
mel on</w>
NO x</w>
advoc ates</w>
oc entric</w>
acces sion</w>
O 2
minim ise</w>
chec ks</w>
C EC</w>
sub division</w>
NC C</w>
prot otypical</w>
T XA</w>
8 A</w>
4 11</w>
ME TH</w>
lymph atics</w>
reproduc ibly</w>
interven e</w>
Con flic
ger man
nc RNA</w>
S LI
IC a</w>
Quanti tation</w>
leptosp irosis</w>
Res veratrol</w>
Nan oc
T MT</w>
PON 1</w>
anaerob es</w>
S DM</w>
K ATP</w>
ca red</w>
VL Ps</w>
neighbour hood</w>
B ed
Sar co
G Pa</w>
3 1.8</w>
DN s</w>
trin itro
supr an
myo epithelial</w>
AQ P4</w>
t 2</w>
5 3.3</w>
par allel
5 5.
An ten
promis cu
osyl -</w>
open ings</w>
pre mise</w>
Pre mature</w>
flur amine</w>
MW CNTs</w>
undoub tedly</w>
P an</w>
9 7.5</w>
Pub med</w>
A do
n ation
4 9.
al oric</w>
arabin ose</w>
re feeding</w>
cf DNA</w>
dorsome dial</w>
f atigu
Ch ir
prioriti zation</w>
polypo id</w>
hyperpolar izing</w>
D aph
embran ous</w>
G onad
CH A</w>
aph thal
G ER</w>
oph ile</w>
Path ogenic</w>
aer o
CL 1</w>
Com mon
On cor
emp fer
jur y</w>
inter ferences</w>
AD G</w>
inter group</w>
P X
bet amethasone</w>
PK R</w>
upreg ulates</w>
prefer ring</w>
h 1</w>
29. 3</w>
tough ness</w>
ir amate</w>
2. 35</w>
Echocardi ographic</w>
T issues</w>
restr aints</w>
n um
V LA</w>
alc ium</w>
H art
r umination</w>
W AF1</w>
CM D</w>
Emplo ying</w>
monophy letic</w>
ro ten
ear um</w>
S ear
An atomic</w>
canal icular</w>
5 8.3</w>
AG T</w>
para ox
oc aly
comp eted</w>
T EM
non polar</w>
Down regulation</w>
remin der</w>
D CD</w>
bot anical</w>
catech in</w>
labyrin th
G d
3 47</w>
h aptic</w>
pro polis</w>
per ineural</w>
TL D</w>
P HT</w>
c anti
I onic</w>
V R
Fac ebook</w>
CD 10</w>
crani oc
bro aden</w>
disco ideum</w>
Instrum ent</w>
E PSPs</w>
ther anos
trans well</w>
ath on</w>
az osin</w>
Su peroxide</w>
Surviv ors</w>
G Y
et uses</w>
SR H</w>
un coated</w>
men th
macro lides</w>
cannabin ol</w>
obtur ator</w>
vo rous</w>
spin ous</w>
14 th</w>
nas ogastric</w>
Re ading</w>
ul is</w>
Intr al
2 7.1</w>
S cor
spac ers</w>
28. 1</w>
FI M</w>
osy stemic</w>
-0. 3</w>
oli pos
nanoc lu
repeat able</w>
Ang II</w>
don ia</w>
nephro toxic</w>
Mar yland</w>
Tot ally</w>
M P2</w>
5 71</w>
ap 1</w>
prov oc
oc la
BD V</w>
chie fly</w>
correl ative</w>
oth rom
Establ ishing</w>
D r</w>
di fluoro
PR K</w>
Com orbidity</w>
stimul ators</w>
4 21</w>
2. 11</w>
seque stered</w>
tic ula</w>
ari ous</w>
Tw in</w>
ophysi ology</w>
Arab ic</w>
W all</w>
acetyl ene</w>
scienti fically</w>
pren eo
28. 4</w>
a ve</w>
ed ited</w>
cou ghing</w>
MM P9</w>
ar med</w>
4 48</w>
par ties</w>
chin ensis</w>
rest aur
00 01</w>
AS O</w>
robo ts</w>
attrac ting</w>
knowled ge
- 14</w>
oph ot
cyt ogenetics</w>
glyc opeptide</w>
SR F</w>
promin ence</w>
3 67</w>
curv il
optim ise</w>
restric ts</w>
dendrim ers</w>
idi zed</w>
eli i</w>
stere otyped</w>
St aff</w>
Acet yl
sensiti ze</w>
k head</w>
pre dilection</w>
ra emia</w>
Tri ticum</w>
neuro development</w>
PE M</w>
Fr uc
hind brain</w>
G HD</w>
viol ation</w>
alve oli</w>
Inc id
re operations</w>
Contro ver
ophthalm ologic</w>
correl ational</w>
Re activity</w>
overex press</w>
osensi tive</w>
tit les</w>
Pap anicol
underpin nings</w>
3 74</w>
run g</w>
Stro mal</w>
enc ement</w>
EC F</w>
pharmac ophore</w>
fo etus</w>
Immun op
otroph oblast</w>
S taining</w>
fl ud
deoxynucle otides</w>
sem is
Emph asis</w>
I DH</w>
ch al</w>
em ig
multi scale</w>
CD 23</w>
recti fying</w>
St ages</w>
Lymph ocytes</w>
or tical</w>
pa use</w>
leg umes</w>
Bel gian</w>
astro glial</w>
adsorb ents</w>
sett led</w>
hydr amnios</w>
stereo chemistry</w>
2 L</w>
3 5.3</w>
de afferen
tuber cular</w>
ta ut
TUR P</w>
Anesthesi ologists</w>
2 7.4</w>
P inus</w>
por tr
gr asping</w>
Ab bot
AS s</w>
inform ant</w>
chimpanze e</w>
short ness</w>
in i
til ted</w>
a ou</w>
in ator</w>
dic arboxylic</w>
scru tiny</w>
Me eting</w>
E DL</w>
exchang eable</w>
spec ifying</w>
ME A</w>
EX TR
str ia</w>
In domethacin</w>
dysmorph ic</w>
2. 50</w>
1, 2,3,
epist axis</w>
IF T</w>
decom posed</w>
2 m</w>
peg ylated</w>
os e
Ne igh
Smad 2</w>
U k
Al umin
CA I</w>
G angli
otox igenic</w>
4 0.5</w>
micro cos
osseo integration</w>
nem atic</w>
t yro
dec ellul
lacun ar</w>
D CP</w>
Ne eds</w>
D PP
disc arded</w>
inte restingly</w>
anti pyrine</w>
dy sen
a ison</w>
B H4</w>
ro toxin</w>
psych ogenic</w>
glyco conjugates</w>
hyp nosis</w>
Cr ude</w>
lute a</w>
sacchar in</w>
N erv
psych ic</w>
ID O</w>
2. 16</w>
substitu ting</w>
DI S</w>
semicir cular</w>
3 77</w>
I ON
mat a</w>
pl antation</w>
br it
PM s</w>
depl eting</w>
pin ch</w>
3 6.8</w>
4 3.5</w>
Inser tion</w>
Endos copy</w>
amplic ons</w>
Trans well</w>
y me
- 1-</w>
car vedilol</w>
hyper secretion</w>
reconstruc ting</w>
LOG ICAL</w>
perfec ta</w>
li m</w>
otyp y</w>
B ER</w>
al together</w>
2. 45</w>
BM s</w>
conven i
digesti ble</w>
- H</w>
pon ds</w>
Aggreg ation</w>
V OR</w>
om ectomy</w>
F SS</w>
por a</w>
r amp</w>
e Health</w>
cul prit</w>
.00 6</w>
Aff ect</w>
ophil es</w>
Ha CaT</w>
R equi
S tom
on er</w>
atr e</w>
am idase</w>
rhe ology</w>
F os
inter s</w>
haem agglutinin</w>
resur facing</w>
Y b</w>
Pro be</w>
N 9</w>
ul na</w>
un remarkable</w>
Det ecting</w>
hin dr
Pla que</w>
co d</w>
av itary</w>
IFN </w>
5 51</w>
til in</w>
3 1.2</w>
ut um</w>
angi omy
inev itably</w>
ren z
F RA
no ti
cre p
ysi a</w>
pati c</w>
rs 1
vide o
bor reli
a ena</w>
excit otoxicity</w>
tab ulated</w>
immunosuppress ant</w>
metabol ize</w>
Upreg ulation</w>
bin ders</w>
3 0.3</w>
ag am
PS F</w>
glucuron idation</w>
myot onic</w>
dec ayed</w>
Plas tic</w>
3 53</w>
5 8.
lev ator</w>
Ca used</w>
sulf ation</w>
Po rous</w>
did n</w>
Nem at
dist antly</w>
ligh ter</w>
C ol</w>
insti lled</w>
C GI</w>
lab s</w>
ole oyl</w>
cholec alciferol</w>
ram us</w>
vibri o</w>
imp ending</w>
arrhyth mogenic</w>
Li Cl</w>
I cel
mal ic</w>
SW S</w>
Difficul ties</w>
lec tures</w>
reticul ocytes</w>
pum ped</w>
normo thermic</w>
P SM</w>
og o</w>
mig ra
New born</w>
F atal</w>
- </w>
to es</w>
Ix odes</w>
7 7.8</w>
s ory</w>
leuc ovorin</w>
Ca esarean</w>
Trans fusion</w>
Hydro x
wet tability</w>
3 95</w>
co transport</w>
PIK3 CA</w>
Feed back</w>
r yp
co administration</w>
typh i</w>
E ll
re implantation</w>
fil trate</w>
anesthesi ologists</w>
oct yl</w>
Thrombo sis</w>
Psych ometric</w>
neighb ors</w>
mis classification</w>
bor onic</w>
Arsen ic</w>
un ruptured</w>
hydro lysates</w>
psych oses</w>
Per for
horiz ontally</w>
hyper kalemia</w>
J ac
re pository</w>
scop ies</w>
l itre</w>
stri ol</w>
lipop olysaccharides</w>
homodi mer</w>
p l</w>
loc ality</w>
anil ide</w>
preclud ed</w>
mor i</w>
glyc osphing
immun izations</w>
umb ers</w>
Mo tiv
repar ative</w>
GRP 78</w>
Oncor hynchus</w>
out liers</w>
Ang le</w>
3 2.4</w>
injec t</w>
S Ps</w>
i ation</w>
stabil isation</w>
lib erated</w>
ul ence</w>
kil ogram</w>
c rop
J P</w>
ex pres
SP ME</w>
F Q</w>
Gu ide</w>
kinetoch ore</w>
Zimbab we</w>
intran uclear</w>
hypophy seal</w>
acti le</w>
gastr ulation</w>
travel ing</w>
guil t</w>
ph ased</w>
Par adox
PV T</w>
clock wise</w>
V N</w>
ven lafaxine</w>
py ogenic</w>
4 24</w>
I RT</w>
chlor pyrifos</w>
thiop ental</w>
Dri ven</w>
ret te</w>
3 1.4</w>
- 50</w>
ind oles</w>
om p
oper ons</w>
vol can
6 G</w>
impro per</w>
HM O</w>
keto profen</w>
Rheum atology</w>
F RC</w>
remed y</w>
r iding</w>
pre pro
par alyzed</w>
mening o
Lif e
tauro cholate</w>
Intra ocular</w>
ec ologic</w>
Jord an</w>
op ril</w>
Predic t</w>
R 4</w>
Fer tility</w>
obenz ene</w>
dorsi flexion</w>
is ob
Op tic</w>
3 89</w>
NH 4
Biomar ker</w>
Cour se</w>
ex tir
9 5.
ometr ical</w>
cas ual</w>
CP K</w>
icul i</w>
Su stain
orb ide</w>
Al ign
RE s</w>
je op
lac eration</w>
Consider ations</w>
op neum
icardi um</w>
9 3.3</w>
om ni
ros ettes</w>
edull in</w>
per col
ou l</w>
Phot odynamic</w>
par ab
ortholog s</w>
Ch annel</w>
Ac upuncture</w>
Modi fications</w>
Decre ase</w>
H ur
strip e</w>
str onic</w>
Me dial</w>
ann a</w>
magn ocellular</w>
ca u
6 80</w>
r onic</w>
A AD</w>
if ts</w>
cor ner</w>
leuk em
rein hard
tar sal</w>
correspond ingly</w>
um ent</w>
bu propion</w>
ultra high</w>
Rh in
commis sural</w>
- L</w>
PT G</w>
dor sum</w>
end plate</w>
mon ogenic</w>
CF R</w>
san itary</w>
A propos</w>
n ac
on ion</w>
lam eness</w>
M a</w>
ter butaline</w>
neuro ectodermal</w>
flatten ing</w>
Orb ital</w>
B alloon</w>
8 S</w>
muscul aris</w>
MC3 T3</w>
par then
approxim ations</w>
Per sistence</w>
lipo philicity</w>
S un
si b</w>
Pre incubation</w>
Car tilage</w>
w ing
In t</w>
all ylic</w>
uro xime</w>
c ush
B 10</w>
ST 1</w>
ana x</w>
epitheli alization</w>
5 C</w>
p v</w>
Z one</w>
es thesia</w>
2. 27</w>
SL S</w>
Peri od</w>
Ultras onic</w>
adeno viruses</w>
ker nels</w>
8 8.9</w>
f ighting</w>
gly ox
K ur
omet allic</w>
S b
9 6.
com min
Leptosp ira</w>
B RS</w>
sul piride</w>
random isation</w>
Sol utions</w>
Cd k
3 2.3</w>
man nos
re activated</w>
Inter face</w>
alb opic
re ar</w>
ph e
vitr onectin</w>
rati onally</w>
Metast ases</w>
retic ulin</w>
f ear
3 6.7</w>
4 6.7</w>
om ethyl
N 0
recogn ise</w>
G PI
F BG</w>
FL AIR</w>
2 4.0</w>
f id
F GFR</w>
li pot
Fra ilty</w>
IF G</w>
F T4</w>
- nucleotidase</w>
50 9</w>
surro gates</w>
ry e</w>
IO Ls</w>
on ation</w>
rin us</w>
Psychi atry</w>
happ ened</w>
gravit ational</w>
ag rel
orbit ofrontal</w>
6 3.6</w>
leuk aemic</w>
lev amisole</w>
poly tetrafluoroethylene</w>
erythro cytic</w>
s. d.</w>
tetra hydro</w>
numer ic</w>
3, 0
abor ted</w>
NF B</w>
scler a</w>
cycl ical</w>
H es
W GS</w>
3 97</w>
scho oling</w>
4 29</w>
ig s</w>
IN T</w>
ig e</w>
atidyl choline</w>
F W</w>
- 0.1</w>
st ack</w>
V MAT</w>
pyrrolid one</w>
hs CRP</w>
3 92</w>
U U
immunop ositive</w>
H s
lam o
Therap ies</w>
posit ories</w>
. A.</w>
cent ros
referen ced</w>
R H
py ran
tubulo interstitial</w>
long standing</w>
immuno electron</w>
25 ,
ind entation</w>
Alk aline</w>
B eg
manif old</w>
eri atr
dissoci ate</w>
Guid eline</w>
opson ized</w>
tap er</w>
intrap ulmonary</w>
wean ling</w>
AL F</w>
F ST</w>
parti tioned</w>
saf egu
ophag ocytic</w>
loos ely</w>
LT C4</w>
M and
ge o
DR F</w>
S ab
AC F</w>
resol utions</w>
a is</w>
chor dom
ph a
str ian</w>
2 K</w>
herbiv ore</w>
laparo scopically</w>
mobil ities</w>
actom yosin</w>
tume faciens</w>
h en
d og
specific s</w>
withdraw ing</w>
hyal uronate</w>
6 4.
co infected</w>
over active</w>
electro spinning</w>
Mo S2</w>
Immun ost
avi d</w>
Rem ote</w>
3 0.2</w>
xyl ene</w>
rham n
D PD</w>
M ast</w>
conduc ive</w>
ophthalm ological</w>
ech in
rh ab
candi d
Tre pon
cardio protection</w>
3 1.1</w>
re teral</w>
ta u
Rec ogn
46 619</w>
hamartom a</w>
O u
w ounded</w>
Ther mod
Chr on
Scre en</w>
TGF beta</w>
seaf ood</w>
Papanicol aou</w>
qui escence</w>
I DC</w>
clos ures</w>
Nutri ent</w>
ster ase</w>
oly tics</w>
iso prost
6 8.
N J</w>
perchlor ate</w>
ch ur
e pers</w>
brach i
F X</w>
comm encement</w>
g hosts</w>
v est</w>
min k</w>
devi ant</w>
assembl age</w>
6 3.
cu ticular</w>
Viet nam
Cost a</w>
sub fractions</w>
hum idi
categor ised</w>
4 1.5</w>
nutri tive</w>
az in</w>
acetab ulum</w>
Citr us</w>
albopic tus</w>
thym idylate</w>
mon d</w>
sig ma
T Z
osteo arthritic</w>
un suspected</w>
purch asing</w>
3 57</w>
3 2.1</w>
K ol
-0. 4</w>
3 64</w>
po unds</w>
syn ten
Inter ference</w>
Aneurys m</w>
RI P</w>
29. 7</w>
SC O</w>
sum med</w>
HR S</w>
F ur
Post traumatic</w>
th ia</w>
ain flu
ogrou p</w>
pol yt
SL Ns</w>
pent ose</w>
cry oglob
Veter inary</w>
week end</w>
D AS
reinnerv ation</w>
z ol</w>
methyl cholanthrene</w>
insuffici ently</w>
os molar</w>
ow els</w>
mamm ograms</w>
evol ves</w>
IF Ns</w>
disp ensed</w>
sta ple</w>
Ass ays</w>
pellucid a</w>
osp ir
C AC
B and</w>
inos us</w>
lamo trigine</w>
1 p
fen o
epiphy sis</w>
re ject</w>
anti diuretic</w>
neuro secretory</w>
TF PI</w>
28. 7</w>
decid ua</w>
A str
J ust</w>
men tion</w>
Bi opsies</w>
Hym enoptera</w>
gambi ae</w>
6 5.
tri valent</w>
hyster oscopy</w>
dr um</w>
con ical</w>
cel y</w>
yt openia</w>
cle arer</w>
trunc al</w>
harb ors</w>
cha os</w>
L ast</w>
K b</w>
gu ai
sl ab</w>
HT 29</w>
Analy zing</w>
resili ent</w>
ban ana</w>
equilib ria</w>
PRO B
ure as</w>
Reg ulates</w>
found ations</w>
roten one</w>
er ol</w>
arres tin</w>
R equ
cl en
myelo fibrosis</w>
forec ast</w>
pres urgical</w>
2. 22</w>
y ear
categor ize</w>
dichloro methane</w>
W .</w>
man ageable</w>
sist ers</w>
cal varial</w>
lact ones</w>
immunomod ulation</w>
r GO</w>
con form</w>
SI V
sc ram
on azole</w>
tele health</w>
thromb ospondin</w>
B HK</w>
ab breviated</w>
nitro cellulose</w>
ber t</w>
un ia</w>
hydroxy propyl</w>
permeabil ization</w>
AB CB1</w>
Cyto plasmic</w>
collim ator</w>
3&apos; UTR</w>
TB A</w>
amend ment</w>
understand ings</w>
N KG
dr yness</w>
PR E</w>
Vietnam ese</w>
N BS</w>
mat ur
micro environments</w>
hydrox yp
myo fibrils</w>
asparag inase</w>
myocl onic</w>
Advant ages</w>
Fan coni</w>
re trac
di eti
com posting</w>
PG S</w>
Ath l
autocor relation</w>
t old</w>
d b
mac ros
herm aphro
D RS</w>
whe eze</w>
syring ae</w>
Intrig u
M HV</w>
nan ob
NO T
bom bar
it o</w>
Tel e
sc orp
MV s</w>
Intrigu ingly</w>
em an</w>
SU I</w>
2. 33</w>
officin alis</w>
ap ing</w>
gust atory</w>
4 7.5</w>
MD SCs</w>
Labor atories</w>
bi otype</w>
pin k</w>
sm ell</w>
eu genol</w>
ly syl</w>
ak in</w>
Sim ulated</w>
unic ellular</w>
P et
2 7.9</w>
M yc
19 64</w>
non covalent</w>
liz ards</w>
TI Ls</w>
id ins</w>
under water</w>
wel ding</w>
insectic idal</w>
scorp ion</w>
4 51</w>
u ity</w>
morph ol
Electroph oretic</w>
Prec ise</w>
5 25</w>
is ome</w>
BCL 2</w>
acrom ial</w>
5 6.
ul lin
oc ulation</w>
ane ph
P aro
ac nes</w>
fl on</w>
F 8</w>
PL E
Gl omerular</w>
U PD
per id
the l</w>
termin alis</w>
Oreg on</w>
P y</w>
traum atized</w>
Syn ap
shi eld</w>
MM TV</w>
VEGF R2</w>
T J</w>
ch illing</w>
f using</w>
Y ou
ne opterin</w>
inter relationships</w>
az ocine</w>
3 76</w>
Pl ain</w>
anthelmin tic</w>
M FS</w>
chem i
raz epam</w>
sc rotum</w>
Pro bing</w>
denti fr
Platel ets</w>
A h</w>
phen oxy</w>
non adherence</w>
carcin omatosis</w>
stern um</w>
re member</w>
ut ter
M arti
N 2
at ability</w>
Radi al</w>
acquisi tions</w>
GSK 3</w>
FI T</w>
Tit anium</w>
biore mediation</w>
e utroph
muc op
Cor tisol</w>
3 1.7</w>
 r
26 ,
po sive</w>
hol m</w>
cylin ders</w>
trabec ulae</w>
Thromb in</w>
GI C</w>
non malignant</w>
los a</w>
porphy ria</w>
G il
G AGs</w>
fluoresc ens</w>
Dis per
Ha ve</w>
hydrox ylamine</w>
ometh ylation</w>
s ong
del usions</w>
Optim izing</w>
prioriti zed</w>
kilodal ton</w>
gener alize</w>
oll is</w>
mut u
Se ed</w>
symbi onts</w>
tachy cardi
meso dermal</w>
disturb ing</w>
5 70</w>
st y
sp rings</w>
den ied</w>
decarbox ylation</w>
forec asting</w>
Princi ples</w>
I PL</w>
M SH2</w>
sem an
Web er</w>
dict ated</w>
Sca ff
L Cs</w>
p enc
O HP</w>
29. 1</w>
m Gy</w>
micro filaments</w>
St ock
constell ation</w>
V G
at taining</w>
pur pos
OK T3</w>
connec ts</w>
protr uding</w>
Mig raine</w>
Me tr
Abbot t</w>
on ensis</w>
n AChRs</w>
transpl antable</w>
motiv ate</w>
TU s</w>
multi plic
p 70</w>
no b
sen iors</w>
heterodi meric</w>
Bol tz
trans abdominal</w>
ogran ul
hydroly ze</w>
rosi glitazone</w>
a eus</w>
omel an
hypot onia</w>
Ultra violet</w>
orh odopsin</w>
S end
F -</w>
cal vari
gp 41</w>
ev ine</w>
hepat oprotective</w>
Aut opsy</w>
R 1
mon grel</w>
Insi ght</w>
hemo chromatosis</w>
Ma x</w>
M PN</w>
cell aneous</w>
cave olae</w>
V FA</w>
sho e</w>
decre ments</w>
mo ul
thym ectomy</w>
remin ders</w>
4 15</w>
N .</w>
orth ologous</w>
Ta x</w>
V UR</w>
prote obacteria</w>
meth em
nano fiber</w>
ventricul ography</w>
pyraz ol
homozyg osity</w>
kilob ases</w>
G ad
Re in
thermo stability</w>
B ID</w>
append ages</w>
en ius</w>
Cat ech
recombin ase</w>
ger bil</w>
Ris ks</w>
Cat ar
meval onate</w>
U SD</w>
em atous</w>
rac ing</w>
E yes</w>
leiomy omas</w>
Cong ress</w>
rh BMP</w>
GL S</w>
IL s</w>
S edi
micro titer</w>
angi omas</w>
in amide</w>
T et
U K
oc ratic</w>
end omy
sub gingival</w>
educ ating</w>
ary otic</w>
Tr act</w>
head space</w>
heter ot
meri stem</w>
PT E</w>
29. 8</w>
no ble</w>
Aut onomic</w>
h MSCs</w>
K un
iso flavones</w>
hydro phila</w>
cardio plegic</w>
centr alized</w>
strong ylus</w>
narcol epsy</w>
d um
constitu tion</w>
u v
in consistency</w>
bi ota</w>
ere rs</w>
dys one</w>
haemat ocrit</w>
yl or</w>
1, 10</w>
AK R</w>
glycos ylase</w>
O OH</w>
2. 18</w>
ov o</w>
CA 19</w>
All ergy</w>
Indu stry</w>
alar ming</w>
angi itis</w>
H ippo</w>
eth i
organ o
surroun dings</w>
rhin oplasty</w>
l om
ur b</w>
3 87</w>
cre w</w>
PM 10</w>
A TS</w>
13 00</w>
fea ther</w>
myc otoxin</w>
D CC</w>
de generating</w>
po ison</w>
Pro pi
read mitted</w>
helmin ths</w>
T rib
ent an</w>
HI E</w>
hemipleg ia</w>
f MLP</w>
amino acyl</w>
homogen ized</w>
omon ocytic</w>
preneo plastic</w>
B CNU</w>
abrup tly</w>
Epid ural</w>
4 55</w>
li b</w>
ric kets</w>
ble ed</w>
coag ulated</w>
2 3.0</w>
AC V</w>
multi loc
ER M</w>
3 49</w>
o proteins</w>
od our</w>
2. 24</w>
Lin ked</w>
D ich
bl ight</w>
ardi ve</w>
PL LA</w>
2 5.1</w>
uc k
lymph oblasts</w>
slur ry</w>
pro caine</w>
Per me
C all
endoc ervical</w>
FK BP
polycy themia</w>
p ale</w>
em sa</w>
Di arr
F n</w>
an ual</w>
ech ogenicity</w>
non equilibrium</w>
lymph otropic</w>
Oper ation</w>
fin ely</w>
catechol aminergic</w>
r uling</w>
ep oxy
suc king</w>
ach s</w>
Mech an
2,3, 7,8</w>
n ica</w>
e tically</w>
N PCs</w>
ar bor
2. 23</w>
TLR 9</w>
megakary ocyte</w>
exci sional</w>
ip id</w>
Hybri dization</w>
ti tu
net working</w>
cef azolin</w>
sed ated</w>
T ER</w>
volun tarily</w>
hang ing</w>
Repeti tive</w>
dis organization</w>
P om
ti e</w>
Con temporary</w>
4 28</w>
B l</w>
B asi
harbo uring</w>
su fentanil</w>
g yp
frac tory</w>
Reli able</w>
fructo kinase</w>
am ellar</w>
Pro pen
clomi phene</w>
a the
AL DH</w>
E ver
ti p
si lo
gen er</w>
stret ches</w>
Pig s</w>
Immun ob
Bay es</w>
o chrom
dis appears</w>
myx oid</w>
de es</w>
T RO
sp rung</w>
lem an</w>
card inal</w>
E B1</w>
mycel ial</w>
C AT
F MF</w>
tu zumab</w>
ore duction</w>
act yl
S Ds</w>
R HD</w>
N MS</w>
F uc
po orest</w>
Se e
good ness</w>
t max</w>
an odic</w>
troph y</w>
flagell in</w>
T u</w>
extrac ellularly</w>
FV IIa</w>
v anish
HT 2A</w>
Abstr act</w>
acti ae</w>
Oc ca
I PP</w>
hyper stimulation</w>
flex ors</w>
spermat ogenic</w>
primi parous</w>
Boltz mann</w>
R b
perioste um</w>
tri oxide</w>
AD F</w>
Pro po
CS I</w>
rep tiles</w>
m Ci</w>
9 5th</w>
W NT</w>
qu etiapine</w>
trim oxazole</w>
ce iling</w>
adrenal ectomized</w>
p soas</w>
ter tiles</w>
pa e</w>
thec a</w>
obarbit one</w>
adrenocortic otropic</w>
FGF 23</w>
oxidi ze</w>
recapit ulate</w>
extrac apsular</w>
Inter ventional</w>
Min i
D ir
as ally</w>
HIF U</w>
N AN
 re</w>
ent anglement</w>
all ogenic</w>
pip razole</w>
Coord ination</w>
S chem
bronch ogenic</w>
arri ve</w>
SET TI
L is
ep er</w>
fung icide</w>
myel osuppression</w>
o uring</w>
if ting</w>
Pul sed</w>
Leuk ocyte</w>
miniatur ized</w>
my ogenesis</w>
az enil</w>
Ph ase
60 3</w>
AG P</w>
T OC</w>
Mg Cl2</w>
voc alizations</w>
Ch el
enucle ated</w>
aler ts</w>
empfer ol</w>
mo tive</w>
soci ocultural</w>
Non linear</w>
cryptoc occal</w>
envel opes</w>
se st
Com pens
spra yed</w>
Nocardi a</w>
w is
Vi sible</w>
lou dness</w>
microgram s.
per idine</w>
sal i
be agle</w>
Per coll</w>
ate tra
tun ica</w>
travel ers</w>
DR E</w>
carbap enem
curvil inear</w>
6 35</w>
ec dy
pres en
DE A</w>
haem olysis</w>
fen fluramine</w>
B TX</w>
er ial</w>
under graduates</w>
thor a</w>
ex pulsion</w>
1 ra</w>
G ap</w>
multi organ</w>
PD 98059</w>
can inum</w>
AR G</w>
millis econds</w>
kin umab</w>
stre ak</w>
dermat oses</w>
biog eo
re ovirus</w>
L aw
3 59</w>
mathem atics</w>
7 5.0</w>
sin ess</w>
SE B</w>
IK K
dor ff</w>
PN I</w>
bil ingual</w>
T OR</w>
gen icity</w>
Stat 3</w>
reinhard tii</w>
r ase</w>
3. 33</w>
PK B</w>
Par athyro
oc top
re appraisal</w>
re atine</w>
dimethyl siloxane</w>
stu ffs</w>
ah l</w>
alk ane</w>
35 80</w>
consen ted</w>
u alized</w>
micro bubbles</w>
2. 26</w>
RA M</w>
Plas mid</w>
pyrid oxine</w>
iqu antel</w>
3 91</w>
as tin
wor tmannin</w>
val ley</w>
scal ar</w>
9 a</w>
inve stments</w>
G U
3 69</w>
mal onyl</w>
Par a
assign ing</w>
trypan osomes</w>
G PC</w>
idi an</w>
PY Y</w>
a em
3. 0
Impl ementing</w>
L AT</w>
Res ources</w>
mor ph</w>
phot ographic</w>
at ta</w>
assi stive</w>
par ities</w>
The il
rhyth micity</w>
M AGE</w>
hyper lipidemic</w>
An aes
neurom a</w>
happ en</w>
7 2.7</w>
- infected</w>
bro ther</w>
util ising</w>
a ken</w>
or nam
im purity</w>
cre ativity</w>
sen te
ST EC</w>
camp tothecin</w>
4 85</w>
if lor
oste olytic</w>
ir regularity</w>
esti bular</w>
Plat eau</w>
endoc annabinoid</w>
Trepon ema</w>
E cu
F AM
monoc linic</w>
immunophen otype</w>
adh esin</w>
Con A</w>
on ym</w>
ox itin</w>
retro gradely</w>
neutr ons</w>
Inhib its</w>
A round</w>
ass uring</w>
Ch ris
arc is
2, 8
Le ad
amygdal oid</w>
slaugh tered</w>
y an</w>
a z</w>
To ols</w>
Tou rette</w>
organochlor ine</w>
3 .</w>
im eth
port osystemic</w>
CT V</w>
she patic</w>
N REM</w>
PR 1</w>
blin ding</w>
ascer tainment</w>
f ates</w>
M CM</w>
acidi fied</w>
uk i</w>
Mac ular</w>
Calcul ations</w>
foot printing</w>
ondyl ar</w>
ris m</w>
Cor tex</w>
se als</w>
bin aural</w>
Su ff
oct ane</w>
TR A</w>
oretin opathy</w>
X III</w>
den om
phot ob
Neuro logic</w>
supr ap
scar cely</w>
Roch e</w>
u st
om b</w>
pil ots</w>
TX B2</w>
L ens</w>
bout ons</w>
SETTI NGS</w>
val sartan</w>
Phen yl
Ne ed</w>
enter opathy</w>
benz oyl
Hamil tonian</w>
LDL R</w>
serogrou ps</w>
Fin ding</w>
Nor thwest</w>
tachy kinin</w>
biog as</w>
enrol lees</w>
F IV</w>
id ine
ip in</w>
G U</w>
m J</w>
t A</w>
I TT</w>
ox LDL</w>
carb ene</w>
P av
trans sphenoidal</w>
Re present
cri ticism</w>
IV H</w>
Tor r</w>
f atin</w>
str ug
pre morbid</w>
liter atures</w>
Propen sity</w>
Mercur y</w>
centr i
oscop ies</w>
Practition ers</w>
oc idal</w>
taz obactam</w>
n l</w>
3 8.9</w>
me dro
PB DEs</w>
45 Ca2</w>
LINC 00
Br un
H2 A</w>
3 4.8</w>
rig or</w>
pteryg ium</w>
conval escent</w>
Prescrip tion</w>
Send ai</w>
Y AC</w>
Cu O</w>
nan ospheres</w>
bur ne
Georg e</w>
k bp</w>
neuro biology</w>
Sc and
Sem i
ico planin</w>
3 7.8</w>
Bi oph
tradi tion</w>
m olysis</w>
3 4.4</w>
PA E</w>
do id</w>
complic ates</w>
50 7</w>
sente eism</w>
3 79</w>
go ides</w>
diver ticula</w>
eicos anoids</w>
c able</w>
M ind
ff ing</w>
opharyn gi
C ox
3 2.7</w>
l ays</w>
x A</w>
Dis section</w>
mes ophilic</w>
SP P</w>
hydroxy phenyl</w>
body weight</w>
- 60</w>
pa ying</w>
enc er</w>
In tim
sest amibi</w>
in congruent</w>
con ut</w>
Gi emsa</w>
im perfecta</w>
constric tor</w>
Expan sion</w>
d well</w>
O thers</w>
histi ocytes</w>
H NF</w>
en flurane</w>
retin oin</w>
EP SP</w>
re pressing</w>
iso quinoline</w>
IR E</w>
Der m
ex ped
Ad op
SR M</w>
HF S</w>
i als</w>
di alytic</w>
liz ard</w>
CI MT</w>
mess aging</w>
dermat osis</w>
Resi d
illumin ate</w>
M ature</w>
Ex cit
CO R</w>
mono hydrate</w>
WO MAC</w>
9 1.7</w>
el astom
qu est</w>
stat e
antihist amines</w>
sit tac
C GS</w>
norm oglyc
un restricted</w>
CS s</w>
apath y</w>
5 3.8</w>
com promises</w>
iner tia</w>
J V</w>
kin dergar
hid rosis</w>
Immun ity</w>
Includ ing</w>
s ob
M AN
4 97</w>
micro dilution</w>
dra ins</w>
z ygotic</w>
skin ned</w>
s tivity</w>
3 2.6</w>
cyt oreductive</w>
bre eders</w>
non structural</w>
orchi ectomy</w>
Malay sian</w>
Fil ms</w>
H BP</w>
C W
yl -</w>
character izations</w>
iso flavone</w>
amphi pathic</w>
M 5</w>
hydro peroxides</w>
groo ves</w>
ol ith</w>
ib acterium</w>
ob liqu
suffici ency</w>
sulf ite</w>
PF OS</w>
3 94</w>
T err
anti tumour</w>
Wal king</w>
a ise</w>
aren es</w>
rol izumab</w>
P ST</w>
o on</w>
Sign s</w>
incarcer ation</w>
bere avement</w>
convol uted</w>
c ART</w>
ot alol</w>
emb rolizumab</w>
alloc atechin</w>
Percent age</w>
3 4.6</w>
design ation</w>
D AD</w>
Neuro endocrine</w>
spre ads</w>
Physi ol</w>
evid ently</w>
D MS</w>
clu b
se as</w>
tom ycin</w>
transmit tance</w>
house keeping</w>
millim olar</w>
10 0.0</w>
organophosph orus</w>
3 3.5</w>
B 8</w>
inc ipient</w>
Re tri
M olecules</w>
the atre</w>
Al b
5 2.5</w>
F ET</w>
intra observer</w>
plasmacyt oma</w>
syring es</w>
cyr rhiz
5 9.
de polymerization</w>
co operatively</w>
br ushes</w>
agon ism</w>
CA RT</w>
t ata</w>
ost s</w>
Pre v
60 5</w>
An alog
2, 6
avi renz</w>
glycer ophosph
illustr ative</w>
FS GS</w>
my opathies</w>
distrib ute</w>
ket orolac</w>
B ell</w>
los an</w>
im pedi
Behavi oural</w>
segreg ating</w>
She ar</w>
4 22</w>
AT D</w>
hist ogenesis</w>
dist ressing</w>
Four th</w>
sn ap
clerk ship</w>
J an</w>
thi ocyanate</w>
wrap ped</w>
Veg et
D AI</w>
mutag en</w>
ID Us</w>
S SP</w>
Ad dressing</w>
B erg
gr inding</w>
b. w.</w>
s ella</w>
T SC
micro dissection</w>
R Ts</w>
ur y</w>
An aerobic</w>
metabol ome</w>
aggra vation</w>
p 15</w>
 -</w>
L ab</w>
3 6.6</w>
recep tivity</w>
hydro chlor
protec tin</w>
mes oc
P SV</w>
intral esional</w>
me si
SM N</w>
municip ality</w>
a esti
O mega</w>
thi ourea</w>
c res
quad rants</w>
hyperinsulin emic</w>
anthra x</w>
SL s</w>
E2 F1</w>
Reproduc ibility</w>
prodrom al</w>
g ossy
trip eptide</w>
Induc es</w>
inf licted</w>
Prom pt</w>
G pp</w>
r pm</w>
sc rat
bo ro
Tax ol</w>
Dox orubicin</w>
I odine</w>
rex ed</w>
5 11</w>
Br ad
compul sory</w>
odor ant</w>
res p</w>
compartment alization</w>
conceptu alization</w>
regul in</w>
behavi orally</w>
leuc yl</w>
intra osseous</w>
ep ez
impl em
trim ers</w>
Oper ating</w>
E gg
th es</w>
ir regularly</w>
id ines</w>
2. 19</w>
1, 8</w>
orth ognathic</w>
50 ,
eyel ids</w>
smooth ing</w>
d R</w>
immuno affinity</w>
CT O</w>
hem orrho
Ad V</w>
Neo adjuvant</w>
r algia</w>
om ain</w>
ox icam</w>
Process es</w>
cau tious</w>
burne tii</w>
SC N
plu gs</w>
at ers</w>
DR 3</w>
K O
tub er</w>
3 0.7</w>
app raised</w>
adul ter
Radio frequency</w>
allant oic</w>
- 2,5</w>
B ED</w>
del toid</w>
bro thers</w>
aly p
Sub cellular</w>
dialy zed</w>
4 ,000</w>
F ar</w>
im od</w>
lith ography</w>
parat uberculosis</w>
clavul anic</w>
Hirsch sprung</w>
L RR</w>
os itol</w>
pos tim
Pre venting</w>
AB CA1</w>
exacerb ates</w>
EXTR ACTION</w>
un vaccinated</w>
ket oglutarate</w>
4 74</w>
O LP</w>
un injured</w>
ocortico ids</w>
Peri odic</w>
Jo b</w>
Sn ail</w>
cass ava</w>
sarcol emma</w>
stig m
muc oid</w>
phot ophysical</w>
cross bred</w>
F MT</w>
In her
tri x</w>
4 34</w>
bas ket</w>
Competi tive</w>
e striol</w>
ar us</w>
plast er</w>
w ings</w>
ok adaic</w>
DM T</w>
ex ported</w>
2. 38</w>
RO D</w>
Bac k
xy progesterone</w>
Concer ns</w>
agglutin ating</w>
vox els</w>
vo ices</w>
D W
omyc etes</w>
P all
fa ith
.00 7</w>
dextr ins</w>
fascin ating</w>
alb endazole</w>
scru tin
veterin arians</w>
ep ib
cus p</w>
G AL</w>
PL s</w>
Na OCl</w>
favour ably</w>
parac ellular</w>
sphing olipid</w>
h l</w>
lu g</w>
regul arization</w>
oxy codone</w>
Tw itter</w>
15 th</w>
trans ference</w>
micro injected</w>
SI D</w>
ket ball</w>
appreci ate</w>
ABC G2</w>
focus sed</w>
T FA</w>
Q CT</w>
methyl mercury</w>
epri stone</w>
v il
Drin king</w>
ste ering</w>
8 1.8</w>
P MR</w>
epez il</w>
L AM
car s</w>
gr asses</w>
requis ites</w>
if epristone</w>
hepat os
qual ification</w>
en ers</w>
tic ide</w>
pol ishing</w>
sk ipping</w>
rs 7
herpes viruses</w>
hydraz ide</w>
D 3
9 2.3</w>
thorac o
P on
c eph
responsi vity</w>
D K
Ph ag
Cam bo
per idol</w>
mon otonic</w>
SB 20
anno unc
colon isation</w>
cereb ell
V OC</w>
cu tis</w>
transp iration</w>
Acceler ated</w>
15 ,000</w>
Mat ter</w>
Heter o
Microbi ota</w>
di chloro</w>
TI M</w>
hom onas</w>
bul losa</w>
kind led</w>
amin ated</w>
- 70</w>
Resi li
methoxy phenyl</w>
o chol
E STs</w>
Col onic</w>
sacro iliac</w>
adenosyl methionine</w>
a virulent</w>
6 0.0</w>
os ol</w>
dri p</w>
PEG ylated</w>
aggrec an</w>
F DP</w>
scler otic</w>
- 18</w>
ti ans</w>
TR US</w>
accul turation</w>
s as</w>
in eal</w>
explo its</w>
cosme tics</w>
offici als</w>
e el</w>
Post partum</w>
credi ble</w>
F OS</w>
Phen otype</w>
d up</w>
N BD</w>
ophthalm ologists</w>
proce edings</w>
P ediatrics</w>
u ts</w>
B yp
Ap parently</w>
CV P</w>
thy retin</w>
Propo fol</w>
NT D</w>
MS G</w>
co el
epilep sies</w>
wave front</w>
pres choolers</w>
sensiti zes</w>
milest ones</w>
w ished</w>
Neutroph ils</w>
o rel
electro catalytic</w>
A AF</w>
hypothalam o</w>
PA X
thi our
recommend ing</w>
Electro my
5 90</w>
am ental</w>
T ar
ro ot
Cardi o
IV D</w>
jo in</w>
gir dle</w>
Cd Se</w>
noro virus</w>
H DM</w>
- B</w>
be et</w>
Cre utz
5 H</w>
thi oate</w>
b. i.d.</w>
om ia</w>
ol ocalization</w>
de bulking</w>
ru tin</w>
3 4.3</w>
valvul oplasty</w>
4 16</w>
viscer a</w>
R </w>
We gener</w>
thermo regulatory</w>
4 37</w>
E rec
O FC</w>
mis cellaneous</w>
millil iter</w>
electrocardi ograms</w>
breast fed</w>
floc k</w>
camp us</w>
min es</w>
dra g</w>
fel dt</w>
oun saturated</w>
Mo S</w>
chromoph ores</w>
s 2</w>
K IF
PW M</w>
dithiocarb amate</w>
H TP</w>
I RES</w>
p ium</w>
M CT
Z ambia</w>
ec dysone</w>
tic asone</w>
P es
Amer ic
ligh tly</w>
Smo oth</w>
0 9
4 6.2</w>
Co 2</w>
Medic ines</w>
computer ised</w>
buc kling</w>
Consider ation</w>
n r
phenyl acetic</w>
3 71</w>
4 1.2</w>
ter pene</w>
to il
Man if
HT T</w>
Ple ist
1 13
ph ere</w>
ocardi tis</w>
DU RES</w>
Avail ability</w>
IGF 1</w>
pup al</w>
d c</w>
ru p</w>
excit otoxic</w>
C esarean</w>
4 95</w>
B P2</w>
am mary</w>
sensi bility</w>
Te ach
Sof tware</w>
B HT</w>
Ne wer</w>
biom es</w>
-- and</w>
For mal
sati vum</w>
arabin oside</w>
R ING</w>
el u
S co
l unch</w>
nucle osomal</w>
SL I</w>
tacti cs</w>
mist aken</w>
Opportun ities</w>
credi bility</w>
PROCE DURES</w>
b A</w>
sec tomized</w>
3 2.2</w>
N ER</w>
ligam entous</w>
7 3.3</w>
In tran
mal practice</w>
hindr ance</w>
pot ence</w>
mox ifloxacin</w>
discol oration</w>
ep o
col oration</w>
ation .
ret ard</w>
imeth amine</w>
bur den
sper matic</w>
pharyng itis</w>
p si
end onasal</w>
rumin ant</w>
den tinal</w>
AP R</w>
trou bles
Brow nian</w>
4 14</w>
or onary</w>
perfor ating</w>
peri aqueductal</w>
consul t</w>
intracor tical</w>
rec idi
M X</w>
end uring</w>
exc ipients</w>
methyl amine</w>
C II</w>
RN S</w>
Ho use</w>
Hind III</w>
cont or
psycho therapeutic</w>
3 2.8</w>
b low
ab duc
par ainflu
orth olog</w>
Br onchial</w>
cauter y</w>
bil ical</w>
PD F</w>
derang ements</w>
enke phal
choc olate</w>
SM s</w>
Quanti fying</w>
re warming</w>
tun ic
ank yrin</w>
Lac tococcus</w>
Br achy
Phase olus</w>
G or
R ico</w>
ag ia</w>
ob long
sur amin</w>
bio diesel</w>
adap table</w>
rehabil itative</w>
og a</w>
cr ine</w>
Stere otactic</w>
NZ B</w>
enrol ment</w>
In d
Fi xed</w>
4 17</w>
spe ak</w>
emet rexed</w>
W it
be am
2. 28</w>
Immunost aining</w>
mon ate</w>
anat om
14 00</w>
promp ting</w>
moll usc
ituit arism</w>
b ol</w>
oc erc
di p</w>
pro posing</w>
mat er</w>
F CR</w>
ni acin</w>
p ated</w>
ol iv
cyt olysis</w>
Multi level</w>
parasit emia</w>
arbitr arily</w>
D PH</w>
leuko encephalopathy</w>
C ephal
ax otomy</w>
pap ules</w>
4 33</w>
not och
ethn ically</w>
Fo rensic</w>
Cri tically</w>
B IO
digit alis</w>
R 2
C GA</w>
ped agog
kappa B
Lip opolysaccharide</w>
si gh
ynam ically</w>
Am es</w>
crani osynostosis</w>
fru stration</w>
G CF</w>
tec tal</w>
repres sive</w>
hibern ation</w>
re structuring</w>
dec h
2, 9
NE FA</w>
Mill er</w>
pre menstrual</w>
PC K</w>
aler tness</w>
u l</w>
T empor
sol d</w>
Carbo hydrate</w>
G DS</w>
cistern ae</w>
T Ps</w>
poly vinyl
predomin ately</w>
epilep t
summar ies</w>
anthrac yclines</w>
pleas ure</w>
res ynchronization</w>
phot ometric</w>
Afr icans</w>
syn decan</w>
Dem ographics</w>
TX A2</w>
L MP</w>
U sers</w>
CV s</w>
I AV</w>
ter ahertz</w>
actin in</w>
LM W</w>
insulin oma</w>
pain ting</w>
anticonvuls ants</w>
vitr ification</w>
put ting</w>
Fl t</w>
Tan dem</w>
Cl in</w>
carbo diimide</w>
alex ithymia</w>
S anta</w>
of ascial</w>
path om
1 E</w>
Ex pec
liqu or</w>
cartrid ge</w>
olith ic</w>
adv ise</w>
don ated</w>
S es
k ur
p BR
ab l</w>
bo died</w>
plat e
F MDV</w>
We ighted</w>
All ogeneic</w>
rox icam</w>
mon omethyl</w>
wr ite</w>
di gn
un dec
sub normal</w>
nor floxacin</w>
equip ot
PROB LEM</w>
ER B
don ations</w>
V 79</w>
ro mo
form is</w>
AF LP</w>
gang ren
pay ers</w>
3 L</w>
F BP</w>
non cardiac</w>
anu fac
ISRCT N
W ill
FI B</w>
PI H</w>
n af
S NA</w>
N TA</w>
CA B</w>
HL 60</w>
-deoxy uridine</w>
supervis ors</w>
distinc tions</w>
K az
cir cles</w>
preserv ative</w>
Ne edle</w>
HE L</w>
P eyer</w>
o ak</w>
c yp
I EC</w>
inter phalangeal</w>
intr usion</w>
spin y</w>
M AG</w>
iev es</w>
tryp an</w>
myco plasma</w>
Pac litaxel</w>
sh otgun</w>
Extr a</w>
l isting</w>
res titu
overestim ate</w>
gib berel
dys genesis</w>
alkal osis</w>
Con sequences</w>
quanti fiable</w>
leng thy</w>
o estrous</w>
eu glycemic</w>
evo kes</w>
uncou pled</w>
Daph nia</w>
state wide</w>
Vari ant</w>
tetra hedral</w>
compar ably</w>
Pl an
PN H</w>
shi vering</w>
Fc gamma
stut tering</w>
bio control</w>
Dis sociation</w>
con clusively</w>
sp A</w>
dis continu
uk es</w>
Multi disciplinary</w>
n 1</w>
enig matic</w>
ec tod
bour ne</w>
Visc eral</w>
ABI LITY</w>
P osition</w>
pent yl
c occi</w>
ann an</w>
G DH</w>
C 60</w>
M PD</w>
electro genic</w>
acet onide</w>
12 6
T TC</w>
fi res</w>
glyc ogen
tro chle
mi Rs</w>
ont ogenetic</w>
CB 2</w>
IT Y</w>
B 10.
in avir</w>
For ces</w>
nap us</w>
FI D</w>
Spectro scopic</w>
Jak ob</w>
in homogeneity</w>
anti parallel</w>
Com plex
metallo protease</w>
OH dG</w>
T 7
re pressors</w>
ch e</w>
am ple</w>
is ep
dec ays</w>
2. 31</w>
bre ech</w>
L PD</w>
- derived</w>
aberr antly</w>
pa x
ill um</w>
auto antigen</w>
r i</w>
l omerular</w>
atic us</w>
sha king</w>
ib e</w>
trapez ius</w>
Ch iral</w>
bre aths</w>
pentag astrin</w>
os umab</w>
fil op
tox igenic</w>
DI AG
succin ic</w>
- negative</w>
K 8</w>
ren dipine</w>
K E</w>
dis place</w>
nitro genase</w>
weak ening</w>
anthrac is</w>
om agnetic</w>
separ ates</w>
Sil icon</w>
oc er
STAT 5</w>
r .
Expl oration</w>
ADAM TS
E b
ov igilance</w>
dig est
summar ise</w>
Sig ma</w>
Mec kel</w>
F MLP</w>
HC H</w>
parasi tized</w>
second ly</w>
b HLH</w>
end olymphatic</w>
W E
4 3.8</w>
cocul tured</w>
encour ages</w>
H erb
C ut
F LC</w>
quin ol</w>
TM B</w>
depic t</w>
F DR</w>
Loc ation</w>
Cle avage</w>
with stand</w>
chloro phenyl</w>
multiv essel</w>
con s</w>
AI L
reat t
nitr ification</w>
PU VA</w>
le f
interrup tions</w>
ex os
oper itoneal</w>
philosoph ical</w>
cef uroxime</w>
TEN S</w>
8 8.
3 4.2</w>
capac itors</w>
CC 2</w>
aff licted</w>
question ing</w>
chondro genesis</w>
tad poles</w>
leptomening eal</w>
e um</w>
ev ade</w>
filari ae</w>
3 86</w>
op ol
rele as
ab ir
inc in
Rec i
Fin ite</w>
glo ve</w>
hyper intense</w>
GT N</w>
nor theast</w>
SE s</w>
scap ularis</w>
tann ins</w>
Somat ostatin</w>
g m
ent e</w>
Inv asion</w>
D i</w>
pro visions</w>
FGF R1</w>
ant e</w>
Ad vis
Cardi opulmonary</w>
lu ting</w>
S inus</w>
2. 21</w>
de acetylation</w>
oc ou
9 4.
pyro sequencing</w>
palin dromic</w>
t ell</w>
par anoid</w>
isi tion</w>
les bian</w>
A AP</w>
ca erul
ov en</w>
Cop enh
estu arine</w>
- 3-</w>
myel omonocytic</w>
Histor ical</w>
s ons</w>
K el
Anti tumor</w>
Coch lear</w>
quinox aline</w>
iz obium</w>
organ izer</w>
osom ally</w>
overl ay</w>
appendic eal</w>
pyl orus</w>
gall ic</w>
B ub
At g
otechn ology</w>
Thor ac
and amide</w>
tub ers</w>
lignoc ellulosic</w>
on ated</w>
lipo ic</w>
schem a</w>
as alazine</w>
dist ensibility</w>
oste ochond
DN MT
cryp togenic</w>
nc RNAs</w>
v y</w>
D PA</w>
T AF
cre ep</w>
resi stivity</w>
deterior ating</w>
epti dases</w>
ogu anine</w>
urin alysis</w>
oc a</w>
tran shepatic</w>
hyper polarized</w>
log ist</w>
su mat
canc er
Pleist ocene</w>
M FC</w>
B lu
in activates</w>
Scand in
S ON</w>
d u</w>
emit ters</w>
C 57</w>
inter dig
ish ments</w>
supra optic</w>
phys ostigmine</w>
form yl
cere brum</w>
otrop ical</w>
SV D</w>
86 44</w>
8 0.0</w>
D acron</w>
re v
pre ganglionic</w>
ELI SAs</w>
e we</w>
histomorph ometric</w>
ot ation</w>
dis continuing</w>
Z er
ific us</w>
micro leakage</w>
Sa O2</w>
d rank</w>
inhab iting</w>
nob yl</w>
M AA</w>
plic ate</w>
fo stering</w>
Aff ected</w>
quic ker</w>
provoc ative</w>
hydro philicity</w>
fun goides</w>
Coun tries</w>
cep acia</w>
end um</w>
hus band</w>
8 4.6</w>
hyper variable</w>
DI T</w>
rs 18
s ae</w>
M y</w>
antim yco
polyke tide</w>
deform able</w>
S cho
3 99</w>
He ight</w>
scler oti
p Rb</w>
neuro modulation</w>
HC N</w>
reticul o
inf r
methion yl</w>
phyt ase</w>
im in
intrad ural</w>
ati veness</w>
un ifying</w>
pe ts</w>
4 75</w>
M ON
an j
Run x2</w>
B at
Chr ys
immen se</w>
distr actors</w>
lith otomy</w>
scap e</w>
Z IP</w>
def ensin</w>
ba it</w>
S PA
4 99</w>
T p</w>
it ers</w>
sec ured</w>
Un ified</w>
al dose</w>
varic osities</w>
au str
di m</w>
St atic</w>
stabil izers</w>
Ech inococcus</w>
mirro red</w>
suprac lavicular</w>
8 6.7</w>
ef s</w>
z onal</w>
Min eral</w>
remot ely</w>
Techn ologies</w>
o dical</w>
en uresis</w>
pro social</w>
D SP</w>
X Y
an x</w>
mit o
Ac tin</w>
Cann abis</w>
V AR</w>
B SO</w>
ut ory</w>
intermit tently</w>
g ers</w>
R K</w>
micro bic
CT LA
Anti viral</w>
N U</w>
fru iting</w>
nephro logy</w>
U 2</w>
lin er</w>
int olerant</w>
LI C</w>
com man
60 6</w>
sc h</w>
PPAR </w>
me res</w>
Bio film</w>
cd c
W W</w>
trans venous</w>
plan ting</w>
yog ur
S entinel</w>
k h
M cl</w>
PC 2</w>
A gain</w>
8 4.
muc ocutaneous</w>
som n
P ACS</w>
F TC</w>
al ar</w>
20 30</w>
log s</w>
desc ended</w>
en vis
ol uminescent</w>
du ties</w>
En zymes</w>
Bioph ys</w>
di aphyseal</w>
ab senteeism</w>
SO X2</w>
P un
os tium</w>
org estrel</w>
arsen ate</w>
Chlo rella</w>
E Ps</w>
re pulsive</w>
Nanop article</w>
b ounds</w>
CB s</w>
Anat omy</w>
Erythro cyte</w>
Ex tension</w>
CF D</w>
a .</w>
ut aneously</w>
contin ual</w>
japon icus</w>
steep er</w>
alis ations</w>
Creutz feldt</w>
z ia</w>
flex neri</w>
vec tive</w>
pyrrol idine</w>
p estis</w>
cotyled ons</w>
borreli osis</w>
I sle
hor ns</w>
dis lod
ure ters</w>
B AP
mon ounsaturated</w>
Af gh
dendrim er</w>
Membran es</w>
legisl ative</w>
S NF</w>
for nix</w>
Prom oter</w>
profession alism</w>
Bar thel</w>
deline ating</w>
Enrich ment</w>
transduc e</w>
zyg omatic</w>
Rever sal</w>
car nos
Spl enic</w>
occupati onally</w>
fru it
Bre ast
Ori entation</w>
M olecule</w>
man dated</w>
SN HL</w>
C li
EC V</w>
schiz o
25 th</w>
Targ ets</w>
C 10</w>
O CTA</w>
glycosi dic</w>
DIAG NO
ed in</w>
P ick</w>
psych opharmac
oto acoustic</w>
7 8.
8 5.
sub sided</w>
bo ars</w>
IC ER</w>
hypoc ot
trifluoro methyl</w>
D Z</w>
Th omas</w>
he ading</w>
3 5.6</w>
yr idine</w>
diver sified</w>
P au
ur in</w>
ble eds</w>
ra xia</w>
r icular</w>
on ization</w>
hydrox yt
So y
Apl ysia</w>
CH 1</w>
Inhib iting</w>
f l</w>
t ling</w>
acros omal</w>
D APT</w>
B PV</w>
CR M</w>
brac ket</w>
lymphaden itis</w>
ir regularities</w>
T omat
EV D</w>
poli omyelitis</w>
d les</w>
proc alc
differenti ates</w>
employ er</w>
fabr icating</w>
de mineralized</w>
DM H</w>
IT D</w>
P BM</w>
2, 5
Sh an
LR RK2</w>
Ret ur
physio therapists</w>
T CF
pre transplant</w>
pu pae</w>
Bi variate</w>
general ist</w>
a R</w>
4 13</w>
hypo albumin
inter conversion</w>
nu trac
HM B</w>
Am ni
resuscit ated</w>
cyto kinin</w>
Fe 3O4</w>
2. 34</w>
stre aming</w>
DL PFC</w>
glum ine</w>
N m</w>
arth ralgia</w>
6, 6</w>
H Z</w>
t 3</w>
s ICAM</w>
Endome tri
am icin</w>
Innov ative</w>
k ings</w>
Graph ical</w>
f ers</w>
I ST</w>
aut otrophic</w>
myel ography</w>
CP G</w>
Arti cle</w>
H im
G HR</w>
sol ani</w>
conveni ently</w>
M s
N Rs</w>
re vascularisation</w>
2. 20</w>
Organis ation</w>
diop ters</w>
PR IM
tric arboxylic</w>
ML ST</w>
Mar ker</w>
replic on</w>
or able</w>
trans aminases</w>
aer odynamic</w>
ocaly x</w>
g allo
inoc erebellar</w>
s ap</w>
9 0.9</w>
sh ame</w>
maglob ulinemia</w>
F H
di substituted</w>
19 50s</w>
gli adin</w>
knowledge able</w>
con strain</w>
Lab eling</w>
patern ity</w>
obstruc tions</w>
spectrophot ometer</w>
F ab
CN R</w>
PV D</w>
straw berry</w>
S usp
- 6.
al utamide</w>
4 8.5</w>
con specific</w>
2. 29</w>
depar ture</w>
in visible</w>
tow ns</w>
ord inarily</w>
crystallo id</w>
encycl idine</w>
D CR</w>
PH N</w>
amni onitis</w>
pill ars</w>
Z 1</w>
thalam ocortical</w>
hypog onad
en i
guan ylyl</w>
P ter
R oss</w>
Y am
pre eclamptic</w>
LI M</w>
magne tically</w>
aqu ifer</w>
gon orrhea</w>
Direc ted</w>
u y
ash i</w>
Foll icular</w>
is etron</w>
mis c
de amination</w>
hom o</w>
SO L</w>
fire arm</w>
ME Cs</w>
wat ching</w>
Il lin
ble b</w>
legitim ate</w>
af ine</w>
multi gene</w>
P2 Y
All erg
d ment</w>
ith ec
2 3,
s intering</w>
consol idated</w>
dec lar
micro U</w>
war dly</w>
sack iev
tri azine</w>
ub stituted</w>
her petic</w>
gest ures</w>
hex achloro
Com pression</w>
aren sis</w>
dys arth
prost anoid</w>
2. 32</w>
muc ociliary</w>
interfer ometer</w>
rein forces</w>
Copenh agen</w>
B us
nin eteen</w>
sp ace
interpre table</w>
Del ay</w>
8 9.
H TA</w>
di l</w>
op os
tri acylglycerols</w>
Re ad
ine es</w>
ef in</w>
hyperprolactin emia</w>
my otomy</w>
multin omial</w>
u ating</w>
my algia</w>
re assor
De ter
HI S</w>
xyl itol</w>
echinoc occosis</w>
benz aldehyde</w>
GAB AB</w>
exer tional</w>
CCR 2</w>
H emis
Challeng e</w>
B LA</w>
organ oids</w>
hn RNP</w>
rec tification</w>
AP TT</w>
ses sile</w>
cos m
Pot ent</w>
O .
cogni tions</w>
Bart onella</w>
dysmen orrhea</w>
lin ess</w>
pul pal</w>
B PS</w>
inter relationship</w>
degrad ative</w>
CV I</w>
DHE AS</w>
pl ase</w>
ne ostigmine</w>
usp irone</w>
Zn S</w>
NF kappaB</w>
.00 8</w>
myo fibroblast</w>
r yl</w>
min ers</w>
pede strian</w>
cockro ach</w>
silk worm</w>
P 50</w>
3 3.8</w>
2. 36</w>
IFN gamma</w>
check points</w>
cyclin s</w>
G 3
3 0.1</w>
Bi as</w>
reproduc ing</w>
ferro electric</w>
at ement</w>
arch ing</w>
proxim ate</w>
Ge ographic</w>
lo x</w>
mid life</w>
LO C</w>
refin ing</w>
Fig ure</w>
keton uria</w>
M PT</w>
cen sored</w>
EB M</w>
BA X</w>
Integr ative</w>
C y</w>
sub chronic</w>
Co ast</w>
ostom ia</w>
D V
M other</w>
N DI</w>
in appropriately</w>
calcane us</w>
lever age</w>
Stan ford</w>
4 27</w>
b ad
di lat
CD 163</w>
biore actors</w>
L ich
K LH</w>
K ip1</w>
aut ografts</w>
AM 1</w>
histi ocytoma</w>
Nucle ic</w>
clean sing</w>
Illin ois</w>
O Me</w>
Del hi</w>
Retro grade</w>
as u</w>
200 ,000</w>
n A</w>
0.0 40</w>
tax in</w>
Bar cel
UV R</w>
dis organized</w>
anti virals</w>
centr ality</w>
biop terin</w>
fene stration</w>
 mol</w>
ou re
iz ona</w>
slow s</w>
tetrahydro cannabinol</w>
i sia</w>
W N</w>
direc tor</w>
ophthal mos</w>
ation ale</w>
3 d</w>
J ane
flu ent</w>
omyel ia</w>
synthet ases</w>
ER AS</w>
aden os
CD11 c</w>
RE F</w>
sol idi
punc h</w>
hem i</w>
pul ling</w>
Nic kel</w>
R ace</w>
B an
con vic
constric ted</w>
procalc itonin</w>
pro pulsion</w>
aden ed</w>
Gluc agon</w>
A ni
4 36</w>
un myelinated</w>
AR V</w>
MO G</w>
A 11</w>
L Ps</w>
bis ulfite</w>
catarrh alis</w>
Refer ral</w>
D URE</w>
Pen insula</w>
3 5.4</w>
S100 B</w>
cement less</w>
splic e
3 8.2</w>
h unting</w>
psych ophysiological</w>
Candi date</w>
eIF 4E</w>
h atch</w>
af e
sen d</w>
investig ative</w>
domin ates</w>
circ RNA</w>
Chrom at
ME s</w>
Man dibular</w>
ogr am
8 6.
l iraglutide</w>
F G
et e
ton ometry</w>
hin ders</w>
GST P1</w>
privileg ed</w>
gluc o
AP O</w>
Sy n</w>
Bur n</w>
HS Ps</w>
ych nine</w>
accred ited</w>
O ther
ost osis</w>
Resi dent</w>
PROCE DURE</w>
aerosol ized</w>
ultras ensitive</w>
DI P</w>
T DM</w>
ME K1</w>
aminolev ulinic</w>
met aphyseal</w>
Cir cum
multis ite</w>
AV S</w>
PW ID</w>
intran asally</w>
agrel or</w>
EB NA</w>
Ol factory</w>
tetram ers</w>
phosphoc reatine</w>
-- an</w>
panc ytopenia</w>
fl ush</w>
Immuno deficiency</w>
muscul us</w>
s aff
FGF 2</w>
Clos ed</w>
Osc ill
D J</w>
Hyper tensive</w>
P reservation</w>
ediatr icians</w>
on orgestrel</w>
ol ism</w>
con tention</w>
Gib bs</w>
equ als</w>
down loaded</w>
r igh
wave guides</w>
tap ering</w>
C ranial</w>
D Y</w>
ox adi
Hem odialysis</w>
g a</w>
th onous</w>
ot i</w>
Fr actional</w>
4 94</w>
tra de
Gl ass</w>
deoxyn ucleotide</w>
c f</w>
bios ensing</w>
group ings</w>
til ting</w>
aver nous</w>
o atrial</w>
M PR</w>
u ge</w>
minim a</w>
gu ardi
Ad diction</w>
ion otropic</w>
down regulate</w>
un ks</w>
mit oses</w>
phil ia</w>
UPD RS</w>
w ide
ag ran
pip iens</w>
BLA ST</w>
3 6.3</w>
3 0.9</w>
phor ia</w>
n ity</w>
k Vp</w>
AR D</w>
PAN SS</w>
oper s</w>
D HP</w>
op a</w>
proxim ally</w>
In come</w>
photo induced</w>
p ear
cas ei</w>
ginsen oside</w>
Acqu isition</w>
enter itidis</w>
hemodi lution</w>
2 h</w>
6 6.6</w>
protec tant</w>
gp 130</w>
TA E</w>
amin ophen
bir ch</w>
hedr a</w>
conson ant</w>
e ful</w>
es eed</w>
M us</w>
B Cs</w>
trop ics</w>
E DA</w>
vul v
DM SA</w>
therm ogra
4 2.3</w>
cinere a</w>
tis ing</w>
Sy novial</w>
sub lines</w>
antagon izes</w>
dystroph ies</w>
O lym
ari piprazole</w>
phyt on</w>
trochan ter</w>
in mates</w>
az i</w>
Var ic
anteced ents</w>
Bam HI</w>
de differentiation</w>
im potence</w>
NH E</w>
Cor rig
4 98</w>
vari eg
CN TF</w>
DMAR Ds</w>
ox an</w>
3 8.3</w>
hem ocytes</w>
Hist ochemical</w>
cis -</w>
Mel bourne</w>
aph osph
r t
comm issure</w>
perme ant</w>
Cros s
Lan gen
W ater
row n</w>
D n
ylo sis</w>
dead ly</w>
C GM</w>
3 4.7</w>
3 6.1</w>
N VP</w>
pol ished</w>
fl ec
cef oxitin</w>
hydroly zing</w>
Sem en</w>
4 41</w>
prud ent</w>
9 9.9</w>
in su
con ate</w>
tend inopathy</w>
Pap illary</w>
Ex clud
al ogs</w>
oc tapeptide</w>
all yl
osens or</w>
Men i
vir ally</w>
domin ating</w>
17 F</w>
preg abalin</w>
Erro r</w>
3 4.1</w>
immun ogen</w>
pyr imethamine</w>
dy ad</w>
pass enger</w>
duc t
ir idium</w>
gradu ated</w>
symbi ont</w>
Mong olian</w>
cem entum</w>
A mi
ic ities</w>
0. 1
ax ially</w>
competi tors</w>
did actic</w>
dy adic</w>
hat ched</w>
end om
Micro wave</w>
Ep it
sympath o
ni er</w>
6 7.
en ate</w>
orth o
Eg r</w>
cab bage</w>
idi xic</w>
sumat riptan</w>
f sky</w>
S AL</w>
m at</w>
tri plex</w>
Sup er</w>
call osal</w>
Eng agement</w>
LDL T</w>
E din
st an
Def ense</w>
adipo kines</w>
ethn ographic</w>
201 Tl</w>
mean while</w>
tor so</w>
ob ular</w>
galac topyran
3 8.6</w>
O G
Rab bits</w>
N R1</w>
omat oid</w>
aver tebral</w>
orth od
Barcel ona</w>
ang es</w>
repor ters</w>
RE ST</w>
uro th
her it
Soci o</w>
energ etically</w>
Ach ieving</w>
G K
SU MO
plic ated</w>
diap ause</w>
j ac
corp uscular</w>
sub divisions</w>
deterior ate</w>
Work shop</w>
non users</w>
lig ases</w>
rever tants</w>
AJ CC</w>
3 alpha</w>
D KA</w>
pe eling</w>
-0. 6</w>
mast ery</w>
berg hei</w>
oc alin</w>
reduc tases</w>
d as
B TV</w>
te ens</w>
par alytic</w>
bas ins</w>
deb ates</w>
myelo ablative</w>
re membered</w>
Dys regulation</w>
E motion</w>
ll a</w>
sulfonyl urea</w>
T ree</w>
with standing</w>
ton sil
Dist ance</w>
promastig otes</w>
a ul
3 8.1</w>
EB US</w>
pass aged</w>
lib er
gen cies</w>
bro adened</w>
adap ter</w>
hepat omegaly</w>
idi osis</w>
alk yne</w>
ethyl en
LE P</w>
Byp ass</w>
y on</w>
oin d
Sil ica</w>
preclud es</w>
sweet ened</w>
p ud
so aked</w>
3 5.2</w>
modul i</w>
doub tful</w>
P er</w>
cl age</w>
co conut</w>
trans arterial</w>
IN F</w>
Si C</w>
27 ,
D ukes</w>
ib us</w>
P Q
V P2</w>
- 17</w>
mic utes</w>
AC EI</w>
ax illa</w>
oct anol</w>
Ay urve
ic om
ys ine</w>
N ON
ru brum</w>
dex ter
7 6.
DQ A1</w>
intestin alis</w>
Other wise</w>
n ilo
met as
hus bands</w>
on i</w>
methyl transferases</w>
devi ated</w>
R if
F AI</w>
ass e</w>
depl ete</w>
Incorpor ating</w>
H PMC</w>
en nium</w>
Acet ylcholine</w>
G OS</w>
micro meters</w>
rhe ic</w>
TL S</w>
Fri end</w>
oligo deoxynucleotides</w>
bombar dment</w>
B CAA</w>
Con trac
Pol yp
scre enings</w>
adel ta</w>
soci alization</w>
Wat son</w>
Hawai i</w>
crib ing</w>
CS R</w>
N t
infra renal</w>
domes tication</w>
cyano acrylate</w>
inadver tent</w>
reven ue</w>
Chil ean</w>
H il
mechanis tically</w>
tel es
PH I</w>
LC 50</w>
on amide</w>
Un treated</w>
phag ocyte</w>
AZ A</w>
unil amellar</w>
Ex plo
biom icro
Imp ul
prognos tication</w>
t Hcy</w>
b id</w>
nucle ob
U MP</w>
pos us</w>
RE R</w>
flic ker</w>
per su
dis counting</w>
path ogn
radi ations</w>
eth oxy</w>
polyp ectomy</w>
pred atory</w>
interview er</w>
P CDD</w>
ul arity</w>
de marc
tw enti
spr uce</w>
P ort</w>
V AC</w>
F ort</w>
sal am
hepati ca</w>
don ating</w>
gli oblastomas</w>
D DR</w>
contrac ts</w>
manuscrip ts</w>
W ES</w>
BM P2</w>
Micro vascular</w>
pros th
pseudot umor</w>
or ia</w>
intra arterial</w>
stilb ene</w>
Injec tions</w>
tic ola</w>
compl ementing</w>
rop ia</w>
DI A</w>
sub specialty</w>
ed itorial</w>
2. 56</w>
Phy toph
Inc ident</w>
AT F</w>
opo res</w>
Sol itary</w>
ulcer ations</w>
L SG</w>
bro od</w>
Plac ement</w>
Erb B</w>
Xanth omonas</w>
ven o</w>
FN AB</w>
7 R</w>
- D</w>
cont empl
Con ditional</w>
profil ed</w>
Com pan
dic tate</w>
but amide</w>
Mll erian</w>
em et</w>
sub capsular</w>
basoph il</w>
transcriptom ics</w>
n exin</w>
B un
0 -</w>
SU S</w>
DE R</w>
ogra fted</w>
Perman ent</w>
Hem ip
ped unc
R el</w>
vec uronium</w>
Electr ic</w>
isobut yl</w>
tri ol</w>
cos mid</w>
clean ed</w>
CD K2</w>
Myo D</w>
8 000</w>
me glumine</w>
poly omavirus</w>
s g
VI A</w>
NF AT
V KA</w>
Altern aria</w>
Lu te
Jane iro</w>
m are</w>
HE MA</w>
BA Y</w>
M SD</w>
Tam oxifen</w>
A SCT</w>
P RT</w>
C over
Th ic
desc end
Stock holm</w>
c aged</w>
tripl ets</w>
pine al
endomy ocardial</w>
7 S</w>
form ulating</w>
PL C
w ishes</w>
trac tography</w>
so oner</w>
squ id</w>
3 3.6</w>
ps or
Scor ing</w>
mo ist</w>
har dening</w>
eicos anoid</w>
retr o</w>
vign ettes</w>
rec umb
cloac ae</w>
E LF</w>
en berg</w>
is ocyanate</w>
evalu ative</w>
Cal ibration</w>
radic ally</w>
Apop totic</w>
co aches</w>
fac i
bo o</w>
ge ological</w>
glob ule</w>
glob ulins</w>
MT CT</w>
parasit oid</w>
T ail
actin ic</w>
Relap se</w>
bio equivalence</w>
osom y</w>
R n</w>
V CR</w>
blo ody</w>
bio electrical</w>
gradu ation</w>
discer n</w>
o a</w>
PT U</w>
uti lities</w>
8 15</w>
Cor respon
mobil isation</w>
2. 30</w>
construc tive</w>
aggra vate</w>
Gene tically</w>
sialy l</w>
Edin burgh</w>
P SE</w>
S mal
W MH</w>
Aff ective</w>
fis cal</w>
thoraco abdominal</w>
fun nel</w>
6 9.
renz epine</w>
7 80</w>
5 7.5</w>
stri ke</w>
H u</w>
4 49</w>
oc eptive</w>
L 929</w>
3 8.8</w>
4 44</w>
Dep osition</w>
hand held</w>
reflec tivity</w>
V ein</w>
ib ustion</w>
equ ality</w>
arc tica</w>
E ud
3 8.7</w>
ad ness</w>
ru vate</w>
byp asses</w>
Barri er</w>
5 58</w>
hydro lysed</w>
guide wire</w>
direc tives</w>
atom istic</w>
M oz
osup pressive</w>
un fortunately</w>
poly protein</w>
Phytoph thora</w>
ac ade
certific ate</w>
P 22</w>
o plasm</w>
4 3.3</w>
at ose</w>
phenomen ology</w>
CV R</w>
Lati nos</w>
3 5.8</w>
F HR</w>
anthrop ometry</w>
L W</w>
te icoplanin</w>
3. 25</w>
iontoph oresis</w>
I BM
ann ulation</w>
bed time</w>
cryptorch idism</w>
P atch</w>
un responsiveness</w>
id yl</w>
PF OA</w>
crani opharyngi
Con cept</w>
PC NL</w>
arthro graphy</w>
hypop ituitarism</w>
RA I</w>
k iss</w>
am eric</w>
Re fractory</w>
caffe ic</w>
medro xyprogesterone</w>
D 7</w>
ac lop
b p
ent als</w>
dynam in</w>
Radi ographs</w>
4 52</w>
Am B</w>
es tic</w>
din o
aliqu ots</w>
fill ers</w>
E ts</w>
organ otypic</w>
Fir micutes</w>
enanti oselectivity</w>
Moun tain</w>
epigene tics</w>
G W</w>
C at</w>
im poses</w>
me sis</w>
Pap ill
ct DNA</w>
B6 C3
tran examic</w>
ech ogenic</w>
nucle ases</w>
10. 10
depic ting</w>
H 9</w>
4 53</w>
pre adipocytes</w>
bronch oscopic</w>
thromb omodulin</w>
analy ser</w>
ST AR</w>
osi der
D AP
fer ulic</w>
haem ostasis</w>
Sp O2</w>
sphing omyel
cinnam ic</w>
G S
S ac
3 4.9</w>
Ad 5</w>
G 5</w>
3 1.9</w>
neur on
H3 T3</w>
od one</w>
ta e</w>
poly phenolic</w>
na ev
PON V</w>
stilb estrol</w>
E TB</w>
ro idal</w>
anti -</w>
st ren
H2 B</w>
hypol ip
aclop rid</w>
P 1
symp atric</w>
perit umoral</w>
Cen sus</w>
encomp assed</w>
19 63</w>
multi sensory</w>
contag ious</w>
i. t.</w>
70 5</w>
dech lor
Parathyro id</w>
B FU</w>
lob ules</w>
Rec ipients</w>
tel encephalon</w>
4 45</w>
ac ry
he donia</w>
clim ates</w>
SV T</w>
ec ologists</w>
inf lo
MD T</w>
H3K 27
c rom
R TA</w>
Ac cred
IVI g</w>
Ot ta
Tomat o</w>
t ell
at i</w>
i ro
p 73</w>
oste ocytes</w>
60 8</w>
di ps
applic ator</w>
arsen ess</w>
phosphoryl ating</w>
M Z
CA E</w>
intenti onally</w>
Tak ay
S tern
F ist
ou in</w>
AI C</w>
Prote ase</w>
w ife</w>
magne tite</w>
C ow
col leges</w>
capac itation</w>
MD C</w>
crow ded</w>
House hold</w>
C 30</w>
di atom</w>
CO C</w>
Sou thwest</w>
pep sinogen</w>
postin jury</w>
Clinic opathological</w>
m util
5 R</w>
per itone
feno fibrate</w>
V .
T SP
cer cari
suff erers</w>
un married</w>
IT O</w>
Gv HD</w>
3 6.2</w>
in gence</w>
yl methyl</w>
DB H</w>
trimethyl ammonium</w>
fall en</w>
t ment</w>
lact ulose</w>
P PO</w>
non etheless</w>
60 7</w>
k go</w>
lor azepam</w>
top iramate</w>
TE N</w>
Transcrip ts</w>
Coron avirus</w>
dis odium</w>
Sy k</w>
With draw
ar m
ev an
Decre ases</w>
convuls ant</w>
n ad
H II
4 6.5</w>
E TT</w>
Dis rup
Fr action
8 7.
sec ular</w>
vag ue</w>
Kar no
B inary</w>
st achian</w>
ograph ers</w>
wee ds</w>
Trich inella</w>
K or
tra ver
fung icides</w>
proce eding</w>
v 2</w>
ozo ite</w>
o G</w>
p recor
sp p.</w>
quanti fies</w>
Pak ist
schizo affective</w>
T NT</w>
inter layer</w>
pat ents</w>
ro su
ere sis</w>
Det ails</w>
mangro ve</w>
al fentanil</w>
ac arb
Edi tion</w>
maxim ized</w>
CB C</w>
phospho fructokinase</w>
cul tur
sho es</w>
pain t</w>
pu romycin</w>
gastroenter ology</w>
Td T</w>
terpen es</w>
anec dotal</w>
pur posive</w>
pow dered</w>
hos tile</w>
Bomb yx</w>
I kappaB</w>
O TUs</w>
R PMI</w>
echocardi ograms</w>
ifi ers</w>
4 2.8</w>
ol u
ep izo
conjug ative</w>
at em
fluor imetric</w>
lich en
C erebellar</w>
4 26</w>
2. 37</w>
phen othi
bas ophilic</w>
melan ocortin</w>
Fr action</w>
NI H3T3</w>
3 5.1</w>
In ner</w>
Lin k</w>
Foc using</w>
4 7.6</w>
harb our</w>
in competent</w>
ph orin</w>
atten tive</w>
MM P2</w>
zol ed
K 12</w>
pseud ocyst</w>
ont ological</w>
Ra w</w>
short ages</w>
odor sal</w>
Prol actin</w>
ne st
fer ret</w>
oly tically</w>
Multi modal</w>
occup ies</w>
septic aemia</w>
re juven
ex quis
S HRs</w>
vis tic</w>
nitro phenol</w>
M CR</w>
sporozo ites</w>
E uk
O swe
por tin</w>
Ch olec
TA Z</w>
dac ry
ot ella</w>
hyper pigmentation</w>
immunob lots</w>
2. 54</w>
transp orts</w>
electro kinetic</w>
gam ete</w>
Or der</w>
Wor d</w>
Otta wa</w>
bi ose</w>
Dor sal</w>
accent uated</w>
GP IIb</w>
7 5.
pre biotic</w>
let o
C ognition</w>
6 4.3</w>
R AB
oph yt
Smar t</w>
R ich</w>
erg on
Tr ace</w>
o sim
di et
og los
gras tim</w>
F DC</w>
al tru
de mineralization</w>
am ation</w>
em ail</w>
AR I
draw back</w>
V ital</w>
ra rer</w>
SGL T2</w>
peristal sis</w>
S arcoma</w>
rh GH</w>
FGF 21</w>
mag ic</w>
HC B</w>
Met allo
defibrill ators</w>
Conserv ation</w>
zyg otes</w>
6 9.2</w>
q 24</w>
leng thened</w>
DE C</w>
Heterogene ous</w>
obstetr icians</w>
amoeb ae</w>
v owels</w>
lo fen
3, 2</w>
illu stration</w>
ka empferol</w>
dap sone</w>
arcis sis
t ardive</w>
app raise</w>
floc cul
Retin opathy</w>
rosu vastatin</w>
i pr
gl omus</w>
pig let</w>
IR B</w>
hypophy sectomized</w>
n esting</w>
L CAT</w>
CH L</w>
AS R</w>
othrom bo
restitu tion</w>
al ensis</w>
Ab und
res ort</w>
sh re
LG N</w>
pyrethro id</w>
ag asc
2. 65</w>
fur an
gar den</w>
sporozo ite</w>
com yc
mat s</w>
2. 43</w>
foc ally</w>
innerv ate</w>
drow ning</w>
U W</w>
fluo rosis</w>
meta plastic</w>
leuko plakia</w>
B ang
Diagnos tics</w>
hir udin</w>
v ores</w>
Gen omics</w>
fluoro genic</w>
Morph ologic</w>
P ath</w>
or mycosis</w>
Bi ob
phal anx</w>
butter fly</w>
A HP</w>
4 2.1</w>
T PR</w>
or ations</w>
or he
pl anted</w>
met ap
kerat ectomy</w>
Influ ences</w>
3 9.1</w>
end osome</w>
fem urs</w>
hel pl
thre e-</w>
C ancers</w>
3 7.2</w>
em ens</w>
compo unded</w>
olip ase</w>
f A</w>
L id
G DF
resc ues</w>
icul aris</w>
top otecan</w>
Oc clusion</w>
squ at</w>
telem etry</w>
C ru
os erine</w>
MR M</w>
hetero trimeric</w>
3, 6</w>
sou thwest</w>
leth arg
HI PEC</w>
tetra ethylammonium</w>
ag nes
DAS 28</w>
Karno fsky</w>
re efs</w>
os econd</w>
parame ter
ran s</w>
amper ometric</w>
flud arabine</w>
ph asing</w>
chemo prophylaxis</w>
Gro EL</w>
cercari ae</w>
60 ,000</w>
TM V</w>
Oswe stry</w>
s anc
introg ression</w>
Athl etes</w>
vi als</w>
Neur o</w>
Ple ural</w>
Suppor ting</w>
penc il</w>
7 74</w>
S ound</w>
th ens</w>
methyl enedi
s otalol</w>
o ogenesis</w>
T AT
ur ines</w>
commun icated</w>
Fibro blasts</w>
4 39</w>
spir alis</w>
estu ary</w>
Dissem inated</w>
Bi os
MV P</w>
f issures</w>
o plast</w>
5 6.5</w>
Di els</w>
3 9.3</w>
di acetate</w>
troph ozoites</w>
PGF 2alpha</w>
F av
en venom
di lator</w>
ver atr
off line</w>
attrib utions</w>
